sampleID	CDE_ID_3226963	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_PANCAN	_PANCAN_DNAMethyl_UCEC	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_UCEC	_PANCAN_mutation_PANCAN	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_treatment_completion_success_outcome	age_at_initial_pathologic_diagnosis	aln_pos_ihc	aln_pos_light_micro	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	birth_control_pill_history_usage_category	clinical_stage	colorectal_cancer	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	diabetes	disease_code	followup_case_report_form_submission_reason	form_completion_date	gender	height	histological_type	history_of_neoadjuvant_treatment	horm_ther	hypertension	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lost_follow_up	menopause_status	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	oct_embedded	other_dx	pathology_report_file_name	patient_id	pct_tumor_invasion	peritoneal_wash	person_neoplasm_cancer_status	pln_pos_ihc	pln_pos_light_micro	postoperative_rx_tx	pregnancies	primary_therapy_outcome_success	prior_tamoxifen_administered_usage_category	project_code	radiation_therapy	recurrence_second_surgery_neoplasm_surgical_procedure_name	recurrence_second_surgery_neoplasm_surgical_procedure_name_other	residual_disease_post_new_tumor_event_margin_status	residual_tumor	sample_type	sample_type_id	surgical_approach	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	total_aor_lnp	total_aor_lnr	total_pelv_lnp	total_pelv_lnr	tumor_tissue_site	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_data/public/TCGA/UCEC/miRNA_GA_gene	_GENOMIC_ID_TCGA_UCEC_PDMRNAseq	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_UCEC_RPPA_RBN	_GENOMIC_ID_TCGA_UCEC_RPPA	_GENOMIC_ID_TCGA_UCEC_PDMarrayCNV	_GENOMIC_ID_TCGA_UCEC_miRNA_GA	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_UCEC_mutation_broad_gene	_GENOMIC_ID_TCGA_UCEC_mutation_wustl_gene	_GENOMIC_ID_TCGA_UCEC_mutation	_GENOMIC_ID_TCGA_UCEC_exp_HiSeqV2	_GENOMIC_ID_TCGA_UCEC_PDMarray	_GENOMIC_ID_TCGA_UCEC_miRNA_HiSeq	_GENOMIC_ID_TCGA_UCEC_exp_GAV2	_GENOMIC_ID_TCGA_UCEC_gistic2thd	_GENOMIC_ID_TCGA_UCEC_G4502A_07_3	_GENOMIC_ID_TCGA_UCEC_gistic2	_GENOMIC_ID_data/public/TCGA/UCEC/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_UCEC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_UCEC_hMethyl450	_GENOMIC_ID_TCGA_UCEC_hMethyl27	_GENOMIC_ID_TCGA_UCEC_exp_GAV2_exon
TCGA-2E-A9G8-01	Indeterminate	0	TCGA-2E-A9G8-01	1249	0	days										TCGA-2E-A9G8	396	1	days	1249	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES		Partial Response	59	0	0	TCGA-2E-A9G8-F66642	TCGA-2E-A9G8	TCGA-2E-A9G8-01A	Never Used	Stage III	NO			957		0	1249			396	NO			2014-10-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.3	8380/3	C54.3	YES		Office Endometrial Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	port site		YES	false	Yes	TCGA-2E-A9G8.921E6140-A03E-4FBD-9FB8-554AE96FD16C.pdf	A9G8	280		TUMOR FREE	0	0	YES	2	Progressive Disease	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	2E	0	9	0	19	Endometrial	A	LIVING	71	2011	8e9f2a41-dddc-4761-8883-ca58f5934d5f		TCGA-2E-A9G8-01	8e9f2a41-dddc-4761-8883-ca58f5934d5f					8e9f2a41-dddc-4761-8883-ca58f5934d5f				8e9f2a41-dddc-4761-8883-ca58f5934d5f		TCGA-2E-A9G8-01		TCGA-2E-A9G8-01A-11D-A402-01		TCGA-2E-A9G8-01A-11D-A402-01	TCGA-2E-A9G8-01	TCGA-2E-A9G8-01	TCGA-2E-A9G8-01A-11D-A409-05		
TCGA-4E-A92E-01	MSS	0	TCGA-4E-A92E-01	13	0	days										TCGA-4E-A92E	13	0	days	13	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54	0	0	TCGA-4E-A92E-F69233	TCGA-4E-A92E	TCGA-4E-A92E-01A	Never Used	Stage I	NO		-19818	90		0	13				NO			2014-12-30	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	140	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-4E-A92E.BC43D6CA-235C-4217-BF72-F33B089C532B.pdf	A92E		negative	TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		YES	NO	4E	0	2	0	4	Endometrial	A	LIVING	76	2013	87087b2e-a589-4a75-a005-2c61cb44b414		TCGA-4E-A92E-01	87087b2e-a589-4a75-a005-2c61cb44b414		9117161E-9271-495E-BC8F-26EBC10D661B			87087b2e-a589-4a75-a005-2c61cb44b414				87087b2e-a589-4a75-a005-2c61cb44b414		TCGA-4E-A92E-01		TCGA-4E-A92E-01A-11D-A37M-01		TCGA-4E-A92E-01A-11D-A37M-01	TCGA-4E-A92E-01	TCGA-4E-A92E-01	TCGA-4E-A92E-01A-11D-A37Q-05		
TCGA-5B-A90C-01	MSS	0	TCGA-5B-A90C-01	1202	0	days										TCGA-5B-A90C	517	1	days	1202	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Complete Response	69			TCGA-5B-A90C-F69362	TCGA-5B-A90C	TCGA-5B-A90C-01A		Stage IA	NO		-25518	811		0	1202		517	517	NO			2015-1-7	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	right pelvic mass	YES	YES	false	No	TCGA-5B-A90C.608E2698-6A3A-4673-89D2-3BE98A74EBE5.pdf	A90C			TUMOR FREE		0	NO	2				YES	Excisional Biopsy				Primary Tumor	01	Minimally Invasive	2009		NO	YES	5B			0	42	Endometrial	A	LIVING	98	2011	4a299385-e7a5-4a82-940b-ff6e36c596c2		TCGA-5B-A90C-01	4a299385-e7a5-4a82-940b-ff6e36c596c2					4a299385-e7a5-4a82-940b-ff6e36c596c2				4a299385-e7a5-4a82-940b-ff6e36c596c2		TCGA-5B-A90C-01		TCGA-5B-A90C-01A-11D-A37M-01		TCGA-5B-A90C-01A-11D-A37M-01	TCGA-5B-A90C-01	TCGA-5B-A90C-01	TCGA-5B-A90C-01A-11D-A37Q-05		
TCGA-5S-A9Q8-01	MSS	0	TCGA-5S-A9Q8-01	313	0	days										TCGA-5S-A9Q8	313	0	days	313	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					51			TCGA-5S-A9Q8-F64486	TCGA-5S-A9Q8	TCGA-5S-A9Q8-01A		Stage IIIA	NO		-18785	103		0	313				YES			2014-9-4	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	690	NO	NO		G2					NO	true	No	TCGA-5S-A9Q8.3F89A501-BE16-4E08-9846-41B4BBDDFCF9.pdf	A9Q8	50			0	0	YES	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	5S		0	0	5	Endometrial	A	LIVING	86	2013	5eb217b7-bf79-475d-8476-a66670ad9ed2		TCGA-5S-A9Q8-01	5eb217b7-bf79-475d-8476-a66670ad9ed2		BABFB88E-883C-4766-BBBA-9EE3781212F0			5eb217b7-bf79-475d-8476-a66670ad9ed2				5eb217b7-bf79-475d-8476-a66670ad9ed2		TCGA-5S-A9Q8-01		TCGA-5S-A9Q8-01A-11D-A402-01		TCGA-5S-A9Q8-01A-11D-A402-01	TCGA-5S-A9Q8-01	TCGA-5S-A9Q8-01	TCGA-5S-A9Q8-01A-11D-A409-05		
TCGA-A5-A0G1-01	MSI-H	1	TCGA-A5-A0G1-01	3251	1	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2		TCGA-A5-A0G1			days	3251	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67	0	0	TCGA-A5-A0G1-F5839	TCGA-A5-A0G1	TCGA-A5-A0G1-01A	Former User	Stage IA	NO		-24477	5015	3251	0					NO			2011-1-7	FEMALE	168	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-A5-A0G1.A2EB7E85-E836-462E-ABBA-65D5110CEB1C.pdf	A0G1	10		TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	4	0	10	Endometrial	A	DECEASED	59	1996			TCGA-A5-A0G1-01		TCGA-A5-A0G1-01A-21-A162-20	CD92C224-42A7-4CC0-BBEF-FE688BE73F3E									TCGA-A5-A0G1-01	c4bc1759-7de2-427c-a936-431f343ea929	TCGA-A5-A0G1-01A-11D-A120-01		TCGA-A5-A0G1-01A-11D-A120-01	TCGA-A5-A0G1-01	TCGA-A5-A0G1-01	TCGA-A5-A0G1-01A-11D-A123-05		c4bc1759-7de2-427c-a936-431f343ea929
TCGA-A5-A0G2-01	MSI-L	0	TCGA-A5-A0G2-01	4549	0	days	GBM	C6-UCEC	BRCA CIMP c7	cluster 1	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-A5-A0G2	4549	0	days	4549	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-A5-A0G2-F17136	TCGA-A5-A0G2	TCGA-A5-A0G2-01A	Never Used	Stage IIIB	NO		-20953	4825		0	4549	4144			NO		Scheduled Follow-up Submission	2011-11-3	FEMALE	152	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0G2.A3CD42AF-D356-415B-958D-D14D7AC52693.pdf	A0G2			WITH TUMOR	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	60	1997		TCGA-A5-A0G2-01	TCGA-A5-A0G2-01		TCGA-A5-A0G2-01A-21-A162-20	F1E8AA4E-0F31-4476-8BE4-4284B284CC3A	TCGA-A5-A0G2-01	TCGA-A5-A0G2-01						TCGA-A5-A0G2-01		4b998fee-a0c6-4039-824f-e5f43d5a3dbc	TCGA-A5-A0G2-01A-11D-A042-01	TCGA-A5-A0G2-01A-11R-A040-07	TCGA-A5-A0G2-01A-11D-A042-01		TCGA-A5-A0G2-01		TCGA-A5-A0G2-01A-11D-A039-05	4b998fee-a0c6-4039-824f-e5f43d5a3dbc
TCGA-A5-A0G3-01	MSS	0	TCGA-A5-A0G3-01	1428	0	days		C6-UCEC	UCEC Serous c4	cluster 3	KIRC-like c1	UCEC-like c11	miRNA cluster 15	cluster 2	mutation cluster 5	TCGA-A5-A0G3	1428	0	days	1428	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium		YES	NO	Progressive Disease	61	2	0	TCGA-A5-A0G3-F16785	TCGA-A5-A0G3	TCGA-A5-A0G3-01A	Former User	Stage IIIC2	NO		-22421	987		0	1428			795	NO		Additional New Tumor Event	2011-10-3	FEMALE	165	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0G3.66DEDB33-CA2C-4967-8074-1EFC1FC3CF29.pdf	A0G3	50		WITH TUMOR	2	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	A5	2	2	2	3	Endometrial	A	LIVING	64	2007		TCGA-A5-A0G3-01	TCGA-A5-A0G3-01		TCGA-A5-A0G3-01A-21-A162-20	86CC5EF9-0D7D-4187-8002-CC774C70EEB1		TCGA-A5-A0G3-01		TCGA-A5-A0G3-01A-11W-A062-09	TCGA-A5-A0G3-01A-11W-A062-09	TCGA-A5-A0G3-01A-11W-A062-09		TCGA-A5-A0G3-01		cf384574-5895-4708-b29c-6906de020406		TCGA-A5-A0G3-01A-11R-A040-07					TCGA-A5-A0G3-01A-11D-A039-05	cf384574-5895-4708-b29c-6906de020406
TCGA-A5-A0G5-01	MSI-L	0	TCGA-A5-A0G5-01	1126	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 2	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-A5-A0G5	1126	0	days	1126	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	0	TCGA-A5-A0G5-F17153	TCGA-A5-A0G5	TCGA-A5-A0G5-01A	Never Used	Stage IB	NO		-26827	856		0	1126				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8310/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0G5.C7C6ABB1-32EE-4D2B-898A-91A1F596EC53.pdf	A0G5		negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	9	0	21	Endometrial	A	LIVING	48	2008		TCGA-A5-A0G5-01	TCGA-A5-A0G5-01		TCGA-A5-A0G5-01A-21-A162-20	105C061D-B8CC-4224-BA49-BBB94112091E	TCGA-A5-A0G5-01	TCGA-A5-A0G5-01		TCGA-A5-A0G5-01A-11W-A062-09	TCGA-A5-A0G5-01A-11W-A062-09	TCGA-A5-A0G5-01A-11W-A062-09		TCGA-A5-A0G5-01		a7ed680c-2af2-47a1-846a-2169f7dd0971	TCGA-A5-A0G5-01A-11D-A042-01	TCGA-A5-A0G5-01A-11R-A040-07	TCGA-A5-A0G5-01A-11D-A042-01		TCGA-A5-A0G5-01		TCGA-A5-A0G5-01A-11D-A039-05	a7ed680c-2af2-47a1-846a-2169f7dd0971
TCGA-A5-A0G9-01	MSI-H	0	TCGA-A5-A0G9-01	2540	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0G9	2540	0	days	2540	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	79	0	0	TCGA-A5-A0G9-F17142	TCGA-A5-A0G9	TCGA-A5-A0G9-01A	Never Used	Stage IB	NO		-29122	2095		0	2540				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0G9.32FB682E-B73F-4525-A845-7F240F9F40CE.pdf	A0G9	70	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	7	Endometrial	A	LIVING	82	2004		TCGA-A5-A0G9-01	TCGA-A5-A0G9-01		TCGA-A5-A0G9-01A-21-A162-20	807AC87F-D82C-4F87-8014-4414E40D4A0B		TCGA-A5-A0G9-01		TCGA-A5-A0G9-01A-11W-A062-09	TCGA-A5-A0G9-01A-11W-A062-09	TCGA-A5-A0G9-01A-11W-A062-09				4575ca5e-968c-419d-9707-4e99d55dddb7	TCGA-A5-A0G9-01A-11D-A042-01		TCGA-A5-A0G9-01A-11D-A042-01		TCGA-A5-A0G9-01		TCGA-A5-A0G9-01A-11D-A039-05	4575ca5e-968c-419d-9707-4e99d55dddb7
TCGA-A5-A0GA-01	MSI-H	1	TCGA-A5-A0GA-01	543	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 1	TCGA-A5-A0GA			days	543	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67	0	3	TCGA-A5-A0GA-F3146	TCGA-A5-A0GA	TCGA-A5-A0GA-01A	Former User	Stage IIIC2	NO		-24659	1312	543	0					NO			2010-9-13	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-A5-A0GA.36A4F391-2F46-4896-8E53-223202E42A38.pdf	A0GA	46		WITH TUMOR	0	3		1	Partial Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		YES	NO	YES	A5	3	3	3	3	Endometrial	A	DECEASED	90	2006		TCGA-A5-A0GA-01	TCGA-A5-A0GA-01		TCGA-A5-A0GA-01A-21-A162-20	4FCEC56D-45CE-420A-868B-3726F1CC9347	TCGA-A5-A0GA-01	TCGA-A5-A0GA-01		TCGA-A5-A0GA-01A-11W-A062-09	TCGA-A5-A0GA-01A-11W-A062-09	TCGA-A5-A0GA-01A-11W-A062-09		TCGA-A5-A0GA-01		e2aee7fd-1c60-471a-931d-878805f4a443	TCGA-A5-A0GA-01A-11D-A042-01	TCGA-A5-A0GA-01A-11R-A040-07	TCGA-A5-A0GA-01A-11D-A042-01		TCGA-A5-A0GA-01		TCGA-A5-A0GA-01A-11D-A039-05	e2aee7fd-1c60-471a-931d-878805f4a443
TCGA-A5-A0GB-01	MSI-H	0	TCGA-A5-A0GB-01	997	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 11	TCGA-A5-A0GB	997	0	days	997	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65	0	0	TCGA-A5-A0GB-F17157	TCGA-A5-A0GB	TCGA-A5-A0GB-01A	Never Used	Stage IB	NO		-23883	583		0	997				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0GB.8AC80DBE-46DE-46D5-B900-C807CBE941A6.pdf	A0GB			TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	A5	0	10	0	5	Endometrial	A	LIVING	122	2008			TCGA-A5-A0GB-01		TCGA-A5-A0GB-01A-21-A162-20	3E2E3076-D429-48E0-8EB2-4021717BEDB3	TCGA-A5-A0GB-01			TCGA-A5-A0GB-01A-11W-A062-09	TCGA-A5-A0GB-01A-11W-A062-09	TCGA-A5-A0GB-01A-11W-A062-09		TCGA-A5-A0GB-01	TCGA-A5-A0GB-01	12960b87-9d83-41e5-8980-a1ebe955fd73	TCGA-A5-A0GB-01A-11D-A042-01	TCGA-A5-A0GB-01A-11R-A040-07	TCGA-A5-A0GB-01A-11D-A042-01	TCGA-A5-A0GB-01	TCGA-A5-A0GB-01		TCGA-A5-A0GB-01A-11D-A039-05	12960b87-9d83-41e5-8980-a1ebe955fd73
TCGA-A5-A0GD-01	MSI-H	1	TCGA-A5-A0GD-01	3423	1	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A5-A0GD	3423	0	days	3423	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75	0	0	TCGA-A5-A0GD-F17139	TCGA-A5-A0GD	TCGA-A5-A0GD-01A	Never Used	Stage IA	NO		-27399	4119	3423	0	98				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0GD.44561792-F2F8-42F7-B697-5D7752F8430E.pdf	A0GD		negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	3	0	9	Endometrial	A	DECEASED	74	1999		TCGA-A5-A0GD-01	TCGA-A5-A0GD-01		TCGA-A5-A0GD-01A-21-A162-20	F1A29822-A75F-46F5-ACAD-6A8C99D7B543		TCGA-A5-A0GD-01		TCGA-A5-A0GD-01A-11W-A062-09	TCGA-A5-A0GD-01A-11W-A062-09	TCGA-A5-A0GD-01A-11W-A062-09				7e36dab1-7cb0-42df-acfc-615f7c0bba2c	TCGA-A5-A0GD-01A-11D-A042-01		TCGA-A5-A0GD-01A-11D-A042-01		TCGA-A5-A0GD-01		TCGA-A5-A0GD-01A-11D-A039-05	7e36dab1-7cb0-42df-acfc-615f7c0bba2c
TCGA-A5-A0GE-01	MSS	0	TCGA-A5-A0GE-01	3205	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 14	TCGA-A5-A0GE	3205	0	days	3205	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	38	0	0	TCGA-A5-A0GE-F17140	TCGA-A5-A0GE	TCGA-A5-A0GE-01A	Never Used	Stage IA	NO		-14170	2941		0	3205				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	No	TCGA-A5-A0GE.7686A445-554F-43EF-BE79-6EA5E5C4DB21.pdf	A0GE			TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	3	Endometrial	A	LIVING	57	2002		TCGA-A5-A0GE-01	TCGA-A5-A0GE-01		TCGA-A5-A0GE-01A-21-A162-20	CFFA7BD4-5310-4035-8ADA-943D90FC2344	TCGA-A5-A0GE-01	TCGA-A5-A0GE-01		TCGA-A5-A0GE-01A-11W-A062-09	TCGA-A5-A0GE-01A-11W-A062-09	TCGA-A5-A0GE-01A-11W-A062-09		TCGA-A5-A0GE-01		34294f7a-7f80-443c-854e-5fe22b4391e0	TCGA-A5-A0GE-01A-11D-A042-01	TCGA-A5-A0GE-01A-11R-A040-07	TCGA-A5-A0GE-01A-11D-A042-01		TCGA-A5-A0GE-01		TCGA-A5-A0GE-01A-11D-A039-05	34294f7a-7f80-443c-854e-5fe22b4391e0
TCGA-A5-A0GG-01	MSI-H	0	TCGA-A5-A0GG-01	3762	0	days	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-A5-A0GG	3762	0	days	3762	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	76	0	0	TCGA-A5-A0GG-F61693	TCGA-A5-A0GG	TCGA-A5-A0GG-01A	Never Used	Stage IA	NO		-27809	2369		0	3762				NO		Scheduled Follow-up Submission	2014-7-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GG.6867E576-1020-41D7-BC18-25160FE17F81.pdf	A0GG	10		TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	A5	0	2	0	13	Endometrial	A	LIVING	64	2003			TCGA-A5-A0GG-01		TCGA-A5-A0GG-01A-21-A163-20	B9DA4BE2-52B2-4824-A299-8E0D9B3E91E4									TCGA-A5-A0GG-01	88e9cdc4-bcf1-49e9-8965-7dc6b3688585	TCGA-A5-A0GG-01A-11D-A120-01		TCGA-A5-A0GG-01A-11D-A120-01	TCGA-A5-A0GG-01	TCGA-A5-A0GG-01	TCGA-A5-A0GG-01A-11D-A123-05		88e9cdc4-bcf1-49e9-8965-7dc6b3688585
TCGA-A5-A0GH-01	MSI-H	0	TCGA-A5-A0GH-01	2254	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	COADREAD-like c15	miRNA cluster 13	cluster 2	mutation c1uster 10	TCGA-A5-A0GH	2254	0	days	2254	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-A5-A0GH-F17143	TCGA-A5-A0GH	TCGA-A5-A0GH-01A	Former User	Stage IA	NO		-21090	2256		0	2254				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0GH.8E29A939-5581-4176-B19E-14076F17726B.pdf	A0GH	33		TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0		0		Endometrial	A	LIVING	55	2004		TCGA-A5-A0GH-01	TCGA-A5-A0GH-01		TCGA-A5-A0GH-01A-11-A162-20	0893B82F-1B83-470D-B60F-6200E66E10F7	TCGA-A5-A0GH-01	TCGA-A5-A0GH-01		TCGA-A5-A0GH-01A-21W-A062-09	TCGA-A5-A0GH-01A-21W-A062-09	TCGA-A5-A0GH-01A-21W-A062-09		TCGA-A5-A0GH-01		ec3e03af-251e-497f-8cb4-b05816df2e12	TCGA-A5-A0GH-01A-21D-A042-01	TCGA-A5-A0GH-01A-21R-A040-07	TCGA-A5-A0GH-01A-21D-A042-01		TCGA-A5-A0GH-01		TCGA-A5-A0GH-01A-21D-A039-05	ec3e03af-251e-497f-8cb4-b05816df2e12
TCGA-A5-A0GI-01	MSI-H	0	TCGA-A5-A0GI-01	2682	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0GI	2682	0	days	2682	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63	0	0	TCGA-A5-A0GI-F53353	TCGA-A5-A0GI	TCGA-A5-A0GI-01A	Never Used	Stage IA	NO		-23195	1779		0	2682				NO			2013-12-11	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	Yes	TCGA-A5-A0GI.F1D23669-8247-4727-8D38-BD444C16FAAE.pdf	A0GI	19		TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	A5	0	1	0	6	Endometrial	A	LIVING	66	2005		TCGA-A5-A0GI-01	TCGA-A5-A0GI-01		TCGA-A5-A0GI-01A-21-A162-20	604B177E-903C-4CC5-AE62-6E473FF21EAF		TCGA-A5-A0GI-01			TCGA-A5-A0GI-01A-11W-A062-09	TCGA-A5-A0GI-01A-11W-A062-09				ccf469e7-f403-4661-b5c4-e3ea020901b5	TCGA-A5-A0GI-01A-11D-A042-01		TCGA-A5-A0GI-01A-11D-A042-01		TCGA-A5-A0GI-01		TCGA-A5-A0GI-01A-11D-A039-05	ccf469e7-f403-4661-b5c4-e3ea020901b5
TCGA-A5-A0GJ-01	MSS	0	TCGA-A5-A0GJ-01	2000	0	days	High	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A5-A0GJ	2000	0	days	2000	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	44	0	0	TCGA-A5-A0GJ-F17144	TCGA-A5-A0GJ	TCGA-A5-A0GJ-01A	Former User	Stage IA	NO	12	-16421	1708		0	2000			12	NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0GJ.83743C19-A9FF-42F0-947E-5697709151C5.pdf	A0GJ	0		TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		NO	Surgical Resection		R0	R0	Primary Tumor	01	open		YES	NO	YES	A5	0	3	0	4	Endometrial	A	LIVING	115	2005		TCGA-A5-A0GJ-01	TCGA-A5-A0GJ-01		TCGA-A5-A0GJ-01A-21-A162-20	AE211CF8-6F17-463C-9F5F-DC177FA3C373		TCGA-A5-A0GJ-01		TCGA-A5-A0GJ-01A-11W-A062-09	TCGA-A5-A0GJ-01A-11W-A062-09	TCGA-A5-A0GJ-01A-11W-A062-09				2b483617-1fc6-4809-b15c-d48d687ca3b8	TCGA-A5-A0GJ-01A-11D-A042-01		TCGA-A5-A0GJ-01A-11D-A042-01		TCGA-A5-A0GJ-01		TCGA-A5-A0GJ-01A-11D-A039-05	2b483617-1fc6-4809-b15c-d48d687ca3b8
TCGA-A5-A0GM-01	MSS	0	TCGA-A5-A0GM-01	1841	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0GM	1841	0	days	1841	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53	0	0	TCGA-A5-A0GM-F17150	TCGA-A5-A0GM	TCGA-A5-A0GM-01A	Former User	Stage IA	NO		-19452	1518		0	1841				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	Yes	TCGA-A5-A0GM.4AAFF034-45D3-4F4F-A283-262BA641D03A.pdf	A0GM	49		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	5	Endometrial	A	LIVING	97	2006		TCGA-A5-A0GM-01	TCGA-A5-A0GM-01		TCGA-A5-A0GM-01A-21-A162-20	2245E2D9-A240-4577-A231-7034D705CF82	TCGA-A5-A0GM-01	TCGA-A5-A0GM-01		TCGA-A5-A0GM-01A-11W-A062-09	TCGA-A5-A0GM-01A-11W-A062-09	TCGA-A5-A0GM-01A-11W-A062-09		TCGA-A5-A0GM-01		75da1901-49d7-4a96-b195-6e38625898e5	TCGA-A5-A0GM-01A-11D-A042-01	TCGA-A5-A0GM-01A-11R-A040-07	TCGA-A5-A0GM-01A-11D-A042-01		TCGA-A5-A0GM-01		TCGA-A5-A0GM-01A-11D-A039-05	75da1901-49d7-4a96-b195-6e38625898e5
TCGA-A5-A0GN-01	MSS	0	TCGA-A5-A0GN-01	1841	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-A5-A0GN	1841	0	days	1841	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65	0	0	TCGA-A5-A0GN-F17151	TCGA-A5-A0GN	TCGA-A5-A0GN-01A	Never Used	Stage IB	NO		-24020	1354		0	1841				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GN.7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58.pdf	A0GN	56		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	5	Endometrial	A	LIVING	68	2006			TCGA-A5-A0GN-01		TCGA-A5-A0GN-01A-21-A162-20	5622D6D1-DC8D-41EC-9088-6ADA060749C4				TCGA-A5-A0GN-01A-11W-A062-09	TCGA-A5-A0GN-01A-11W-A062-09	TCGA-A5-A0GN-01A-11W-A062-09			TCGA-A5-A0GN-01	53a3dd36-866d-4c44-9b79-b9f9564996b3	TCGA-A5-A0GN-01A-11D-A042-01		TCGA-A5-A0GN-01A-11D-A042-01	TCGA-A5-A0GN-01	TCGA-A5-A0GN-01		TCGA-A5-A0GN-01A-11D-A039-05	53a3dd36-866d-4c44-9b79-b9f9564996b3
TCGA-A5-A0GP-01	MSS	0	TCGA-A5-A0GP-01	1416	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 3	mutation cluster 11	TCGA-A5-A0GP	1416	0	days	1416	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-A5-A0GP-F17152	TCGA-A5-A0GP	TCGA-A5-A0GP-01A	Never Used	Stage IA	NO		-21365	1030		0	1416				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GP.A730192C-227E-4A86-96B9-8670D3F5EF59.pdf	A0GP			TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	1	0	1	Endometrial	A	LIVING	60	2007		TCGA-A5-A0GP-01	TCGA-A5-A0GP-01				TCGA-A5-A0GP-01	TCGA-A5-A0GP-01			TCGA-A5-A0GP-01A-11W-A062-09	TCGA-A5-A0GP-01A-11W-A062-09		TCGA-A5-A0GP-01		0ac50ce8-8c72-4b83-98c3-6efdb138d7a1	TCGA-A5-A0GP-01A-11D-A042-01	TCGA-A5-A0GP-01A-11R-A040-07	TCGA-A5-A0GP-01A-11D-A042-01		TCGA-A5-A0GP-01		TCGA-A5-A0GP-01A-11D-A039-05	0ac50ce8-8c72-4b83-98c3-6efdb138d7a1
TCGA-A5-A0GQ-01	MSS	0	TCGA-A5-A0GQ-01	2247	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 12	TCGA-A5-A0GQ	2247	0	days	2247	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	76			TCGA-A5-A0GQ-F51570	TCGA-A5-A0GQ	TCGA-A5-A0GQ-01A	Never Used	Stage IB	NO		-28078	1022		0	2247				NO			2013-11-26	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GQ.7B57FD81-AA42-4C76-BF65-0BA2B3451065.pdf	A0GQ	50		TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	A5		0	0	2	Endometrial	A	LIVING	57	2007			TCGA-A5-A0GQ-01		TCGA-A5-A0GQ-01A-21-A162-20	35256B27-92B1-4905-9571-7269212E85A6				TCGA-A5-A0GQ-01A-11D-A122-09	TCGA-A5-A0GQ-01A-11D-A122-09	TCGA-A5-A0GQ-01A-11D-A122-09			TCGA-A5-A0GQ-01	2386cca4-1d9d-490e-b188-c0e266952a5f	TCGA-A5-A0GQ-01A-11D-A120-01		TCGA-A5-A0GQ-01A-11D-A120-01	TCGA-A5-A0GQ-01	TCGA-A5-A0GQ-01	TCGA-A5-A0GQ-01A-11D-A123-05		2386cca4-1d9d-490e-b188-c0e266952a5f
TCGA-A5-A0GR-01	MSS	0	TCGA-A5-A0GR-01	1120	0	days	Squamous	C6-UCEC	Cluster 5	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-A5-A0GR	1120	0	days	1120	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69	0	0	TCGA-A5-A0GR-F17155	TCGA-A5-A0GR	TCGA-A5-A0GR-01A	Never Used	Stage IA	NO		-25353	632		0	1120				YES		Scheduled Follow-up Submission	2011-10-3	FEMALE	177	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0GR.009B5049-74B7-49B8-8B64-28184A3ACA2B.pdf	A0GR	10		TUMOR FREE	0	0		1	Complete Remission/Response	Former User		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	3	0	0	Endometrial	A	LIVING	88	2008			TCGA-A5-A0GR-01		TCGA-A5-A0GR-01A-21-A162-20	2F6C92AF-8F69-4F30-B8DD-D752A11DF831									TCGA-A5-A0GR-01	10b2b797-1ddd-4ef8-b0e7-38f96fb06f57	TCGA-A5-A0GR-01A-11D-A120-01		TCGA-A5-A0GR-01A-11D-A120-01	TCGA-A5-A0GR-01	TCGA-A5-A0GR-01	TCGA-A5-A0GR-01A-11D-A123-05		10b2b797-1ddd-4ef8-b0e7-38f96fb06f57
TCGA-A5-A0GU-01	MSS	0	TCGA-A5-A0GU-01	860	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 14	TCGA-A5-A0GU	860	0	days	860	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-A5-A0GU-F17158	TCGA-A5-A0GU	TCGA-A5-A0GU-01A	Never Used	Stage IA	NO		-21192	471		0	860				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GU.B284E409-4AC1-45E5-9133-39659987D7F9.pdf	A0GU	18		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	10	Endometrial	A	LIVING	95	2009		TCGA-A5-A0GU-01	TCGA-A5-A0GU-01		TCGA-A5-A0GU-01A-21-A162-20	5BD1CBD7-EF39-4774-8A6A-3BADD82989F0	TCGA-A5-A0GU-01	TCGA-A5-A0GU-01		TCGA-A5-A0GU-01A-11W-A062-09	TCGA-A5-A0GU-01A-11W-A062-09	TCGA-A5-A0GU-01A-11W-A062-09		TCGA-A5-A0GU-01		95ea81fa-025d-4338-94db-ec7024562d8f	TCGA-A5-A0GU-01A-11D-A042-01	TCGA-A5-A0GU-01A-11R-A040-07	TCGA-A5-A0GU-01A-11D-A042-01		TCGA-A5-A0GU-01		TCGA-A5-A0GU-01A-11D-A039-05	95ea81fa-025d-4338-94db-ec7024562d8f
TCGA-A5-A0GV-01	MSS	0	TCGA-A5-A0GV-01	1643	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0GV	1643	0	days	1643	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Complete Response	67			TCGA-A5-A0GV-F61694	TCGA-A5-A0GV	TCGA-A5-A0GV-01A	Former User	Stage IA	NO		-24540	454		0	1643			304	NO		Scheduled Follow-up Submission	2014-7-7	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	330	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-A5-A0GV.0E6417D3-6E95-4EEF-AE93-40D69D4F6525.pdf	A0GV		negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	Locoregional		R0	Primary Tumor	01	open	1988	NO	NO	YES	A5		0	0	21	Endometrial	A	LIVING	63	2009		TCGA-A5-A0GV-01	TCGA-A5-A0GV-01		TCGA-A5-A0GV-01A-21-A162-20	C86E0866-3F2C-4364-91F3-BA8602F13866		TCGA-A5-A0GV-01		TCGA-A5-A0GV-01A-31W-A062-09	TCGA-A5-A0GV-01A-31W-A062-09	TCGA-A5-A0GV-01A-31W-A062-09				e1c80dfd-3db5-4005-9bb5-245124d4dc0f	TCGA-A5-A0GV-01A-31D-A042-01		TCGA-A5-A0GV-01A-31D-A042-01		TCGA-A5-A0GV-01		TCGA-A5-A0GV-01A-31D-A039-05	e1c80dfd-3db5-4005-9bb5-245124d4dc0f
TCGA-A5-A0GW-01	MSI-H	0	TCGA-A5-A0GW-01	706	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-A5-A0GW	706	0	days	706	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	46	0	0	TCGA-A5-A0GW-F17162	TCGA-A5-A0GW	TCGA-A5-A0GW-01A	Never Used	Stage IA	NO		-17092	302		0	706				YES		Scheduled Follow-up Submission	2011-10-3	FEMALE	142	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0GW.0EE4FD56-D0BA-43E8-A434-CD86B21F21BF.pdf	A0GW	7		TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	5	0	4	Endometrial	A	LIVING	49	2009		TCGA-A5-A0GW-01	TCGA-A5-A0GW-01		TCGA-A5-A0GW-01A-21-A162-20	F6BCE3D4-F521-491C-AE2E-978BD90B9CAD		TCGA-A5-A0GW-01		TCGA-A5-A0GW-01A-11W-A062-09	TCGA-A5-A0GW-01A-11W-A062-09	TCGA-A5-A0GW-01A-11W-A062-09				1e4969e5-6bf8-4b8d-970e-96f4424356a8	TCGA-A5-A0GW-01A-11D-A042-01		TCGA-A5-A0GW-01A-11D-A042-01		TCGA-A5-A0GW-01		TCGA-A5-A0GW-01A-11D-A039-05	1e4969e5-6bf8-4b8d-970e-96f4424356a8
TCGA-A5-A0GX-01	MSS	0	TCGA-A5-A0GX-01	2088	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-A5-A0GX	2088	0	days	2088	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53	0	0	TCGA-A5-A0GX-F17145	TCGA-A5-A0GX	TCGA-A5-A0GX-01A	Never Used	Stage IA	NO		-19625	1654		0	2088				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0GX.AE5229ED-8906-4D55-9B11-4E8E214D6446.pdf	A0GX	10		TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	108	2005		TCGA-A5-A0GX-01	TCGA-A5-A0GX-01		TCGA-A5-A0GX-01A-21-A162-20	8ABB876D-F6CD-4120-9949-8AA46323B51B		TCGA-A5-A0GX-01		TCGA-A5-A0GX-01A-11W-A062-09	TCGA-A5-A0GX-01A-11W-A062-09	TCGA-A5-A0GX-01A-11W-A062-09				d98e99e1-ee3e-4427-90ec-24e624aa1b46	TCGA-A5-A0GX-01A-11D-A042-01		TCGA-A5-A0GX-01A-11D-A042-01		TCGA-A5-A0GX-01		TCGA-A5-A0GX-01A-11D-A039-05	d98e99e1-ee3e-4427-90ec-24e624aa1b46
TCGA-A5-A0R6-01	MSS	0	TCGA-A5-A0R6-01	1153	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-A5-A0R6	961	1	days	1153	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-A5-A0R6-F64187	TCGA-A5-A0R6	TCGA-A5-A0R6-01A	Never Used	Stage IIIC1	YES		-23449	259		0	1153		961	961	NO		Scheduled Follow-up Submission	2014-8-27	FEMALE	157	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	New Primary Tumor	Rectum	YES	YES	true	No	TCGA-A5-A0R6.2F8BAD18-8A37-4F1A-A1BA-31494035E05F.pdf	A0R6	82		TUMOR FREE	0	1	YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	A5	0	3	1	17	Endometrial	A	LIVING	68	2009		TCGA-A5-A0R6-01	TCGA-A5-A0R6-01		TCGA-A5-A0R6-01A-21-A163-20	353D2D07-37FD-40EC-9D30-D608AB218149		TCGA-A5-A0R6-01		TCGA-A5-A0R6-01A-11D-A10B-09	TCGA-A5-A0R6-01A-11D-A10B-09	TCGA-A5-A0R6-01A-11D-A10B-09				20977188-9019-4672-a435-760abd19ee5b	TCGA-A5-A0R6-01A-11D-A102-01		TCGA-A5-A0R6-01A-11D-A102-01		TCGA-A5-A0R6-01		TCGA-A5-A0R6-01A-11D-A10Q-05	20977188-9019-4672-a435-760abd19ee5b
TCGA-A5-A0R7-01	MSS	0	TCGA-A5-A0R7-01	535	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-A5-A0R7	535	0	days	535	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55	0	0	TCGA-A5-A0R7-F17164	TCGA-A5-A0R7	TCGA-A5-A0R7-01A		Stage IA	NO		-20250	173		0	535				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0R7.3BBA7591-082A-44CE-829F-23D16A91772D.pdf	A0R7	40		TUMOR FREE	0	0		0	Complete Remission/Response			NO				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	8	0	8	Endometrial	A	LIVING	136	2010		TCGA-A5-A0R7-01	TCGA-A5-A0R7-01		TCGA-A5-A0R7-01A-21-A162-20	819982FF-44F4-47CA-8897-9718955ECA98		TCGA-A5-A0R7-01		TCGA-A5-A0R7-01A-31D-A10B-09	TCGA-A5-A0R7-01A-31D-A10B-09	TCGA-A5-A0R7-01A-31D-A10B-09				0824e6ac-f3f0-4b71-81a3-7ee671a256eb	TCGA-A5-A0R7-01A-31D-A102-01		TCGA-A5-A0R7-01A-31D-A102-01		TCGA-A5-A0R7-01		TCGA-A5-A0R7-01A-31D-A10Q-05	0824e6ac-f3f0-4b71-81a3-7ee671a256eb
TCGA-A5-A0R8-01	MSS	0	TCGA-A5-A0R8-01	596	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A5-A0R8	596	0	days	596	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	YES	Complete Response	81	0	0	TCGA-A5-A0R8-F17165	TCGA-A5-A0R8	TCGA-A5-A0R8-01A	Never Used	Stage IB	NO	66	-29777	155		0	596			42	NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0R8.CA537524-B83F-4AC5-B721-38570E5B21BB.pdf	A0R8	57		TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES	Surgical Resection		R0	R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	7	Endometrial	A	LIVING	62	2010		TCGA-A5-A0R8-01	TCGA-A5-A0R8-01		TCGA-A5-A0R8-01A-21-A163-20	9C6EC7CC-4E83-4DE9-B194-F83829765C1D		TCGA-A5-A0R8-01		TCGA-A5-A0R8-01A-11D-A10B-09	TCGA-A5-A0R8-01A-11D-A10B-09	TCGA-A5-A0R8-01A-11D-A10B-09				414c904a-29d0-44d0-bceb-ce7d024f1a58	TCGA-A5-A0R8-01A-11D-A102-01		TCGA-A5-A0R8-01A-11D-A102-01		TCGA-A5-A0R8-01		TCGA-A5-A0R8-01A-11D-A10Q-05	414c904a-29d0-44d0-bceb-ce7d024f1a58
TCGA-A5-A0R9-01	MSS	0	TCGA-A5-A0R9-01	749	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-A5-A0R9	749	0	days	749	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51	0	0	TCGA-A5-A0R9-F17161	TCGA-A5-A0R9	TCGA-A5-A0R9-01A	Never Used	Stage IA	NO		-18982	471		0	749				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0R9.0AAD58D4-7865-4235-AE18-8685DC5F4FE1.pdf	A0R9	49		TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	A5	0	0	0	4	Endometrial	A	LIVING	145	2009		TCGA-A5-A0R9-01	TCGA-A5-A0R9-01		TCGA-A5-A0R9-01A-21-A163-20	3B00EFD8-7548-464C-879B-67DA5D69F15C		TCGA-A5-A0R9-01		TCGA-A5-A0R9-01A-11D-A10B-09	TCGA-A5-A0R9-01A-11D-A10B-09	TCGA-A5-A0R9-01A-11D-A10B-09				d4ab800e-e0c4-40ae-8256-7271d22d1470	TCGA-A5-A0R9-01A-11D-A102-01		TCGA-A5-A0R9-01A-11D-A102-01		TCGA-A5-A0R9-01		TCGA-A5-A0R9-01A-11D-A10Q-05	d4ab800e-e0c4-40ae-8256-7271d22d1470
TCGA-A5-A0RA-01	MSS	0	TCGA-A5-A0RA-01	884	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-A5-A0RA	884	0	days	884	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68	0	0	TCGA-A5-A0RA-F17160	TCGA-A5-A0RA	TCGA-A5-A0RA-01A	Never Used	Stage IB	NO		-25060	492		0	884				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0RA.EB6E4309-9CE1-468A-A94B-907874BDE9DE.pdf	A0RA	75		TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	6	Endometrial	A	LIVING	113	2009		TCGA-A5-A0RA-01	TCGA-A5-A0RA-01		TCGA-A5-A0RA-01A-11-A163-20	83A77885-4D57-487B-AE02-BB38572E0E44		TCGA-A5-A0RA-01		TCGA-A5-A0RA-01A-21D-A10B-09	TCGA-A5-A0RA-01A-21D-A10B-09	TCGA-A5-A0RA-01A-21D-A10B-09				7a051ecb-ad2d-4c98-8b91-96b66110a46e	TCGA-A5-A0RA-01A-21D-A102-01		TCGA-A5-A0RA-01A-21D-A102-01		TCGA-A5-A0RA-01		TCGA-A5-A0RA-01A-21D-A10Q-05	7a051ecb-ad2d-4c98-8b91-96b66110a46e
TCGA-A5-A0VO-01	MSS	1	TCGA-A5-A0VO-01	875	1	days		C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 1	TCGA-A5-A0VO	875	0	days	875	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-A5-A0VO-F63925	TCGA-A5-A0VO	TCGA-A5-A0VO-01A	Former User	Stage IB	NO		-23547	133	875	0	364				NO		Scheduled Follow-up Submission	2014-8-21	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	320	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A0VO.6ABBA2C9-8920-4785-BFAB-40E560D2DBE6.pdf	A0VO	64		TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	A5	0	4	0	5	Endometrial	A	DECEASED	86	2010		TCGA-A5-A0VO-01	TCGA-A5-A0VO-01		TCGA-A5-A0VO-01A-11-A163-20	5D42C10D-E328-4165-961D-CF8EEE9EFBE1		TCGA-A5-A0VO-01		TCGA-A5-A0VO-01A-21D-A10G-09	TCGA-A5-A0VO-01A-21D-A10G-09	TCGA-A5-A0VO-01A-21D-A10G-09				b07b341a-32ba-4863-b202-6fae769d1dd2						TCGA-A5-A0VO-01A-21D-A10A-05		b07b341a-32ba-4863-b202-6fae769d1dd2
TCGA-A5-A0VP-01	MSI-H	0	TCGA-A5-A0VP-01	1288	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 11	TCGA-A5-A0VP	1288	0	days	1288	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74	0	0	TCGA-A5-A0VP-F17166	TCGA-A5-A0VP	TCGA-A5-A0VP-01A	Never Used	Stage IA	NO		-27335	930		0	1288				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0VP.960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F.pdf	A0VP			TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	A5	0	0	0	14	Endometrial	A	LIVING	58	2008		TCGA-A5-A0VP-01	TCGA-A5-A0VP-01		TCGA-A5-A0VP-01A-11-A163-20	82ADD7F4-FACD-40DF-A2F0-FAC4DCFEB876		TCGA-A5-A0VP-01			TCGA-A5-A0VP-01A-21D-A10B-09	TCGA-A5-A0VP-01A-21D-A10B-09				65e557db-24de-47df-827c-d8336cb099eb	TCGA-A5-A0VP-01A-21D-A102-01		TCGA-A5-A0VP-01A-21D-A102-01		TCGA-A5-A0VP-01		TCGA-A5-A0VP-01A-21D-A10Q-05	65e557db-24de-47df-827c-d8336cb099eb
TCGA-A5-A0VQ-01	MSI-H	0	TCGA-A5-A0VQ-01	485	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-A5-A0VQ	485	0	days	485	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62	0	0	TCGA-A5-A0VQ-F17167	TCGA-A5-A0VQ	TCGA-A5-A0VQ-01A		Stage IA	NO		-22995	133		0	485				NO		Scheduled Follow-up Submission	2011-10-3	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A0VQ.6FE81DF0-D9DF-420F-8A91-40421175A12F.pdf	A0VQ	36		TUMOR FREE	0	0		4+	Complete Remission/Response			YES				R0	Primary Tumor	01	open		YES	NO	YES	A5	0	12	0	12	Endometrial	A	LIVING	89	2010		TCGA-A5-A0VQ-01	TCGA-A5-A0VQ-01		TCGA-A5-A0VQ-01A-21-A163-20	9E0707C4-CBB5-4AFD-8528-FB9F95EC5A91		TCGA-A5-A0VQ-01		TCGA-A5-A0VQ-01A-11D-A10B-09	TCGA-A5-A0VQ-01A-11D-A10B-09	TCGA-A5-A0VQ-01A-11D-A10B-09				e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d	TCGA-A5-A0VQ-01A-11D-A102-01		TCGA-A5-A0VQ-01A-11D-A102-01		TCGA-A5-A0VQ-01		TCGA-A5-A0VQ-01A-11D-A10Q-05	e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d
TCGA-A5-A1OF-01	MSI-H	0	TCGA-A5-A1OF-01	973	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-A5-A1OF	973	0	days	973	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47	0	0	TCGA-A5-A1OF-F53494	TCGA-A5-A1OF	TCGA-A5-A1OF-01A	Never Used	Stage IA	NO		-17308	128		0	973				NO		Scheduled Follow-up Submission	2013-12-14	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	210	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	true	No	TCGA-A5-A1OF.C0A753A3-5202-4DD2-948E-2921AFBCB3BC.pdf	A1OF	13		TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5	0	3	0	4	Endometrial	A	LIVING	70	2010			TCGA-A5-A1OF-01		TCGA-A5-A1OF-01A-21-A18Q-20	3992BB1A-39A7-456D-B706-8AD7048A3EFB									TCGA-A5-A1OF-01	56fa9065-a4cd-435b-941b-d4507aef815b	TCGA-A5-A1OF-01A-11D-A14F-01		TCGA-A5-A1OF-01A-11D-A14F-01	TCGA-A5-A1OF-01	TCGA-A5-A1OF-01	TCGA-A5-A1OF-01A-11D-A14H-05		56fa9065-a4cd-435b-941b-d4507aef815b
TCGA-A5-A1OG-01	MSS	1	TCGA-A5-A1OG-01	973	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2		TCGA-A5-A1OG	973	0	days	973	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	65	0	4	TCGA-A5-A1OG-F51580	TCGA-A5-A1OG	TCGA-A5-A1OG-01A	Never Used	Stage IIIC2	NO		-23956	223	973	0	348			337	YES		Scheduled Follow-up Submission	2013-11-22	FEMALE	158	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	190	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			NO	true	No	TCGA-A5-A1OG.7BE01FDF-C4CF-471E-B395-8D7C4531CD6F.pdf	A1OG	70		WITH TUMOR	0	3	YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	4	4	3	3	Endometrial	A	DECEASED	64	2010			TCGA-A5-A1OG-01		TCGA-A5-A1OG-01A-21-A18Q-20	7B3713CB-8B91-4E9C-9DEF-EA02D94F9D64									TCGA-A5-A1OG-01	f501c084-03d5-48ad-b365-085773a7bd2d	TCGA-A5-A1OG-01A-11D-A14F-01		TCGA-A5-A1OG-01A-11D-A14F-01	TCGA-A5-A1OG-01	TCGA-A5-A1OG-01	TCGA-A5-A1OG-01A-11D-A14H-05		f501c084-03d5-48ad-b365-085773a7bd2d
TCGA-A5-A1OH-01	MSS	0	TCGA-A5-A1OH-01	1105	0	days	High		UCEC Serous c4		KIRC-like c1		miRNA c1uster 9			TCGA-A5-A1OH	1105	0	days	1105	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	86	0	0	TCGA-A5-A1OH-F41438	TCGA-A5-A1OH	TCGA-A5-A1OH-01A	Former User	Stage IIIA	NO		-31451	358		0	1105				NO			2013-3-20	FEMALE	155	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A1OH.AAF1B591-1A0D-48D2-BF59-95B0D605950A.pdf	A1OH	100	positive	TUMOR FREE	0	0	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	A5	0	0	0	0	Endometrial	A	LIVING	59	2010	303036f4-8c7a-484d-8458-8db4803ad6b5		TCGA-A5-A1OH-01	303036f4-8c7a-484d-8458-8db4803ad6b5	TCGA-A5-A1OH-01A-32-A23Z-20	CCB3C579-1FC7-43B1-8DAB-85F26E151F35			303036f4-8c7a-484d-8458-8db4803ad6b5				303036f4-8c7a-484d-8458-8db4803ad6b5		TCGA-A5-A1OH-01		TCGA-A5-A1OH-01A-21D-A227-01		TCGA-A5-A1OH-01A-21D-A227-01	TCGA-A5-A1OH-01	TCGA-A5-A1OH-01	TCGA-A5-A1OH-01A-21D-A22B-05		
TCGA-A5-A1OJ-01	MSS	0	TCGA-A5-A1OJ-01	1006	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-A5-A1OJ	1006	0	days	1006	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	31			TCGA-A5-A1OJ-F51584	TCGA-A5-A1OJ	TCGA-A5-A1OJ-01A	Former User	Stage IA	NO		-11635	161		0	1006				NO		Scheduled Follow-up Submission	2013-11-26	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	No	TCGA-A5-A1OJ.F696BCE9-707C-4825-8A53-EFED20EBF656.pdf	A1OJ	10		TUMOR FREE	0	0	NO	0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5		0	0	17	Endometrial	A	LIVING	94	2010			TCGA-A5-A1OJ-01		TCGA-A5-A1OJ-01A-21-A18Q-20	F8816AD0-EFF9-40C9-9A73-0D95CA01B355									TCGA-A5-A1OJ-01	adddccb0-d276-4450-a8cf-aef663a6f45c	TCGA-A5-A1OJ-01A-11D-A14F-01		TCGA-A5-A1OJ-01A-11D-A14F-01	TCGA-A5-A1OJ-01	TCGA-A5-A1OJ-01	TCGA-A5-A1OJ-01A-11D-A14H-05		adddccb0-d276-4450-a8cf-aef663a6f45c
TCGA-A5-A1OK-01	MSS	0	TCGA-A5-A1OK-01	917	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-A5-A1OK	917	0	days	917	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63	0	0	TCGA-A5-A1OK-F51587	TCGA-A5-A1OK	TCGA-A5-A1OK-01A	Former User	Stage IIIA	NO		-23179	113		0	917				YES		Scheduled Follow-up Submission	2013-11-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-A5-A1OK.1B0C95FC-7AA7-4F82-807D-85C579B6BF74.pdf	A1OK	100		TUMOR FREE	0	0	YES	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	3	0	13	Endometrial	A	LIVING	87	2010			TCGA-A5-A1OK-01		TCGA-A5-A1OK-01A-21-A18Q-20	89E5A639-E1A4-424B-9739-8A19067FFAE0									TCGA-A5-A1OK-01	f26a449d-f3c6-4968-a2f7-4708a5686707	TCGA-A5-A1OK-01A-11D-A14J-01		TCGA-A5-A1OK-01A-11D-A14J-01	TCGA-A5-A1OK-01	TCGA-A5-A1OK-01	TCGA-A5-A1OK-01A-11D-A14N-05		f26a449d-f3c6-4968-a2f7-4708a5686707
TCGA-A5-A2K2-01	MSS	0	TCGA-A5-A2K2-01	3595	0	days	Squamous		UCEC non-CIMP c3				miRNA cluster 14			TCGA-A5-A2K2	3595	0	days	3595	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77			TCGA-A5-A2K2-F51569	TCGA-A5-A2K2	TCGA-A5-A2K2-01A	Former User	Stage IA	NO		-28456	2812		0	3595				NO		Scheduled Follow-up Submission	2013-11-26	FEMALE	155	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A2K2.D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C.pdf	A2K2	49		TUMOR FREE	0	0	YES	0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	A5		0	0	6	Endometrial	A	LIVING	50	2003	4341d180-bcb4-47e5-83b4-df5ecc4f7eec		TCGA-A5-A2K2-01	4341d180-bcb4-47e5-83b4-df5ecc4f7eec					4341d180-bcb4-47e5-83b4-df5ecc4f7eec				4341d180-bcb4-47e5-83b4-df5ecc4f7eec		TCGA-A5-A2K2-01		TCGA-A5-A2K2-01A-11D-A18N-01		TCGA-A5-A2K2-01A-11D-A18N-01	TCGA-A5-A2K2-01	TCGA-A5-A2K2-01	TCGA-A5-A2K2-01A-11D-A18O-05		
TCGA-A5-A2K3-01	MSI-H	0	TCGA-A5-A2K3-01	2012	0	days	High		BRCA CIMP c7		BRCA basal-like c6		miRNA cluster 5			TCGA-A5-A2K3	2012	0	days	2012	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-A5-A2K3-F51572	TCGA-A5-A2K3	TCGA-A5-A2K3-01A	Never Used	Stage IA	NO		-24907	1431		0	2012				NO		Scheduled Follow-up Submission	2013-11-22	FEMALE	160	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A2K3.D38D2FD4-78EF-4F49-976E-529055A6D9A9.pdf	A2K3	0		TUMOR FREE	0	0	YES	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	A5		0	0	9	Endometrial	A	LIVING	80	2007	ef76bd16-f313-4d92-8040-44e7068958a7		TCGA-A5-A2K3-01	ef76bd16-f313-4d92-8040-44e7068958a7	TCGA-A5-A2K3-01A-21-A18Q-20	5DC692F2-49FA-4E7A-95C8-81D47EE698F1			ef76bd16-f313-4d92-8040-44e7068958a7				ef76bd16-f313-4d92-8040-44e7068958a7		TCGA-A5-A2K3-01		TCGA-A5-A2K3-01A-11D-A17U-01		TCGA-A5-A2K3-01A-11D-A17U-01	TCGA-A5-A2K3-01	TCGA-A5-A2K3-01	TCGA-A5-A2K3-01A-11D-A17Z-05		
TCGA-A5-A2K4-01	MSI-L	1	TCGA-A5-A2K4-01	871	1	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-A5-A2K4	528	1	days	871	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Complete Response	69	0	0	TCGA-A5-A2K4-F17269	TCGA-A5-A2K4	TCGA-A5-A2K4-01A	Former User	Stage IIIA	NO		-25270	849	871	0				528	NO		Scheduled Follow-up Submission	2011-10-6	FEMALE	168	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Tumor resection	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	Bowel		YES	true	No	TCGA-A5-A2K4.CB29CD1C-584B-42EA-BF1D-11B6DF8EA756.pdf	A2K4	53		WITH TUMOR	0	0		3	Complete Remission/Response	Never Used		NO				R1	Primary Tumor	01	open	2009	YES	NO	YES	A5	0	0	0	0	Endometrial	A	DECEASED	51	2009	586c18a6-7278-4200-9d64-20b2c7ccbc60		TCGA-A5-A2K4-01	586c18a6-7278-4200-9d64-20b2c7ccbc60	TCGA-A5-A2K4-01A-21-A23Z-20	D61371B8-56B1-44A5-85CD-EF1E560E4C1D			586c18a6-7278-4200-9d64-20b2c7ccbc60				586c18a6-7278-4200-9d64-20b2c7ccbc60		TCGA-A5-A2K4-01		TCGA-A5-A2K4-01A-11D-A18N-01		TCGA-A5-A2K4-01A-11D-A18N-01	TCGA-A5-A2K4-01	TCGA-A5-A2K4-01	TCGA-A5-A2K4-01A-11D-A18O-05		
TCGA-A5-A2K5-01	MSS	0	TCGA-A5-A2K5-01	752	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-A5-A2K5	752	0	days	752	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	76			TCGA-A5-A2K5-F51589	TCGA-A5-A2K5	TCGA-A5-A2K5-01A	Never Used	Stage IA	NO		-28057	171		0	752				YES		Scheduled Follow-up Submission	2013-11-26	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	290	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A2K5.FF305857-5814-4815-90D3-B54BAA0DACB4.pdf	A2K5	49		TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	A5		0	0	4	Endometrial	A	LIVING	127	2011	98327e51-9e30-4d72-a4b1-19b62b4d3cd2		TCGA-A5-A2K5-01	98327e51-9e30-4d72-a4b1-19b62b4d3cd2	TCGA-A5-A2K5-01A-21-A18R-20	6074A3B3-E5D0-48BD-9877-8435B1314590			98327e51-9e30-4d72-a4b1-19b62b4d3cd2				98327e51-9e30-4d72-a4b1-19b62b4d3cd2		TCGA-A5-A2K5-01		TCGA-A5-A2K5-01A-11D-A17U-01		TCGA-A5-A2K5-01A-11D-A17U-01	TCGA-A5-A2K5-01	TCGA-A5-A2K5-01	TCGA-A5-A2K5-01A-11D-A17Z-05		
TCGA-A5-A2K7-01	MSI-H	0	TCGA-A5-A2K7-01	1063	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-A5-A2K7	1063	0	days	1063	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	41	0	0	TCGA-A5-A2K7-F54486	TCGA-A5-A2K7	TCGA-A5-A2K7-01A		Stage II	NO		-14980	195		0	1063				YES		Scheduled Follow-up Submission	2013-12-23	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	No	TCGA-A5-A2K7.1880F604-34C9-4B58-92DC-D67C7E656E3B.pdf	A2K7	50		TUMOR FREE	0	0	YES	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	7	0	11	Endometrial	A	LIVING	72	2011	7f9fd176-6826-4472-bf00-89632783b629		TCGA-A5-A2K7-01	7f9fd176-6826-4472-bf00-89632783b629	TCGA-A5-A2K7-01A-21-A18R-20	C088EF25-623E-416A-B21F-1AE65E1638A0			7f9fd176-6826-4472-bf00-89632783b629				7f9fd176-6826-4472-bf00-89632783b629		TCGA-A5-A2K7-01		TCGA-A5-A2K7-01A-11D-A17U-01		TCGA-A5-A2K7-01A-11D-A17U-01	TCGA-A5-A2K7-01	TCGA-A5-A2K7-01	TCGA-A5-A2K7-01A-11D-A17Z-05		
TCGA-A5-A3LO-01	MSS	0	TCGA-A5-A3LO-01	776	0	days	Squamous		UCEC non-CIMP c3		squamous c3		miRNA cluster 5			TCGA-A5-A3LO	776	0	days	776	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-A5-A3LO-F51590	TCGA-A5-A3LO	TCGA-A5-A3LO-01A		Stage IB	NO		-23401	182		0	776				NO		Scheduled Follow-up Submission	2013-11-26	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A3LO.2AB1F28D-151D-4AFE-807A-9F98B48C51CE.pdf	A3LO	65	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	YES	NO	A5	0	6	0	7	Endometrial	A	LIVING	103	2011	70a9e739-6f24-44b7-97cc-7197097a4f83		TCGA-A5-A3LO-01	70a9e739-6f24-44b7-97cc-7197097a4f83	TCGA-A5-A3LO-01A-21-A23Z-20	4E001E6E-EB22-4F46-BDF4-CEDD10AA9338			70a9e739-6f24-44b7-97cc-7197097a4f83				70a9e739-6f24-44b7-97cc-7197097a4f83		TCGA-A5-A3LO-01		TCGA-A5-A3LO-01A-11D-A227-01		TCGA-A5-A3LO-01A-11D-A227-01	TCGA-A5-A3LO-01	TCGA-A5-A3LO-01	TCGA-A5-A3LO-01A-11D-A22B-05		
TCGA-A5-A3LP-01	MSS	0	TCGA-A5-A3LP-01	455	0	days	High		UCEC Serous c4		BRCA basal-like c6		miRNA cluster 4			TCGA-A5-A3LP	455	0	days	455	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74	0	0	TCGA-A5-A3LP-F43459	TCGA-A5-A3LP	TCGA-A5-A3LP-01A	Former User	Stage IB	NO		-27131	111		0	455				NO		Scheduled Follow-up Submission	2013-5-22	FEMALE	159	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-A5-A3LP.A20CDB07-D90C-42B7-AE0A-254E27C6153B.pdf	A3LP	90	negative	TUMOR FREE	0	0	YES	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	A5	0	0	0	6	Endometrial	A	LIVING	46	2011	5359ca45-0d86-43b9-b318-adbee53c7381		TCGA-A5-A3LP-01	5359ca45-0d86-43b9-b318-adbee53c7381	TCGA-A5-A3LP-01A-21-A23Z-20	90E488D4-EABB-4A2B-9BA4-B669167D24A6			5359ca45-0d86-43b9-b318-adbee53c7381				5359ca45-0d86-43b9-b318-adbee53c7381		TCGA-A5-A3LP-01		TCGA-A5-A3LP-01A-11D-A227-01		TCGA-A5-A3LP-01A-11D-A227-01	TCGA-A5-A3LP-01	TCGA-A5-A3LP-01	TCGA-A5-A3LP-01A-11D-A22B-05		
TCGA-A5-A7WJ-01	MSI-H	0	TCGA-A5-A7WJ-01	341	0	days										TCGA-A5-A7WJ	341	0	days	341	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-A5-A7WJ-F64296	TCGA-A5-A7WJ	TCGA-A5-A7WJ-01A	Never Used	Stage IA	NO		-23723	439		0	341				NO			2014-8-28	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-A5-A7WJ.402A6ED4-B9EC-43A0-B47C-A0B95282678D.pdf	A7WJ	39	negative	TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	A5	0	3	0	2	Endometrial	A	LIVING	64	2012	382f8e3e-6414-4bfd-81de-fa4260be7ede		TCGA-A5-A7WJ-01	382f8e3e-6414-4bfd-81de-fa4260be7ede		E76A6335-F295-4BB2-B04E-4B69A461837C			382f8e3e-6414-4bfd-81de-fa4260be7ede				382f8e3e-6414-4bfd-81de-fa4260be7ede		TCGA-A5-A7WJ-01		TCGA-A5-A7WJ-01A-12D-A34P-01		TCGA-A5-A7WJ-01A-12D-A34P-01	TCGA-A5-A7WJ-01	TCGA-A5-A7WJ-01	TCGA-A5-A7WJ-01A-12D-A34S-05		
TCGA-A5-A7WK-01	MSS	0	TCGA-A5-A7WK-01	560	0	days										TCGA-A5-A7WK	350	1	days	560	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Progressive Disease	71	0	0	TCGA-A5-A7WK-F63886	TCGA-A5-A7WK	TCGA-A5-A7WK-01A	Never Used	Stage IA	NO		-26044	253		0	560			350	YES			2014-8-20	FEMALE	168	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	160	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Paraaortic lymph node	NO	YES	true	No	TCGA-A5-A7WK.9101DD17-9216-4526-9A87-8C4E94B1F435.pdf	A7WK	49	negative	WITH TUMOR	0	0	YES	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	A5	0	0	0	0	Endometrial	A	LIVING	97	2013	e2c72ce3-f010-4f7f-832b-6277b8409f87		TCGA-A5-A7WK-01	e2c72ce3-f010-4f7f-832b-6277b8409f87		982A1758-B333-4AC0-96A8-9E4DEF8F7A97			e2c72ce3-f010-4f7f-832b-6277b8409f87				e2c72ce3-f010-4f7f-832b-6277b8409f87		TCGA-A5-A7WK-01		TCGA-A5-A7WK-01A-11D-A34P-01		TCGA-A5-A7WK-01A-11D-A34P-01	TCGA-A5-A7WK-01	TCGA-A5-A7WK-01	TCGA-A5-A7WK-01A-11D-A34S-05		
TCGA-A5-AB3J-01	MSS	0	TCGA-A5-AB3J-01	512	0	days										TCGA-A5-AB3J	512	0	days	512	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	52	0	0	TCGA-A5-AB3J-F71139	TCGA-A5-AB3J	TCGA-A5-AB3J-01A	Never Used	Stage II	NO		-19020	126		0	512				YES			2015-3-18	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Cervical polypectomy	Other method, specify:	210	NO	NO	Peri (6-12 months since last menstrual period)	G2					NO	true	Yes	TCGA-A5-AB3J.41CDFB48-33A6-4FCD-97CA-30C73A9E6FED.pdf	AB3J	49		TUMOR FREE	0	0	YES	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	A5	0	4	0	6	Endometrial	A	LIVING	59	2013	8cda2390-3a6c-422e-b827-5c62c015f020		TCGA-A5-AB3J-01	8cda2390-3a6c-422e-b827-5c62c015f020		10735EAE-8427-4413-BF92-D9A29F5A3796			8cda2390-3a6c-422e-b827-5c62c015f020				8cda2390-3a6c-422e-b827-5c62c015f020		TCGA-A5-AB3J-01		TCGA-A5-AB3J-01A-11D-A402-01		TCGA-A5-AB3J-01A-11D-A402-01	TCGA-A5-AB3J-01	TCGA-A5-AB3J-01	TCGA-A5-AB3J-01A-11D-A409-05		
TCGA-AJ-A23M-01	MSS	1	TCGA-AJ-A23M-01	616	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 5	mutation cluster 3	TCGA-AJ-A23M	516	1	days	616	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	61			TCGA-AJ-A23M-F56158	TCGA-AJ-A23M	TCGA-AJ-A23M-01A	Never Used	Stage II	NO		-22430	274	616	0	36			516	YES			2014-1-29	FEMALE	152	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES			90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Abdominal Fluid	NO	YES	false	No	TCGA-AJ-A23M.B9651546-290B-405B-8275-24C8A53A10A3.pdf	A23M		positive	WITH TUMOR		0	YES	1	Stable Disease	Never Used		YES					Primary Tumor	01	open	2009		NO	YES	AJ		0		4	Endometrial	A	DECEASED	141	2010			TCGA-AJ-A23M-01		TCGA-AJ-A23M-01A-21-A18R-20	36BE1D89-9FC1-4743-8B67-A32071FEF91E					TCGA-AJ-A23M-01A-11D-A159-09	TCGA-AJ-A23M-01A-11D-A159-09			TCGA-AJ-A23M-01	9cde3009-e59c-4a08-bd85-e3f5ab521d41	TCGA-AJ-A23M-01A-11D-A160-01		TCGA-AJ-A23M-01A-11D-A160-01	TCGA-AJ-A23M-01	TCGA-AJ-A23M-01	TCGA-AJ-A23M-01A-11D-A161-05		9cde3009-e59c-4a08-bd85-e3f5ab521d41
TCGA-AJ-A23N-01	MSS	1	TCGA-AJ-A23N-01	439	1	days	High		UCEC Serous c4		OV-like c4		miRNA cluster 14			TCGA-AJ-A23N	439	0	days	439	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	70			TCGA-AJ-A23N-F47000	TCGA-AJ-A23N	TCGA-AJ-A23N-01A	Former User	Stage IIIA	NO		-25772	84	439	0	33				NO			2013-8-21	FEMALE		Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A23N.38EB6233-9777-4640-A896-26D16A9DBD8E.pdf	A23N	27	negative	WITH TUMOR			YES	2	Progressive Disease	Never Used		YES				R2	Primary Tumor	01		2009		YES	NO	AJ		0		0	Endometrial	A	DECEASED		2011	fefa50dc-29a7-4c27-a735-ab6eb500a5d5		TCGA-AJ-A23N-01	fefa50dc-29a7-4c27-a735-ab6eb500a5d5	TCGA-AJ-A23N-01A-21-A23Z-20	6EDED36B-2F9E-460F-875B-21634AC908BA			fefa50dc-29a7-4c27-a735-ab6eb500a5d5				fefa50dc-29a7-4c27-a735-ab6eb500a5d5		TCGA-AJ-A23N-01		TCGA-AJ-A23N-01A-11D-A227-01		TCGA-AJ-A23N-01A-11D-A227-01	TCGA-AJ-A23N-01	TCGA-AJ-A23N-01	TCGA-AJ-A23N-01A-11D-A22B-05		
TCGA-AJ-A23O-01	MSI-H	1	TCGA-AJ-A23O-01	312	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 4		TCGA-AJ-A23O	312	0	days	312	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					69		0	TCGA-AJ-A23O-F22151	TCGA-AJ-A23O	TCGA-AJ-A23O-01A		Stage IB	NO		-25433	165	312	0	60				NO		Scheduled Follow-up Submission	2012-2-24	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A23O.4D477218-A4D1-4940-AEF5-D8F46931594C.pdf	A23O	81	negative	TUMOR FREE		0				Never Used		NO				R0	Primary Tumor	01		2009	NO	NO	YES	AJ		4		15	Endometrial	A	DECEASED	60	2010			TCGA-AJ-A23O-01		TCGA-AJ-A23O-01A-21-A18R-20	3CB29D8C-B588-480C-9C2E-DEA19BC85744									TCGA-AJ-A23O-01	aaece63d-8d6f-4048-81e3-d4e7e3706948	TCGA-AJ-A23O-01A-11D-A160-01		TCGA-AJ-A23O-01A-11D-A160-01	TCGA-AJ-A23O-01	TCGA-AJ-A23O-01	TCGA-AJ-A23O-01A-11D-A161-05		aaece63d-8d6f-4048-81e3-d4e7e3706948
TCGA-AJ-A2QK-01	MSS	0	TCGA-AJ-A2QK-01	643	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-AJ-A2QK	606	1	days	643	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	65		0	TCGA-AJ-A2QK-F43981	TCGA-AJ-A2QK	TCGA-AJ-A2QK-01A	Never Used	Stage IA	NO		-23945	146		0	643		606	606	YES			2013-6-10	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Distant Metastasis		YES	YES	false	No	TCGA-AJ-A2QK.01A114A2-098F-4AAD-9010-54910FB89B4A.pdf	A2QK	25		WITH TUMOR		0	NO		Complete Remission/Response	Never Used		YES	Other Method, Specify Below	tumor debulking	R2	R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	0	18	Endometrial	A	LIVING	119	2011			TCGA-AJ-A2QK-01		TCGA-AJ-A2QK-01A-21-A23Z-20	B814B728-9DAC-41EC-812D-8EB841B8E96F									TCGA-AJ-A2QK-01	3ec89fd3-b1fe-495c-99ef-122ab708e633	TCGA-AJ-A2QK-01A-11D-A18N-01		TCGA-AJ-A2QK-01A-11D-A18N-01	TCGA-AJ-A2QK-01	TCGA-AJ-A2QK-01	TCGA-AJ-A2QK-01A-11D-A18O-05		3ec89fd3-b1fe-495c-99ef-122ab708e633
TCGA-AJ-A2QL-01	MSS	0	TCGA-AJ-A2QL-01	602	0	days	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AJ-A2QL	602	0	days	602	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-AJ-A2QL-F43202	TCGA-AJ-A2QL	TCGA-AJ-A2QL-01A		Stage IIIC1	NO		-22057	138		0	602				YES			2013-5-15	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A2QL.4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4.pdf	A2QL		negative	TUMOR FREE	1	0	YES		Complete Remission/Response	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	1	18	Endometrial	A	LIVING	112	2011			TCGA-AJ-A2QL-01		TCGA-AJ-A2QL-01A-21-A23Z-20	A02B4058-B864-489A-9FAE-360F60438D12									TCGA-AJ-A2QL-01	575c927a-b846-4ef3-9644-7879d522a2cb	TCGA-AJ-A2QL-01A-11D-A18N-01		TCGA-AJ-A2QL-01A-11D-A18N-01	TCGA-AJ-A2QL-01	TCGA-AJ-A2QL-01	TCGA-AJ-A2QL-01A-11D-A18O-05		575c927a-b846-4ef3-9644-7879d522a2cb
TCGA-AJ-A2QL-11	MSS	0	TCGA-AJ-A2QL-11	602	0	days		C6-UCEC								TCGA-AJ-A2QL	602	0	days	602	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-AJ-A2QL-F43202	TCGA-AJ-A2QL	TCGA-AJ-A2QL-11A		Stage IIIC1	NO		-22057	138		0	602				YES			2013-5-15	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A2QL		negative	TUMOR FREE	1	0	YES		Complete Remission/Response	Never Used		NO					Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ	0	7	1	18	Endometrial	A	LIVING	112	2011															TCGA-AJ-A2QL-11	59022898-5d0a-4109-90fa-9f8ad89b9758				TCGA-AJ-A2QL-11		TCGA-AJ-A2QL-11A-11D-A18O-05		59022898-5d0a-4109-90fa-9f8ad89b9758
TCGA-AJ-A2QM-01	MSS	0	TCGA-AJ-A2QM-01	894	0	days	High		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A2QM	894	0	days	894	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67	0	0	TCGA-AJ-A2QM-F60105	TCGA-AJ-A2QM	TCGA-AJ-A2QM-01A		Stage II	NO		-24776	108		0	894				NO			2014-5-29	FEMALE	170	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	210	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-AJ-A2QM.282D10FF-370D-4252-B1CB-3410A43C8F82.pdf	A2QM		negative	TUMOR FREE	0	0	YES		Complete Remission/Response	Never Used		YES					Primary Tumor	01	open	2009		YES	NO	AJ	0	13	0	20	Endometrial	A	LIVING	74	2011	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1		TCGA-AJ-A2QM-01	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1	TCGA-AJ-A2QM-01A-21-A23Z-20	E6999DEA-FA88-4C3E-8DE5-C2DDCE73F606			2bd4aa66-5a09-4bac-bfd0-fc3519d398a1				2bd4aa66-5a09-4bac-bfd0-fc3519d398a1		TCGA-AJ-A2QM-01		TCGA-AJ-A2QM-01A-11D-A18N-01		TCGA-AJ-A2QM-01A-11D-A18N-01	TCGA-AJ-A2QM-01	TCGA-AJ-A2QM-01	TCGA-AJ-A2QM-01A-11D-A18O-05		
TCGA-AJ-A2QN-01	MSS	0	TCGA-AJ-A2QN-01	1069	0	days	Kirc+		UCEC non-CIMP c3			UCEC-like c11	miRNA cluster 5			TCGA-AJ-A2QN	1069	0	days	1069	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60		0	TCGA-AJ-A2QN-F58977	TCGA-AJ-A2QN	TCGA-AJ-A2QN-01A		Stage II	NO		-21915	289		0	1069				YES			2014-4-29	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	25	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A2QN.F92EF591-695A-4E48-9ACF-67497880AC20.pdf	A2QN		negative	TUMOR FREE		0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	8	0	4	Endometrial	A	LIVING	132	2010			TCGA-AJ-A2QN-01												TCGA-AJ-A2QN-01	13a499dd-2bb6-4750-b24a-1c76993f5b97	TCGA-AJ-A2QN-01A-11D-A18N-01		TCGA-AJ-A2QN-01A-11D-A18N-01	TCGA-AJ-A2QN-01	TCGA-AJ-A2QN-01	TCGA-AJ-A2QN-01A-11D-A18O-05		13a499dd-2bb6-4750-b24a-1c76993f5b97
TCGA-AJ-A2QO-01	MSI-H	1	TCGA-AJ-A2QO-01	1045	1	days	Quiet		UCEC CIMP c18				miRNA cluster 12			TCGA-AJ-A2QO	1045	0	days	1045	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	85		0	TCGA-AJ-A2QO-F58978	TCGA-AJ-A2QO	TCGA-AJ-A2QO-01A		Stage IB	NO		-31222	174	1045	0	92				NO			2014-4-29	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	16	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A2QO.5351BF98-9E1D-4F4D-A3EE-26A83B867D58.pdf	A2QO	84	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	5	0	11	Endometrial	A	DECEASED	67	2011	0ebc7d28-128d-4842-9e10-28abb1953b72		TCGA-AJ-A2QO-01	0ebc7d28-128d-4842-9e10-28abb1953b72					0ebc7d28-128d-4842-9e10-28abb1953b72				0ebc7d28-128d-4842-9e10-28abb1953b72		TCGA-AJ-A2QO-01		TCGA-AJ-A2QO-01A-11D-A18N-01		TCGA-AJ-A2QO-01A-11D-A18N-01	TCGA-AJ-A2QO-01	TCGA-AJ-A2QO-01	TCGA-AJ-A2QO-01A-11D-A18O-05		
TCGA-AJ-A3BD-01	MSS	0	TCGA-AJ-A3BD-01	1039	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3BD	1039	0	days	1039	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	2	TCGA-AJ-A3BD-F58983	TCGA-AJ-A3BD	TCGA-AJ-A3BD-01A		Stage IIIC2	NO		-20998	170		0	1039				NO			2014-4-29	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8460/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3BD.8B7CB7C6-86B5-41EA-A6CB-FC496C311888.pdf	A3BD		negative	TUMOR FREE	0	3	YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	AJ	2	9	3	17	Endometrial	A	LIVING	85	2011	b38f9ed4-266f-4b44-b42f-48396fb0be68		TCGA-AJ-A3BD-01	b38f9ed4-266f-4b44-b42f-48396fb0be68	TCGA-AJ-A3BD-01A-21-A23Z-20	EAB8433C-32F7-48FF-98B7-3DFB2D5E7E87			b38f9ed4-266f-4b44-b42f-48396fb0be68				b38f9ed4-266f-4b44-b42f-48396fb0be68		TCGA-AJ-A3BD-01		TCGA-AJ-A3BD-01A-11D-A19X-01		TCGA-AJ-A3BD-01A-11D-A19X-01	TCGA-AJ-A3BD-01	TCGA-AJ-A3BD-01	TCGA-AJ-A3BD-01A-11D-A19Z-05		
TCGA-AJ-A3BF-01	MSS	0	TCGA-AJ-A3BF-01	551	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 2			TCGA-AJ-A3BF	509	1	days	551	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	65	0	6	TCGA-AJ-A3BF-F43706	TCGA-AJ-A3BF	TCGA-AJ-A3BF-01A	Former User	Stage IIIC2	NO		-23906	92		0	551			509	NO			2013-5-31	FEMALE	170	Serous endometrial adenocarcinoma	No		YES	C54.1	8460/3	C54.1	YES		Dilation and curettage procedure	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	Supraclavicular LN	NO	YES	false	No	TCGA-AJ-A3BF.3673A111-6F2E-4374-A0E7-BA436D644F0D.pdf	A3BF		negative	TUMOR FREE	0	2	YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	AJ	6	14	2	43	Endometrial	A	LIVING	113	2011	f282d6e9-6a6a-4515-8efd-d5fff0367ee8		TCGA-AJ-A3BF-01	f282d6e9-6a6a-4515-8efd-d5fff0367ee8	TCGA-AJ-A3BF-01A-21-A23Z-20	9B9F7D60-88B6-4A7B-8FDC-6878C65E00B5			f282d6e9-6a6a-4515-8efd-d5fff0367ee8				f282d6e9-6a6a-4515-8efd-d5fff0367ee8		TCGA-AJ-A3BF-01		TCGA-AJ-A3BF-01A-11D-A20R-01		TCGA-AJ-A3BF-01A-11D-A20R-01	TCGA-AJ-A3BF-01	TCGA-AJ-A3BF-01	TCGA-AJ-A3BF-01A-11D-A212-05		
TCGA-AJ-A3BG-01	MSI-H	0	TCGA-AJ-A3BG-01	550	0	days	Kirc+		BRCA CIMP c7				miRNA c1uster 10			TCGA-AJ-A3BG	480	1	days	550	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Partial Response	65	0	0	TCGA-AJ-A3BG-F43755	TCGA-AJ-A3BG			Stage IA	NO		-23861			0	550			480	NO			2013-6-3	FEMALE	163	Mixed serous and endometrioid	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vagina	NO	YES		Yes		A3BG	33	negative	WITH TUMOR	0	0	YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	AJ	0	4	0	13	Endometrial		LIVING	66	2011	f3004f55-be95-4c2c-92f8-9ec3e96701cd		TCGA-AJ-A3BG-01	f3004f55-be95-4c2c-92f8-9ec3e96701cd					f3004f55-be95-4c2c-92f8-9ec3e96701cd				f3004f55-be95-4c2c-92f8-9ec3e96701cd		TCGA-AJ-A3BG-01		TCGA-AJ-A3BG-01A-11D-A19X-01		TCGA-AJ-A3BG-01A-11D-A19X-01	TCGA-AJ-A3BG-01	TCGA-AJ-A3BG-01	TCGA-AJ-A3BG-01A-11D-A19Z-05		
TCGA-AJ-A3BH-01	MSI-H		TCGA-AJ-A3BH-01			days	Kirc+		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3BH			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium									TCGA-AJ-A3BH	TCGA-AJ-A3BH-01A		Stage IB														2012-2-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES			100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AJ-A3BH.469A2D52-09E6-4B67-B8D0-D6292AC22285.pdf	A3BH	69		TUMOR FREE		0										R0	Primary Tumor	01	open	2009		YES	NO	AJ				1	Endometrial	A	LIVING	71	2011	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e		TCGA-AJ-A3BH-01	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e	TCGA-AJ-A3BH-01A-21-A23Z-20	44F1F9B9-348C-45D3-9E94-E3FC9BCFE9F6			9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e				9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e		TCGA-AJ-A3BH-01		TCGA-AJ-A3BH-01A-11D-A19X-01		TCGA-AJ-A3BH-01A-11D-A19X-01	TCGA-AJ-A3BH-01	TCGA-AJ-A3BH-01	TCGA-AJ-A3BH-01A-11D-A19Z-05		
TCGA-AJ-A3BI-01	MSS	0	TCGA-AJ-A3BI-01	575	0	days	High		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-AJ-A3BI	373	1	days	575	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Complete Response	67		0	TCGA-AJ-A3BI-F43699	TCGA-AJ-A3BI	TCGA-AJ-A3BI-01A		Stage IA	NO		-24623	137		0	575			373	YES			2013-5-31	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	19	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Anterior Abd. Mass	NO	YES	false	No	TCGA-AJ-A3BI.19B5518D-075F-40BE-A104-75C925F133A4.pdf	A3BI	15	negative	TUMOR FREE		0	NO			Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	6	0	10	Endometrial	A	LIVING	100	2011	5dc20b99-8440-4d30-a803-1e10cdb29dbe		TCGA-AJ-A3BI-01	5dc20b99-8440-4d30-a803-1e10cdb29dbe					5dc20b99-8440-4d30-a803-1e10cdb29dbe				5dc20b99-8440-4d30-a803-1e10cdb29dbe		TCGA-AJ-A3BI-01		TCGA-AJ-A3BI-01A-11D-A20R-01		TCGA-AJ-A3BI-01A-11D-A20R-01	TCGA-AJ-A3BI-01	TCGA-AJ-A3BI-01	TCGA-AJ-A3BI-01A-11D-A212-05		
TCGA-AJ-A3BK-01	MSI-L	0	TCGA-AJ-A3BK-01	1031	0	days	Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3BK	1031	0	days	1031	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-AJ-A3BK-F46662	TCGA-AJ-A3BK	TCGA-AJ-A3BK-01A		Stage IC	NO		-24943	547		0	1031				NO			2013-8-13	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3BK.026350F0-3203-49E5-8CCC-9DE88B2C8625.pdf	A3BK	66	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	AJ		0	0	22	Endometrial	A	LIVING	92	2010	18b41a91-88d1-4938-a57f-0464fc7422bc		TCGA-AJ-A3BK-01	18b41a91-88d1-4938-a57f-0464fc7422bc	TCGA-AJ-A3BK-01A-21-A23Z-20	07A8EC1F-8905-4DC9-94F1-EE80E3E59295			18b41a91-88d1-4938-a57f-0464fc7422bc				18b41a91-88d1-4938-a57f-0464fc7422bc		TCGA-AJ-A3BK-01		TCGA-AJ-A3BK-01A-11D-A19X-01		TCGA-AJ-A3BK-01A-11D-A19X-01	TCGA-AJ-A3BK-01	TCGA-AJ-A3BK-01	TCGA-AJ-A3BK-01A-11D-A19Z-05		
TCGA-AJ-A3EJ-01	MSS	1	TCGA-AJ-A3EJ-01	50	1	days	High		UCEC Serous c4				miRNA cluster 13			TCGA-AJ-A3EJ	50	0	days	50	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					74		2	TCGA-AJ-A3EJ-F43201	TCGA-AJ-A3EJ	TCGA-AJ-A3EJ-01A		Stage IIIC2	NO		-27317	332	50	0					NO			2013-5-15	FEMALE	168	Mixed serous and endometrioid	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	20	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3EJ.FB99D237-4583-4298-844F-43B2F99F83E3.pdf	A3EJ	85	negative	WITH TUMOR		9	NO	4+		Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	2	11	9	26	Endometrial	A	DECEASED	73	2010	6c10f0d4-fd7e-459e-af27-8cde9dc42860		TCGA-AJ-A3EJ-01	6c10f0d4-fd7e-459e-af27-8cde9dc42860					6c10f0d4-fd7e-459e-af27-8cde9dc42860				6c10f0d4-fd7e-459e-af27-8cde9dc42860		TCGA-AJ-A3EJ-01		TCGA-AJ-A3EJ-01A-11D-A19X-01		TCGA-AJ-A3EJ-01A-11D-A19X-01	TCGA-AJ-A3EJ-01	TCGA-AJ-A3EJ-01	TCGA-AJ-A3EJ-01A-11D-A19Z-05		
TCGA-AJ-A3EK-01	MSI-H	0	TCGA-AJ-A3EK-01	446	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3EK	446	0	days	446	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53		0	TCGA-AJ-A3EK-F45626	TCGA-AJ-A3EK	TCGA-AJ-A3EK-01A		Stage IA	NO		-19609	127		0	446				NO			2013-7-17	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	false	No	TCGA-AJ-A3EK.F153EAC2-7347-4CEF-916A-995C7BB8B0F1.pdf	A3EK	5	negative	TUMOR FREE		0	YES	3	Complete Remission/Response	Never Used		YES					Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	0	10	Endometrial	A	LIVING	60	2011	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4		TCGA-AJ-A3EK-01	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4	TCGA-AJ-A3EK-01A-21-A23Z-20	5A19C935-72ED-45F3-B42D-5AC8BFDB4789			1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4				1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4		TCGA-AJ-A3EK-01		TCGA-AJ-A3EK-01A-11D-A19X-01		TCGA-AJ-A3EK-01A-11D-A19X-01	TCGA-AJ-A3EK-01	TCGA-AJ-A3EK-01	TCGA-AJ-A3EK-01A-11D-A19Z-05		
TCGA-AJ-A3EL-01	MSI-L	0	TCGA-AJ-A3EL-01	684	0	days	Quiet		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-AJ-A3EL	684	0	days	684	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47		0	TCGA-AJ-A3EL-F46677	TCGA-AJ-A3EL			Stage IA	NO		-17442			0	684							2013-8-13	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO		No		A3EL	6	negative	TUMOR FREE		0	NO	0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	13	0	15	Endometrial		LIVING	57	2010	a7a5bc3b-d82d-447d-8679-47b48612834a		TCGA-AJ-A3EL-01	a7a5bc3b-d82d-447d-8679-47b48612834a					a7a5bc3b-d82d-447d-8679-47b48612834a				a7a5bc3b-d82d-447d-8679-47b48612834a		TCGA-AJ-A3EL-01		TCGA-AJ-A3EL-01A-11D-A20R-01		TCGA-AJ-A3EL-01A-11D-A20R-01	TCGA-AJ-A3EL-01	TCGA-AJ-A3EL-01	TCGA-AJ-A3EL-01A-11D-A212-05		
TCGA-AJ-A3EM-01	MSS	0	TCGA-AJ-A3EM-01	677	0	days	High		UCEC non-CIMP c3				miRNA cluster 5			TCGA-AJ-A3EM	677	0	days	677	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69		0	TCGA-AJ-A3EM-F46680	TCGA-AJ-A3EM	TCGA-AJ-A3EM-01A		Stage IB	NO		-25557	296		0	677				NO			2013-8-13	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	9	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3EM.E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF.pdf	A3EM	3.6	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	8	0	6	Endometrial	A	LIVING	82	2011	4835dbe5-983f-458a-91d2-8e1d754259c3		TCGA-AJ-A3EM-01	4835dbe5-983f-458a-91d2-8e1d754259c3					4835dbe5-983f-458a-91d2-8e1d754259c3				4835dbe5-983f-458a-91d2-8e1d754259c3		TCGA-AJ-A3EM-01		TCGA-AJ-A3EM-01A-11D-A20R-01		TCGA-AJ-A3EM-01A-11D-A20R-01	TCGA-AJ-A3EM-01	TCGA-AJ-A3EM-01	TCGA-AJ-A3EM-01A-11D-A212-05		
TCGA-AJ-A3I9-01	MSS	1	TCGA-AJ-A3I9-01	519	1	days	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AJ-A3I9	370	1	days	519	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	52	0	0	TCGA-AJ-A3I9-F66208	TCGA-AJ-A3I9		Former User	Stage II	NO		-19139		519	0	39			370	NO			2014-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Bone	Distant Metastasis		NO	YES		No		A3I9			WITH TUMOR	0	0	NO	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	0	11	Endometrial		DECEASED	72	2011	e7517bb2-68d3-49c5-b298-4203845ae7db		TCGA-AJ-A3I9-01	e7517bb2-68d3-49c5-b298-4203845ae7db					e7517bb2-68d3-49c5-b298-4203845ae7db				e7517bb2-68d3-49c5-b298-4203845ae7db		TCGA-AJ-A3I9-01		TCGA-AJ-A3I9-01A-11D-A227-01		TCGA-AJ-A3I9-01A-11D-A227-01	TCGA-AJ-A3I9-01	TCGA-AJ-A3I9-01	TCGA-AJ-A3I9-01A-11D-A22B-05		
TCGA-AJ-A3IA-01	MSS	0	TCGA-AJ-A3IA-01	633	0	days	High		OV-like c1				miRNA cluster 5			TCGA-AJ-A3IA	633	0	days	633	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77	0	0	TCGA-AJ-A3IA-F48781	TCGA-AJ-A3IA			Stage IB	NO		-28470			0	633				NO			2013-9-20	FEMALE	157	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		Yes		A3IA	88	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	0	17	Endometrial		LIVING	58	2011	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf		TCGA-AJ-A3IA-01	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf					c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf				c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf		TCGA-AJ-A3IA-01		TCGA-AJ-A3IA-01A-11D-A20R-01		TCGA-AJ-A3IA-01A-11D-A20R-01	TCGA-AJ-A3IA-01	TCGA-AJ-A3IA-01	TCGA-AJ-A3IA-01A-11D-A212-05		
TCGA-AJ-A3NC-01	MSS	0	TCGA-AJ-A3NC-01	1125	0	days	Iq		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-AJ-A3NC	1125	0	days	1125	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-AJ-A3NC-F58716	TCGA-AJ-A3NC	TCGA-AJ-A3NC-01A		Stage IA	NO		-23353	282		0	1125				YES			2014-4-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3NC.B6DB87F4-E88A-4209-92E2-75ADB364FB28.pdf	A3NC	21	negative	TUMOR FREE	0	0	NO		Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0	0	13	Endometrial	A	LIVING	110	2011	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53		TCGA-AJ-A3NC-01	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53	TCGA-AJ-A3NC-01A-21-A23Z-20	C156B816-181C-4A58-B620-01C7A857C8A1			e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53				e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53		TCGA-AJ-A3NC-01		TCGA-AJ-A3NC-01A-11D-A227-01		TCGA-AJ-A3NC-01A-11D-A227-01	TCGA-AJ-A3NC-01	TCGA-AJ-A3NC-01	TCGA-AJ-A3NC-01A-11D-A22B-05		
TCGA-AJ-A3NC-11	MSS	0	TCGA-AJ-A3NC-11	1125	0	days										TCGA-AJ-A3NC	1125	0	days	1125	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-AJ-A3NC-F58716	TCGA-AJ-A3NC			Stage IA	NO		-23353			0	1125				YES			2014-4-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A3NC	21	negative	TUMOR FREE	0	0	NO		Complete Remission/Response	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ		0	0	13	Endometrial		LIVING	110	2011	cd0ccc13-2ce8-408e-aceb-1b363e98584f			cd0ccc13-2ce8-408e-aceb-1b363e98584f					cd0ccc13-2ce8-408e-aceb-1b363e98584f				cd0ccc13-2ce8-408e-aceb-1b363e98584f		TCGA-AJ-A3NC-11					TCGA-AJ-A3NC-11		TCGA-AJ-A3NC-11A-11D-A22B-05		
TCGA-AJ-A3NE-01	MSI-H	0	TCGA-AJ-A3NE-01	628	0	days	Kirc+		UCEC non-CIMP c3				miRNA cluster 11			TCGA-AJ-A3NE	628	0	days	628	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	46		0	TCGA-AJ-A3NE-F47713	TCGA-AJ-A3NE			Stage IA	NO		-16957			0	628							2013-8-28	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO		No		A3NE	4	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	12	0	24	Endometrial		LIVING	80	2011	a133035a-7076-4fe7-b260-f866b409aba4		TCGA-AJ-A3NE-01	a133035a-7076-4fe7-b260-f866b409aba4					a133035a-7076-4fe7-b260-f866b409aba4				a133035a-7076-4fe7-b260-f866b409aba4		TCGA-AJ-A3NE-01		TCGA-AJ-A3NE-01A-11D-A227-01		TCGA-AJ-A3NE-01A-11D-A227-01	TCGA-AJ-A3NE-01	TCGA-AJ-A3NE-01	TCGA-AJ-A3NE-01A-11D-A22B-05		
TCGA-AJ-A3NE-11	MSI-H	0	TCGA-AJ-A3NE-11	628	0	days										TCGA-AJ-A3NE	628	0	days	628	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	46		0	TCGA-AJ-A3NE-F47713	TCGA-AJ-A3NE			Stage IA	NO		-16957			0	628							2013-8-28	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO		No		A3NE	4	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ	0	12	0	24	Endometrial		LIVING	80	2011	b4a85000-c0fd-4287-83f2-fc0757fe4a60			b4a85000-c0fd-4287-83f2-fc0757fe4a60					b4a85000-c0fd-4287-83f2-fc0757fe4a60				b4a85000-c0fd-4287-83f2-fc0757fe4a60		TCGA-AJ-A3NE-11					TCGA-AJ-A3NE-11		TCGA-AJ-A3NE-11A-11D-A22B-05		
TCGA-AJ-A3NF-01	MSS	0	TCGA-AJ-A3NF-01	645	0	days	Squamous		UCEC Serous c4				miRNA cluster 5			TCGA-AJ-A3NF	645	0	days	645	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-AJ-A3NF-F58988	TCGA-AJ-A3NF	TCGA-AJ-A3NF-01A		Stage IIIC	NO		-22210	85		0	645				NO			2014-4-29	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	22	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3NF.7003815D-F09A-46A0-8A8E-E0685A765788.pdf	A3NF	54	negative	TUMOR FREE	0	1	YES	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	9	1	23	Endometrial	A	LIVING	117	2011	5ab8bc7b-9e70-426f-8f84-d8c691440e98		TCGA-AJ-A3NF-01	5ab8bc7b-9e70-426f-8f84-d8c691440e98					5ab8bc7b-9e70-426f-8f84-d8c691440e98				5ab8bc7b-9e70-426f-8f84-d8c691440e98		TCGA-AJ-A3NF-01		TCGA-AJ-A3NF-01A-11D-A227-01		TCGA-AJ-A3NF-01A-11D-A227-01	TCGA-AJ-A3NF-01	TCGA-AJ-A3NF-01	TCGA-AJ-A3NF-01A-11D-A22B-05		
TCGA-AJ-A3NG-01	MSS	0	TCGA-AJ-A3NG-01	475	0	days	Kirc+		Cluster 5		squamous c3		miRNA cluster 5			TCGA-AJ-A3NG	475	0	days	475	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	83		0	TCGA-AJ-A3NG-F47019	TCGA-AJ-A3NG	TCGA-AJ-A3NG-01A		Stage II	NO		-30351	101		0	475				NO			2013-8-21	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3NG.32C3C850-5F65-424E-894C-75B4725BBD09.pdf	A3NG	60	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	7	0	10	Endometrial	A	LIVING	93	2011	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b		TCGA-AJ-A3NG-01	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b	TCGA-AJ-A3NG-01A-21-A23Z-20	FD29E3BB-3256-48A8-877D-E9D5CDC953BC			3bf26a40-da0a-4b9f-9c8d-ef307c8f239b				3bf26a40-da0a-4b9f-9c8d-ef307c8f239b		TCGA-AJ-A3NG-01		TCGA-AJ-A3NG-01A-11D-A227-01		TCGA-AJ-A3NG-01A-11D-A227-01	TCGA-AJ-A3NG-01	TCGA-AJ-A3NG-01	TCGA-AJ-A3NG-01A-11D-A22B-05		
TCGA-AJ-A3NH-01	MSS	1	TCGA-AJ-A3NH-01	310	1	days	High		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3NH	310	0	days	310	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	90			TCGA-AJ-A3NH-F46995	TCGA-AJ-A3NH	TCGA-AJ-A3NH-01A	Never Used	Stage IB	NO		-32871	67	310	0	23				NO			2013-8-21	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-AJ-A3NH.8FC0BB09-C917-4552-96A4-B4868FD33D27.pdf	A3NH		positive	TUMOR FREE			YES	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0		0	Endometrial	A	DECEASED	65	2011	1b48e1cd-3c89-4508-9326-7fdd69841776		TCGA-AJ-A3NH-01	1b48e1cd-3c89-4508-9326-7fdd69841776	TCGA-AJ-A3NH-01A-21-A23Z-20	DFCB26A6-1294-4CF4-AB1F-9D6F2773C04C			1b48e1cd-3c89-4508-9326-7fdd69841776				1b48e1cd-3c89-4508-9326-7fdd69841776		TCGA-AJ-A3NH-01		TCGA-AJ-A3NH-01A-11D-A227-01		TCGA-AJ-A3NH-01A-11D-A227-01	TCGA-AJ-A3NH-01	TCGA-AJ-A3NH-01	TCGA-AJ-A3NH-01A-11D-A22B-05		
TCGA-AJ-A3NH-11	MSS	1	TCGA-AJ-A3NH-11	310	1	days										TCGA-AJ-A3NH	310	0	days	310	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	90			TCGA-AJ-A3NH-F46995	TCGA-AJ-A3NH	TCGA-AJ-A3NH-11A	Never Used	Stage IB	NO		-32871	67	310	0	23				NO			2013-8-21	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes		A3NH		positive	TUMOR FREE			YES	3	Complete Remission/Response	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	AJ		0		0	Endometrial	A	DECEASED	65	2011	1b2609b8-8c1f-4407-aba5-e47f9e83ebb1			1b2609b8-8c1f-4407-aba5-e47f9e83ebb1					1b2609b8-8c1f-4407-aba5-e47f9e83ebb1				1b2609b8-8c1f-4407-aba5-e47f9e83ebb1		TCGA-AJ-A3NH-11					TCGA-AJ-A3NH-11		TCGA-AJ-A3NH-11A-11D-A22B-05		
TCGA-AJ-A3OJ-01	MSI-H	0	TCGA-AJ-A3OJ-01	467	0	days	Quiet		BRCA CIMP c7		UCEC-like c5		miRNA cluster 4			TCGA-AJ-A3OJ	467	0	days	467	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54		0	TCGA-AJ-A3OJ-F47049	TCGA-AJ-A3OJ	TCGA-AJ-A3OJ-01A		Stage II	NO		-19826	97		0	467				NO			2013-8-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	260	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	No	TCGA-AJ-A3OJ.89CAF35B-187A-499C-9E01-3992A0DEBCFD.pdf	A3OJ	95	negative	TUMOR FREE		0	YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	11	0	14	Endometrial	A	LIVING	104	2011	f141342e-fbed-4ccf-8e4a-7299397e6e77		TCGA-AJ-A3OJ-01	f141342e-fbed-4ccf-8e4a-7299397e6e77	TCGA-AJ-A3OJ-01A-21-A23Z-20	81CF93AA-064D-43BA-AD1B-417F00852E28			f141342e-fbed-4ccf-8e4a-7299397e6e77				f141342e-fbed-4ccf-8e4a-7299397e6e77		TCGA-AJ-A3OJ-01		TCGA-AJ-A3OJ-01A-11D-A227-01		TCGA-AJ-A3OJ-01A-11D-A227-01	TCGA-AJ-A3OJ-01	TCGA-AJ-A3OJ-01	TCGA-AJ-A3OJ-01A-11D-A22B-05		
TCGA-AJ-A3OK-01	MSI-L	0	TCGA-AJ-A3OK-01	485	0	days	Quiet		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AJ-A3OK	485	0	days	485	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73		0	TCGA-AJ-A3OK-F45615	TCGA-AJ-A3OK	TCGA-AJ-A3OK-01A		Stage IA	NO		-26851	162		0	485							2013-7-17	FEMALE	160	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3OK.54D4BBBE-D458-44B2-8F7C-0185DD16D961.pdf	A3OK	20	negative	TUMOR FREE		0	YES	2	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	3	0	21	Endometrial	A	LIVING	75	2011	33dc8709-5c3e-4944-8e41-2bc36b26fced		TCGA-AJ-A3OK-01	33dc8709-5c3e-4944-8e41-2bc36b26fced	TCGA-AJ-A3OK-01A-21-A23Z-20	F7EB2D40-8596-4F8A-8AAF-D3F1A41F6AC5			33dc8709-5c3e-4944-8e41-2bc36b26fced				33dc8709-5c3e-4944-8e41-2bc36b26fced		TCGA-AJ-A3OK-01		TCGA-AJ-A3OK-01A-12D-A227-01		TCGA-AJ-A3OK-01A-12D-A227-01	TCGA-AJ-A3OK-01	TCGA-AJ-A3OK-01	TCGA-AJ-A3OK-01A-12D-A22B-05		
TCGA-AJ-A3OL-01	MSI-H	1	TCGA-AJ-A3OL-01	449	1	days	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-AJ-A3OL	424	1	days	449	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	55		0	TCGA-AJ-A3OL-F47006	TCGA-AJ-A3OL	TCGA-AJ-A3OL-01A		Stage IIIA	NO		-20115	81	449	0	57			424	NO			2013-8-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	190	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	Lung, Liver, and Brain	NO	YES	false	No	TCGA-AJ-A3OL.B42FF342-34F0-4611-A275-B979D7658510.pdf	A3OL	80	negative	WITH TUMOR		0	YES	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	0	9	Endometrial	A	DECEASED	64	2011	69fbadaa-5a9f-4fc6-b676-e938179ee830		TCGA-AJ-A3OL-01	69fbadaa-5a9f-4fc6-b676-e938179ee830	TCGA-AJ-A3OL-01A-21-A23Z-20	956AEB98-315D-492E-AFD1-F3C590EE790C			69fbadaa-5a9f-4fc6-b676-e938179ee830				69fbadaa-5a9f-4fc6-b676-e938179ee830		TCGA-AJ-A3OL-01		TCGA-AJ-A3OL-01A-11D-A227-01		TCGA-AJ-A3OL-01A-11D-A227-01	TCGA-AJ-A3OL-01	TCGA-AJ-A3OL-01	TCGA-AJ-A3OL-01A-11D-A22B-05		
TCGA-AJ-A3QS-01	Indeterminate	0	TCGA-AJ-A3QS-01	513	0	days	High		UCEC Serous c4				miRNA cluster 5			TCGA-AJ-A3QS	513	0	days	513	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57		0	TCGA-AJ-A3QS-F47011	TCGA-AJ-A3QS	TCGA-AJ-A3QS-01A		Stage IIIA	NO		-21162	129		0	513				YES			2013-8-21	FEMALE	165	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	34	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AJ-A3QS.73D1F890-5799-4166-9F9A-F9852979FD29.pdf	A3QS	0	negative	TUMOR FREE		1	YES	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	AJ	0	6	1	1	Endometrial	A	LIVING	71	2011	6f0ffee6-d69f-459e-b401-f7dbcb17cb13		TCGA-AJ-A3QS-01	6f0ffee6-d69f-459e-b401-f7dbcb17cb13					6f0ffee6-d69f-459e-b401-f7dbcb17cb13				6f0ffee6-d69f-459e-b401-f7dbcb17cb13		TCGA-AJ-A3QS-01		TCGA-AJ-A3QS-01A-11D-A227-01		TCGA-AJ-A3QS-01A-11D-A227-01	TCGA-AJ-A3QS-01	TCGA-AJ-A3QS-01	TCGA-AJ-A3QS-01A-11D-A22B-05		
TCGA-AJ-A3TW-01	MSS	0	TCGA-AJ-A3TW-01	513	0	days	High		UCEC Serous c4		BRCA basal-like c6		miRNA cluster 4			TCGA-AJ-A3TW	513	0	days	513	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	78		0	TCGA-AJ-A3TW-F48779	TCGA-AJ-A3TW	TCGA-AJ-A3TW-01A		Stage IB	NO		-28559	71		0	513				NO			2013-9-20	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	230	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AJ-A3TW.1271A645-AF29-453E-BEA8-420ECCD0DFDC.pdf	A3TW		negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	AJ	0	1	0	18	Endometrial	A	LIVING	55	2012	a1ba7666-0fb4-4fa6-8530-242d32ca3708		TCGA-AJ-A3TW-01	a1ba7666-0fb4-4fa6-8530-242d32ca3708	TCGA-AJ-A3TW-01A-21-A23Z-20	B25EC080-F61A-41EB-85CE-40820BDCE279			a1ba7666-0fb4-4fa6-8530-242d32ca3708				a1ba7666-0fb4-4fa6-8530-242d32ca3708		TCGA-AJ-A3TW-01		TCGA-AJ-A3TW-01A-11D-A227-01		TCGA-AJ-A3TW-01A-11D-A227-01	TCGA-AJ-A3TW-01	TCGA-AJ-A3TW-01	TCGA-AJ-A3TW-01A-11D-A22B-05		
TCGA-AJ-A4ZG-01	MSS	0	TCGA-AJ-A4ZG-01	498	0	days										TCGA-AJ-A4ZG	498	0	days	498	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-AJ-A4ZG-F58972	TCGA-AJ-A4ZG	TCGA-AJ-A4ZG-01A		Stage IVB	NO		-19492	57		0	498				YES			2014-4-29	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	90	NO	NO		G3					NO	false	No	TCGA-AJ-A4ZG.639D98FB-EFCA-4FDC-A4A0-308951C91710.pdf	A4ZG	31	positive	TUMOR FREE			YES	1	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01		2009		YES	NO	AJ		0		0	Endometrial	A	LIVING	85	2012						9F1D2D24-2358-41C9-A2E6-D505AD6FA71E																		
TCGA-AJ-A5DV-01	MSS	0	TCGA-AJ-A5DV-01	679	0	days										TCGA-AJ-A5DV	679	0	days	679	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65			TCGA-AJ-A5DV-F64110	TCGA-AJ-A5DV		Never Used	Stage IA	NO		-23892			0	679				YES			2014-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Biopsy, NOS	Other method, specify:			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A5DV	3	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01		2009		YES	NO	AJ		0	0	5	Endometrial		LIVING	147	2012	f9cc97ae-9b1a-46fa-ab38-c46bccf84380		TCGA-AJ-A5DV-01	f9cc97ae-9b1a-46fa-ab38-c46bccf84380					f9cc97ae-9b1a-46fa-ab38-c46bccf84380				f9cc97ae-9b1a-46fa-ab38-c46bccf84380		TCGA-AJ-A5DV-01		TCGA-AJ-A5DV-01A-11D-A27O-01		TCGA-AJ-A5DV-01A-11D-A27O-01	TCGA-AJ-A5DV-01	TCGA-AJ-A5DV-01	TCGA-AJ-A5DV-01A-11D-A27Y-05		
TCGA-AJ-A5DW-01	MSS	0	TCGA-AJ-A5DW-01	390	0	days										TCGA-AJ-A5DW	390	0	days	390	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-AJ-A5DW-F66007	TCGA-AJ-A5DW	TCGA-AJ-A5DW-01A	Never Used	Stage IA	NO		-20711	133		0	390				NO			2014-10-1	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Biopsy, NOS	Other method, specify:	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AJ-A5DW.8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724.pdf	A5DW			TUMOR FREE	0	0	NO	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	AJ	0	13	0	12	Endometrial	A	LIVING	109	2012	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd		TCGA-AJ-A5DW-01	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd		D9A34298-570F-49D3-9252-7ECFA9059DB8			25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd				25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd		TCGA-AJ-A5DW-01		TCGA-AJ-A5DW-01A-11D-A27O-01		TCGA-AJ-A5DW-01A-11D-A27O-01	TCGA-AJ-A5DW-01	TCGA-AJ-A5DW-01	TCGA-AJ-A5DW-01A-11D-A27Y-05		
TCGA-AJ-A6NU-01	MSS	0	TCGA-AJ-A6NU-01	632	0	days										TCGA-AJ-A6NU	632	0	days	632	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64		0	TCGA-AJ-A6NU-F66207	TCGA-AJ-A6NU	TCGA-AJ-A6NU-01A	Former User	Stage II	NO		-23498	439		0	632				NO			2014-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-AJ-A6NU.43BA8AFC-DE95-4260-88BF-EB184430B5A4.pdf	A6NU	0	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ	0	0	0	10	Endometrial	A	LIVING	167	2012	31594ace-9586-4e98-ab81-1dfe4fb9d20e		TCGA-AJ-A6NU-01	31594ace-9586-4e98-ab81-1dfe4fb9d20e					31594ace-9586-4e98-ab81-1dfe4fb9d20e				31594ace-9586-4e98-ab81-1dfe4fb9d20e		TCGA-AJ-A6NU-01		TCGA-AJ-A6NU-01A-11D-A34P-01		TCGA-AJ-A6NU-01A-11D-A34P-01	TCGA-AJ-A6NU-01	TCGA-AJ-A6NU-01	TCGA-AJ-A6NU-01A-11D-A34S-05		
TCGA-AJ-A8CT-01	MSI-H	0	TCGA-AJ-A8CT-01	82	0	days										TCGA-AJ-A8CT	82	0	days	82	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-AJ-A8CT-F61504	TCGA-AJ-A8CT	TCGA-AJ-A8CT-01A		Stage IA	NO		-21515	587		0	82							2014-6-30	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-AJ-A8CT.67EF8128-8F99-4B19-9B64-9C5E5BD0786F.pdf	A8CT	17	negative	TUMOR FREE		0			Complete Remission/Response	Never Used						R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0	0	18	Endometrial	A	LIVING	115	2012	4c56a6cc-f912-4b2f-b301-d6a64f211d31		TCGA-AJ-A8CT-01	4c56a6cc-f912-4b2f-b301-d6a64f211d31					4c56a6cc-f912-4b2f-b301-d6a64f211d31				4c56a6cc-f912-4b2f-b301-d6a64f211d31		TCGA-AJ-A8CT-01		TCGA-AJ-A8CT-01A-11D-A37M-01		TCGA-AJ-A8CT-01A-11D-A37M-01	TCGA-AJ-A8CT-01	TCGA-AJ-A8CT-01	TCGA-AJ-A8CT-01A-11D-A37Q-05		
TCGA-AJ-A8CV-01	MSI-H	0	TCGA-AJ-A8CV-01	1068	0	days										TCGA-AJ-A8CV	1068	0	days	1068	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-AJ-A8CV-F65831	TCGA-AJ-A8CV			Stage IB	NO		-21336			0	1068				NO			2014-9-30	FEMALE	156	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO		No		A8CV	65		TUMOR FREE		0	NO	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	AJ		0	0	14	Endometrial		LIVING	86	2011	ff8eb6f4-876e-4b08-8ed7-8c7930765bee		TCGA-AJ-A8CV-01	ff8eb6f4-876e-4b08-8ed7-8c7930765bee					ff8eb6f4-876e-4b08-8ed7-8c7930765bee				ff8eb6f4-876e-4b08-8ed7-8c7930765bee		TCGA-AJ-A8CV-01		TCGA-AJ-A8CV-01A-11D-A37M-01		TCGA-AJ-A8CV-01A-11D-A37M-01	TCGA-AJ-A8CV-01	TCGA-AJ-A8CV-01	TCGA-AJ-A8CV-01A-11D-A37Q-05		
TCGA-AJ-A8CW-01	MSI-H	0	TCGA-AJ-A8CW-01	4	0	days										TCGA-AJ-A8CW	4	0	days	4	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					64				TCGA-AJ-A8CW	TCGA-AJ-A8CW-01A		Stage IA	NO		-23554	840		0	4							2014-2-27	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AJ-A8CW.146E0540-B6F0-495F-ADD5-90F7564C14CA.pdf	A8CW	6	negative	TUMOR FREE		0				Never Used						R0	Primary Tumor	01	open	2009		YES	NO	AJ		0	0	28	Endometrial	A	LIVING	134	2011	409104d7-db15-448e-96c6-e50fb7e5d67b		TCGA-AJ-A8CW-01	409104d7-db15-448e-96c6-e50fb7e5d67b					409104d7-db15-448e-96c6-e50fb7e5d67b				409104d7-db15-448e-96c6-e50fb7e5d67b		TCGA-AJ-A8CW-01		TCGA-AJ-A8CW-01A-11D-A37M-01		TCGA-AJ-A8CW-01A-11D-A37M-01	TCGA-AJ-A8CW-01	TCGA-AJ-A8CW-01	TCGA-AJ-A8CW-01A-11D-A37Q-05		
TCGA-AP-A051-01	MSI-H	0	TCGA-AP-A051-01	3948	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-AP-A051	3948	0	days	3948	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69			TCGA-AP-A051-F68440	TCGA-AP-A051	TCGA-AP-A051-01A	Never Used	Stage IA	NO		-25269	2475		0	3948				NO			2014-11-17	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A051.2146A2FC-99EE-4939-AD9F-086BB77D2B21.pdf	A051	37	negative	TUMOR FREE			NO	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP		0		0	Endometrial	A	LIVING	97	2003		TCGA-AP-A051-01	TCGA-AP-A051-01		TCGA-AP-A051-01A-11-A162-20	E1F9F4C1-CBB9-49FB-BBAC-E1CA174F5FCB	TCGA-AP-A051-01	TCGA-AP-A051-01			TCGA-AP-A051-01A-21W-A027-09	TCGA-AP-A051-01A-21W-A027-09		TCGA-AP-A051-01		520ac0a0-a49f-4990-8a49-dfe312361e30	TCGA-AP-A051-01A-21D-A00X-01	TCGA-AP-A051-01A-21R-A00V-07	TCGA-AP-A051-01A-21D-A00X-01		TCGA-AP-A051-01		TCGA-AP-A051-01A-21D-A00U-05	520ac0a0-a49f-4990-8a49-dfe312361e30
TCGA-AP-A052-01	MSS	1	TCGA-AP-A052-01	669	1	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 3	TCGA-AP-A052			days	669	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	59	0	0	TCGA-AP-A052-F3393	TCGA-AP-A052	TCGA-AP-A052-01A	Former User	Stage IVB	NO		-21721	2211	669	0				394	NO			2010-9-23	FEMALE	165	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	500	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AP-A052.830EF496-4672-4E9A-B662-DCB4678E99B0.pdf	A052	0	negative	WITH TUMOR	0	0		1	Complete Remission/Response	Never Used		NO				R2	Primary Tumor	01	open		YES	NO	YES	AP	0	0	0	0	Endometrial	A	DECEASED	126	2004			TCGA-AP-A052-01		TCGA-AP-A052-01A-21-A162-20	48950750-AF24-4930-A739-4D029A0D5B2D	TCGA-AP-A052-01			TCGA-AP-A052-01A-11W-A027-09	TCGA-AP-A052-01A-11W-A027-09	TCGA-AP-A052-01A-11W-A027-09		TCGA-AP-A052-01		2b64fee1-6e95-417d-b9b7-25bad9db4dc3	TCGA-AP-A052-01A-11D-A00X-01	TCGA-AP-A052-01A-11R-A00V-07	TCGA-AP-A052-01A-11D-A00X-01		TCGA-AP-A052-01		TCGA-AP-A052-01A-11D-A00U-05	2b64fee1-6e95-417d-b9b7-25bad9db4dc3
TCGA-AP-A053-01	MSS	1	TCGA-AP-A053-01	3365	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-AP-A053			days	3365	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					90	0	0	TCGA-AP-A053-F68441	TCGA-AP-A053	TCGA-AP-A053-01A	Never Used	Stage IA	NO		-32872	2163	3365	0	18				YES			2014-11-17	FEMALE	156	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	Yes	TCGA-AP-A053.6179478F-93BE-4C03-9F65-D74E66AFE449.pdf	A053	25	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Former User		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	3	0	12	Endometrial	A	DECEASED	48	2004			TCGA-AP-A053-01		TCGA-AP-A053-01A-11-A162-20	C6D00B82-9791-4C99-AC08-263A2BC2E33E	TCGA-AP-A053-01			TCGA-AP-A053-01A-21W-A027-09	TCGA-AP-A053-01A-21W-A027-09	TCGA-AP-A053-01A-21W-A027-09		TCGA-AP-A053-01		bd558781-2e3b-4fb0-aeb8-a8cefbf3272d	TCGA-AP-A053-01A-21D-A00X-01	TCGA-AP-A053-01A-21R-A00V-07	TCGA-AP-A053-01A-21D-A00X-01		TCGA-AP-A053-01		TCGA-AP-A053-01A-21D-A00U-05	bd558781-2e3b-4fb0-aeb8-a8cefbf3272d
TCGA-AP-A054-01	MSI-H	1	TCGA-AP-A054-01	709	1	days	Iq	C11-small-various	UCEC CIMP c18	cluster 1	OV-like c4	GBM-like c6	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-AP-A054			days	709	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES	Progressive Disease	64	0	0	TCGA-AP-A054-F3409	TCGA-AP-A054	TCGA-AP-A054-01A	Never Used	Stage IIIC1	NO	604	-23404	2086	709	0				566	NO			2010-9-23	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AP-A054.72028DF7-DAD0-487E-914B-C3AA69A1E6C4.pdf	A054	100	positive	WITH TUMOR	0	1		2	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	Metastatic	R0	R1	Primary Tumor	01	open		YES	NO	YES	AP	0	4	1	22	Endometrial	A	DECEASED	75	2004		TCGA-AP-A054-01	TCGA-AP-A054-01		TCGA-AP-A054-01A-21-A162-20	566C65B2-4775-4AC8-B63D-21ED246B0523	TCGA-AP-A054-01	TCGA-AP-A054-01			TCGA-AP-A054-01A-11W-A062-09	TCGA-AP-A054-01A-11W-A062-09		TCGA-AP-A054-01		2fc92e79-f56f-46b9-b378-a242dd7642d6	TCGA-AP-A054-01A-11D-A042-01	TCGA-AP-A054-01A-11R-A040-07	TCGA-AP-A054-01A-11D-A042-01		TCGA-AP-A054-01		TCGA-AP-A054-01A-11D-A039-05	2fc92e79-f56f-46b9-b378-a242dd7642d6
TCGA-AP-A056-01	MSI-L	0	TCGA-AP-A056-01	2618	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 11	TCGA-AP-A056	2618	0	days	2618	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-AP-A056-F29046	TCGA-AP-A056	TCGA-AP-A056-01A		Stage II	NO		-23707	2017		0	2618	2096			NO			2012-3-6	FEMALE	151	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	Pap Smear	Other method, specify:	400	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A056.008786AD-6CA8-488D-A5AC-BA558985E765.pdf	A056	96	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	18	0	20	Endometrial	A	LIVING	56	2004			TCGA-AP-A056-01		TCGA-AP-A056-01A-21-A162-20	7940CC0D-31A6-4780-9516-A7DDF53EEBBF	TCGA-AP-A056-01				TCGA-AP-A056-01A-11W-A027-09	TCGA-AP-A056-01A-11W-A027-09		TCGA-AP-A056-01		833990d5-5a6c-4d68-b15b-f2cc2309c611	TCGA-AP-A056-01A-11D-A00X-01	TCGA-AP-A056-01A-11R-A00V-07	TCGA-AP-A056-01A-11D-A00X-01		TCGA-AP-A056-01		TCGA-AP-A056-01A-11D-A00U-05	833990d5-5a6c-4d68-b15b-f2cc2309c611
TCGA-AP-A059-01	MSI-H	0	TCGA-AP-A059-01	1461	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 11	TCGA-AP-A059			days	1461	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					69	0	0	TCGA-AP-A059-F68482	TCGA-AP-A059	TCGA-AP-A059-01A	Never Used	Stage IA	NO		-25311	1476		0	1461				NO			2014-11-19	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AP-A059.29A150D3-D5F0-4222-B082-6ABE35A2BB46.pdf	A059	12	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	6	0	13	Endometrial	A	LIVING	99	2006			TCGA-AP-A059-01		TCGA-AP-A059-01A-11-A162-20	F2B96570-CB63-4102-95C8-A42A6F59F620					TCGA-AP-A059-01A-21D-A122-09	TCGA-AP-A059-01A-21D-A122-09			TCGA-AP-A059-01	1d8b3e3b-590d-4087-9506-d6b0b2bab9a9	TCGA-AP-A059-01A-21D-A120-01		TCGA-AP-A059-01A-21D-A120-01	TCGA-AP-A059-01	TCGA-AP-A059-01	TCGA-AP-A059-01A-21D-A123-05		1d8b3e3b-590d-4087-9506-d6b0b2bab9a9
TCGA-AP-A05A-01	MSS	1	TCGA-AP-A05A-01	1944	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 5	TCGA-AP-A05A	1944	0	days	1944	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	81	0	0	TCGA-AP-A05A-F29051	TCGA-AP-A05A	TCGA-AP-A05A-01A		Stage II	NO		-29914	1479	1944	0	1199	1634			YES			2012-3-6	FEMALE		Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A05A.1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08.pdf	A05A	91	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	0	0	6	Endometrial	A	DECEASED		2006			TCGA-AP-A05A-01		TCGA-AP-A05A-01A-21-A162-20	4DB12D27-16C1-4BE7-B060-977F3F5CAA30	TCGA-AP-A05A-01			TCGA-AP-A05A-01A-11W-A027-09	TCGA-AP-A05A-01A-11W-A027-09	TCGA-AP-A05A-01A-11W-A027-09		TCGA-AP-A05A-01		02528092-3a7a-4ddf-8801-e47a48fdeafe	TCGA-AP-A05A-01A-11D-A00X-01	TCGA-AP-A05A-01A-11R-A00V-07	TCGA-AP-A05A-01A-11D-A00X-01		TCGA-AP-A05A-01		TCGA-AP-A05A-01A-11D-A00U-05	02528092-3a7a-4ddf-8801-e47a48fdeafe
TCGA-AP-A05D-01	MSS	0	TCGA-AP-A05D-01	1758	0	days	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 3	TCGA-AP-A05D	1758	0	days	1758	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67	0	1	TCGA-AP-A05D-F29055	TCGA-AP-A05D	TCGA-AP-A05D-01A	Never Used	Stage IIIC2	YES		-24597	1063		0	1758				NO			2012-3-6	FEMALE	161	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-AP-A05D.3312F531-00A3-4104-8C9C-8734C32C89C0.pdf	A05D	73	negative	TUMOR FREE	0	1		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	1	8	1	29	Endometrial	A	LIVING	98	2007			TCGA-AP-A05D-01		TCGA-AP-A05D-01A-21-A162-20	8949703E-7677-4A5F-9DE7-19C9EDBCF894	TCGA-AP-A05D-01			TCGA-AP-A05D-01A-11W-A027-09	TCGA-AP-A05D-01A-11W-A027-09	TCGA-AP-A05D-01A-11W-A027-09		TCGA-AP-A05D-01		c60df680-5bd6-48cc-a112-985f73d9092c	TCGA-AP-A05D-01A-11D-A00X-01	TCGA-AP-A05D-01A-11R-A00V-07	TCGA-AP-A05D-01A-11D-A00X-01		TCGA-AP-A05D-01		TCGA-AP-A05D-01A-11D-A00U-05	c60df680-5bd6-48cc-a112-985f73d9092c
TCGA-AP-A05H-01	MSS	0	TCGA-AP-A05H-01	1385	0	days	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 13	TCGA-AP-A05H	1385	0	days	1385	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75	0	0	TCGA-AP-A05H-F29059	TCGA-AP-A05H	TCGA-AP-A05H-01A		Stage IB	NO		-27744	706		0	1385	863			NO			2012-3-6	FEMALE	153	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A05H.805B997D-9755-4AC1-8695-294806148F25.pdf	A05H	61	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	7	0	24	Endometrial	A	LIVING	89	2008			TCGA-AP-A05H-01		TCGA-AP-A05H-01A-21-A162-20	9E9C27A1-EBEF-41DC-891A-7256F805297F	TCGA-AP-A05H-01			TCGA-AP-A05H-01A-11W-A027-09	TCGA-AP-A05H-01A-11W-A027-09	TCGA-AP-A05H-01A-11W-A027-09		TCGA-AP-A05H-01		b3516570-4a66-418f-87e1-32829d67ec1c	TCGA-AP-A05H-01A-11D-A00X-01	TCGA-AP-A05H-01A-11R-A00V-07	TCGA-AP-A05H-01A-11D-A00X-01		TCGA-AP-A05H-01		TCGA-AP-A05H-01A-11D-A00U-05	b3516570-4a66-418f-87e1-32829d67ec1c
TCGA-AP-A05J-01	MSS	0	TCGA-AP-A05J-01	1122	0	days	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11			mutation cluster 5	TCGA-AP-A05J	1122	0	days	1122	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	66	0	0	TCGA-AP-A05J-F29060	TCGA-AP-A05J	TCGA-AP-A05J-01A		Stage II	NO		-24119	566		0	1122	729			NO			2012-3-6	FEMALE	168	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A05J.C6426DA0-86C5-49CC-9983-A0002DA0D4F2.pdf	A05J	0	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	1	0	14	Endometrial	A	LIVING	79	2008			TCGA-AP-A05J-01		TCGA-AP-A05J-01A-21-A162-20	7B9D2566-40DC-4A4F-A4BE-A5CD1E56BFA2	TCGA-AP-A05J-01			TCGA-AP-A05J-01A-11W-A027-09	TCGA-AP-A05J-01A-11W-A027-09	TCGA-AP-A05J-01A-11W-A027-09		TCGA-AP-A05J-01		dbe07c69-fd67-4dcd-b69d-6bdc4a85110c	TCGA-AP-A05J-01A-11D-A00X-01	TCGA-AP-A05J-01A-11R-A00V-07	TCGA-AP-A05J-01A-11D-A00X-01		TCGA-AP-A05J-01		TCGA-AP-A05J-01A-11D-A00U-05	dbe07c69-fd67-4dcd-b69d-6bdc4a85110c
TCGA-AP-A05N-01	MSI-H	1	TCGA-AP-A05N-01	726	1	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11			mutation cluster 14	TCGA-AP-A05N	726	0	days	726	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-AP-A05N-F16693	TCGA-AP-A05N	TCGA-AP-A05N-01A	Former User	Stage IA	NO		-21254	232	726	0	239	394			NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	350	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	No	TCGA-AP-A05N.E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5.pdf	A05N	23	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	2	Endometrial	A	DECEASED	123	2009			TCGA-AP-A05N-01		TCGA-AP-A05N-01A-21-A162-20	E5EB1353-69A4-4A11-BB90-B4C98225B1DA	TCGA-AP-A05N-01			TCGA-AP-A05N-01A-11W-A027-09	TCGA-AP-A05N-01A-11W-A027-09	TCGA-AP-A05N-01A-11W-A027-09		TCGA-AP-A05N-01		63ba785b-9345-4cc3-b0af-a1a1d45b59b3	TCGA-AP-A05N-01A-11D-A00X-01	TCGA-AP-A05N-01A-11R-A00V-07	TCGA-AP-A05N-01A-11D-A00X-01		TCGA-AP-A05N-01		TCGA-AP-A05N-01A-11D-A00U-05	63ba785b-9345-4cc3-b0af-a1a1d45b59b3
TCGA-AP-A05O-01	MSI-H	0	TCGA-AP-A05O-01	384	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AP-A05O	340	1	days	384	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			YES	Complete Response	68			TCGA-AP-A05O-F68484	TCGA-AP-A05O	TCGA-AP-A05O-01A	Never Used	Stage IB	NO	344	-24978	209		0	384			340	YES			2014-11-19	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	No	TCGA-AP-A05O.9C8BD34A-DC49-4547-850A-80DCD2D073F8.pdf	A05O	80	negative	TUMOR FREE	0	0	YES	3	Complete Remission/Response	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	AP		0	0	23	Endometrial	A	LIVING	103	2009			TCGA-AP-A05O-01		TCGA-AP-A05O-01A-21-A162-20	FA95D970-8B04-40E4-B2DF-1A2E9E2910E7									TCGA-AP-A05O-01	00186124-cecf-4580-9dca-cef7c09f741c	TCGA-AP-A05O-01A-12D-A120-01		TCGA-AP-A05O-01A-12D-A120-01	TCGA-AP-A05O-01	TCGA-AP-A05O-01	TCGA-AP-A05O-01A-12D-A123-05		00186124-cecf-4580-9dca-cef7c09f741c
TCGA-AP-A05P-01	MSS	0	TCGA-AP-A05P-01	636	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-AP-A05P	636	0	days	636	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54	0	0	TCGA-AP-A05P-F16694	TCGA-AP-A05P	TCGA-AP-A05P-01A	Never Used	Stage IA	NO		-20017	203		0	636				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	No	TCGA-AP-A05P.5BA23C70-805A-4356-B739-AFBAFD29D7FC.pdf	A05P	0	negative	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	4	Endometrial	A	LIVING	74	2009		TCGA-AP-A05P-01	TCGA-AP-A05P-01		TCGA-AP-A05P-01A-21-A162-20	7E58EFEF-758A-4B54-A989-7E76AD97D014	TCGA-AP-A05P-01	TCGA-AP-A05P-01		TCGA-AP-A05P-01A-11W-A062-09	TCGA-AP-A05P-01A-11W-A062-09	TCGA-AP-A05P-01A-11W-A062-09		TCGA-AP-A05P-01		167b2ac1-034d-4eac-982e-b96f65bedfb2	TCGA-AP-A05P-01A-11D-A042-01	TCGA-AP-A05P-01A-11R-A040-07	TCGA-AP-A05P-01A-11D-A042-01		TCGA-AP-A05P-01		TCGA-AP-A05P-01A-11D-A039-05	167b2ac1-034d-4eac-982e-b96f65bedfb2
TCGA-AP-A0L8-01	MSS	1	TCGA-AP-A0L8-01	1484	1	days	High	C6-UCEC	UCEC Serous c4	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-AP-A0L8			days	1484	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Progressive Disease	70	0	1	TCGA-AP-A0L8-F3824	TCGA-AP-A0L8		Never Used	Stage IIIC2	NO		-25733		1484	0				1453	NO			2010-9-23	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							No		A0L8	87	negative	WITH TUMOR	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	AP	1	6	0	6	Endometrial		DECEASED	61	2000		TCGA-AP-A0L8-01	TCGA-AP-A0L8-01				TCGA-AP-A0L8-01	TCGA-AP-A0L8-01		TCGA-AP-A0L8-01A-11W-A062-09	TCGA-AP-A0L8-01A-11W-A062-09	TCGA-AP-A0L8-01A-11W-A062-09		TCGA-AP-A0L8-01		ca1e32b0-7daf-403e-a3b2-7cfd3948cedf	TCGA-AP-A0L8-01A-11D-A042-01	TCGA-AP-A0L8-01A-11R-A040-07	TCGA-AP-A0L8-01A-11D-A042-01		TCGA-AP-A0L8-01		TCGA-AP-A0L8-01A-11D-A039-05	ca1e32b0-7daf-403e-a3b2-7cfd3948cedf
TCGA-AP-A0L9-01	MSS	0	TCGA-AP-A0L9-01	3815	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-AP-A0L9	3815	0	days	3815	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71	0	0	TCGA-AP-A0L9-F29042	TCGA-AP-A0L9	TCGA-AP-A0L9-01A		Stage IA	NO		-26185	3402		0	3815	3456			NO			2012-3-6	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A0L9.62E44C56-838D-4318-B8F7-80476A148C03.pdf	A0L9	0	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	2	0	12	Endometrial	A	LIVING	60	2001		TCGA-AP-A0L9-01	TCGA-AP-A0L9-01				TCGA-AP-A0L9-01	TCGA-AP-A0L9-01		TCGA-AP-A0L9-01A-11W-A062-09	TCGA-AP-A0L9-01A-11W-A062-09	TCGA-AP-A0L9-01A-11W-A062-09		TCGA-AP-A0L9-01		43abe272-41cb-4b54-b6f6-50a27c670e46	TCGA-AP-A0L9-01A-11D-A042-01	TCGA-AP-A0L9-01A-11R-A040-07	TCGA-AP-A0L9-01A-11D-A042-01		TCGA-AP-A0L9-01		TCGA-AP-A0L9-01A-11D-A039-05	43abe272-41cb-4b54-b6f6-50a27c670e46
TCGA-AP-A0LD-01	MSI-H	0	TCGA-AP-A0LD-01	3589	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 1	TCGA-AP-A0LD	3589	0	days	3589	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63	0	0	TCGA-AP-A0LD-F29043	TCGA-AP-A0LD	TCGA-AP-A0LD-01A	Never Used	Stage IB	NO		-23216	2993		0	3589	3083			YES			2012-3-6	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A0LD.10B9E917-C1FB-480D-9DB2-8E93FA446ADC.pdf	A0LD	87	negative	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	12	0	20	Endometrial	A	LIVING	68	2002		TCGA-AP-A0LD-01	TCGA-AP-A0LD-01		TCGA-AP-A0LD-01A-21-A162-20	833628B6-91CA-4896-9796-6D9F0F57DCF1	TCGA-AP-A0LD-01	TCGA-AP-A0LD-01		TCGA-AP-A0LD-01A-11W-A062-09	TCGA-AP-A0LD-01A-11W-A062-09	TCGA-AP-A0LD-01A-11W-A062-09		TCGA-AP-A0LD-01		c094698b-0de5-4f14-9b3e-7f2deedde428	TCGA-AP-A0LD-01A-11D-A042-01	TCGA-AP-A0LD-01A-11R-A040-07	TCGA-AP-A0LD-01A-11D-A042-01		TCGA-AP-A0LD-01		TCGA-AP-A0LD-01A-11D-A039-05	c094698b-0de5-4f14-9b3e-7f2deedde428
TCGA-AP-A0LE-01	MSI-H	0	TCGA-AP-A0LE-01	3357	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-AP-A0LE	3357	0	days	3357	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-AP-A0LE-F29044	TCGA-AP-A0LE	TCGA-AP-A0LE-01A	Former User	Stage IA	NO		-20967	2988		0	3357				YES			2012-3-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A0LE.3EA84930-6B34-43B8-A5A8-3D2B3754155F.pdf	A0LE	5	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	5	0	19	Endometrial	A	LIVING	75	2002		TCGA-AP-A0LE-01	TCGA-AP-A0LE-01		TCGA-AP-A0LE-01A-21-A162-20	164F62FF-A3BE-465D-B511-EBA500C9E7FA		TCGA-AP-A0LE-01		TCGA-AP-A0LE-01A-11D-A127-09	TCGA-AP-A0LE-01A-11D-A127-09	TCGA-AP-A0LE-01A-11D-A127-09				3701ff8a-afd6-4a3d-aae4-735325390d1f	TCGA-AP-A0LE-01A-11D-A102-01		TCGA-AP-A0LE-01A-11D-A102-01		TCGA-AP-A0LE-01		TCGA-AP-A0LE-01A-11D-A10Q-05	3701ff8a-afd6-4a3d-aae4-735325390d1f
TCGA-AP-A0LF-01	MSS	0	TCGA-AP-A0LF-01	2859	0	days	High	C6-UCEC	UCEC Serous c4	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 13	TCGA-AP-A0LF			days	2859	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					82	0	0	TCGA-AP-A0LF-F68473	TCGA-AP-A0LF	TCGA-AP-A0LF-01A	Never Used	Stage IVB	NO		-30027	2891		0	2859				NO			2014-11-19	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	Yes	TCGA-AP-A0LF.7112CE75-9EFD-4989-9F2A-4D0F517B8EDE.pdf	A0LF	17		WITH TUMOR	0	14		2		Never Used		NO				R2	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	10	14	32	Endometrial	A	LIVING	72	2002			TCGA-AP-A0LF-01		TCGA-AP-A0LF-01A-21-A162-20	4F747B8B-48BD-4672-AD42-B142645B56F5				TCGA-AP-A0LF-01A-11D-A122-09	TCGA-AP-A0LF-01A-11D-A122-09	TCGA-AP-A0LF-01A-11D-A122-09			TCGA-AP-A0LF-01	2c5d86e0-2e3d-4259-97e9-023df54c8c56	TCGA-AP-A0LF-01A-11D-A120-01		TCGA-AP-A0LF-01A-11D-A120-01	TCGA-AP-A0LF-01	TCGA-AP-A0LF-01	TCGA-AP-A0LF-01A-11D-A123-05		2c5d86e0-2e3d-4259-97e9-023df54c8c56
TCGA-AP-A0LG-01	MSI-H	0	TCGA-AP-A0LG-01	2015	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-AP-A0LG			days	2015	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					54	0	0	TCGA-AP-A0LG-F68442	TCGA-AP-A0LG	TCGA-AP-A0LG-01A	Never Used	Stage IA	NO		-20047	2833		0	2015				NO			2014-11-17	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AP-A0LG.7343A9B5-276E-4EE1-AC06-27835D63B0E2.pdf	A0LG	18	negative	TUMOR FREE	0	0	NO	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	2	0	3	Endometrial	A	LIVING	76	2002		TCGA-AP-A0LG-01	TCGA-AP-A0LG-01		TCGA-AP-A0LG-01A-21-A162-20	7058B69A-0F87-471D-A36D-E355BC950F3E	TCGA-AP-A0LG-01	TCGA-AP-A0LG-01		TCGA-AP-A0LG-01A-11W-A062-09	TCGA-AP-A0LG-01A-11W-A062-09	TCGA-AP-A0LG-01A-11W-A062-09		TCGA-AP-A0LG-01		e4db21b5-9a76-47c1-b838-10f49d2696d0	TCGA-AP-A0LG-01A-11D-A042-01	TCGA-AP-A0LG-01A-11R-A040-07	TCGA-AP-A0LG-01A-11D-A042-01		TCGA-AP-A0LG-01		TCGA-AP-A0LG-01A-11D-A039-05	e4db21b5-9a76-47c1-b838-10f49d2696d0
TCGA-AP-A0LH-01	MSS	1	TCGA-AP-A0LH-01	1106	1	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	COADREAD-like c15	miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-AP-A0LH			days	1106	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	60	0	0	TCGA-AP-A0LH-F3950	TCGA-AP-A0LH	TCGA-AP-A0LH-01A	Never Used	Stage IA	NO		-22169	2772	1106	0				302	NO			2010-9-23	FEMALE	164	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AP-A0LH.78E73020-1173-45DA-BDBA-DFB1CF7BCB41.pdf	A0LH	0	positive	WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	0	14	0	17	Endometrial	A	DECEASED	83	2002		TCGA-AP-A0LH-01	TCGA-AP-A0LH-01		TCGA-AP-A0LH-01A-21-A162-20	186CD641-E906-4F42-B3CE-8CF9B361AE3A	TCGA-AP-A0LH-01	TCGA-AP-A0LH-01		TCGA-AP-A0LH-01A-11W-A062-09	TCGA-AP-A0LH-01A-11W-A062-09	TCGA-AP-A0LH-01A-11W-A062-09		TCGA-AP-A0LH-01		39dbc57b-dd7d-4ebe-a905-47b500adef88	TCGA-AP-A0LH-01A-11D-A042-01	TCGA-AP-A0LH-01A-11R-A040-07	TCGA-AP-A0LH-01A-11D-A042-01		TCGA-AP-A0LH-01		TCGA-AP-A0LH-01A-11D-A039-05	39dbc57b-dd7d-4ebe-a905-47b500adef88
TCGA-AP-A0LI-01	MSS	0	TCGA-AP-A0LI-01	2972	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 13	TCGA-AP-A0LI	2972	0	days	2972	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67	0	2	TCGA-AP-A0LI-F29045	TCGA-AP-A0LI	TCGA-AP-A0LI-01A	Never Used	Stage IIIC2	NO		-24573	2567		0	2972				NO			2012-3-6	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES	Cervical biopsy	Other method, specify:	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A0LI.EFEA05D7-E720-4FE4-977C-6A6369B1BA2E.pdf	A0LI	83	negative	TUMOR FREE	0			4+	Complete Remission/Response	Never Used		NO				R2	Primary Tumor	01	open		NO	NO	YES	AP	2	3		26	Endometrial	A	LIVING	86	2003		TCGA-AP-A0LI-01	TCGA-AP-A0LI-01		TCGA-AP-A0LI-01A-21-A162-20	7625DF56-46C8-401F-9FE3-D95D692BC04A		TCGA-AP-A0LI-01		TCGA-AP-A0LI-01A-11W-A062-09	TCGA-AP-A0LI-01A-11W-A062-09	TCGA-AP-A0LI-01A-11W-A062-09				0fd52e18-275a-4c3d-8c8d-9e27859a5482	TCGA-AP-A0LI-01A-11D-A042-01		TCGA-AP-A0LI-01A-11D-A042-01		TCGA-AP-A0LI-01		TCGA-AP-A0LI-01A-11D-A039-05	0fd52e18-275a-4c3d-8c8d-9e27859a5482
TCGA-AP-A0LJ-01	MSS	0	TCGA-AP-A0LJ-01	1421	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AP-A0LJ			days	1421	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					42	0	0	TCGA-AP-A0LJ-F68468	TCGA-AP-A0LJ	TCGA-AP-A0LJ-01A	Never Used	Stage IA	NO		-15577	2290		0	1421				NO			2014-11-19	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	680	NO	YES	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1						true	No	TCGA-AP-A0LJ.859CBF70-D72E-4843-B3AA-6226B707AA2B.pdf	A0LJ	0	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	6	0	14	Endometrial	A	LIVING	80	2004		TCGA-AP-A0LJ-01	TCGA-AP-A0LJ-01		TCGA-AP-A0LJ-01A-21-A162-20	FE469D1C-3900-4649-A36E-562F8047F8E0	TCGA-AP-A0LJ-01	TCGA-AP-A0LJ-01		TCGA-AP-A0LJ-01A-11W-A062-09	TCGA-AP-A0LJ-01A-11W-A062-09	TCGA-AP-A0LJ-01A-11W-A062-09		TCGA-AP-A0LJ-01		db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6	TCGA-AP-A0LJ-01A-11D-A042-01	TCGA-AP-A0LJ-01A-11R-A040-07	TCGA-AP-A0LJ-01A-11D-A042-01		TCGA-AP-A0LJ-01		TCGA-AP-A0LJ-01A-11D-A039-05	db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6
TCGA-AP-A0LL-01	MSS	0	TCGA-AP-A0LL-01	2554	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-AP-A0LL	2554	0	days	2554	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	56	0	0	TCGA-AP-A0LL-F29047	TCGA-AP-A0LL	TCGA-AP-A0LL-01A		Stage IA	NO	792	-20700	2066		0	2554			790	NO			2012-3-6	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-AP-A0LL.B4A6F5DE-E477-48FD-ADA1-EAE436FBC576.pdf	A0LL	8	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	LOCOREGIOL	R0	R0	Primary Tumor	01	open		NO	NO	YES	AP	0	8	0	29	Endometrial	A	LIVING	72	2004		TCGA-AP-A0LL-01	TCGA-AP-A0LL-01		TCGA-AP-A0LL-01A-21-A162-20	5B026F34-12B6-4DCC-838A-E65120AED9C7		TCGA-AP-A0LL-01		TCGA-AP-A0LL-01A-12D-A127-09	TCGA-AP-A0LL-01A-12D-A127-09	TCGA-AP-A0LL-01A-12D-A127-09				96756b4d-0e43-404d-a819-dc6da126eef8	TCGA-AP-A0LL-01A-12D-A102-01		TCGA-AP-A0LL-01A-12D-A102-01		TCGA-AP-A0LL-01		TCGA-AP-A0LL-01A-12D-A10Q-05	96756b4d-0e43-404d-a819-dc6da126eef8
TCGA-AP-A0LM-01	MSS	0	TCGA-AP-A0LM-01	825	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 11	TCGA-AP-A0LM			days	825	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					33	0	1	TCGA-AP-A0LM-F6990	TCGA-AP-A0LM	TCGA-AP-A0LM-01A		Stage IIIC2	NO		-12309	2019		0	825				NO			2011-2-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						true	No	TCGA-AP-A0LM.BF380986-0279-41FC-AAE8-BA9772456CE6.pdf	A0LM	71	negative	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	1	13	0	40	Endometrial	A	LIVING	100	2004			TCGA-AP-A0LM-01		TCGA-AP-A0LM-01A-21-A162-20	11FA828B-C9E3-4BD4-B7C6-35F19EBEAA9A					TCGA-AP-A0LM-01A-11D-A122-09	TCGA-AP-A0LM-01A-11D-A122-09			TCGA-AP-A0LM-01	db91880d-1e53-4852-8a94-dd40e2b9aa6c	TCGA-AP-A0LM-01A-11D-A120-01		TCGA-AP-A0LM-01A-11D-A120-01	TCGA-AP-A0LM-01	TCGA-AP-A0LM-01	TCGA-AP-A0LM-01A-11D-A123-05		db91880d-1e53-4852-8a94-dd40e2b9aa6c
TCGA-AP-A0LN-01	MSS	0	TCGA-AP-A0LN-01	2510	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AP-A0LN	2510	0	days	2510	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-AP-A0LN-F29048	TCGA-AP-A0LN	TCGA-AP-A0LN-01A		Stage IA	NO		-20704	1907		0	2510				NO		Scheduled Follow-up Submission	2012-3-6	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-AP-A0LN.D50C7207-D840-48A2-8D73-E1C71FFA73E1.pdf	A0LN	0	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP		0	0	36	Endometrial	A	LIVING	119	2005		TCGA-AP-A0LN-01	TCGA-AP-A0LN-01		TCGA-AP-A0LN-01A-21-A162-20	DC2D620E-E811-473A-8780-61287FC2F992	TCGA-AP-A0LN-01	TCGA-AP-A0LN-01		TCGA-AP-A0LN-01A-11W-A062-09	TCGA-AP-A0LN-01A-11W-A062-09	TCGA-AP-A0LN-01A-11W-A062-09		TCGA-AP-A0LN-01		cc57fe2e-2370-4697-828f-eee51aacbe0b	TCGA-AP-A0LN-01A-11D-A042-01	TCGA-AP-A0LN-01A-11R-A040-07	TCGA-AP-A0LN-01A-11D-A042-01		TCGA-AP-A0LN-01		TCGA-AP-A0LN-01A-11D-A039-05	cc57fe2e-2370-4697-828f-eee51aacbe0b
TCGA-AP-A0LO-01	MSS	1	TCGA-AP-A0LO-01	1016	1	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11			mutation cluster 4	TCGA-AP-A0LO			days	1016	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	YES	Complete Response	45	0	0	TCGA-AP-A0LO-F4021	TCGA-AP-A0LO		Former User	Stage IA	NO	585	-16493		1016	0				516	YES			2010-9-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							No		A0LO	0	negative	WITH TUMOR	0	0		3	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	LOCOREGIOL	R2	R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	6	0	15	Endometrial		DECEASED	67	2005			TCGA-AP-A0LO-01							TCGA-AP-A0LO-01A-11W-A062-09	TCGA-AP-A0LO-01A-11W-A062-09	TCGA-AP-A0LO-01A-11W-A062-09			TCGA-AP-A0LO-01	e563cfb5-6904-45c6-acbb-ac96bfb9770b	TCGA-AP-A0LO-01A-11D-A042-01		TCGA-AP-A0LO-01A-11D-A042-01	TCGA-AP-A0LO-01	TCGA-AP-A0LO-01		TCGA-AP-A0LO-01A-11D-A039-05	e563cfb5-6904-45c6-acbb-ac96bfb9770b
TCGA-AP-A0LP-01	MSI-H	0	TCGA-AP-A0LP-01	1875	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 14	TCGA-AP-A0LP			days	1875	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					76	0	0	TCGA-AP-A0LP-F4030	TCGA-AP-A0LP	TCGA-AP-A0LP-01A	Never Used	Stage IA	NO		-27898	1884		0	1875				NO			2010-9-23	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						true	No	TCGA-AP-A0LP.ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3.pdf	A0LP	12	positive	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	AP	0	10	0	17	Endometrial	A	LIVING	60	2005		TCGA-AP-A0LP-01	TCGA-AP-A0LP-01		TCGA-AP-A0LP-01A-21-A162-20	1A47B25B-E5B8-4D98-900B-F0D2D0ABB3A8		TCGA-AP-A0LP-01		TCGA-AP-A0LP-01A-12D-A10B-09	TCGA-AP-A0LP-01A-12D-A10B-09	TCGA-AP-A0LP-01A-12D-A10B-09				1fea8c9c-7f1f-40d9-944a-f542b91c16b5	TCGA-AP-A0LP-01A-12D-A102-01		TCGA-AP-A0LP-01A-12D-A102-01		TCGA-AP-A0LP-01		TCGA-AP-A0LP-01A-12D-A10Q-05	1fea8c9c-7f1f-40d9-944a-f542b91c16b5
TCGA-AP-A0LQ-01	MSS	0	TCGA-AP-A0LQ-01	2457	0	days	Kirc+		UCEC non-CIMP c3	cluster 4			miRNA cluster 11	cluster 2	mutation cluster 4	TCGA-AP-A0LQ	2457	0	days	2457	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59	0	0	TCGA-AP-A0LQ-F29049	TCGA-AP-A0LQ			Stage IA	NO		-21629			0	2457				NO			2012-3-6	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO		No		A0LQ	5	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	6	0	33	Endometrial		LIVING	95	2005		TCGA-AP-A0LQ-01						TCGA-AP-A0LQ-01		TCGA-AP-A0LQ-01A-12D-A10B-09	TCGA-AP-A0LQ-01A-12D-A10B-09	TCGA-AP-A0LQ-01A-12D-A10B-09					TCGA-AP-A0LQ-01A-12D-A102-01		TCGA-AP-A0LQ-01A-12D-A102-01				TCGA-AP-A0LQ-01A-12D-A10Q-05	
TCGA-AP-A0LS-01	MSI-H	0	TCGA-AP-A0LS-01	2904	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AP-A0LS	2904	0	days	2904	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-AP-A0LS-F68432	TCGA-AP-A0LS	TCGA-AP-A0LS-01A		Stage IA			-23126	1421		0	2904							2014-11-17	FEMALE	169	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	Yes	TCGA-AP-A0LS.E802CEF6-BC3F-4C35-85E8-2B37531571CD.pdf	A0LS	21		TUMOR FREE	0	0	NO					YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP		0	0	14	Endometrial	A	LIVING	81	2006			TCGA-AP-A0LS-01		TCGA-AP-A0LS-01A-21-A18Q-20	86FD0DBA-0947-4AC8-B145-E8799F8C335C									TCGA-AP-A0LS-01	929006f8-5f5c-4215-80a9-0ff6a91ef1d6	TCGA-AP-A0LS-01A-11D-A14F-01		TCGA-AP-A0LS-01A-11D-A14F-01	TCGA-AP-A0LS-01	TCGA-AP-A0LS-01	TCGA-AP-A0LS-01A-11D-A14H-05		929006f8-5f5c-4215-80a9-0ff6a91ef1d6
TCGA-AP-A0LT-01	MSI-H	0	TCGA-AP-A0LT-01	1497	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-AP-A0LT	1497	0	days	1497	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-AP-A0LT-F29053	TCGA-AP-A0LT	TCGA-AP-A0LT-01A	Former User	Stage II	NO		-21107	1404		0	1497				NO			2012-3-6	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-AP-A0LT.4A25211C-354E-4FC8-B81B-29766B7962D4.pdf	A0LT	38	negative	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	AP	0	0	0	16	Endometrial	A	LIVING	91	2006		TCGA-AP-A0LT-01	TCGA-AP-A0LT-01		TCGA-AP-A0LT-01A-21-A162-20	D535B5D0-490A-41CE-8FBF-9D6B01DD164A	TCGA-AP-A0LT-01	TCGA-AP-A0LT-01		TCGA-AP-A0LT-01A-11W-A062-09	TCGA-AP-A0LT-01A-11W-A062-09	TCGA-AP-A0LT-01A-11W-A062-09		TCGA-AP-A0LT-01		cda60e53-f917-454b-b1f5-d1f0f8b8f130	TCGA-AP-A0LT-01A-11D-A042-01	TCGA-AP-A0LT-01A-11R-A040-07	TCGA-AP-A0LT-01A-11D-A042-01		TCGA-AP-A0LT-01		TCGA-AP-A0LT-01A-11D-A039-05	cda60e53-f917-454b-b1f5-d1f0f8b8f130
TCGA-AP-A0LV-01	MSS	0	TCGA-AP-A0LV-01	763	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-AP-A0LV	763	0	days	763	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	39	0	0	TCGA-AP-A0LV-F29062	TCGA-AP-A0LV	TCGA-AP-A0LV-01A	Former User	Stage IA	NO		-14556	341		0	763				NO			2012-3-6	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	No	TCGA-AP-A0LV.75767B04-9FDF-4EE9-8DFF-350B60AF281C.pdf	A0LV	36	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	AP	0	0	0	16	Endometrial	A	LIVING	76	2009		TCGA-AP-A0LV-01	TCGA-AP-A0LV-01		TCGA-AP-A0LV-01A-21-A162-20	F9285FF1-70D2-4E1C-B8EE-9CCDE52D9D46	TCGA-AP-A0LV-01	TCGA-AP-A0LV-01		TCGA-AP-A0LV-01A-11W-A062-09	TCGA-AP-A0LV-01A-11W-A062-09	TCGA-AP-A0LV-01A-11W-A062-09		TCGA-AP-A0LV-01		0d04e718-95ff-4eb9-b56f-99c0ee5970d2	TCGA-AP-A0LV-01A-11D-A042-01	TCGA-AP-A0LV-01A-11R-A040-07	TCGA-AP-A0LV-01A-11D-A042-01		TCGA-AP-A0LV-01		TCGA-AP-A0LV-01A-11D-A039-05	0d04e718-95ff-4eb9-b56f-99c0ee5970d2
TCGA-AP-A1DH-01		0	TCGA-AP-A1DH-01	2180	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AP-A1DH	2180	0	days	2180	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62	0	0	TCGA-AP-A1DH-F29050	TCGA-AP-A1DH	TCGA-AP-A1DH-01A		Stage IA			-22652	1843		0	2180							2012-3-6	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A1DH.B77EE1CD-716C-4441-B4A9-CCCC37BD1379.pdf	A1DH	41	negative	TUMOR FREE	0	0						NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	0	0	25	Endometrial	A	LIVING	127	2005			TCGA-AP-A1DH-01		TCGA-AP-A1DH-01A-21-A18Q-20	BF108ABC-32D7-4B1C-8B19-2ADEDB1F178A									TCGA-AP-A1DH-01	c5d7f9d3-70d3-469d-8588-5a125a24efa3	TCGA-AP-A1DH-01A-31D-A134-01		TCGA-AP-A1DH-01A-31D-A134-01	TCGA-AP-A1DH-01	TCGA-AP-A1DH-01	TCGA-AP-A1DH-01A-31D-A138-05		c5d7f9d3-70d3-469d-8588-5a125a24efa3
TCGA-AP-A1DK-01	MSI-H	0	TCGA-AP-A1DK-01	2767	0	days	Quiet		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-AP-A1DK	2767	0	days	2767	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53	0	0	TCGA-AP-A1DK-F68435	TCGA-AP-A1DK	TCGA-AP-A1DK-01A		Stage IA			-19509	1541		0	2767							2014-11-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A1DK.9A3BB88B-F16F-4773-8912-CF519B847354.pdf	A1DK	36	negative	TUMOR FREE	0	0	NO					YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	7	0	20	Endometrial	A	LIVING	56	2006			TCGA-AP-A1DK-01												TCGA-AP-A1DK-01	13096ff9-ae2d-4ccb-8127-8e4238cef4d3	TCGA-AP-A1DK-01A-11D-A134-01		TCGA-AP-A1DK-01A-11D-A134-01	TCGA-AP-A1DK-01	TCGA-AP-A1DK-01	TCGA-AP-A1DK-01A-11D-A138-05		13096ff9-ae2d-4ccb-8127-8e4238cef4d3
TCGA-AP-A1DM-01	MSI-H	0	TCGA-AP-A1DM-01	1700	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AP-A1DM	1700	0	days	1700	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-AP-A1DM-F29056	TCGA-AP-A1DM	TCGA-AP-A1DM-01A		Stage IA			-22239	1309		0	1700							2012-3-6	FEMALE	159	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-AP-A1DM.E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C.pdf	A1DM	23	negative	TUMOR FREE	0	0						NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	4	0	22	Endometrial	A	LIVING	92	2007			TCGA-AP-A1DM-01		TCGA-AP-A1DM-01A-11-A18Q-20	2DA765F6-6546-491B-A2A8-07FCB86B94D0									TCGA-AP-A1DM-01	631c96e1-7e11-4c0f-a6ea-49cd942f4390	TCGA-AP-A1DM-01A-21D-A134-01		TCGA-AP-A1DM-01A-21D-A134-01	TCGA-AP-A1DM-01	TCGA-AP-A1DM-01	TCGA-AP-A1DM-01A-21D-A138-05		631c96e1-7e11-4c0f-a6ea-49cd942f4390
TCGA-AP-A1DO-01	MSI-H	0	TCGA-AP-A1DO-01	952	0	days	Iq	C6-UCEC	BRCA CIMP c7	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1		TCGA-AP-A1DO	952	0	days	952	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62	0	0	TCGA-AP-A1DO-F13624	TCGA-AP-A1DO	TCGA-AP-A1DO-01A	Never Used	Stage IA	NO		-22787	1210		0	952				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-AP-A1DO.EAC1A113-68BB-4D45-AB57-E59E392029BC.pdf	A1DO	24	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	9	0	17	Endometrial	A	LIVING	80	2007			TCGA-AP-A1DO-01		TCGA-AP-A1DO-01A-21-A18Q-20	88B9B7C3-CFE9-4AC9-9B91-110B626EBA6E									TCGA-AP-A1DO-01	6ff22866-1896-4200-bef2-f05724bf15a3	TCGA-AP-A1DO-01A-11D-A134-01		TCGA-AP-A1DO-01A-11D-A134-01	TCGA-AP-A1DO-01	TCGA-AP-A1DO-01	TCGA-AP-A1DO-01A-11D-A138-05		6ff22866-1896-4200-bef2-f05724bf15a3
TCGA-AP-A1DP-01	MSI-H	1	TCGA-AP-A1DP-01	1081	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 1		TCGA-AP-A1DP	831	1	days	1081	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	70	0	0	TCGA-AP-A1DP-F13648	TCGA-AP-A1DP	TCGA-AP-A1DP-01A	Never Used	Stage IA	NO		-25601	1105	1081	0				831	YES		Scheduled Follow-up Submission	2011-9-23	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Metastatic	Lung, liver, lymph nodes		YES	true	No	TCGA-AP-A1DP.20EEB047-0185-4B65-9A6A-43D6C97307C8.pdf	A1DP	46	negative	WITH TUMOR	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	7	0	17	Endometrial	A	DECEASED	83	2008			TCGA-AP-A1DP-01		TCGA-AP-A1DP-01A-21-A18Q-20	4F1CABB5-0907-49C7-80CC-AE14712D3DCA									TCGA-AP-A1DP-01	97b9cac2-2c23-4759-b558-24f7b90fe787	TCGA-AP-A1DP-01A-11D-A134-01		TCGA-AP-A1DP-01A-11D-A134-01	TCGA-AP-A1DP-01	TCGA-AP-A1DP-01	TCGA-AP-A1DP-01A-11D-A138-05		97b9cac2-2c23-4759-b558-24f7b90fe787
TCGA-AP-A1DQ-01	MSS	1	TCGA-AP-A1DQ-01	1423	1	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-AP-A1DQ	1423	0	days	1423	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	76	0	0	TCGA-AP-A1DQ-F29057	TCGA-AP-A1DQ	TCGA-AP-A1DQ-01A		Stage IIIC1			-27815	1074	1423	0	1185							2012-3-6	FEMALE	163	Serous endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	true	No	TCGA-AP-A1DQ.F5983E58-F466-42CF-8905-B942D2BDF702.pdf	A1DQ	82	negative	WITH TUMOR	0	6						NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	1	6	20	Endometrial	A	DECEASED	60	2008			TCGA-AP-A1DQ-01		TCGA-AP-A1DQ-01A-21-A18Q-20	903A7E22-F05E-40BC-A40B-7833FC342F07					TCGA-AP-A1DQ-01A-11D-A135-09	TCGA-AP-A1DQ-01A-11D-A135-09			TCGA-AP-A1DQ-01	19d3602e-79e6-467f-b49d-c2fa216418ed	TCGA-AP-A1DQ-01A-11D-A134-01		TCGA-AP-A1DQ-01A-11D-A134-01	TCGA-AP-A1DQ-01	TCGA-AP-A1DQ-01	TCGA-AP-A1DQ-01A-11D-A138-05		19d3602e-79e6-467f-b49d-c2fa216418ed
TCGA-AP-A1DR-01	MSI-H	0	TCGA-AP-A1DR-01	1495	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-AP-A1DR	1495	0	days	1495	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59	0	0	TCGA-AP-A1DR-F29058	TCGA-AP-A1DR	TCGA-AP-A1DR-01A		Stage IIIC1			-21904	1095		0	1495							2012-3-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-AP-A1DR.75A10A08-04CB-49C2-8086-5F7B1D57524E.pdf	A1DR	27	negative	TUMOR FREE	2	0						NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	2	18	Endometrial	A	LIVING	109	2008			TCGA-AP-A1DR-01		TCGA-AP-A1DR-01A-21-A18Q-20	F10639F4-19FB-4548-ADC6-F6E92B342732									TCGA-AP-A1DR-01	2aacc974-7ee5-4be2-b511-1543745df0bf	TCGA-AP-A1DR-01A-11D-A134-01		TCGA-AP-A1DR-01A-11D-A134-01	TCGA-AP-A1DR-01	TCGA-AP-A1DR-01	TCGA-AP-A1DR-01A-11D-A138-05		2aacc974-7ee5-4be2-b511-1543745df0bf
TCGA-AP-A1DV-01	MSI-L	0	TCGA-AP-A1DV-01	204	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AP-A1DV	204	0	days	204	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59	0	0	TCGA-AP-A1DV-F13635	TCGA-AP-A1DV	TCGA-AP-A1DV-01A	Former User	Stage II	NO		-21901	876		0	204				NO		Scheduled Follow-up Submission	2011-9-23	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A1DV.F3163501-DD37-4C13-A921-3C2A74928BA7.pdf	A1DV	94	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	5	0	21	Endometrial	A	LIVING	46	2008			TCGA-AP-A1DV-01		TCGA-AP-A1DV-01A-11-A18Q-20	CA09409F-45A8-4006-BA8A-23FC3847BFD0									TCGA-AP-A1DV-01	ca0261c0-0935-450b-9e9c-db02f92ecb0e	TCGA-AP-A1DV-01A-21D-A134-01		TCGA-AP-A1DV-01A-21D-A134-01	TCGA-AP-A1DV-01	TCGA-AP-A1DV-01	TCGA-AP-A1DV-01A-21D-A138-05		ca0261c0-0935-450b-9e9c-db02f92ecb0e
TCGA-AP-A1E0-01	MSI-L	0	TCGA-AP-A1E0-01	1832	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AP-A1E0	1832	0	days	1832	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	40	0	1	TCGA-AP-A1E0-F68436	TCGA-AP-A1E0	TCGA-AP-A1E0-01A		Stage IIIC2			-14653	582		0	1832							2014-11-17	FEMALE	158	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	No	TCGA-AP-A1E0.700FD29A-69DC-4B34-B841-FFFA7E76A5AF.pdf	A1E0	35	positive	TUMOR FREE	0	0	YES					NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	AP	1	9	0	3	Endometrial	A	LIVING	59	2009			TCGA-AP-A1E0-01		TCGA-AP-A1E0-01A-21-A18Q-20	D70F0543-7F46-409A-B78E-FB4C215FB336									TCGA-AP-A1E0-01	d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61	TCGA-AP-A1E0-01A-11D-A134-01		TCGA-AP-A1E0-01A-11D-A134-01	TCGA-AP-A1E0-01	TCGA-AP-A1E0-01	TCGA-AP-A1E0-01A-11D-A138-05		d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61
TCGA-AP-A1E1-01	MSI-H	0	TCGA-AP-A1E1-01	1395	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AP-A1E1	1395	0	days	1395	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74	0	0	TCGA-AP-A1E1-F68437	TCGA-AP-A1E1	TCGA-AP-A1E1-01A		Stage IA	NO		-27072	470		0	1395				NO		Scheduled Follow-up Submission	2014-11-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	260	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-AP-A1E1.E8873536-294D-4E41-9165-EE403A11B439.pdf	A1E1	10	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	0	2	Endometrial	A	LIVING	73	2009			TCGA-AP-A1E1-01		TCGA-AP-A1E1-01A-21-A18Q-20	601B63EA-312B-4BFF-A107-2DC549F295C2									TCGA-AP-A1E1-01	2e11f69d-8c0d-484e-8f22-1ad97f26c78d	TCGA-AP-A1E1-01A-11D-A134-01		TCGA-AP-A1E1-01A-11D-A134-01	TCGA-AP-A1E1-01	TCGA-AP-A1E1-01	TCGA-AP-A1E1-01A-11D-A138-05		2e11f69d-8c0d-484e-8f22-1ad97f26c78d
TCGA-AP-A1E3-01	MSS	0	TCGA-AP-A1E3-01	847	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AP-A1E3	847	0	days	847	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	45	0	0	TCGA-AP-A1E3-F29063	TCGA-AP-A1E3	TCGA-AP-A1E3-01A		Stage IIIC1			-16544	440		0	847							2012-3-6	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	350	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	No	TCGA-AP-A1E3.FDA2C217-5267-41CC-AC07-CBACFF8E7B8D.pdf	A1E3	77	negative	WITH TUMOR	0	1						NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	AP	0	0	1	1	Endometrial	A	LIVING	130	2009			TCGA-AP-A1E3-01		TCGA-AP-A1E3-01A-21-A18Q-20	CD1D4130-E1BC-4829-934D-67ACF926D474									TCGA-AP-A1E3-01	0aa199cd-4fa0-4773-9659-1a246e42ad88	TCGA-AP-A1E3-01A-11D-A134-01		TCGA-AP-A1E3-01A-11D-A134-01	TCGA-AP-A1E3-01	TCGA-AP-A1E3-01	TCGA-AP-A1E3-01A-11D-A138-05		0aa199cd-4fa0-4773-9659-1a246e42ad88
TCGA-AP-A1E4-01	MSS	0	TCGA-AP-A1E4-01	1555	0	days	Iq	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AP-A1E4	158	1	days	1555	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	54	0	0	TCGA-AP-A1E4-F68438	TCGA-AP-A1E4	TCGA-AP-A1E4-01A		Stage IB			-19814	154		0	1555			158				2014-11-17	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					YES	true	No	TCGA-AP-A1E4.1E33ABA3-0B55-4021-A370-DB8E2CA4C022.pdf	A1E4	58	negative	WITH TUMOR	0	0	NO					YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	AP	0	0	0	3	Endometrial	A	LIVING	54	2010			TCGA-AP-A1E4-01		TCGA-AP-A1E4-01A-21-A18Q-20	50B326F9-9A74-4C1D-A08D-46B5DDDFACDF									TCGA-AP-A1E4-01	2a549626-7bc3-4ba9-9822-35af631afd0c	TCGA-AP-A1E4-01A-12D-A134-01		TCGA-AP-A1E4-01A-12D-A134-01	TCGA-AP-A1E4-01	TCGA-AP-A1E4-01	TCGA-AP-A1E4-01A-12D-A138-05		2a549626-7bc3-4ba9-9822-35af631afd0c
TCGA-AP-A3K1-01	MSI-L	1	TCGA-AP-A3K1-01	666	1	days	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 13			TCGA-AP-A3K1	198	1	days	666	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	56	0	12	TCGA-AP-A3K1-F38425	TCGA-AP-A3K1	TCGA-AP-A3K1-01A	Never Used	Stage IVB	NO		-20594	450	666	0	555			198	NO			2012-12-14	FEMALE	157	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	190	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Other, specify	Locoregional Recurrence	Paracolic gutter	NO	YES	true	No	TCGA-AP-A3K1.A2E4C9FE-F82D-440E-AA52-88379EBC2442.pdf	A3K1	58.8	positive	WITH TUMOR	0	3	YES	0	Progressive Disease	Never Used		NO				RX	Primary Tumor	01	open	2009		NO	YES	AP	12	29	3	34	Endometrial	A	DECEASED	60	2010	c6b592eb-d131-4344-9135-7d9964143c28		TCGA-AP-A3K1-01	c6b592eb-d131-4344-9135-7d9964143c28	TCGA-AP-A3K1-01A-21-A23Z-20	B8160651-765E-4FDD-A02A-1612113DA755			c6b592eb-d131-4344-9135-7d9964143c28				c6b592eb-d131-4344-9135-7d9964143c28		TCGA-AP-A3K1-01		TCGA-AP-A3K1-01A-11D-A20R-01		TCGA-AP-A3K1-01A-11D-A20R-01	TCGA-AP-A3K1-01	TCGA-AP-A3K1-01	TCGA-AP-A3K1-01A-11D-A212-05		
TCGA-AP-A5FX-01	MSS	1	TCGA-AP-A5FX-01	1099	1	days										TCGA-AP-A5FX	1099	0	days	1099	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	68	0	0	TCGA-AP-A5FX-F58067	TCGA-AP-A5FX	TCGA-AP-A5FX-01A	Never Used	Stage IIIC1	NO		-25063	878	1099	0	1026				YES			2014-3-31	FEMALE	168	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8255/3	C54.1	YES		Dilation and curettage procedure	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-AP-A5FX.AF38CD86-2F5A-46A3-903A-81A8067F2456.pdf	A5FX	96	positive	WITH TUMOR	0	4	YES	4+	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open	2009		NO	YES	AP	0	0	4	4	Endometrial	A	DECEASED	80	2010	e55857c5-0581-471c-ba7a-cd9b83afbc14		TCGA-AP-A5FX-01	e55857c5-0581-471c-ba7a-cd9b83afbc14		383E90E4-0DD9-4887-B3F5-B7FF175F3A99			e55857c5-0581-471c-ba7a-cd9b83afbc14				e55857c5-0581-471c-ba7a-cd9b83afbc14		TCGA-AP-A5FX-01		TCGA-AP-A5FX-01A-11D-A27O-01		TCGA-AP-A5FX-01A-11D-A27O-01	TCGA-AP-A5FX-01	TCGA-AP-A5FX-01	TCGA-AP-A5FX-01A-11D-A27Y-05		
TCGA-AW-A1PO-01	MSS	0	TCGA-AW-A1PO-01	17	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AW-A1PO			days	17	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					66	0	0	TCGA-AW-A1PO-F68990	TCGA-AW-A1PO	TCGA-AW-A1PO-01A		Stage IIIA			-24225	331		0	17							2014-12-24	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	190	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-AW-A1PO.B5351001-32B2-4BA9-998D-F6631F6BE705.pdf	A1PO	70		TUMOR FREE	0	0	NO					NO				R0	Primary Tumor	01	open	2009		NO	YES	AW	0	0	0	7	Endometrial	A	LIVING	58	2010			TCGA-AW-A1PO-01		TCGA-AW-A1PO-01A-21-A18Q-20	BC4CAC82-65CC-46C9-880A-C933FEBEB7DE									TCGA-AW-A1PO-01	c9bdd9d8-f0f6-4abb-aca8-11d274f90995	TCGA-AW-A1PO-01A-12D-A160-01		TCGA-AW-A1PO-01A-12D-A160-01	TCGA-AW-A1PO-01	TCGA-AW-A1PO-01	TCGA-AW-A1PO-01A-12D-A161-05		c9bdd9d8-f0f6-4abb-aca8-11d274f90995
TCGA-AX-A05S-01	MSI-H	1	TCGA-AX-A05S-01	413	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AX-A05S			days	413	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO		81		0	TCGA-AX-A05S-F5583	TCGA-AX-A05S	TCGA-AX-A05S-01A		Stage IIIC	NO		-29928	507	413	0				338	NO			2011-5-23	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A05S.571B1EC2-3698-4FF2-89DD-7C5A8A048660.pdf	A05S	50	negative	WITH TUMOR		5		3	Progressive Disease			YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	4	5	18	Endometrial	A	DECEASED	48	2008		TCGA-AX-A05S-01	TCGA-AX-A05S-01		TCGA-AX-A05S-01A-21-A162-20	51E13F14-0AA7-4DF2-A28C-9B20734EEC2E	TCGA-AX-A05S-01	TCGA-AX-A05S-01		TCGA-AX-A05S-01A-11W-A027-09	TCGA-AX-A05S-01A-11W-A027-09	TCGA-AX-A05S-01A-11W-A027-09		TCGA-AX-A05S-01		f9533750-9b2f-44a2-8b4e-941fe0c53acb	TCGA-AX-A05S-01A-11D-A00X-01	TCGA-AX-A05S-01A-11R-A00V-07	TCGA-AX-A05S-01A-11D-A00X-01		TCGA-AX-A05S-01		TCGA-AX-A05S-01A-11D-A00U-05	f9533750-9b2f-44a2-8b4e-941fe0c53acb
TCGA-AX-A05T-01	MSS	0	TCGA-AX-A05T-01	1010	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-AX-A05T	1010	0	days	1010	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	82		0	TCGA-AX-A05T-F62985	TCGA-AX-A05T	TCGA-AX-A05T-01A		Stage IB	NO		-30137	310		0	1010							2014-7-29	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-AX-A05T.85F75553-6E10-4AF5-9BDF-DAB52D00615B.pdf	A05T	50	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	7	0	14	Endometrial	A	LIVING	61	2009		TCGA-AX-A05T-01	TCGA-AX-A05T-01		TCGA-AX-A05T-01A-21-A162-20	92B1BAEC-3052-4773-AB10-466CFB9CCE84	TCGA-AX-A05T-01	TCGA-AX-A05T-01		TCGA-AX-A05T-01A-11W-A027-09	TCGA-AX-A05T-01A-11W-A027-09	TCGA-AX-A05T-01A-11W-A027-09		TCGA-AX-A05T-01		8cfdaa7a-34fe-4b0f-9916-60e7158c893e	TCGA-AX-A05T-01A-11D-A00X-01	TCGA-AX-A05T-01A-11R-A00V-07	TCGA-AX-A05T-01A-11D-A00X-01		TCGA-AX-A05T-01		TCGA-AX-A05T-01A-11D-A00U-05	8cfdaa7a-34fe-4b0f-9916-60e7158c893e
TCGA-AX-A05U-01	MSS	0	TCGA-AX-A05U-01	903	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AX-A05U			days	903	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					56		0	TCGA-AX-A05U-F5579	TCGA-AX-A05U	TCGA-AX-A05U-01A		Stage IB	NO		-20533	500		0	903				YES			2011-5-23	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	No	TCGA-AX-A05U.1F51E982-37A1-40C6-BFAC-782B93D9967F.pdf	A05U	50	negative	TUMOR FREE		0		4+	Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	11	0	12	Endometrial	A	LIVING	62	2008		TCGA-AX-A05U-01	TCGA-AX-A05U-01		TCGA-AX-A05U-01A-21-A162-20	83BDFCC6-9E1F-4683-AD35-D6978DA1A959	TCGA-AX-A05U-01	TCGA-AX-A05U-01		TCGA-AX-A05U-01A-11W-A027-09	TCGA-AX-A05U-01A-11W-A027-09	TCGA-AX-A05U-01A-11W-A027-09		TCGA-AX-A05U-01		cadb8d53-b172-421d-ac3e-1583f5e55049	TCGA-AX-A05U-01A-11D-A00X-01	TCGA-AX-A05U-01A-11R-A00V-07	TCGA-AX-A05U-01A-11D-A00X-01		TCGA-AX-A05U-01		TCGA-AX-A05U-01A-11D-A00U-05	cadb8d53-b172-421d-ac3e-1583f5e55049
TCGA-AX-A05W-01	MSS	0	TCGA-AX-A05W-01	2450	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 4	cluster 2	mutation cluster 1	TCGA-AX-A05W	2450	0	days	2450	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					60		0	TCGA-AX-A05W-F65206	TCGA-AX-A05W	TCGA-AX-A05W-01A		Stage IIB	NO		-22200	1935		0	2450							2014-9-19	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	210	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-AX-A05W.4C960E79-D109-4C4C-B99F-F73D4DD73B40.pdf	A05W	50	negative	TUMOR FREE		0	NO	2	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	15	Endometrial	A	LIVING	74	2004	ceba19ee-6da0-4917-a4ba-e9bd20ad7f10	TCGA-AX-A05W-01	TCGA-AX-A05W-01	ceba19ee-6da0-4917-a4ba-e9bd20ad7f10	TCGA-AX-A05W-01A-11-A162-20	2DDFA76D-9935-4B66-BAC4-051E44960A93	TCGA-AX-A05W-01	TCGA-AX-A05W-01	ceba19ee-6da0-4917-a4ba-e9bd20ad7f10	TCGA-AX-A05W-01A-21W-A027-09	TCGA-AX-A05W-01A-21W-A027-09	TCGA-AX-A05W-01A-21W-A027-09	ceba19ee-6da0-4917-a4ba-e9bd20ad7f10	TCGA-AX-A05W-01			TCGA-AX-A05W-01A-21D-A00X-01	TCGA-AX-A05W-01A-21R-A00V-07	TCGA-AX-A05W-01A-21D-A00X-01		TCGA-AX-A05W-01		TCGA-AX-A05W-01A-21D-A00U-05	
TCGA-AX-A05Y-01	MSI-H	0	TCGA-AX-A05Y-01	2684	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-AX-A05Y	2684	0	days	2684	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES		57		0	TCGA-AX-A05Y-F65207	TCGA-AX-A05Y	TCGA-AX-A05Y-01A		Stage IB	NO		-20904	1967		0	2684			194	YES			2014-9-19	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-AX-A05Y.7E7D9403-AA77-4F14-9017-3B69F66D8EBC.pdf	A05Y	50	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			NO	Other Method, Specify Below	Whipple Procedure		R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	24	Endometrial	A	LIVING	92	2004		TCGA-AX-A05Y-01	TCGA-AX-A05Y-01		TCGA-AX-A05Y-01A-21-A162-20	52EF3E35-2A73-4880-91BE-E768E8DD7D08	TCGA-AX-A05Y-01	TCGA-AX-A05Y-01		TCGA-AX-A05Y-01A-11W-A027-09	TCGA-AX-A05Y-01A-11W-A027-09	TCGA-AX-A05Y-01A-11W-A027-09		TCGA-AX-A05Y-01		153cecfe-8963-4b96-8cc3-d2870ce8e584	TCGA-AX-A05Y-01A-11D-A00X-01	TCGA-AX-A05Y-01A-11R-A00V-07	TCGA-AX-A05Y-01A-11D-A00X-01		TCGA-AX-A05Y-01		TCGA-AX-A05Y-01A-11D-A00U-05	153cecfe-8963-4b96-8cc3-d2870ce8e584
TCGA-AX-A05Y-11	MSI-H	0	TCGA-AX-A05Y-11	2684	0	days		C6-UCEC							mutation cluster 4	TCGA-AX-A05Y	2684	0	days	2684	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES		57		0	TCGA-AX-A05Y-F65207	TCGA-AX-A05Y	TCGA-AX-A05Y-11A		Stage IB	NO		-20904	2391		0	2684			194	YES			2014-9-19	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No		A05Y	50	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			NO	Other Method, Specify Below	Whipple Procedure		R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	6	0	24	Endometrial	A	LIVING	92	2004	1011cb92-17a6-48b0-95ab-da22acddfb5a			1011cb92-17a6-48b0-95ab-da22acddfb5a					1011cb92-17a6-48b0-95ab-da22acddfb5a				1011cb92-17a6-48b0-95ab-da22acddfb5a		TCGA-AX-A05Y-11					TCGA-AX-A05Y-11		TCGA-AX-A05Y-11A-11D-A27Y-05		
TCGA-AX-A05Z-01	MSS	0	TCGA-AX-A05Z-01	2175	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 11	TCGA-AX-A05Z	2175	0	days	2175	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					37		0	TCGA-AX-A05Z-F65208	TCGA-AX-A05Z	TCGA-AX-A05Z-01A		Stage IIIA	NO		-13529	1416		0	2175							2014-9-19	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G2					NO	false	No	TCGA-AX-A05Z.5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F.pdf	A05Z	50	negative	TUMOR FREE		0	NO		Complete Remission/Response			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	7	0	13	Endometrial	A	LIVING	66	2006		TCGA-AX-A05Z-01	TCGA-AX-A05Z-01		TCGA-AX-A05Z-01A-21-A162-20	5ADB0EFC-74E1-4C20-8516-88D70CB851A0	TCGA-AX-A05Z-01	TCGA-AX-A05Z-01			TCGA-AX-A05Z-01A-11W-A027-09	TCGA-AX-A05Z-01A-11W-A027-09		TCGA-AX-A05Z-01		5e6246e7-35a3-4ce5-b234-b4dec034a6a8	TCGA-AX-A05Z-01A-11D-A00X-01	TCGA-AX-A05Z-01A-11R-A00V-07	TCGA-AX-A05Z-01A-11D-A00X-01		TCGA-AX-A05Z-01		TCGA-AX-A05Z-01A-11D-A00U-05	5e6246e7-35a3-4ce5-b234-b4dec034a6a8
TCGA-AX-A060-01	MSI-H	0	TCGA-AX-A060-01	1075	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 2	TCGA-AX-A060			days	1075	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					77		0	TCGA-AX-A060-F5558	TCGA-AX-A060	TCGA-AX-A060-01A		Stage IC	NO		-28472	1033		0	1075							2011-5-24	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A060.9086A79B-F764-42D4-BD9A-4C4F9F65C92B.pdf	A060	50	negative	TUMOR FREE		0		4+	Complete Remission/Response			YES				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	6	0	17	Endometrial	A	LIVING	87	2007		TCGA-AX-A060-01	TCGA-AX-A060-01		TCGA-AX-A060-01A-21-A162-20	97D25271-925A-4D51-95D3-AE0C5B584BB3	TCGA-AX-A060-01	TCGA-AX-A060-01		TCGA-AX-A060-01A-11W-A027-09	TCGA-AX-A060-01A-11W-A027-09	TCGA-AX-A060-01A-11W-A027-09		TCGA-AX-A060-01		3289fb8a-7268-4669-8d0c-471fc24a8607	TCGA-AX-A060-01A-11D-A00X-01	TCGA-AX-A060-01A-11R-A00V-07	TCGA-AX-A060-01A-11D-A00X-01		TCGA-AX-A060-01		TCGA-AX-A060-01A-11D-A00U-05	3289fb8a-7268-4669-8d0c-471fc24a8607
TCGA-AX-A062-01	MSS	0	TCGA-AX-A062-01	1399	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-AX-A062			days	1399	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					53		0	TCGA-AX-A062-F5504	TCGA-AX-A062	TCGA-AX-A062-01A		Stage IB	NO		-19643	1610		0	1399							2011-5-24	FEMALE	173	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Indeterminate (neither Pre or Postmenopausal)	G1						false	No	TCGA-AX-A062.FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E.pdf	A062	50	negative	TUMOR FREE		0		1	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	25	Endometrial	A	LIVING	122	2005		TCGA-AX-A062-01	TCGA-AX-A062-01		TCGA-AX-A062-01A-21-A162-20	DEC72ADB-614C-4E2A-A8DC-DB9FDABA89A6	TCGA-AX-A062-01	TCGA-AX-A062-01		TCGA-AX-A062-01A-11W-A027-09	TCGA-AX-A062-01A-11W-A027-09	TCGA-AX-A062-01A-11W-A027-09		TCGA-AX-A062-01		cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9	TCGA-AX-A062-01A-11D-A00X-01	TCGA-AX-A062-01A-11R-A00V-07	TCGA-AX-A062-01A-11D-A00X-01		TCGA-AX-A062-01		TCGA-AX-A062-01A-11D-A00U-05	cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9
TCGA-AX-A063-01	MSI-H	0	TCGA-AX-A063-01	2417	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 3	TCGA-AX-A063	2417	0	days	2417	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					63		0	TCGA-AX-A063-F65210	TCGA-AX-A063	TCGA-AX-A063-01A		Stage IB	NO		-23045	1950		0	2417							2014-9-19	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AX-A063.E911408A-8447-4CB8-8A3F-B2C24875ACF0.pdf	A063	50	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	19	Endometrial	A	LIVING	88	2004		TCGA-AX-A063-01	TCGA-AX-A063-01		TCGA-AX-A063-01A-21-A162-20	C40DB171-2B0B-48BD-AA20-C787378D57D3	TCGA-AX-A063-01	TCGA-AX-A063-01			TCGA-AX-A063-01A-11W-A027-09	TCGA-AX-A063-01A-11W-A027-09		TCGA-AX-A063-01		4c101954-7344-4cf7-a1bd-4cfcf472e05d	TCGA-AX-A063-01A-11D-A00X-01	TCGA-AX-A063-01A-11R-A00V-07	TCGA-AX-A063-01A-11D-A00X-01		TCGA-AX-A063-01		TCGA-AX-A063-01A-11D-A00U-05	4c101954-7344-4cf7-a1bd-4cfcf472e05d
TCGA-AX-A064-01	MSI-H	0	TCGA-AX-A064-01	1517	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-AX-A064	1517	0	days	1517	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	81		0	TCGA-AX-A064-F65211	TCGA-AX-A064	TCGA-AX-A064-01A		Stage IIA	NO		-29625	1024		0	1517							2014-9-19	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AX-A064.F760DFF2-7A11-4465-8581-397ABAA76BE4.pdf	A064	50	negative	TUMOR FREE		0	NO		Complete Remission/Response			NO					Primary Tumor	01	open	1988	NO	NO	YES	AX	0	5	0	29	Endometrial	A	LIVING	48	2007			TCGA-AX-A064-01		TCGA-AX-A064-01A-21-A162-20	146A3777-8123-40F5-91E7-117DD9CE360B	TCGA-AX-A064-01			TCGA-AX-A064-01A-11W-A027-09	TCGA-AX-A064-01A-11W-A027-09	TCGA-AX-A064-01A-11W-A027-09		TCGA-AX-A064-01	TCGA-AX-A064-01	91340f00-f5e1-496d-b7d5-08c2ccf57292	TCGA-AX-A064-01A-11D-A00X-01	TCGA-AX-A064-01A-11R-A00V-07	TCGA-AX-A064-01A-11D-A00X-01	TCGA-AX-A064-01	TCGA-AX-A064-01		TCGA-AX-A064-01A-11D-A00U-05	91340f00-f5e1-496d-b7d5-08c2ccf57292
TCGA-AX-A06B-01	MSS	0	TCGA-AX-A06B-01	2058	0	days	High	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 3	TCGA-AX-A06B	2058	0	days	2058	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					72			TCGA-AX-A06B-F65213	TCGA-AX-A06B	TCGA-AX-A06B-01A		Stage IIA	NO		-26348	1563		0	2058							2014-9-19	FEMALE	151	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	210	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-AX-A06B.394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B.pdf	A06B	50	negative	TUMOR FREE		0	NO	3	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	13	Endometrial	A	LIVING	93	2005		TCGA-AX-A06B-01	TCGA-AX-A06B-01		TCGA-AX-A06B-01A-21-A162-20	3A631688-46E7-40E7-BABA-DAA439DA508D	TCGA-AX-A06B-01	TCGA-AX-A06B-01		TCGA-AX-A06B-01A-11W-A027-09	TCGA-AX-A06B-01A-11W-A027-09	TCGA-AX-A06B-01A-11W-A027-09		TCGA-AX-A06B-01		e62793b0-8fb2-4c91-9f64-c0eae21571a7	TCGA-AX-A06B-01A-11D-A00X-01	TCGA-AX-A06B-01A-11R-A00V-07	TCGA-AX-A06B-01A-11D-A00X-01		TCGA-AX-A06B-01		TCGA-AX-A06B-01A-11D-A00U-05	e62793b0-8fb2-4c91-9f64-c0eae21571a7
TCGA-AX-A06D-01	MSS	1	TCGA-AX-A06D-01	373	1	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A06D			days	373	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO		82		0	TCGA-AX-A06D-F9718	TCGA-AX-A06D	TCGA-AX-A06D-01A		Stage IIIA	NO		-30024	1066	373	0				253	YES			2011-5-13	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	Yes	TCGA-AX-A06D.B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F.pdf	A06D	50	positive	WITH TUMOR		0			Progressive Disease	Former User		NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	3	0	7	Endometrial	A	DECEASED	91	2007			TCGA-AX-A06D-01		TCGA-AX-A06D-01A-21-A162-20	5269E40A-C8F6-4F21-BAEF-CD506B1D8493										f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9	TCGA-AX-A06D-01A-11D-A120-01		TCGA-AX-A06D-01A-11D-A120-01		TCGA-AX-A06D-01	TCGA-AX-A06D-01A-11D-A123-05		f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9
TCGA-AX-A06F-01	MSI-L	0	TCGA-AX-A06F-01	1748	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A06F			days	1748	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59		0	TCGA-AX-A06F-F62986	TCGA-AX-A06F	TCGA-AX-A06F-01A		Stage IVA	YES		-21624	1267		0	1748							2014-7-29	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A06F.4904C404-B17E-4471-AA2F-6DC705E4FBF2.pdf	A06F	50		TUMOR FREE		2	YES	2	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	1	2	16	Endometrial	A	LIVING	84	2006		TCGA-AX-A06F-01	TCGA-AX-A06F-01		TCGA-AX-A06F-01A-21-A162-20	7C89DB66-FE87-47CA-B4CF-7A851F36F37F	TCGA-AX-A06F-01	TCGA-AX-A06F-01						TCGA-AX-A06F-01		6eb1ae77-4d92-4823-ad9e-2a15cae95db2	TCGA-AX-A06F-01A-11D-A00X-01	TCGA-AX-A06F-01A-11R-A00V-07	TCGA-AX-A06F-01A-11D-A00X-01		TCGA-AX-A06F-01		TCGA-AX-A06F-01A-11D-A00U-05	6eb1ae77-4d92-4823-ad9e-2a15cae95db2
TCGA-AX-A06H-01	MSI-H	0	TCGA-AX-A06H-01	833	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 6	TCGA-AX-A06H	833	0	days	833	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					60		0	TCGA-AX-A06H-F29312	TCGA-AX-A06H			Stage IIIA	NO		-22270			0	833						Scheduled Follow-up Submission	2011-5-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A06H	50	negative	WITH TUMOR		0		1	Complete Remission/Response			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	4	0	20	Endometrial		LIVING	98	2008			TCGA-AX-A06H-01							TCGA-AX-A06H-01A-11D-A122-09	TCGA-AX-A06H-01A-11D-A122-09	TCGA-AX-A06H-01A-11D-A122-09			TCGA-AX-A06H-01	fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf	TCGA-AX-A06H-01A-11D-A120-01		TCGA-AX-A06H-01A-11D-A120-01	TCGA-AX-A06H-01	TCGA-AX-A06H-01	TCGA-AX-A06H-01A-11D-A123-05		fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf
TCGA-AX-A06J-01	MSS	0	TCGA-AX-A06J-01	913	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-AX-A06J			days	913	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					71		0	TCGA-AX-A06J-F5542	TCGA-AX-A06J	TCGA-AX-A06J-01A		Stage IB	NO		-26000	662		0	913							2011-5-26	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A06J.553324CE-44B8-416F-B965-074CE5FF9834.pdf	A06J	50	negative	TUMOR FREE		0		3	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	10	0	15	Endometrial	A	LIVING	119	2008		TCGA-AX-A06J-01	TCGA-AX-A06J-01		TCGA-AX-A06J-01A-21-A162-20	06500A95-B79C-47B8-8777-34E5DB32AB3C	TCGA-AX-A06J-01	TCGA-AX-A06J-01						TCGA-AX-A06J-01		3d4e6413-b717-45c2-8531-118ed3a593a0	TCGA-AX-A06J-01A-11D-A00X-01	TCGA-AX-A06J-01A-11R-A00V-07	TCGA-AX-A06J-01A-11D-A00X-01		TCGA-AX-A06J-01		TCGA-AX-A06J-01A-11D-A00U-05	3d4e6413-b717-45c2-8531-118ed3a593a0
TCGA-AX-A06L-01	MSS	0	TCGA-AX-A06L-01	1845	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-AX-A06L			days	1845	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					63		0	TCGA-AX-A06L-F9726	TCGA-AX-A06L	TCGA-AX-A06L-01A		Stage IB	NO		-23294	1499		0	1845							2011-5-17	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	No	TCGA-AX-A06L.926937F8-6057-4D39-BB3B-0115B0ACFE1A.pdf	A06L	50	negative	TUMOR FREE		0			Complete Remission/Response			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	4	0	21	Endometrial	A	LIVING	112	2006			TCGA-AX-A06L-01		TCGA-AX-A06L-01A-21-A162-20	BF44A950-E005-4031-8F27-52901F8E5963					TCGA-AX-A06L-01A-11D-A122-09	TCGA-AX-A06L-01A-11D-A122-09			TCGA-AX-A06L-01	06ee29fc-036c-4c36-b62b-f304c6ccad50	TCGA-AX-A06L-01A-11D-A120-01		TCGA-AX-A06L-01A-11D-A120-01	TCGA-AX-A06L-01	TCGA-AX-A06L-01	TCGA-AX-A06L-01A-11D-A123-05		06ee29fc-036c-4c36-b62b-f304c6ccad50
TCGA-AX-A0IS-01	MSS	1	TCGA-AX-A0IS-01	1858	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-AX-A0IS			days	1858	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO		52		0	TCGA-AX-A0IS-F72576	TCGA-AX-A0IS	TCGA-AX-A0IS-01A		Stage IC	NO		-19173	805	1858	0	1065			448	YES			2015-7-27	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	Endocervical Biopsy	Other method, specify:	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	No	TCGA-AX-A0IS.35606B48-9820-4F59-8090-1F8D448DB9FB.pdf	A0IS	50	negative	WITH TUMOR		0	[Discrepancy]		Complete Remission/Response			NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	4	0	10	Endometrial	A	DECEASED	132	2008		TCGA-AX-A0IS-01	TCGA-AX-A0IS-01		TCGA-AX-A0IS-01A-21-A162-20	BD9FE914-A8A6-4F03-9C96-557466D03CAC		TCGA-AX-A0IS-01		TCGA-AX-A0IS-01A-12D-A10M-09	TCGA-AX-A0IS-01A-12D-A10M-09	TCGA-AX-A0IS-01A-12D-A10M-09				0cbb432d-fbb9-4c0e-b126-3bb862ab8602	TCGA-AX-A0IS-01A-12D-A10L-01		TCGA-AX-A0IS-01A-12D-A10L-01		TCGA-AX-A0IS-01	TCGA-AX-A0IS-01A-12D-A10N-05		0cbb432d-fbb9-4c0e-b126-3bb862ab8602
TCGA-AX-A0IU-01	MSS	0	TCGA-AX-A0IU-01	1087	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 5	TCGA-AX-A0IU			days	1087	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	79		1	TCGA-AX-A0IU-F62988	TCGA-AX-A0IU			Stage IIIC	NO		-29063			0	1087				YES			2014-7-29	FEMALE	158	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							No		A0IU	50	negative	TUMOR FREE		1			Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	6	1	7	Endometrial		LIVING	76	2008		TCGA-AX-A0IU-01	TCGA-AX-A0IU-01					TCGA-AX-A0IU-01		TCGA-AX-A0IU-01A-11D-A10B-09	TCGA-AX-A0IU-01A-11D-A10B-09	TCGA-AX-A0IU-01A-11D-A10B-09				fb355c45-282b-4eff-8d06-074d9acf1ea5	TCGA-AX-A0IU-01A-11D-A102-01		TCGA-AX-A0IU-01A-11D-A102-01		TCGA-AX-A0IU-01		TCGA-AX-A0IU-01A-11D-A10Q-05	fb355c45-282b-4eff-8d06-074d9acf1ea5
TCGA-AX-A0IW-01	MSI-L	0	TCGA-AX-A0IW-01	1149	0	days	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 5	TCGA-AX-A0IW			days	1149	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67		0	TCGA-AX-A0IW-F5518	TCGA-AX-A0IW	TCGA-AX-A0IW-01A		Stage IIIA	NO		-24488	854		0	1149							2011-5-23	FEMALE	163	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A0IW.DE971C2D-31E8-42AC-A943-29E76FCD8F68.pdf	A0IW	50	negative	TUMOR FREE		0		3	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	24	Endometrial	A	LIVING	61	2008		TCGA-AX-A0IW-01	TCGA-AX-A0IW-01		TCGA-AX-A0IW-01A-21-A162-20	1619E238-C173-4981-A0BD-8F7138F26FDD	TCGA-AX-A0IW-01	TCGA-AX-A0IW-01		TCGA-AX-A0IW-01A-11W-A062-09	TCGA-AX-A0IW-01A-11W-A062-09	TCGA-AX-A0IW-01A-11W-A062-09		TCGA-AX-A0IW-01		60bb00e3-9ac9-4c61-bb38-b85b27bff865	TCGA-AX-A0IW-01A-11D-A042-01	TCGA-AX-A0IW-01A-11R-A040-07	TCGA-AX-A0IW-01A-11D-A042-01		TCGA-AX-A0IW-01		TCGA-AX-A0IW-01A-11D-A039-05	60bb00e3-9ac9-4c61-bb38-b85b27bff865
TCGA-AX-A0IZ-01	MSI-H	0	TCGA-AX-A0IZ-01	1333	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AX-A0IZ			days	1333	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53		0	TCGA-AX-A0IZ-F62989	TCGA-AX-A0IZ	TCGA-AX-A0IZ-01A		Stage IB	NO		-19364	1114		0	1333							2014-7-29	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A0IZ.1DEA7C0C-3280-4E11-B0A4-13562DDF307B.pdf	A0IZ	50	negative	TUMOR FREE		0		2	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	21	Endometrial	A	LIVING	60	2007			TCGA-AX-A0IZ-01		TCGA-AX-A0IZ-01A-21-A162-20	9AADB315-ED0B-44AB-9391-6E3E04B0B4FA									TCGA-AX-A0IZ-01	e76c4434-3eaf-4ab2-a994-6c27237d344d	TCGA-AX-A0IZ-01A-11D-A120-01		TCGA-AX-A0IZ-01A-11D-A120-01	TCGA-AX-A0IZ-01	TCGA-AX-A0IZ-01	TCGA-AX-A0IZ-01A-11D-A123-05		e76c4434-3eaf-4ab2-a994-6c27237d344d
TCGA-AX-A0IZ-11	MSI-H	0	TCGA-AX-A0IZ-11	1333	0	days		C6-UCEC								TCGA-AX-A0IZ			days	1333	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53		0	TCGA-AX-A0IZ-F62989	TCGA-AX-A0IZ	TCGA-AX-A0IZ-11A		Stage IB	NO		-19364	1485		0	1333							2014-7-29	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No		A0IZ	50	negative	TUMOR FREE		0		2	Complete Remission/Response			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	21	Endometrial	A	LIVING	60	2007	9d6c70ea-ec88-4b78-a495-cd31cc048ece			9d6c70ea-ec88-4b78-a495-cd31cc048ece					9d6c70ea-ec88-4b78-a495-cd31cc048ece				9d6c70ea-ec88-4b78-a495-cd31cc048ece		TCGA-AX-A0IZ-11					TCGA-AX-A0IZ-11		TCGA-AX-A0IZ-11A-11D-A27Y-05		
TCGA-AX-A0J0-01	MSI-L	0	TCGA-AX-A0J0-01	1220	0	days	Quiet	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-AX-A0J0			days	1220	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					47		0	TCGA-AX-A0J0-F5464	TCGA-AX-A0J0	TCGA-AX-A0J0-01A		Stage IB	NO		-17466	1581		0	1220							2011-5-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	No	TCGA-AX-A0J0.EC377A34-B219-4A4F-95DB-DF6E0050A63A.pdf	A0J0	50	negative	TUMOR FREE		0		2	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	26	Endometrial	A	LIVING	53	2006		TCGA-AX-A0J0-01	TCGA-AX-A0J0-01		TCGA-AX-A0J0-01A-21-A162-20	2B44D365-A7F6-4A4E-99C5-019A2BDC6384		TCGA-AX-A0J0-01			TCGA-AX-A0J0-01A-11D-A117-09	TCGA-AX-A0J0-01A-11D-A117-09				cb236783-68e6-4522-8618-ea19fd0b8ab5	TCGA-AX-A0J0-01A-11D-A107-01		TCGA-AX-A0J0-01A-11D-A107-01		TCGA-AX-A0J0-01	TCGA-AX-A0J0-01A-11D-A10A-05		cb236783-68e6-4522-8618-ea19fd0b8ab5
TCGA-AX-A0J0-11	MSI-L	0	TCGA-AX-A0J0-11	1220	0	days		C6-UCEC							mutation cluster 11	TCGA-AX-A0J0			days	1220	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					47		0	TCGA-AX-A0J0-F5464	TCGA-AX-A0J0			Stage IB	NO		-17466			0	1220							2011-5-23	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							No		A0J0	50	negative	TUMOR FREE		0		2	Complete Remission/Response			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	26	Endometrial		LIVING	53	2006	bdb31196-8bc4-4c2a-bbcf-641e1916733f			bdb31196-8bc4-4c2a-bbcf-641e1916733f					bdb31196-8bc4-4c2a-bbcf-641e1916733f				bdb31196-8bc4-4c2a-bbcf-641e1916733f		TCGA-AX-A0J0-11					TCGA-AX-A0J0-11		TCGA-AX-A0J0-11A-11D-A27Y-05		
TCGA-AX-A0J1-01	MSI-H	0	TCGA-AX-A0J1-01	2354	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 11	TCGA-AX-A0J1	2354	0	days	2354	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					80		0	TCGA-AX-A0J1-F65220	TCGA-AX-A0J1	TCGA-AX-A0J1-01A		Stage IB	NO		-29501	1721		0	2354							2014-9-19	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AX-A0J1.38FCBC4A-2CAB-46EF-805D-121BEF85912E.pdf	A0J1	50	negative	TUMOR FREE		0	NO		Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	7	0	15	Endometrial	A	LIVING	57	2005		TCGA-AX-A0J1-01	TCGA-AX-A0J1-01		TCGA-AX-A0J1-01A-21-A162-20	2EE962C0-8925-47C7-8AEA-9AE3B1375A6B	TCGA-AX-A0J1-01	TCGA-AX-A0J1-01			TCGA-AX-A0J1-01A-11W-A062-09	TCGA-AX-A0J1-01A-11W-A062-09		TCGA-AX-A0J1-01		20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247	TCGA-AX-A0J1-01A-11D-A042-01	TCGA-AX-A0J1-01A-11R-A040-07	TCGA-AX-A0J1-01A-11D-A042-01		TCGA-AX-A0J1-01		TCGA-AX-A0J1-01A-11D-A039-05	20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247
TCGA-AX-A1C4-01	MSI-H	0	TCGA-AX-A1C4-01	404	0	days	Kirc+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AX-A1C4			days	404	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					52		0	TCGA-AX-A1C4-F10395	TCGA-AX-A1C4	TCGA-AX-A1C4-01A		Stage IB	NO		-19209	575		0	404				YES			2011-5-12	FEMALE	178	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Indeterminate (neither Pre or Postmenopausal)	G2						false	No	TCGA-AX-A1C4.81C6DDE6-ACC3-4659-91EC-D986671B592A.pdf	A1C4	50	negative	TUMOR FREE		0		0				YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	8	0	13	Endometrial	A	LIVING	115	2009			TCGA-AX-A1C4-01												TCGA-AX-A1C4-01	58623d8a-f51b-470a-bde3-f31e91f9bd80	TCGA-AX-A1C4-01A-11D-A134-01		TCGA-AX-A1C4-01A-11D-A134-01	TCGA-AX-A1C4-01	TCGA-AX-A1C4-01	TCGA-AX-A1C4-01A-11D-A138-05		58623d8a-f51b-470a-bde3-f31e91f9bd80
TCGA-AX-A1C5-01	MSI-H	0	TCGA-AX-A1C5-01	1001	0	days	Kirc+		UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A1C5	1001	0	days	1001	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	47		1	TCGA-AX-A1C5-F65223	TCGA-AX-A1C5	TCGA-AX-A1C5-01A		Stage IIIC	NO		-17383	517		0	1001	404			YES			2014-9-19	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	No	TCGA-AX-A1C5.6F79B83A-90B4-45DF-8542-A6BC2F93470D.pdf	A1C5	50	negative	WITH TUMOR		1	YES		Complete Remission/Response			YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	1	1	2	Endometrial	A	LIVING	107	2009			TCGA-AX-A1C5-01												TCGA-AX-A1C5-01	1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1	TCGA-AX-A1C5-01A-11D-A134-01		TCGA-AX-A1C5-01A-11D-A134-01	TCGA-AX-A1C5-01	TCGA-AX-A1C5-01	TCGA-AX-A1C5-01A-11D-A138-05		1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1
TCGA-AX-A1C7-01	MSS	0	TCGA-AX-A1C7-01	1054	0	days	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AX-A1C7	1054	0	days	1054	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO		77		0	TCGA-AX-A1C7-F65224	TCGA-AX-A1C7	TCGA-AX-A1C7-01A		Stage IB			-28198	423		0	1054			390				2014-9-19	FEMALE	152	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A1C7.10458026-49D7-40EC-BC7B-0D6A381FB025.pdf	A1C7	50	negative			0	YES					NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	24	Endometrial	A	LIVING	60	2009	284f6163-92f2-4e21-8649-45dcfce6634f		TCGA-AX-A1C7-01	284f6163-92f2-4e21-8649-45dcfce6634f					284f6163-92f2-4e21-8649-45dcfce6634f		TCGA-AX-A1C7-01A-11D-A135-09	TCGA-AX-A1C7-01A-11D-A135-09	284f6163-92f2-4e21-8649-45dcfce6634f		TCGA-AX-A1C7-01	284f6163-92f2-4e21-8649-45dcfce6634f	TCGA-AX-A1C7-01A-11D-A134-01		TCGA-AX-A1C7-01A-11D-A134-01	TCGA-AX-A1C7-01	TCGA-AX-A1C7-01	TCGA-AX-A1C7-01A-11D-A138-05		284f6163-92f2-4e21-8649-45dcfce6634f
TCGA-AX-A1C8-01	MSS	0	TCGA-AX-A1C8-01	776	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 13	TCGA-AX-A1C8	776	0	days	776	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					77		0	TCGA-AX-A1C8-F65226	TCGA-AX-A1C8	TCGA-AX-A1C8-01A		Stage IIIC	NO		-28452	475		0	776							2014-9-19	FEMALE	156	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A1C8.5F0E78BA-B827-4DB6-99EB-5FA3D3598793.pdf	A1C8	50	negative			1	YES	4+				NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	3	1	12	Endometrial	A	LIVING	66	2009			TCGA-AX-A1C8-01							TCGA-AX-A1C8-01A-11D-A135-09	TCGA-AX-A1C8-01A-11D-A135-09	TCGA-AX-A1C8-01A-11D-A135-09			TCGA-AX-A1C8-01	34149234-2d6a-46ac-b7e0-52787cf2c49a	TCGA-AX-A1C8-01A-11D-A134-01		TCGA-AX-A1C8-01A-11D-A134-01	TCGA-AX-A1C8-01	TCGA-AX-A1C8-01	TCGA-AX-A1C8-01A-11D-A138-05		34149234-2d6a-46ac-b7e0-52787cf2c49a
TCGA-AX-A1C9-01	MSI-H	0	TCGA-AX-A1C9-01	802	0	days	Kirc+		UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1C9	802	0	days	802	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					73		0	TCGA-AX-A1C9-F65227	TCGA-AX-A1C9			Stage IB	NO		-26903			0	802				YES			2014-9-19	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO		No		A1C9	50	negative	TUMOR FREE		0	NO					NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	AX	0	3	0	17	Endometrial		LIVING	73	2009			TCGA-AX-A1C9-01												TCGA-AX-A1C9-01	a5a45936-135b-499e-a0bb-7c2d992ef962	TCGA-AX-A1C9-01A-11D-A134-01		TCGA-AX-A1C9-01A-11D-A134-01	TCGA-AX-A1C9-01	TCGA-AX-A1C9-01	TCGA-AX-A1C9-01A-11D-A138-05		a5a45936-135b-499e-a0bb-7c2d992ef962
TCGA-AX-A1CA-01	Indeterminate	0	TCGA-AX-A1CA-01	974	0	days	High		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CA	974	0	days	974	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70		0	TCGA-AX-A1CA-F63035	TCGA-AX-A1CA			Stage IB	NO		-25817			0	974							2014-7-30	FEMALE	157	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			NO		G3					NO		No		A1CA	50	negative	TUMOR FREE		0	YES					NO				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	4	0	10	Endometrial		LIVING	77	2009			TCGA-AX-A1CA-01												TCGA-AX-A1CA-01	cadf8449-cd8e-4581-ad35-37a0aa2f7a9b	TCGA-AX-A1CA-01A-12D-A134-01		TCGA-AX-A1CA-01A-12D-A134-01	TCGA-AX-A1CA-01	TCGA-AX-A1CA-01	TCGA-AX-A1CA-01A-12D-A138-05		cadf8449-cd8e-4581-ad35-37a0aa2f7a9b
TCGA-AX-A1CC-01	MSI-L	0	TCGA-AX-A1CC-01	788	0	days	COAD-READ		Low purity c2	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1CC	788	0	days	788	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					65		0	TCGA-AX-A1CC-F62990	TCGA-AX-A1CC			Stage IC	NO		-23795			0	788				NO			2014-7-29	FEMALE	156	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A1CC	50	negative	TUMOR FREE		0	YES	2				NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	11	Endometrial		LIVING	99	2010			TCGA-AX-A1CC-01												TCGA-AX-A1CC-01	ac3b86dc-2dd8-41e8-832a-5625f5cd5a27	TCGA-AX-A1CC-01A-11D-A134-01		TCGA-AX-A1CC-01A-11D-A134-01	TCGA-AX-A1CC-01	TCGA-AX-A1CC-01	TCGA-AX-A1CC-01A-11D-A138-05		ac3b86dc-2dd8-41e8-832a-5625f5cd5a27
TCGA-AX-A1CE-01	MSI-H	0	TCGA-AX-A1CE-01	1037	0	days	Quiet		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CE	1037	0	days	1037	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Complete Response	60		0	TCGA-AX-A1CE-F65229	TCGA-AX-A1CE	TCGA-AX-A1CE-01A		Stage IB	NO		-21969	504		0	1037							2014-9-19	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Total hysterectomy, bilateral salpingo-oophorectomy with pelvic and para-aortic lymph node dissection	Other method, specify:	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A1CE.79482353-F9A0-4A36-97B3-F270241B2B50.pdf	A1CE	50	negative	TUMOR FREE		0	YES	3				YES			R0	R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	5	0	12	Endometrial	A	LIVING	58	2009			TCGA-AX-A1CE-01												TCGA-AX-A1CE-01	2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf	TCGA-AX-A1CE-01A-11D-A134-01		TCGA-AX-A1CE-01A-11D-A134-01	TCGA-AX-A1CE-01	TCGA-AX-A1CE-01	TCGA-AX-A1CE-01A-11D-A138-05		2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf
TCGA-AX-A1CF-01	MSS	0	TCGA-AX-A1CF-01	2337	0	days	Squamous		OV-like c1	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-AX-A1CF			days	2337	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO		69		0	TCGA-AX-A1CF-F10338	TCGA-AX-A1CF			Stage IVB	NO		-25300			0	2337			875				2011-5-10	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy					G3							No		A1CF	50	positive	WITH TUMOR					Progressive Disease	Former User		YES				R2	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	7	0	0	Endometrial		LIVING	79	2004			TCGA-AX-A1CF-01												TCGA-AX-A1CF-01	ee60f261-392f-4583-8ddb-b29f07f20e6e	TCGA-AX-A1CF-01A-11D-A134-01		TCGA-AX-A1CF-01A-11D-A134-01	TCGA-AX-A1CF-01	TCGA-AX-A1CF-01	TCGA-AX-A1CF-01A-11D-A138-05		ee60f261-392f-4583-8ddb-b29f07f20e6e
TCGA-AX-A1CF-11	MSS	0	TCGA-AX-A1CF-11	2337	0	days										TCGA-AX-A1CF			days	2337	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO		69		0	TCGA-AX-A1CF-F10338	TCGA-AX-A1CF			Stage IVB	NO		-25300			0	2337			875				2011-5-10	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy					G3							No		A1CF	50	positive	WITH TUMOR					Progressive Disease	Former User		YES				R2	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	0	7	0	0	Endometrial		LIVING	79	2004															TCGA-AX-A1CF-11	c588b29f-0abf-47c6-bff2-d0589ea506ee				TCGA-AX-A1CF-11		TCGA-AX-A1CF-11A-11D-A138-05		c588b29f-0abf-47c6-bff2-d0589ea506ee
TCGA-AX-A1CI-01	MSS	0	TCGA-AX-A1CI-01	2600	0	days	Iq		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A1CI	2600	0	days	2600	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					61		0	TCGA-AX-A1CI-F65231	TCGA-AX-A1CI			Stage IB	NO		-22582			0	2600							2014-9-19	FEMALE	164	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A1CI	50	negative	TUMOR FREE		0	NO					NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	13	Endometrial		LIVING	74	2004			TCGA-AX-A1CI-01												TCGA-AX-A1CI-01	e54b7e44-82a3-4016-bc32-129799097b4c	TCGA-AX-A1CI-01A-11D-A134-01		TCGA-AX-A1CI-01A-11D-A134-01	TCGA-AX-A1CI-01	TCGA-AX-A1CI-01	TCGA-AX-A1CI-01A-11D-A138-05		e54b7e44-82a3-4016-bc32-129799097b4c
TCGA-AX-A1CI-11	MSS	0	TCGA-AX-A1CI-11	2600	0	days										TCGA-AX-A1CI	2600	0	days	2600	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					61		0	TCGA-AX-A1CI-F65231	TCGA-AX-A1CI			Stage IB	NO		-22582			0	2600							2014-9-19	FEMALE	164	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A1CI	50	negative	TUMOR FREE		0	NO					NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	13	Endometrial		LIVING	74	2004															TCGA-AX-A1CI-11	ce5b0ba0-2777-4c92-ac50-483174cc5dca				TCGA-AX-A1CI-11		TCGA-AX-A1CI-11A-11D-A138-05		ce5b0ba0-2777-4c92-ac50-483174cc5dca
TCGA-AX-A1CJ-01	Indeterminate	0	TCGA-AX-A1CJ-01	2233	0	days	Iq		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A1CJ	2233	0	days	2233	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					59			TCGA-AX-A1CJ-F65232	TCGA-AX-A1CJ	TCGA-AX-A1CJ-01A		Stage IC	NO		-21655	1758		0	2233							2014-9-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G2					NO	false	No	TCGA-AX-A1CJ.AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3.pdf	A1CJ	50	negative	TUMOR FREE			NO					YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	LIVING	115	2006			TCGA-AX-A1CJ-01												TCGA-AX-A1CJ-01	87d95a5d-174b-4f13-a00f-85a28bfd1fb7	TCGA-AX-A1CJ-01A-11D-A134-01		TCGA-AX-A1CJ-01A-11D-A134-01	TCGA-AX-A1CJ-01	TCGA-AX-A1CJ-01	TCGA-AX-A1CJ-01A-11D-A138-05		87d95a5d-174b-4f13-a00f-85a28bfd1fb7
TCGA-AX-A1CJ-11	Indeterminate	0	TCGA-AX-A1CJ-11	2233	0	days										TCGA-AX-A1CJ	2233	0	days	2233	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					59			TCGA-AX-A1CJ-F65232	TCGA-AX-A1CJ	TCGA-AX-A1CJ-11A		Stage IC	NO		-21655	1758		0	2233							2014-9-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G2					NO	false	No		A1CJ	50	negative	TUMOR FREE			NO					YES				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	LIVING	115	2006																						TCGA-AX-A1CJ-11A-11D-A138-05		
TCGA-AX-A1CK-01	MSS	0	TCGA-AX-A1CK-01	2441	0	days	BRCA-LUAD+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A1CK	2441	0	days	2441	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES		58		0	TCGA-AX-A1CK-F65233	TCGA-AX-A1CK	TCGA-AX-A1CK-01A		Stage IB	NO	1027	-21200	2115		0	2441				NO			2014-9-25	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-AX-A1CK.5810919B-7778-4566-A024-2D70BDE9A4F5.pdf	A1CK	50	negative	WITH TUMOR		0	NO					NO	Surgical Resection			R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	72	2005			TCGA-AX-A1CK-01												TCGA-AX-A1CK-01	5755caa5-b187-498f-a7a9-22e8ddcd2830	TCGA-AX-A1CK-01A-11D-A134-01		TCGA-AX-A1CK-01A-11D-A134-01	TCGA-AX-A1CK-01	TCGA-AX-A1CK-01	TCGA-AX-A1CK-01A-11D-A138-05		5755caa5-b187-498f-a7a9-22e8ddcd2830
TCGA-AX-A1CK-11	MSS	0	TCGA-AX-A1CK-11	2441	0	days										TCGA-AX-A1CK	2441	0	days	2441	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES		58		0	TCGA-AX-A1CK-F65233	TCGA-AX-A1CK	TCGA-AX-A1CK-11A		Stage IB	NO	1027	-21200	2115		0	2441				NO			2014-9-25	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No		A1CK	50	negative	WITH TUMOR		0	NO					NO	Surgical Resection			R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	72	2005															TCGA-AX-A1CK-11	3aba63fa-86d2-4ca9-b064-fe782a749161				TCGA-AX-A1CK-11		TCGA-AX-A1CK-11A-11D-A138-05		3aba63fa-86d2-4ca9-b064-fe782a749161
TCGA-AX-A1CN-01	MSI-L	0	TCGA-AX-A1CN-01	1143	0	days	Kirc+		OV-like c1	cluster 3		RNA cluster 3	miRNA cluster 12	cluster 5		TCGA-AX-A1CN	1105	1	days	1143	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	54		0	TCGA-AX-A1CN-F65235	TCGA-AX-A1CN	TCGA-AX-A1CN-01A		Stage IIB	NO		-19860	701		0	1143			1105				2014-9-19	FEMALE	175	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	New Primary Tumor			YES	false	No	TCGA-AX-A1CN.D0FB2179-60D4-4B3C-9D88-B07D802F772E.pdf	A1CN	50	negative	WITH TUMOR		0	YES	1				YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	5	0	13	Endometrial	A	LIVING	146	2009			TCGA-AX-A1CN-01												TCGA-AX-A1CN-01	222512dc-7088-4c86-a82c-99c2e4cd427c	TCGA-AX-A1CN-01A-11D-A134-01		TCGA-AX-A1CN-01A-11D-A134-01	TCGA-AX-A1CN-01	TCGA-AX-A1CN-01	TCGA-AX-A1CN-01A-11D-A138-05		222512dc-7088-4c86-a82c-99c2e4cd427c
TCGA-AX-A1CP-01	MSS	0	TCGA-AX-A1CP-01	1107	0	days	Squamous	C6-UCEC	OV-like c1	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-AX-A1CP			days	1107	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO		84		0	TCGA-AX-A1CP-F9828	TCGA-AX-A1CP			Stage IA	NO		-30737			0	1107			722	YES			2011-5-12	FEMALE	156	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							Yes		A1CP	0	negative			0						NO				R1	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	AX	0	5	0	11	Endometrial		LIVING	55	2008			TCGA-AX-A1CP-01							TCGA-AX-A1CP-01A-11D-A135-09	TCGA-AX-A1CP-01A-11D-A135-09	TCGA-AX-A1CP-01A-11D-A135-09				da204d4a-922e-4501-9db6-8034ae6b8177	TCGA-AX-A1CP-01A-11D-A134-01		TCGA-AX-A1CP-01A-11D-A134-01		TCGA-AX-A1CP-01	TCGA-AX-A1CP-01A-11D-A138-05		da204d4a-922e-4501-9db6-8034ae6b8177
TCGA-AX-A1CR-01	MSS	0	TCGA-AX-A1CR-01	701	0	days	High		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-AX-A1CR	701	0	days	701	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					70			TCGA-AX-A1CR-F65236	TCGA-AX-A1CR			Stage IIB	NO		-25812			0	701							2014-9-19	FEMALE	165	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		Yes		A1CR	50	negative	TUMOR FREE			YES	0				NO				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	12	0	17	Endometrial		LIVING	97	2010			TCGA-AX-A1CR-01													d979abda-1498-41e5-848c-8dc20d6c7eee	TCGA-AX-A1CR-01A-12D-A134-01		TCGA-AX-A1CR-01A-12D-A134-01		TCGA-AX-A1CR-01	TCGA-AX-A1CR-01A-12D-A138-05		d979abda-1498-41e5-848c-8dc20d6c7eee
TCGA-AX-A2H2-01	MSS	1	TCGA-AX-A2H2-01	145	1	days	High	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A2H2	145	0	days	145	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	86			TCGA-AX-A2H2-F31588	TCGA-AX-A2H2	TCGA-AX-A2H2-01A		Stage IIA	NO		-31524	1079	145	0					YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	162	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A2H2.1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60.pdf	A2H2		negative	TUMOR FREE				4+	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	5	Endometrial	A	DECEASED	65	2008			TCGA-AX-A2H2-01		TCGA-AX-A2H2-01A-21-A18R-20	17E73B0A-942F-4EA2-95E5-F1A0618240B3									TCGA-AX-A2H2-01	245e65eb-ec7a-4a85-a524-194afbdf67ef	TCGA-AX-A2H2-01A-11D-A17U-01		TCGA-AX-A2H2-01A-11D-A17U-01	TCGA-AX-A2H2-01	TCGA-AX-A2H2-01	TCGA-AX-A2H2-01A-11D-A17Z-05		245e65eb-ec7a-4a85-a524-194afbdf67ef
TCGA-AX-A2H4-01	MSS	1	TCGA-AX-A2H4-01	916	1	days	Squamous		UCEC non-CIMP c3				miRNA cluster 14			TCGA-AX-A2H4	520	1	days	916	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	66			TCGA-AX-A2H4-F31597	TCGA-AX-A2H4	TCGA-AX-A2H4-01A		Stage IIIA	NO		-24234	1981	916	0				520	YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Vaginal cuff, iliac		YES	false	No	TCGA-AX-A2H4.5230A27B-4AA6-4ED9-90BB-98C6671E0B2E.pdf	A2H4		negative	WITH TUMOR					Complete Remission/Response			NO				R2	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	DECEASED	84	2006	46eaeac0-bacb-4c76-b86d-5bd912229f69		TCGA-AX-A2H4-01	46eaeac0-bacb-4c76-b86d-5bd912229f69					46eaeac0-bacb-4c76-b86d-5bd912229f69				46eaeac0-bacb-4c76-b86d-5bd912229f69		TCGA-AX-A2H4-01		TCGA-AX-A2H4-01A-21D-A18N-01		TCGA-AX-A2H4-01A-21D-A18N-01	TCGA-AX-A2H4-01	TCGA-AX-A2H4-01	TCGA-AX-A2H4-01A-21D-A18O-05		
TCGA-AX-A2H4-11	MSS	1	TCGA-AX-A2H4-11	916	1	days										TCGA-AX-A2H4	520	1	days	916	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	66			TCGA-AX-A2H4-F31597	TCGA-AX-A2H4	TCGA-AX-A2H4-11A		Stage IIIA	NO		-24234	1981	916	0				520	YES		Scheduled Follow-up Submission	2012-5-7	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Vaginal cuff, iliac		YES	false	No		A2H4		negative	WITH TUMOR					Complete Remission/Response			NO				R2	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	0	0	0	Endometrial	A	DECEASED	84	2006																						TCGA-AX-A2H4-11A-11D-A18O-05		
TCGA-AX-A2H5-01	MSS	0	TCGA-AX-A2H5-01	2167	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 2	TCGA-AX-A2H5	2167	0	days	2167	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-AX-A2H5-F31616	TCGA-AX-A2H5	TCGA-AX-A2H5-01A		Stage IIIC	NO		-24757	2206		0	2167						Scheduled Follow-up Submission	2012-5-7	FEMALE	161	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	No	TCGA-AX-A2H5.BF4BE7F8-7D37-4CB2-B340-FAE14155F257.pdf	A2H5		negative	TUMOR FREE					Complete Remission/Response			YES				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	3	5	9	13	Endometrial	A	LIVING	87	2005			TCGA-AX-A2H5-01		TCGA-AX-A2H5-01A-21-A18R-20	5298E5E5-5AAF-46F4-8D91-AA10FAB8F2B2				TCGA-AX-A2H5-01A-11D-A17D-09	TCGA-AX-A2H5-01A-11D-A17D-09	TCGA-AX-A2H5-01A-11D-A17D-09			TCGA-AX-A2H5-01	2f712e62-f400-4922-bdc5-d5d06276101d	TCGA-AX-A2H5-01A-11D-A17C-01		TCGA-AX-A2H5-01A-11D-A17C-01	TCGA-AX-A2H5-01	TCGA-AX-A2H5-01	TCGA-AX-A2H5-01A-11D-A17F-05		2f712e62-f400-4922-bdc5-d5d06276101d
TCGA-AX-A2H5-11	MSS	0	TCGA-AX-A2H5-11	2167	0	days		C6-UCEC							mutation cluster 2	TCGA-AX-A2H5	2167	0	days	2167	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-AX-A2H5-F31616	TCGA-AX-A2H5	TCGA-AX-A2H5-11A		Stage IIIC	NO		-24757	2206		0	2167						Scheduled Follow-up Submission	2012-5-7	FEMALE	161	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	130	NO			G3					NO	false	No		A2H5		negative	TUMOR FREE					Complete Remission/Response			YES				R1	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	3	5	9	13	Endometrial	A	LIVING	87	2005																						TCGA-AX-A2H5-11A-11D-A17F-05		
TCGA-AX-A2H7-01	MSS	1	TCGA-AX-A2H7-01	1241	1	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AX-A2H7	684	1	days	1241	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	NO	Progressive Disease	87			TCGA-AX-A2H7-F31704	TCGA-AX-A2H7	TCGA-AX-A2H7-01A		Stage IC	NO		-32100	951	1241	0	1020			684	YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO			G3	Lung	Metastatic			YES	false	No	TCGA-AX-A2H7.76630DF8-2D08-4CF8-8B07-ACCE872B3ED1.pdf	A2H7		negative	WITH TUMOR				4+	Complete Remission/Response			YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	12	Endometrial	A	DECEASED	60	2008			TCGA-AX-A2H7-01		TCGA-AX-A2H7-01A-21-A23Z-20	808DF04C-E181-48B1-A9C5-0EB8617CC26F									TCGA-AX-A2H7-01	25dd0765-735c-4146-9551-cdfdd9213593	TCGA-AX-A2H7-01A-12D-A18N-01		TCGA-AX-A2H7-01A-12D-A18N-01	TCGA-AX-A2H7-01	TCGA-AX-A2H7-01	TCGA-AX-A2H7-01A-12D-A18O-05		25dd0765-735c-4146-9551-cdfdd9213593
TCGA-AX-A2H7-11	MSS	1	TCGA-AX-A2H7-11	1241	1	days		C6-UCEC								TCGA-AX-A2H7	684	1	days	1241	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	NO	Progressive Disease	87			TCGA-AX-A2H7-F31704	TCGA-AX-A2H7	TCGA-AX-A2H7-11A		Stage IC	NO		-32100	951	1241	0	1020			684	YES		Scheduled Follow-up Submission	2012-5-8	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO			G3	Lung	Metastatic			YES	false	No		A2H7		negative	WITH TUMOR				4+	Complete Remission/Response			YES				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	12	Endometrial	A	DECEASED	60	2008																						TCGA-AX-A2H7-11A-11D-A18O-05		
TCGA-AX-A2H8-01	MSI-L	0	TCGA-AX-A2H8-01	1861	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-AX-A2H8	1861	0	days	1861	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64			TCGA-AX-A2H8-F31709	TCGA-AX-A2H8	TCGA-AX-A2H8-01A		Stage IB	NO		-23448	1974		0	1861						Scheduled Follow-up Submission	2012-5-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-AX-A2H8.1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD.pdf	A2H8		negative	TUMOR FREE				3	Complete Remission/Response			YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	17	0	22	Endometrial	A	LIVING	113	2006			TCGA-AX-A2H8-01		TCGA-AX-A2H8-01A-21-A18R-20	EB4C8FF0-F085-401B-A1D7-B37B1DEEE592										99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda	TCGA-AX-A2H8-01A-11D-A17C-01		TCGA-AX-A2H8-01A-11D-A17C-01		TCGA-AX-A2H8-01	TCGA-AX-A2H8-01A-11D-A17F-05		99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda
TCGA-AX-A2H8-11	MSI-L	0	TCGA-AX-A2H8-11	1861	0	days		C6-UCEC								TCGA-AX-A2H8	1861	0	days	1861	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64			TCGA-AX-A2H8-F31709	TCGA-AX-A2H8	TCGA-AX-A2H8-11A		Stage IB	NO		-23448	1974		0	1861						Scheduled Follow-up Submission	2012-5-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes		A2H8		negative	TUMOR FREE				3	Complete Remission/Response			YES				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	17	0	22	Endometrial	A	LIVING	113	2006																8e59d005-8361-457f-9316-04c989d0b74f						TCGA-AX-A2H8-11A-11D-A17F-05		8e59d005-8361-457f-9316-04c989d0b74f
TCGA-AX-A2HA-01	MSI-H	0	TCGA-AX-A2HA-01	2475	0	days	Iq	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-AX-A2HA	2475	0	days	2475	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	35			TCGA-AX-A2HA-F31721	TCGA-AX-A2HA	TCGA-AX-A2HA-01A	Former User	Stage IB	NO		-13142	2188		0	2475				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	No	TCGA-AX-A2HA.E44408C9-53DE-4FF7-8D8E-6BFAB24302C3.pdf	A2HA		negative	TUMOR FREE					Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	3	0	24	Endometrial	A	LIVING	60	2005			TCGA-AX-A2HA-01		TCGA-AX-A2HA-01A-21-A23Z-20	91D657B3-74C5-4978-81F8-249127F92199									TCGA-AX-A2HA-01	3df718d2-9089-4055-8190-adc218fd3216	TCGA-AX-A2HA-01A-12D-A18N-01		TCGA-AX-A2HA-01A-12D-A18N-01	TCGA-AX-A2HA-01	TCGA-AX-A2HA-01	TCGA-AX-A2HA-01A-12D-A18O-05		3df718d2-9089-4055-8190-adc218fd3216
TCGA-AX-A2HA-11	MSI-H	0	TCGA-AX-A2HA-11	2475	0	days		C6-UCEC								TCGA-AX-A2HA	2475	0	days	2475	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	35			TCGA-AX-A2HA-F31721	TCGA-AX-A2HA	TCGA-AX-A2HA-11A	Former User	Stage IB	NO		-13142	2188		0	2475				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	No		A2HA		negative	TUMOR FREE					Complete Remission/Response			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	3	0	24	Endometrial	A	LIVING	60	2005															TCGA-AX-A2HA-11	0f659732-62d9-4b13-b4c4-cd6b231bdedb				TCGA-AX-A2HA-11		TCGA-AX-A2HA-11A-11D-A18O-05		0f659732-62d9-4b13-b4c4-cd6b231bdedb
TCGA-AX-A2HC-01	MSI-H	0	TCGA-AX-A2HC-01	1044	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	GBM-like c6	miRNA cluster 12	cluster 5		TCGA-AX-A2HC	756	1	days	1044	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Progressive Disease	53			TCGA-AX-A2HC-F31735	TCGA-AX-A2HC	TCGA-AX-A2HC-01A		Stage IIIC	NO		-19485	1786		0	1044			756			Scheduled Follow-up Submission	2012-5-8	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO			G3	Other, specify	Metastatic	Abdomen		YES	false	No	TCGA-AX-A2HC.90DC9BBA-4666-4702-8BA1-F57253E43CDD.pdf	A2HC		negative	WITH TUMOR				2	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	1	1	3	20	Endometrial	A	LIVING	118	2006			TCGA-AX-A2HC-01		TCGA-AX-A2HC-01A-21-A18R-20	76DDEA74-3A3A-4604-A8F6-954228149A76									TCGA-AX-A2HC-01	3e40a983-aba5-4454-88df-a271c296ada6	TCGA-AX-A2HC-01A-11D-A17C-01		TCGA-AX-A2HC-01A-11D-A17C-01	TCGA-AX-A2HC-01	TCGA-AX-A2HC-01	TCGA-AX-A2HC-01A-11D-A17F-05		3e40a983-aba5-4454-88df-a271c296ada6
TCGA-AX-A2HC-11	MSI-H	0	TCGA-AX-A2HC-11	1044	0	days		C6-UCEC								TCGA-AX-A2HC	756	1	days	1044	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Progressive Disease	53			TCGA-AX-A2HC-F31735	TCGA-AX-A2HC	TCGA-AX-A2HC-11A		Stage IIIC	NO		-19485	1786		0	1044			756			Scheduled Follow-up Submission	2012-5-8	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO			G3	Other, specify	Metastatic	Abdomen		YES	false	No		A2HC		negative	WITH TUMOR				2	Complete Remission/Response			NO				R0	Solid Tissue Normal	11	open	1988	YES	NO	YES	AX	1	1	3	20	Endometrial	A	LIVING	118	2006	0959be20-00aa-4736-9cf1-41b3c1d5c5b4			0959be20-00aa-4736-9cf1-41b3c1d5c5b4					0959be20-00aa-4736-9cf1-41b3c1d5c5b4				0959be20-00aa-4736-9cf1-41b3c1d5c5b4		TCGA-AX-A2HC-11					TCGA-AX-A2HC-11		TCGA-AX-A2HC-11A-11D-A17F-05		
TCGA-AX-A2HD-01	MSI-H	0	TCGA-AX-A2HD-01	1414	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-AX-A2HD	1414	0	days	1414	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Partial Response	69			TCGA-AX-A2HD-F31844	TCGA-AX-A2HD	TCGA-AX-A2HD-01A		Stage IIIA	NO		-25499	1175		0	1414						Scheduled Follow-up Submission	2012-5-9	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G3					NO	false	No	TCGA-AX-A2HD.83BDA3FE-254F-4F99-B41E-FC1F8C128906.pdf	A2HD		positive	WITH TUMOR				4+	Partial Remission/Response			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	5	0	21	Endometrial	A	LIVING	51	2008			TCGA-AX-A2HD-01		TCGA-AX-A2HD-01A-11-A18R-20	6BD35FAB-31F7-42F9-BD81-F8083DF351AC									TCGA-AX-A2HD-01	03141105-bc66-4e89-ad97-c54fcf189468	TCGA-AX-A2HD-01A-21D-A17C-01		TCGA-AX-A2HD-01A-21D-A17C-01	TCGA-AX-A2HD-01	TCGA-AX-A2HD-01	TCGA-AX-A2HD-01A-21D-A17F-05		03141105-bc66-4e89-ad97-c54fcf189468
TCGA-AX-A2HD-11	MSI-H	0	TCGA-AX-A2HD-11	1414	0	days		C6-UCEC								TCGA-AX-A2HD	1414	0	days	1414	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Partial Response	69			TCGA-AX-A2HD-F31844	TCGA-AX-A2HD	TCGA-AX-A2HD-11A		Stage IIIA	NO		-25499	1175		0	1414						Scheduled Follow-up Submission	2012-5-9	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO			G3					NO	false	No		A2HD		positive	WITH TUMOR				4+	Partial Remission/Response			NO				R1	Solid Tissue Normal	11	open	1988	NO	NO	YES	AX	0	5	0	21	Endometrial	A	LIVING	51	2008	773d237c-995c-4e0b-aaf1-3b78763ae704			773d237c-995c-4e0b-aaf1-3b78763ae704					773d237c-995c-4e0b-aaf1-3b78763ae704				773d237c-995c-4e0b-aaf1-3b78763ae704		TCGA-AX-A2HD-11					TCGA-AX-A2HD-11		TCGA-AX-A2HD-11A-11D-A17F-05		
TCGA-AX-A2HF-01	MSS	0	TCGA-AX-A2HF-01	848	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-AX-A2HF	848	0	days	848	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-AX-A2HF-F65239	TCGA-AX-A2HF	TCGA-AX-A2HF-01A		Stage IB			-24689	440		0	848				YES		Scheduled Follow-up Submission	2014-9-19	FEMALE	157	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-AX-A2HF.5454BF58-3D26-4D61-B0A8-30A06ECD0E60.pdf	A2HF		negative	WITH TUMOR			YES		Complete Remission/Response			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	9	0	27	Endometrial	A	LIVING	70	2010			TCGA-AX-A2HF-01		TCGA-AX-A2HF-01A-21-A18R-20	84A10878-AFC0-4880-A277-D06ACFDFCA8C				TCGA-AX-A2HF-01A-11D-A17D-09	TCGA-AX-A2HF-01A-11D-A17D-09	TCGA-AX-A2HF-01A-11D-A17D-09				2ffda10e-5941-4c80-9291-a5ebbe0d5a2a	TCGA-AX-A2HF-01A-11D-A17C-01		TCGA-AX-A2HF-01A-11D-A17C-01		TCGA-AX-A2HF-01	TCGA-AX-A2HF-01A-11D-A17F-05		2ffda10e-5941-4c80-9291-a5ebbe0d5a2a
TCGA-AX-A2HG-01	MSI-H	0	TCGA-AX-A2HG-01	1163	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-AX-A2HG	1163	0	days	1163	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-AX-A2HG-F62992	TCGA-AX-A2HG	TCGA-AX-A2HG-01A		Stage IC	NO		-20771	582		0	1163				NO		Scheduled Follow-up Submission	2014-7-29	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A2HG.EF863B73-4C80-42E6-8AAF-2EF72559212A.pdf	A2HG	67		TUMOR FREE			NO		Complete Remission/Response			YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	2	0	27	Endometrial	A	LIVING	115	2009			TCGA-AX-A2HG-01		TCGA-AX-A2HG-01A-21-A18R-20	C506AB11-CE52-4097-B686-C7962D68B9B5									TCGA-AX-A2HG-01	8d2b2907-863e-4db9-8d4b-ce877e562531	TCGA-AX-A2HG-01A-11D-A17C-01		TCGA-AX-A2HG-01A-11D-A17C-01	TCGA-AX-A2HG-01	TCGA-AX-A2HG-01	TCGA-AX-A2HG-01A-11D-A17F-05		8d2b2907-863e-4db9-8d4b-ce877e562531
TCGA-AX-A2HH-01	MSS	0	TCGA-AX-A2HH-01	540	0	days	Kirc+		UCEC CIMP c18	cluster 2	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-AX-A2HH	540	0	days	540	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Partial Response	60			TCGA-AX-A2HH-F31851	TCGA-AX-A2HH	TCGA-AX-A2HH-01A		Stage IA	NO		-21924	462		0	540						Scheduled Follow-up Submission	2012-5-9	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO			G3					NO	false	No	TCGA-AX-A2HH.2EE7245F-7069-456A-A215-41E59D9FE606.pdf	A2HH		negative	WITH TUMOR					Partial Remission/Response			NO				R1	Primary Tumor	01	open	1988	NO	NO	YES	AX	0	4	0	18	Endometrial	A	LIVING	65	2010	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810		TCGA-AX-A2HH-01	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810	TCGA-AX-A2HH-01A-21-A18R-20	E63D7EF7-EE98-4738-9BA6-D2BB407CBBCA			9cfe7287-c1aa-4fc0-8d4f-dc72655b2810				9cfe7287-c1aa-4fc0-8d4f-dc72655b2810		TCGA-AX-A2HH-01		TCGA-AX-A2HH-01A-11D-A17C-01		TCGA-AX-A2HH-01A-11D-A17C-01	TCGA-AX-A2HH-01	TCGA-AX-A2HH-01	TCGA-AX-A2HH-01A-11D-A17F-05		
TCGA-AX-A2HJ-01	MSI-H	0	TCGA-AX-A2HJ-01	935	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-AX-A2HJ	935	0	days	935	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	35			TCGA-AX-A2HJ-F31575	TCGA-AX-A2HJ	TCGA-AX-A2HJ-01A		Stage IC	NO		-13112	779		0	935						Scheduled Follow-up Submission	2012-5-7	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO			G3					NO	false	No	TCGA-AX-A2HJ.84FF1AB9-47F4-4884-9345-43878BDEF379.pdf	A2HJ	80	negative	TUMOR FREE				0	Complete Remission/Response			YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	11	0	7	Endometrial	A	LIVING	56	2009			TCGA-AX-A2HJ-01		TCGA-AX-A2HJ-01A-21-A18R-20	4E7CA333-8EC4-4C6D-A98F-554F67D74087									TCGA-AX-A2HJ-01	b3b47f11-3e7c-475e-8f39-cefb8db8fa35	TCGA-AX-A2HJ-01A-11D-A17C-01		TCGA-AX-A2HJ-01A-11D-A17C-01	TCGA-AX-A2HJ-01	TCGA-AX-A2HJ-01	TCGA-AX-A2HJ-01A-11D-A17F-05		b3b47f11-3e7c-475e-8f39-cefb8db8fa35
TCGA-AX-A2HK-01	MSS	1	TCGA-AX-A2HK-01	90	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	KIRC-like c1	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-AX-A2HK	90	0	days	90	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77			TCGA-AX-A2HK-F31847	TCGA-AX-A2HK	TCGA-AX-A2HK-01A		Stage IIIC	NO		-28316	2045	90	0							Scheduled Follow-up Submission	2012-5-9	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-AX-A2HK.DBC5CE66-3BC0-4A86-A53C-06DEF90A752B.pdf	A2HK	84	negative	WITH TUMOR				4+	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	AX	2	6	3	25	Endometrial	A	DECEASED	73	2005			TCGA-AX-A2HK-01		TCGA-AX-A2HK-01A-21-A18R-20	494C2E2E-C337-420E-BBBE-3981C02497AA									TCGA-AX-A2HK-01	28e3b0f0-29e2-4726-8e28-c6f5a2275fff	TCGA-AX-A2HK-01A-11D-A17C-01		TCGA-AX-A2HK-01A-11D-A17C-01	TCGA-AX-A2HK-01	TCGA-AX-A2HK-01	TCGA-AX-A2HK-01A-11D-A17F-05		28e3b0f0-29e2-4726-8e28-c6f5a2275fff
TCGA-AX-A2IN-01	MSI-H	1	TCGA-AX-A2IN-01	947	1	days	Iq		UCEC CIMP c18				miRNA cluster 6	cluster 1		TCGA-AX-A2IN	358	1	days	947	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	63			TCGA-AX-A2IN-F58273	TCGA-AX-A2IN			Stage IC			-23275		947	0				358				2014-4-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Brain	Distant Metastasis			YES		No		A2IN	85	negative	WITH TUMOR			NO					YES				R0	Primary Tumor	01	open	1988		NO	YES	AX	0	4	0	21	Endometrial		DECEASED	100	2007	af153b10-b6c0-4345-b242-9ad4c676e6c4		TCGA-AX-A2IN-01	af153b10-b6c0-4345-b242-9ad4c676e6c4					af153b10-b6c0-4345-b242-9ad4c676e6c4				af153b10-b6c0-4345-b242-9ad4c676e6c4		TCGA-AX-A2IN-01		TCGA-AX-A2IN-01A-12D-A17U-01		TCGA-AX-A2IN-01A-12D-A17U-01	TCGA-AX-A2IN-01	TCGA-AX-A2IN-01	TCGA-AX-A2IN-01A-12D-A17Z-05		
TCGA-AX-A2IO-01	MSS	0	TCGA-AX-A2IO-01	1975	0	days	High		UCEC Serous c4			UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-AX-A2IO	1975	0	days	1975	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	83			TCGA-AX-A2IO-F58276	TCGA-AX-A2IO			Stage IIA			-30539			0	1975							2014-4-3	FEMALE	162	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A2IO		negative	TUMOR FREE			YES					YES				R1	Primary Tumor	01	open	1988		NO	YES	AX	0	3	0	7	Endometrial		LIVING	64	2008			TCGA-AX-A2IO-01												TCGA-AX-A2IO-01	e216a53d-5300-45af-985d-9d397e990acf	TCGA-AX-A2IO-01A-11D-A17U-01		TCGA-AX-A2IO-01A-11D-A17U-01	TCGA-AX-A2IO-01	TCGA-AX-A2IO-01	TCGA-AX-A2IO-01A-11D-A17Z-05		e216a53d-5300-45af-985d-9d397e990acf
TCGA-AX-A3FS-01	MSI-H	0	TCGA-AX-A3FS-01	1	0	days	Kirc+		UCEC CIMP c18		BRCA basal-like c6		miRNA cluster 5			TCGA-AX-A3FS			days	1	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					82			TCGA-AX-A3FS-F58279	TCGA-AX-A3FS	TCGA-AX-A3FS-01A		Stage IA			-30102	609		0	1							2014-4-3	FEMALE	139	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Laparoscopy, robotic-assisted lysis of adhesions, robotic-assisted lysis total hysterectomy, bso, bilateral pelvic lymphadenectomy and cystoscopy	Other method, specify:	80	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A3FS.1AEA9AC0-3B22-4819-9542-1F6A6AD474BC.pdf	A3FS		negative														Primary Tumor	01	open	1988		NO	YES	AX		0	0	16	Endometrial	A	LIVING	98	2010	2db9f19e-4614-44f9-a9f5-7541d6a20369		TCGA-AX-A3FS-01	2db9f19e-4614-44f9-a9f5-7541d6a20369	TCGA-AX-A3FS-01A-21-A23Z-20	07244A31-9016-4B5E-B95C-E2EC48438634			2db9f19e-4614-44f9-a9f5-7541d6a20369				2db9f19e-4614-44f9-a9f5-7541d6a20369		TCGA-AX-A3FS-01		TCGA-AX-A3FS-01A-11D-A227-01		TCGA-AX-A3FS-01A-11D-A227-01	TCGA-AX-A3FS-01	TCGA-AX-A3FS-01	TCGA-AX-A3FS-01A-11D-A22B-05		
TCGA-AX-A3FT-01	MSI-H	0	TCGA-AX-A3FT-01	6	0	days	Kirc+		BRCA CIMP c7		UCEC-like c5		miRNA cluster 13			TCGA-AX-A3FT			days	6	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					64			TCGA-AX-A3FT-F58280	TCGA-AX-A3FT	TCGA-AX-A3FT-01A		Stage IB			-23543	524		0	6							2014-4-3	FEMALE	161	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Exploratory Laparotomy, TAH, BSO, Pelvic and pariaortic LND.	Other method, specify:	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A3FT.EF16D53F-14A2-4127-B5F7-F318EC60C5C0.pdf	A3FT																Primary Tumor	01	open	1988		NO	YES	AX	0	4	0	21	Endometrial	A	LIVING	82	2010	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b		TCGA-AX-A3FT-01	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b	TCGA-AX-A3FT-01A-21-A23Z-20	3F2A36E1-DC43-4EB6-B0C0-F7D255496FB0			9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b				9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b		TCGA-AX-A3FT-01		TCGA-AX-A3FT-01A-11D-A227-01		TCGA-AX-A3FT-01A-11D-A227-01	TCGA-AX-A3FT-01	TCGA-AX-A3FT-01	TCGA-AX-A3FT-01A-11D-A22B-05		
TCGA-AX-A3FV-01	MSS		TCGA-AX-A3FV-01			days	High		Cluster 13 (HNSC-LUSC)		BRCA basal-like c6		miRNA cluster 12			TCGA-AX-A3FV			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					62			TCGA-AX-A3FV-F58281	TCGA-AX-A3FV	TCGA-AX-A3FV-01A		Stage IIIA			-22752	799		0	-6							2014-4-3	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	YES		G3						false	No	TCGA-AX-A3FV.0D1601D0-E0F4-4DBA-91EA-62092FE8621F.pdf	A3FV																Primary Tumor	01	open	1988		NO	YES	AX		0		0	Endometrial	A	LIVING	113	2009	3f24dcf1-9ec6-4ec4-9379-f9051151c639		TCGA-AX-A3FV-01	3f24dcf1-9ec6-4ec4-9379-f9051151c639	TCGA-AX-A3FV-01A-21-A23Z-20	C39A1125-5A35-4983-B5F7-290CBA28EE1A			3f24dcf1-9ec6-4ec4-9379-f9051151c639				3f24dcf1-9ec6-4ec4-9379-f9051151c639		TCGA-AX-A3FV-01		TCGA-AX-A3FV-01A-11D-A227-01		TCGA-AX-A3FV-01A-11D-A227-01	TCGA-AX-A3FV-01	TCGA-AX-A3FV-01	TCGA-AX-A3FV-01A-11D-A22B-05		
TCGA-AX-A3FW-01	MSS	0	TCGA-AX-A3FW-01	17	0	days	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-AX-A3FW			days	17	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					66			TCGA-AX-A3FW-F58282	TCGA-AX-A3FW	TCGA-AX-A3FW-01A		Stage IB			-24419	723		0	17							2014-4-3	FEMALE	167	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Robotic hysterectomy with Lymph Node Dissection	Other method, specify:	90	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A3FW.AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15.pdf	A3FW	27															Primary Tumor	01	open	1988		NO	YES	AX		0	0	12	Endometrial	A	LIVING	84	2009	bbf7786d-0996-47fc-8af9-482d2087ccb1		TCGA-AX-A3FW-01	bbf7786d-0996-47fc-8af9-482d2087ccb1	TCGA-AX-A3FW-01A-21-A23Z-20	21B45816-6F8E-4657-9E16-9953FD234D09			bbf7786d-0996-47fc-8af9-482d2087ccb1				bbf7786d-0996-47fc-8af9-482d2087ccb1		TCGA-AX-A3FW-01		TCGA-AX-A3FW-01A-11D-A227-01		TCGA-AX-A3FW-01A-11D-A227-01	TCGA-AX-A3FW-01	TCGA-AX-A3FW-01	TCGA-AX-A3FW-01A-11D-A22B-05		
TCGA-AX-A3FX-01	MSS	1	TCGA-AX-A3FX-01	1333	1	days	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 12			TCGA-AX-A3FX	938	1	days	1333	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Progressive Disease	69			TCGA-AX-A3FX-F58283	TCGA-AX-A3FX	TCGA-AX-A3FX-01A		Stage IIB			-25260	736	1333	0	4			938				2014-4-3	FEMALE	149	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	TAH/BSO/LND/Panniculectomy	Other method, specify:	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Chest		YES	false	No	TCGA-AX-A3FX.B3326BA1-71E3-4207-9727-B157A3E195E7.pdf	A3FX						YES					NO					Primary Tumor	01	open	1988		NO	YES	AX	0	2	0	24	Endometrial	A	DECEASED	85	2009	73d3142f-9060-488c-9108-3b1abd12f323		TCGA-AX-A3FX-01	73d3142f-9060-488c-9108-3b1abd12f323	TCGA-AX-A3FX-01A-21-A23Z-20	8BB9A436-20C4-45D9-98BD-FFCAF66C9C8B			73d3142f-9060-488c-9108-3b1abd12f323				73d3142f-9060-488c-9108-3b1abd12f323		TCGA-AX-A3FX-01		TCGA-AX-A3FX-01A-11D-A227-01		TCGA-AX-A3FX-01A-11D-A227-01	TCGA-AX-A3FX-01	TCGA-AX-A3FX-01	TCGA-AX-A3FX-01A-11D-A22B-05		
TCGA-AX-A3FZ-01	MSS	0	TCGA-AX-A3FZ-01	2	0	days	High		UCEC non-CIMP c3		KIRC-like c1		miRNA cluster 15			TCGA-AX-A3FZ			days	2	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					33			TCGA-AX-A3FZ-F58286	TCGA-AX-A3FZ	TCGA-AX-A3FZ-01A		Stage IIIB			-12331	658		0	2							2014-4-3	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Exploratory laparotomy, total abdominal hysterectomy, bso, major debulking, omentectomy, appendectomy, bilateral pelvic lymphadenectomy, segmental small bowel resection, cystoscopy	Other method, specify:	100	NO	YES		G3						false	No	TCGA-AX-A3FZ.4989F66F-57F8-4B1C-97DD-69F3036EB0BA.pdf	A3FZ		positive														Primary Tumor	01	open	1988		NO	YES	AX		0	0	9	Endometrial	A	LIVING	113	2010	da84a25d-fd15-40ff-80c1-e3f2d2b2b301		TCGA-AX-A3FZ-01	da84a25d-fd15-40ff-80c1-e3f2d2b2b301	TCGA-AX-A3FZ-01A-21-A23Z-20	A6279404-9822-4FE1-A21E-949EAAF4A31F			da84a25d-fd15-40ff-80c1-e3f2d2b2b301				da84a25d-fd15-40ff-80c1-e3f2d2b2b301		TCGA-AX-A3FZ-01		TCGA-AX-A3FZ-01A-11D-A227-01		TCGA-AX-A3FZ-01A-11D-A227-01	TCGA-AX-A3FZ-01	TCGA-AX-A3FZ-01	TCGA-AX-A3FZ-01A-11D-A22B-05		
TCGA-AX-A3G1-01	MSS	1	TCGA-AX-A3G1-01	624	1	days	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AX-A3G1	624	0	days	624	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					84			TCGA-AX-A3G1-F21258	TCGA-AX-A3G1			Stage IC	NO		-31037		624	0							Scheduled Follow-up Submission	2012-2-7	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Total abdominal hysterectomy with bso	Other method, specify:				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A3G1							4+				NO					Primary Tumor	01	open	1988	NO	NO	YES	AX	0	6	0	21	Endometrial		DECEASED	61	2009	b774f929-57f2-4f5a-9080-82b390a7a7f9		TCGA-AX-A3G1-01	b774f929-57f2-4f5a-9080-82b390a7a7f9					b774f929-57f2-4f5a-9080-82b390a7a7f9				b774f929-57f2-4f5a-9080-82b390a7a7f9		TCGA-AX-A3G1-01		TCGA-AX-A3G1-01A-11D-A227-01		TCGA-AX-A3G1-01A-11D-A227-01	TCGA-AX-A3G1-01	TCGA-AX-A3G1-01	TCGA-AX-A3G1-01A-11D-A22B-05		
TCGA-AX-A3G3-01	MSS	0	TCGA-AX-A3G3-01	42	0	days	High		OV-like c1		UCEC-like c5		miRNA cluster 4			TCGA-AX-A3G3			days	42	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					58			TCGA-AX-A3G3-F58287	TCGA-AX-A3G3	TCGA-AX-A3G3-01A		Stage IIIA			-21308	713		0	42							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	total laparascopic hysterectomy, bso, bilateral pelvic and obturator lymphadenectomy, omentectomy and staging biopsies	Other method, specify:	140	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	Yes	TCGA-AX-A3G3.3D86258F-2C9B-4DF2-86C5-E12B3FCB480D.pdf	A3G3																Primary Tumor	01	open	1988		NO	YES	AX	0	3	0	14	Endometrial	A	LIVING	55	2009	11e82091-a9fb-4b7b-b0a2-7908e50e2c60		TCGA-AX-A3G3-01	11e82091-a9fb-4b7b-b0a2-7908e50e2c60	TCGA-AX-A3G3-01A-21-A23Z-20	8FBE82B9-42A9-4451-A36F-9DE16D55BEB3			11e82091-a9fb-4b7b-b0a2-7908e50e2c60				11e82091-a9fb-4b7b-b0a2-7908e50e2c60				TCGA-AX-A3G3-01A-11D-A20R-01		TCGA-AX-A3G3-01A-11D-A20R-01		TCGA-AX-A3G3-01	TCGA-AX-A3G3-01A-11D-A212-05		
TCGA-AX-A3G4-01	MSS	0	TCGA-AX-A3G4-01	9	0	days	BRCA-LUAD+		UCEC Serous c4		UCEC-like c5		miRNA cluster 5			TCGA-AX-A3G4			days	9	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					60			TCGA-AX-A3G4-F58288	TCGA-AX-A3G4	TCGA-AX-A3G4-01A		Stage IIIC			-22099	463		0	9							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	TAH, BSO, bilateral pelvic and periaortic lymphadenectomy and omentecomy.	Other method, specify:	130	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A3G4.7E8857D6-4347-4BC5-8655-40AAD7197789.pdf	A3G4																Primary Tumor	01	open	1988		NO	YES	AX	2	4		2	Endometrial	A	LIVING	107	2010	a598aef0-10a2-41bb-b755-4b2788b32e10		TCGA-AX-A3G4-01	a598aef0-10a2-41bb-b755-4b2788b32e10	TCGA-AX-A3G4-01A-21-A23Z-20	AC600CA3-2BAC-46B1-A370-C17D6BB200DE			a598aef0-10a2-41bb-b755-4b2788b32e10				a598aef0-10a2-41bb-b755-4b2788b32e10		TCGA-AX-A3G4-01		TCGA-AX-A3G4-01A-11D-A20R-01		TCGA-AX-A3G4-01A-11D-A20R-01	TCGA-AX-A3G4-01	TCGA-AX-A3G4-01	TCGA-AX-A3G4-01A-11D-A212-05		
TCGA-AX-A3G6-01	MSS	0	TCGA-AX-A3G6-01	8	0	days	Squamous		UCEC non-CIMP c3				miRNA cluster 12			TCGA-AX-A3G6			days	8	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67			TCGA-AX-A3G6-F58289	TCGA-AX-A3G6	TCGA-AX-A3G6-01A		Stage IA			-24681	456		0	8							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	TAH, BSO, bilateral pelvic lymphadenectomy, periaortic node dissection	Other method, specify:	50	NO	YES		G2						false	No	TCGA-AX-A3G6.53586ED5-5C68-4517-8543-7508AF37F68C.pdf	A3G6																Primary Tumor	01	open	1988		NO	YES	AX	0	5	0	11	Endometrial	A	LIVING	60	2010	99e76a2e-9162-4345-9155-cc7267c0325b		TCGA-AX-A3G6-01	99e76a2e-9162-4345-9155-cc7267c0325b					99e76a2e-9162-4345-9155-cc7267c0325b				99e76a2e-9162-4345-9155-cc7267c0325b		TCGA-AX-A3G6-01		TCGA-AX-A3G6-01A-11D-A20R-01		TCGA-AX-A3G6-01A-11D-A20R-01	TCGA-AX-A3G6-01	TCGA-AX-A3G6-01	TCGA-AX-A3G6-01A-11D-A212-05		
TCGA-AX-A3G7-01	MSS	0	TCGA-AX-A3G7-01	9	0	days	Squamous		UCEC Serous c4							TCGA-AX-A3G7			days	9	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					71			TCGA-AX-A3G7-F58290	TCGA-AX-A3G7	TCGA-AX-A3G7-01A		Stage IVB			-26187	520		0	9							2014-4-3	FEMALE	154	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	Exploratory laparotomy, TAH, BSO, radical optimal tumor debulking with gastrocolic omentectomy	Other method, specify:	50	NO	YES		G3						false	No	TCGA-AX-A3G7.81608C78-6495-4FC7-9210-1132E9335D01.pdf	A3G7																Primary Tumor	01	open	1988		NO	YES	AX		0		0	Endometrial	A	LIVING	74	2010	8d020165-5475-4257-87c3-c98fc2d201d2		TCGA-AX-A3G7-01	8d020165-5475-4257-87c3-c98fc2d201d2					8d020165-5475-4257-87c3-c98fc2d201d2				8d020165-5475-4257-87c3-c98fc2d201d2		TCGA-AX-A3G7-01		TCGA-AX-A3G7-01A-12D-A20R-01		TCGA-AX-A3G7-01A-12D-A20R-01	TCGA-AX-A3G7-01	TCGA-AX-A3G7-01	TCGA-AX-A3G7-01A-12D-A212-05		
TCGA-AX-A3G8-01	MSI-H	0	TCGA-AX-A3G8-01	30	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-AX-A3G8			days	30	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					76			TCGA-AX-A3G8-F58291	TCGA-AX-A3G8	TCGA-AX-A3G8-01A		Stage IA			-27899	350		0	30							2014-4-3	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-AX-A3G8.FD22A233-9333-4DA2-A913-4DBA90600247.pdf	A3G8		negative														Primary Tumor	01	open	1988		NO	YES	AX	0	2	0	30	Endometrial	A	LIVING	62	2010	9c949f30-455e-48a6-ae31-73f26c609ffd		TCGA-AX-A3G8-01	9c949f30-455e-48a6-ae31-73f26c609ffd	TCGA-AX-A3G8-01A-21-A23Z-20	208B07DB-EF6D-4B9E-9E76-1F24126FFD67			9c949f30-455e-48a6-ae31-73f26c609ffd				9c949f30-455e-48a6-ae31-73f26c609ffd		TCGA-AX-A3G8-01		TCGA-AX-A3G8-01A-11D-A227-01		TCGA-AX-A3G8-01A-11D-A227-01	TCGA-AX-A3G8-01	TCGA-AX-A3G8-01	TCGA-AX-A3G8-01A-11D-A22B-05		
TCGA-AX-A3G9-01	MSI-H	0	TCGA-AX-A3G9-01	558	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-AX-A3G9	558	0	days	558	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					63			TCGA-AX-A3G9-F21262	TCGA-AX-A3G9	TCGA-AX-A3G9-01A		Stage IIIC			-23361	560		0	558						Scheduled Follow-up Submission	2012-2-7	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Robotic laparoscopic hysterectomy, BSO, pelvic and periaortic LND	Other method, specify:	110	NO			G3					NO	false	No	TCGA-AX-A3G9.FADFF649-7518-4EFB-B96C-9390DD308DBD.pdf	A3G9		negative					2				YES				R1	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	1	1	4	Endometrial	A	LIVING	60	2010	f31b5e70-af25-4f1a-b7e3-13f17998e7e2		TCGA-AX-A3G9-01	f31b5e70-af25-4f1a-b7e3-13f17998e7e2	TCGA-AX-A3G9-01A-21-A23Z-20	AD5918E9-5828-4266-95F1-38E5C9F20F80			f31b5e70-af25-4f1a-b7e3-13f17998e7e2				f31b5e70-af25-4f1a-b7e3-13f17998e7e2		TCGA-AX-A3G9-01		TCGA-AX-A3G9-01A-11D-A227-01		TCGA-AX-A3G9-01A-11D-A227-01	TCGA-AX-A3G9-01	TCGA-AX-A3G9-01	TCGA-AX-A3G9-01A-11D-A22B-05		
TCGA-AX-A3GB-01	MSS	0	TCGA-AX-A3GB-01	440	0	days	Iq		UCEC CIMP c18				miRNA c1uster 9			TCGA-AX-A3GB	440	0	days	440	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					73			TCGA-AX-A3GB-F21266	TCGA-AX-A3GB			Stage IB	NO		-26724			0	440						Scheduled Follow-up Submission	2012-2-7	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	TAH, BSO, pelvic and paraaortic LND, intracolic omentectomy	Other method, specify:				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A3GB		negative									NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	AX	0	6	0	19	Endometrial		LIVING	87	2010	ba01a4cb-d7cd-4a9a-ae28-978262154683		TCGA-AX-A3GB-01	ba01a4cb-d7cd-4a9a-ae28-978262154683					ba01a4cb-d7cd-4a9a-ae28-978262154683				ba01a4cb-d7cd-4a9a-ae28-978262154683		TCGA-AX-A3GB-01		TCGA-AX-A3GB-01A-11D-A227-01		TCGA-AX-A3GB-01A-11D-A227-01	TCGA-AX-A3GB-01	TCGA-AX-A3GB-01	TCGA-AX-A3GB-01A-11D-A22B-05		
TCGA-AX-A3GI-01	Indeterminate	0	TCGA-AX-A3GI-01	12	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-AX-A3GI			days	12	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					66			TCGA-AX-A3GI-F58292	TCGA-AX-A3GI	TCGA-AX-A3GI-01A		Stage IIIC			-24388	300		0	12							2014-4-3	FEMALE	167	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES	Exploratory Laparotomy, TAH, BSO, bilateral pelvic and periaortic LND.	Other method, specify:	110	NO	YES		G3						false	No	TCGA-AX-A3GI.A803E376-399C-4841-A6AE-E82B99CD57B7.pdf	A3GI																Primary Tumor	01	open	1988		NO	YES	AX	3	4	4	4	Endometrial	A	LIVING	87	2011	9d42a9c4-305b-4e25-a260-82805d6b059a		TCGA-AX-A3GI-01	9d42a9c4-305b-4e25-a260-82805d6b059a	TCGA-AX-A3GI-01A-21-A23Z-20	4E4812F1-7DB6-4475-BBE6-DE4A4AEB82E1			9d42a9c4-305b-4e25-a260-82805d6b059a				9d42a9c4-305b-4e25-a260-82805d6b059a		TCGA-AX-A3GI-01		TCGA-AX-A3GI-01A-11D-A20R-01		TCGA-AX-A3GI-01A-11D-A20R-01	TCGA-AX-A3GI-01	TCGA-AX-A3GI-01	TCGA-AX-A3GI-01A-11D-A212-05		
TCGA-B5-A0JN-01	MSI-L	0	TCGA-B5-A0JN-01	2445	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5		miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-B5-A0JN			days	2445	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					84	0	0	TCGA-B5-A0JN-F11873	TCGA-B5-A0JN	TCGA-B5-A0JN-01A		Stage IVB	NO		-30933	2164		0	2445				NO			2011-5-18	FEMALE	154	Serous endometrial adenocarcinoma	Yes	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection	440	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	Yes	TCGA-B5-A0JN.A22F4C33-7630-4595-8415-24C87949B211.pdf	A0JN	0	positive	TUMOR FREE	0	0		0	Complete Remission/Response	Former User		NO					Primary Tumor	01	open	1988	YES	NO	YES	B5	0	0	0	0	Endometrial	A	LIVING	58	2004	cbd18c2a-4544-4a90-904e-533c3f776f32	TCGA-B5-A0JN-01	TCGA-B5-A0JN-01	cbd18c2a-4544-4a90-904e-533c3f776f32	TCGA-B5-A0JN-01A-21-A163-20	90FFCFFB-C276-438C-AD00-0DA5CABA8596		TCGA-B5-A0JN-01	cbd18c2a-4544-4a90-904e-533c3f776f32	TCGA-B5-A0JN-01A-11D-A10B-09	TCGA-B5-A0JN-01A-11D-A10B-09	TCGA-B5-A0JN-01A-11D-A10B-09	cbd18c2a-4544-4a90-904e-533c3f776f32				TCGA-B5-A0JN-01A-11D-A102-01		TCGA-B5-A0JN-01A-11D-A102-01		TCGA-B5-A0JN-01		TCGA-B5-A0JN-01A-11D-A10Q-05	
TCGA-B5-A0JR-01	MSI-H	0	TCGA-B5-A0JR-01	1731	0	days	BRCA-LUAD+		UCEC CIMP c18	cluster 1					mutation cluster 7	TCGA-B5-A0JR	1731	0	days	1731	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	0	TCGA-B5-A0JR-F12807	TCGA-B5-A0JR			Stage IB	NO		-26814			0	1731				NO		Scheduled Follow-up Submission	2011-6-8	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A0JR	71	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	6	0	32	Endometrial		LIVING	105	2006	a67adcd5-7f63-44f2-a127-568569c9a357		TCGA-B5-A0JR-01	a67adcd5-7f63-44f2-a127-568569c9a357			TCGA-B5-A0JR-01		a67adcd5-7f63-44f2-a127-568569c9a357	TCGA-B5-A0JR-01A-13W-A062-09	TCGA-B5-A0JR-01A-13W-A062-09	TCGA-B5-A0JR-01A-13W-A062-09	a67adcd5-7f63-44f2-a127-568569c9a357	TCGA-B5-A0JR-01	TCGA-B5-A0JR-01		TCGA-B5-A0JR-01A-13D-A042-01	TCGA-B5-A0JR-01A-13R-A040-07	TCGA-B5-A0JR-01A-13D-A042-01	TCGA-B5-A0JR-01	TCGA-B5-A0JR-01		TCGA-B5-A0JR-01A-13D-A039-05	
TCGA-B5-A0JS-01	MSS	0	TCGA-B5-A0JS-01	2627	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-B5-A0JS	2627	0	days	2627	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54			TCGA-B5-A0JS-F72215	TCGA-B5-A0JS			Stage IA	NO		-19995			0	2627				NO		Scheduled Follow-up Submission	2015-4-29	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A0JS	11	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5		0	0	28	Endometrial		LIVING	110	2007		TCGA-B5-A0JS-01	TCGA-B5-A0JS-01					TCGA-B5-A0JS-01		TCGA-B5-A0JS-01A-11D-A10B-09	TCGA-B5-A0JS-01A-11D-A10B-09	TCGA-B5-A0JS-01A-11D-A10B-09				a18fa5ae-5c28-426a-a7ae-d0c0b223991f	TCGA-B5-A0JS-01A-11D-A102-01		TCGA-B5-A0JS-01A-11D-A102-01		TCGA-B5-A0JS-01		TCGA-B5-A0JS-01A-11D-A10Q-05	a18fa5ae-5c28-426a-a7ae-d0c0b223991f
TCGA-B5-A0JT-01	MSS	0	TCGA-B5-A0JT-01	1682	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-B5-A0JT	1682	0	days	1682	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-B5-A0JT-F32680	TCGA-B5-A0JT	TCGA-B5-A0JT-01A	Former User	Stage IIIA			-23041	1128		0	1682						Scheduled Follow-up Submission	2012-6-7	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	750	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A0JT.CC6EE5B1-5548-4DE7-873F-332DBF81710F.pdf	A0JT	12	positive	TUMOR FREE				0				NO					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	14	Endometrial	A	LIVING	119	2007			TCGA-B5-A0JT-01		TCGA-B5-A0JT-01A-11-A162-20	4E93B9DF-D389-4EDB-B2D5-CFD48CEBB426					TCGA-B5-A0JT-01A-21D-A122-09	TCGA-B5-A0JT-01A-21D-A122-09			TCGA-B5-A0JT-01	b3e039bf-945c-4974-a4ec-8e3b177aef8d	TCGA-B5-A0JT-01A-21D-A120-01		TCGA-B5-A0JT-01A-21D-A120-01	TCGA-B5-A0JT-01	TCGA-B5-A0JT-01	TCGA-B5-A0JT-01A-21D-A123-05		b3e039bf-945c-4974-a4ec-8e3b177aef8d
TCGA-B5-A0JU-01	MSI-H	0	TCGA-B5-A0JU-01	1802	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-B5-A0JU	1802	0	days	1802	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-B5-A0JU-F32684	TCGA-B5-A0JU	TCGA-B5-A0JU-01B	Former User	Stage IB			-21159	1345		0	1802						Scheduled Follow-up Submission	2012-6-7	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A0JU.1EB80878-50FF-4E79-AF16-E809E6EE7DEC.pdf	A0JU	19	negative	TUMOR FREE				2				NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	17	Endometrial	B	LIVING	137	2007			TCGA-B5-A0JU-01		TCGA-B5-A0JU-01B-21-A18Q-20	7899C98B-FB71-4CE0-993B-FCBEA706104B									TCGA-B5-A0JU-01	26ef4a16-ddf1-4585-949b-14057cc8a5bf	TCGA-B5-A0JU-01B-11D-A14F-01		TCGA-B5-A0JU-01B-11D-A14F-01	TCGA-B5-A0JU-01	TCGA-B5-A0JU-01	TCGA-B5-A0JU-01B-11D-A14H-05		26ef4a16-ddf1-4585-949b-14057cc8a5bf
TCGA-B5-A0JV-01	MSI-H	0	TCGA-B5-A0JV-01	2616	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-B5-A0JV	2616	0	days	2616	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES	Complete Response	63	0	0	TCGA-B5-A0JV-F72216	TCGA-B5-A0JV	TCGA-B5-A0JV-01A		Stage IA	NO	728	-23295	1001		0	2616			698			Scheduled Follow-up Submission	2015-4-29	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	40	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	vaginal wall		NO	true	No	TCGA-B5-A0JV.71A1DE5B-7CE5-4884-A91E-3BE753036E4F.pdf	A0JV	26	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response			YES	Surgical Resection		R0		Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	2	0	16	Endometrial	A	LIVING	94	2007		TCGA-B5-A0JV-01	TCGA-B5-A0JV-01					TCGA-B5-A0JV-01		TCGA-B5-A0JV-01A-11D-A10B-09	TCGA-B5-A0JV-01A-11D-A10B-09	TCGA-B5-A0JV-01A-11D-A10B-09				39b1ee4d-b57a-44d5-8b14-20b02f878123	TCGA-B5-A0JV-01A-11D-A102-01		TCGA-B5-A0JV-01A-11D-A102-01		TCGA-B5-A0JV-01		TCGA-B5-A0JV-01A-11D-A10Q-05	39b1ee4d-b57a-44d5-8b14-20b02f878123
TCGA-B5-A0JX-01	MSS	0	TCGA-B5-A0JX-01	1787	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-B5-A0JX	1787	0	days	1787	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62			TCGA-B5-A0JX-F72217	TCGA-B5-A0JX	TCGA-B5-A0JX-01A	Never Used	Stage IB			-22834	952		0	1787						Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A0JX.E511CFF9-9687-4134-B85D-37C037B71643.pdf	A0JX	23	negative	TUMOR FREE			NO	1	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	2	0	40	Endometrial	A	LIVING	113	2007			TCGA-B5-A0JX-01		TCGA-B5-A0JX-01A-11-A18Q-20	FD2FA120-9178-48CD-A4EF-B93D243FF172									TCGA-B5-A0JX-01	093be209-e5ac-4129-83b2-5f79f6a5c15f	TCGA-B5-A0JX-01A-21D-A14J-01		TCGA-B5-A0JX-01A-21D-A14J-01	TCGA-B5-A0JX-01	TCGA-B5-A0JX-01	TCGA-B5-A0JX-01A-21D-A14N-05		093be209-e5ac-4129-83b2-5f79f6a5c15f
TCGA-B5-A0JY-01	MSS	0	TCGA-B5-A0JY-01	2107	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-B5-A0JY	2107	0	days	2107	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	50			TCGA-B5-A0JY-F72218	TCGA-B5-A0JY	TCGA-B5-A0JY-01A		Stage IIIC1	NO		-18475	632		0	2107				NO		Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8020/3	C54.1	YES		Dilation and curettage procedure	1170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A0JY.9708BE95-175D-458B-8BA1-02D9C488225D.pdf	A0JY	100	negative	TUMOR FREE			YES	2	Complete Remission/Response			NO					Primary Tumor	01	open	1988	YES	NO	YES	B5		0	2	17	Endometrial	A	LIVING	67	2008		TCGA-B5-A0JY-01	TCGA-B5-A0JY-01		TCGA-B5-A0JY-01A-21-A162-20	67F7ACE8-BFC1-4162-B334-D70ADF7A75EF		TCGA-B5-A0JY-01			TCGA-B5-A0JY-01A-11D-A10B-09	TCGA-B5-A0JY-01A-11D-A10B-09				bbc76639-b9f4-4e9f-afa2-e319eee91b48	TCGA-B5-A0JY-01A-11D-A102-01		TCGA-B5-A0JY-01A-11D-A102-01		TCGA-B5-A0JY-01		TCGA-B5-A0JY-01A-11D-A10Q-05	bbc76639-b9f4-4e9f-afa2-e319eee91b48
TCGA-B5-A0JZ-01	MSI-H	0	TCGA-B5-A0JZ-01	2173	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 6	TCGA-B5-A0JZ	2173	0	days	2173	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	YES	Complete Response	60			TCGA-B5-A0JZ-F72219	TCGA-B5-A0JZ	TCGA-B5-A0JZ-01A	Never Used	Stage IIIC1	NO	356	-22106	642		0	2173			356	NO		Scheduled Follow-up Submission	2015-4-29	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	400	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	inguinal lymph node		NO	true	No	TCGA-B5-A0JZ.B275A085-067D-42ED-8E41-8461D5183A6E.pdf	A0JZ	61	negative	TUMOR FREE			YES	0	Progressive Disease			YES	Other Method, Specify Below	lymph node dissection			Primary Tumor	01	open	1988	YES	NO	YES	B5	0	8	1	19	Endometrial	A	LIVING	87	2008		TCGA-B5-A0JZ-01	TCGA-B5-A0JZ-01		TCGA-B5-A0JZ-01A-21-A162-20	D30AC09F-6CFC-4660-A8BF-6C5538C8456D	TCGA-B5-A0JZ-01	TCGA-B5-A0JZ-01		TCGA-B5-A0JZ-01A-11W-A062-09	TCGA-B5-A0JZ-01A-11W-A062-09	TCGA-B5-A0JZ-01A-11W-A062-09		TCGA-B5-A0JZ-01		3bc43656-d16a-4ec6-9fde-aab0446c6e50	TCGA-B5-A0JZ-01A-11D-A042-01	TCGA-B5-A0JZ-01A-11R-A040-07	TCGA-B5-A0JZ-01A-11D-A042-01		TCGA-B5-A0JZ-01		TCGA-B5-A0JZ-01A-11D-A039-05	3bc43656-d16a-4ec6-9fde-aab0446c6e50
TCGA-B5-A0K0-01	MSS	0	TCGA-B5-A0K0-01	1478	0	days	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-B5-A0K0	1478	0	days	1478	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	48			TCGA-B5-A0K0-F72220	TCGA-B5-A0K0	TCGA-B5-A0K0-01A	Former User	Stage IA	NO		-17810	615		0	1478				YES		Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	440	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G1					NO	true	No	TCGA-B5-A0K0.6284E0A9-FACB-4297-ABC6-308715ABAFCD.pdf	A0K0	0	negative	TUMOR FREE			NO	3	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5		0	0	15	Endometrial	A	LIVING	140	2008		TCGA-B5-A0K0-01	TCGA-B5-A0K0-01		TCGA-B5-A0K0-01A-21-A162-20	712B8668-113A-4AE1-92C6-8D3104282749	TCGA-B5-A0K0-01	TCGA-B5-A0K0-01		TCGA-B5-A0K0-01A-11W-A062-09	TCGA-B5-A0K0-01A-11W-A062-09	TCGA-B5-A0K0-01A-11W-A062-09		TCGA-B5-A0K0-01		2df1abb0-b25b-4486-a5ed-728964eb0a1b	TCGA-B5-A0K0-01A-11D-A042-01	TCGA-B5-A0K0-01A-11R-A040-07	TCGA-B5-A0K0-01A-11D-A042-01		TCGA-B5-A0K0-01		TCGA-B5-A0K0-01A-11D-A039-05	2df1abb0-b25b-4486-a5ed-728964eb0a1b
TCGA-B5-A0K1-01	MSS	0	TCGA-B5-A0K1-01	1110	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-B5-A0K1	1110	0	days	1110	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69			TCGA-B5-A0K1-F72221	TCGA-B5-A0K1	TCGA-B5-A0K1-01A		Stage IA	NO		-25291	636		0	1110				YES		Scheduled Follow-up Submission	2015-4-29	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A0K1.826BF8E6-F928-4962-9322-78FA74F9FB0E.pdf	A0K1	45	negative	TUMOR FREE			NO	4+	Complete Remission/Response			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5		0	0	22	Endometrial	A	LIVING	117	2008		TCGA-B5-A0K1-01	TCGA-B5-A0K1-01		TCGA-B5-A0K1-01A-21-A162-20	6E5666F2-50BE-4591-878C-723948CDF9C8	TCGA-B5-A0K1-01	TCGA-B5-A0K1-01		TCGA-B5-A0K1-01A-11W-A062-09	TCGA-B5-A0K1-01A-11W-A062-09	TCGA-B5-A0K1-01A-11W-A062-09		TCGA-B5-A0K1-01		bacdb0de-d29b-4ac1-a163-35376a7b2b9b	TCGA-B5-A0K1-01A-11D-A042-01	TCGA-B5-A0K1-01A-11R-A040-07	TCGA-B5-A0K1-01A-11D-A042-01		TCGA-B5-A0K1-01		TCGA-B5-A0K1-01A-11D-A039-05	bacdb0de-d29b-4ac1-a163-35376a7b2b9b
TCGA-B5-A0K2-01	MSI-H	0	TCGA-B5-A0K2-01	2209	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 1	TCGA-B5-A0K2	2209	0	days	2209	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54			TCGA-B5-A0K2-F72222	TCGA-B5-A0K2	TCGA-B5-A0K2-01A	Never Used	Stage IIIA	NO		-20080	534		0	2209				NO		Scheduled Follow-up Submission	2015-4-29	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G1					NO	true	No	TCGA-B5-A0K2.5D780459-F4E6-4BB8-939D-5FDFD9BF7073.pdf	A0K2	0	positive	TUMOR FREE			YES	2	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5		0	0	25	Endometrial	A	LIVING	84	2008		TCGA-B5-A0K2-01	TCGA-B5-A0K2-01		TCGA-B5-A0K2-01A-21-A162-20	A0DA1E80-290C-4AF2-AE26-9492B418C580		TCGA-B5-A0K2-01		TCGA-B5-A0K2-01A-12W-A10C-09	TCGA-B5-A0K2-01A-12W-A10C-09	TCGA-B5-A0K2-01A-12W-A10C-09				c30924bd-cb0b-43ee-832e-1b470ec39d21	TCGA-B5-A0K2-01A-12D-A102-01		TCGA-B5-A0K2-01A-12D-A102-01		TCGA-B5-A0K2-01		TCGA-B5-A0K2-01A-12D-A10Q-05	c30924bd-cb0b-43ee-832e-1b470ec39d21
TCGA-B5-A0K3-01	MSS	0	TCGA-B5-A0K3-01	700	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 2	TCGA-B5-A0K3	529	1	days	700	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES		62			TCGA-B5-A0K3-F13268	TCGA-B5-A0K3	TCGA-B5-A0K3-01A		Stage IA		150	-22664	523		0	700			529			Additional New Tumor Event	2011-6-22	FEMALE	164	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	390	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	diffuse carcinomatosis		YES	true	No	TCGA-B5-A0K3.2D78431C-7385-4BD3-B597-85E613D89BF6.pdf	A0K3	10	negative	WITH TUMOR									Surgical Resection				Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	11	0	27	Endometrial	A	LIVING	88	2009		TCGA-B5-A0K3-01	TCGA-B5-A0K3-01		TCGA-B5-A0K3-01A-21-A162-20	7854E580-34CD-4714-A5FF-58219FDC22BE		TCGA-B5-A0K3-01		TCGA-B5-A0K3-01A-11W-A062-09	TCGA-B5-A0K3-01A-11W-A062-09	TCGA-B5-A0K3-01A-11W-A062-09				a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a	TCGA-B5-A0K3-01A-11D-A042-01		TCGA-B5-A0K3-01A-11D-A042-01		TCGA-B5-A0K3-01		TCGA-B5-A0K3-01A-11D-A039-05	a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a
TCGA-B5-A0K4-01	MSS	0	TCGA-B5-A0K4-01	1757	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 12	cluster 3	mutation c1uster 10	TCGA-B5-A0K4	1757	0	days	1757	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51			TCGA-B5-A0K4-F72223	TCGA-B5-A0K4	TCGA-B5-A0K4-01A	Never Used	Stage IB	NO		-18631	264		0	1757						Scheduled Follow-up Submission	2015-4-29	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	280	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A0K4.80DE2981-089A-47A2-B221-F7C28ECAF3F2.pdf	A0K4	87	negative	TUMOR FREE			YES	0	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	3	0	23	Endometrial	A	LIVING	75	2009		TCGA-B5-A0K4-01	TCGA-B5-A0K4-01		TCGA-B5-A0K4-01A-21-A162-20	AB1E33D6-97E4-43CA-BAC8-612E767BE9EF	TCGA-B5-A0K4-01	TCGA-B5-A0K4-01		TCGA-B5-A0K4-01A-11W-A062-09	TCGA-B5-A0K4-01A-11W-A062-09	TCGA-B5-A0K4-01A-11W-A062-09		TCGA-B5-A0K4-01		73e01a38-164c-44ce-ab36-ed429af8af44	TCGA-B5-A0K4-01A-11D-A042-01	TCGA-B5-A0K4-01A-11R-A040-07	TCGA-B5-A0K4-01A-11D-A042-01		TCGA-B5-A0K4-01		TCGA-B5-A0K4-01A-11D-A039-05	73e01a38-164c-44ce-ab36-ed429af8af44
TCGA-B5-A0K6-01	MSI-H	0	TCGA-B5-A0K6-01	1953	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 1	TCGA-B5-A0K6	1953	0	days	1953	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-B5-A0K6-F72224	TCGA-B5-A0K6	TCGA-B5-A0K6-01A		Stage IA	NO		-21515	206		0	1953				YES		Scheduled Follow-up Submission	2015-4-29	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A0K6.B7F34F79-DB7F-4C98-B1B3-80C3187AE91C.pdf	A0K6	7	negative	TUMOR FREE			NO	0	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	LIVING	132	2009		TCGA-B5-A0K6-01	TCGA-B5-A0K6-01					TCGA-B5-A0K6-01		TCGA-B5-A0K6-01A-11W-A062-09	TCGA-B5-A0K6-01A-11W-A062-09	TCGA-B5-A0K6-01A-11W-A062-09				4534628b-5eb9-4123-b56b-b00447ee730b	TCGA-B5-A0K6-01A-11D-A042-01		TCGA-B5-A0K6-01A-11D-A042-01		TCGA-B5-A0K6-01		TCGA-B5-A0K6-01A-11D-A039-05	4534628b-5eb9-4123-b56b-b00447ee730b
TCGA-B5-A0K7-01	MSS	0	TCGA-B5-A0K7-01	1933	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-B5-A0K7	1933	0	days	1933	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Complete Response	64			TCGA-B5-A0K7-F72225	TCGA-B5-A0K7	TCGA-B5-A0K7-01A		Stage IA	NO		-23429	184		0	1933			322			Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1160	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	Metastatic	vagina		NO	true	No	TCGA-B5-A0K7.5C3818CE-5DA9-403E-B895-61DEA4BBFA57.pdf	A0K7	0	negative	TUMOR FREE			NO	2	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0	0	6	Endometrial	A	LIVING	61	2009		TCGA-B5-A0K7-01	TCGA-B5-A0K7-01		TCGA-B5-A0K7-01A-21-A162-20	4CC6CB63-CD6A-4683-B5C9-4C9F9FBF09C8		TCGA-B5-A0K7-01		TCGA-B5-A0K7-01A-11W-A10C-09	TCGA-B5-A0K7-01A-11W-A10C-09	TCGA-B5-A0K7-01A-11W-A10C-09				444a9114-2e40-4e7c-979a-624bc95d4c47	TCGA-B5-A0K7-01A-11D-A102-01		TCGA-B5-A0K7-01A-11D-A102-01		TCGA-B5-A0K7-01		TCGA-B5-A0K7-01A-11D-A10Q-05	444a9114-2e40-4e7c-979a-624bc95d4c47
TCGA-B5-A0K8-01	MSS	0	TCGA-B5-A0K8-01	847	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-B5-A0K8	847	0	days	847	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-B5-A0K8-F32705	TCGA-B5-A0K8	TCGA-B5-A0K8-01A		Stage IB			-25992	191		0	847						Scheduled Follow-up Submission	2012-6-7	FEMALE	160	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A0K8.1E7C9CA2-73AA-4443-A125-D5588F93BEF9.pdf	A0K8	5	negative	TUMOR FREE				4+	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5		0	0	12	Endometrial	A	LIVING	61	2009			TCGA-B5-A0K8-01		TCGA-B5-A0K8-01A-21-A18Q-20	FDF53DCD-50F1-4C8A-83A2-FA68972DDA16				TCGA-B5-A0K8-01A-11D-A14K-09	TCGA-B5-A0K8-01A-11D-A14K-09	TCGA-B5-A0K8-01A-11D-A14K-09			TCGA-B5-A0K8-01	71cdc7a1-4bbb-461c-ab98-34cad8c3a767	TCGA-B5-A0K8-01A-11D-A14J-01		TCGA-B5-A0K8-01A-11D-A14J-01	TCGA-B5-A0K8-01	TCGA-B5-A0K8-01	TCGA-B5-A0K8-01A-11D-A14N-05		71cdc7a1-4bbb-461c-ab98-34cad8c3a767
TCGA-B5-A0K9-01	MSI-H	1	TCGA-B5-A0K9-01	409	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 13	cluster 6	mutation cluster 6	TCGA-B5-A0K9	409	0	days	409	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	88			TCGA-B5-A0K9-F71992	TCGA-B5-A0K9	TCGA-B5-A0K9-01A	Never Used	Stage II	NO		-32289	182	409	0	335				YES		Scheduled Follow-up Submission	2015-4-1	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	600	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A0K9.8278F457-C0A5-4441-9105-3FC015E3F0EF.pdf	A0K9	87	negative	TUMOR FREE			NO	3	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	DECEASED	65	2009	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	TCGA-B5-A0K9-01	TCGA-B5-A0K9-01	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	TCGA-B5-A0K9-01A-11-A162-20	BFE971A5-CADC-45EE-8CE3-991809A3479E		TCGA-B5-A0K9-01	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	TCGA-B5-A0K9-01A-21D-A10O-09	TCGA-B5-A0K9-01A-21D-A10O-09	TCGA-B5-A0K9-01A-21D-A10O-09	ac3970c9-575a-4d72-a2b3-45f1ab671bbb				TCGA-B5-A0K9-01A-21D-A102-01		TCGA-B5-A0K9-01A-21D-A102-01		TCGA-B5-A0K9-01		TCGA-B5-A0K9-01A-21D-A10Q-05	
TCGA-B5-A0KB-01	MSS	0	TCGA-B5-A0KB-01	824	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 4	squamous c3	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-B5-A0KB	689	1	days	824	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	62			TCGA-B5-A0KB-F32711	TCGA-B5-A0KB	TCGA-B5-A0KB-01B		Stage IB			-22669	368		0	824			689			Scheduled Follow-up Submission	2012-6-7	FEMALE	161	Endometrioid endometrial adenocarcinoma	Yes			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	cul de sac mass		YES	true	Yes	TCGA-B5-A0KB.2C744545-8FF8-4A07-A8F2-A47D28B2A8E2.pdf	A0KB	72	negative	WITH TUMOR				1	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	0	0	0	Endometrial	B	LIVING	76	2010			TCGA-B5-A0KB-01		TCGA-B5-A0KB-01B-21-A18Q-20	FDAB5E26-83C0-46A6-859F-18727FBB2B21										b5ee1a9b-caca-4abf-9317-d6bf673b8e65	TCGA-B5-A0KB-01B-11D-A14F-01		TCGA-B5-A0KB-01B-11D-A14F-01		TCGA-B5-A0KB-01	TCGA-B5-A0KB-01B-11D-A14H-05		b5ee1a9b-caca-4abf-9317-d6bf673b8e65
TCGA-B5-A11E-01	MSI-L	0	TCGA-B5-A11E-01	1820	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-B5-A11E	1820	0	days	1820	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-B5-A11E-F72226	TCGA-B5-A11E	TCGA-B5-A11E-01A		Stage IB	NO		-19458	198		0	1820						Scheduled Follow-up Submission	2015-4-29	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	890	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true	No	TCGA-B5-A11E.2058131C-09EA-4DC7-A84A-EB055A68F1B6.pdf	A11E	69	negative	TUMOR FREE			NO	2	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	4	0	20	Endometrial	A	LIVING	52	2010		TCGA-B5-A11E-01	TCGA-B5-A11E-01		TCGA-B5-A11E-01A-21-A163-20	E4F73CB4-DF3F-467F-BE19-6037F9871CCE		TCGA-B5-A11E-01			TCGA-B5-A11E-01A-11D-A10M-09	TCGA-B5-A11E-01A-11D-A10M-09				7e923dc8-9920-4f06-a98b-085a5935b29c	TCGA-B5-A11E-01A-11D-A10L-01		TCGA-B5-A11E-01A-11D-A10L-01		TCGA-B5-A11E-01	TCGA-B5-A11E-01A-11D-A10N-05		7e923dc8-9920-4f06-a98b-085a5935b29c
TCGA-B5-A11F-01	MSS	0	TCGA-B5-A11F-01	5651	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-B5-A11F	1610	1	days	5651	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Complete Response	55			TCGA-B5-A11F-F17642	TCGA-B5-A11F	TCGA-B5-A11F-01A		Stage IA	NO		-20171	5482		0	5651			1610	NO		Scheduled Follow-up Submission	2011-10-20	FEMALE		Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	380	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Bone	Metastatic			YES	true	No	TCGA-B5-A11F.228E437D-FB45-452B-A5A0-299C125F4CC4.pdf	A11F	7	negative	TUMOR FREE					Complete Remission/Response			YES	Other Method, Specify Below	CT guided thin needle aspirate			Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0	0	13	Endometrial	A	LIVING		1995		TCGA-B5-A11F-01	TCGA-B5-A11F-01		TCGA-B5-A11F-01A-21-A163-20	8C6D529C-DAD0-4264-A2FD-D7250A73C825		TCGA-B5-A11F-01		TCGA-B5-A11F-01A-11D-A10M-09	TCGA-B5-A11F-01A-11D-A10M-09	TCGA-B5-A11F-01A-11D-A10M-09				fb1c341a-34f7-482c-a954-de07652990b1	TCGA-B5-A11F-01A-11D-A10L-01		TCGA-B5-A11F-01A-11D-A10L-01		TCGA-B5-A11F-01	TCGA-B5-A11F-01A-11D-A10N-05		fb1c341a-34f7-482c-a954-de07652990b1
TCGA-B5-A11G-01	MSI-H	0	TCGA-B5-A11G-01	3448	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 11	TCGA-B5-A11G	3448	0	days	3448	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-B5-A11G-F17657	TCGA-B5-A11G	TCGA-B5-A11G-01A		Stage IA	NO		-25995	3248		0	3448				NO		Scheduled Follow-up Submission	2011-5-23	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11G.7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1.pdf	A11G	0	negative	TUMOR FREE				2	Complete Remission/Response			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	10	Endometrial	A	LIVING	77	2001			TCGA-B5-A11G-01		TCGA-B5-A11G-01A-21-A163-20	A166DDC1-C6D9-4125-81AE-7CA62778D347					TCGA-B5-A11G-01A-13D-A122-09	TCGA-B5-A11G-01A-13D-A122-09			TCGA-B5-A11G-01	b213f9e2-4253-41db-9a05-e91791f4ec7e	TCGA-B5-A11G-01A-13D-A120-01		TCGA-B5-A11G-01A-13D-A120-01	TCGA-B5-A11G-01	TCGA-B5-A11G-01	TCGA-B5-A11G-01A-13D-A123-05		b213f9e2-4253-41db-9a05-e91791f4ec7e
TCGA-B5-A11H-01	MSI-H	0	TCGA-B5-A11H-01	2687	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-B5-A11H	2687	0	days	2687	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-B5-A11H-F17659	TCGA-B5-A11H	TCGA-B5-A11H-01A		Stage IIIA	NO		-24556	2324		0	2687				YES		Scheduled Follow-up Submission	2011-10-20	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	620	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A11H.40813C61-4B78-4677-89A4-4B9488613F57.pdf	A11H	0	positive	TUMOR FREE					Complete Remission/Response			NO					Primary Tumor	01	open	1988	YES	NO	YES	B5	0	0	0	15	Endometrial	A	LIVING	101	2004			TCGA-B5-A11H-01		TCGA-B5-A11H-01A-21-A163-20	84A856DF-6E1C-48D8-AF42-3430608432F1					TCGA-B5-A11H-01A-11D-A122-09	TCGA-B5-A11H-01A-11D-A122-09			TCGA-B5-A11H-01	c0294497-87d4-481f-864a-e4fa9baab8c5	TCGA-B5-A11H-01A-11D-A120-01		TCGA-B5-A11H-01A-11D-A120-01	TCGA-B5-A11H-01	TCGA-B5-A11H-01	TCGA-B5-A11H-01A-11D-A123-05		c0294497-87d4-481f-864a-e4fa9baab8c5
TCGA-B5-A11I-01	MSS	0	TCGA-B5-A11I-01	2303	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 3	TCGA-B5-A11I	1940	1	days	2303	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium		YES	NO	Stable Disease	65			TCGA-B5-A11I-F17675	TCGA-B5-A11I	TCGA-B5-A11I-01A		Stage IVB	NO		-23857	1974		0	2303			1940	YES		Additional New Tumor Event	2011-10-21	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8140/3	C54.1	YES		Office Endometrial Biopsy	970	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			YES	true	No	TCGA-B5-A11I.850EFCC5-484B-4E09-801A-2FAFB4CFD72B.pdf	A11I	8	negative	TUMOR FREE				0	Complete Remission/Response	Current User		YES	Excisional Biopsy				Primary Tumor	01	open	1988	YES	NO	YES	B5	0	7	0	6	Endometrial	A	LIVING	124	2005		TCGA-B5-A11I-01	TCGA-B5-A11I-01		TCGA-B5-A11I-01A-21-A163-20	354106A1-BA91-416A-B95C-05ACAE0EC86B		TCGA-B5-A11I-01		TCGA-B5-A11I-01A-11D-A10M-09	TCGA-B5-A11I-01A-11D-A10M-09	TCGA-B5-A11I-01A-11D-A10M-09				5706f1b9-2c2c-4906-a9fb-64ba5a57d47e	TCGA-B5-A11I-01A-11D-A10L-01		TCGA-B5-A11I-01A-11D-A10L-01		TCGA-B5-A11I-01	TCGA-B5-A11I-01A-11D-A10N-05		5706f1b9-2c2c-4906-a9fb-64ba5a57d47e
TCGA-B5-A11J-01	MSI-H	0	TCGA-B5-A11J-01	1656	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 2	TCGA-B5-A11J	1656	0	days	1656	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64			TCGA-B5-A11J-F17687	TCGA-B5-A11J	TCGA-B5-A11J-01A		Stage IA	NO		-23485	1536		0	1656				YES		Scheduled Follow-up Submission	2011-10-21	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A11J.1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED.pdf	A11J	9	negative	TUMOR FREE				1	Complete Remission/Response			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	17	Endometrial	A	LIVING	134	2006			TCGA-B5-A11J-01								TCGA-B5-A11J-01A-11D-A122-09	TCGA-B5-A11J-01A-11D-A122-09			TCGA-B5-A11J-01	4f3e68ae-cf3c-491d-a3ed-0fc30261ead3	TCGA-B5-A11J-01A-11D-A120-01		TCGA-B5-A11J-01A-11D-A120-01	TCGA-B5-A11J-01	TCGA-B5-A11J-01	TCGA-B5-A11J-01A-11D-A123-05		4f3e68ae-cf3c-491d-a3ed-0fc30261ead3
TCGA-B5-A11L-01	MSS	1	TCGA-B5-A11L-01	2240	1	days	COAD-READ	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-B5-A11L	131	1	days	2240	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71	0		TCGA-B5-A11L-F37005	TCGA-B5-A11L	TCGA-B5-A11L-01B		Stage IC			-26120	1297	2240	0	1396			131				2012-11-21	FEMALE	163	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	Vaginal Apex	NO	YES	true	No	TCGA-B5-A11L.ABA26FE8-0C80-459A-9DF8-537D1A08A92E.pdf	A11L	85	negative	TUMOR FREE			NO		Complete Remission/Response			YES	Other Method, Specify Below	Whole Pelvic Radiation			Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0	0	9	Endometrial	B	DECEASED	92	2007			TCGA-B5-A11L-01		TCGA-B5-A11L-01B-11-A18Q-20	8D1A88C2-9AD4-4A1B-80CE-864D78A2089A									TCGA-B5-A11L-01	d262b256-5452-4df1-9526-9a1b11da775f	TCGA-B5-A11L-01B-21D-A13J-01		TCGA-B5-A11L-01B-21D-A13J-01	TCGA-B5-A11L-01	TCGA-B5-A11L-01	TCGA-B5-A11L-01B-21D-A13K-05		d262b256-5452-4df1-9526-9a1b11da775f
TCGA-B5-A11M-01	MSS	0	TCGA-B5-A11M-01	1362	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-B5-A11M	1362	0	days	1362	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	43			TCGA-B5-A11M-F17720	TCGA-B5-A11M		Former User	Stage IA	NO		-16063			0	1362				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	153	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO		No		A11M	4	negative	TUMOR FREE				0	Complete Remission/Response			NO					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	0	0	0	Endometrial		LIVING	139	2007			TCGA-B5-A11M-01							TCGA-B5-A11M-01A-11D-A122-09	TCGA-B5-A11M-01A-11D-A122-09	TCGA-B5-A11M-01A-11D-A122-09			TCGA-B5-A11M-01	aefe6191-1196-4614-b319-4ce263d3cc90				TCGA-B5-A11M-01		TCGA-B5-A11M-01A-11D-A123-05		aefe6191-1196-4614-b319-4ce263d3cc90
TCGA-B5-A11N-01	MSI-L	0	TCGA-B5-A11N-01	1876	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-B5-A11N	1876	0	days	1876	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69			TCGA-B5-A11N-F72227	TCGA-B5-A11N	TCGA-B5-A11N-01A		Stage IA	NO		-25442	1140		0	1876						Scheduled Follow-up Submission	2015-4-29	FEMALE	174	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11N.A4C1DE15-A45A-4D31-B363-C6652370C09C.pdf	A11N	5	negative	TUMOR FREE			NO	3	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5		0	0	46	Endometrial	A	LIVING	90	2007			TCGA-B5-A11N-01		TCGA-B5-A11N-01A-21-A163-20	0DA12AA8-1686-4705-90CD-B50DB7F41C24					TCGA-B5-A11N-01A-11D-A122-09	TCGA-B5-A11N-01A-11D-A122-09			TCGA-B5-A11N-01	823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f	TCGA-B5-A11N-01A-11D-A120-01		TCGA-B5-A11N-01A-11D-A120-01	TCGA-B5-A11N-01	TCGA-B5-A11N-01	TCGA-B5-A11N-01A-11D-A123-05		823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f
TCGA-B5-A11O-01	MSI-L	0	TCGA-B5-A11O-01	2609	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 1	TCGA-B5-A11O	1924	1	days	2609	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES		Complete Response	62			TCGA-B5-A11O-F72228	TCGA-B5-A11O	TCGA-B5-A11O-01A		Stage IA	NO		-22720	993		0	2609		2111	1924	YES		Scheduled Follow-up Submission	2015-4-29	FEMALE	177	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	New Primary Tumor	Right Breast	YES	YES	true	No	TCGA-B5-A11O.078AA8A2-E812-4603-9084-8414937B88E1.pdf	A11O	13	negative	TUMOR FREE			YES	2	Complete Remission/Response			YES	Surgical Resection				Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	B5	0	0	0	18	Endometrial	A	LIVING	114	2008			TCGA-B5-A11O-01							TCGA-B5-A11O-01A-11D-A122-09	TCGA-B5-A11O-01A-11D-A122-09	TCGA-B5-A11O-01A-11D-A122-09			TCGA-B5-A11O-01	7e3666db-df81-4413-b742-c475e786772e	TCGA-B5-A11O-01A-11D-A120-01		TCGA-B5-A11O-01A-11D-A120-01	TCGA-B5-A11O-01	TCGA-B5-A11O-01	TCGA-B5-A11O-01A-11D-A123-05		7e3666db-df81-4413-b742-c475e786772e
TCGA-B5-A11P-01	MSI-L	0	TCGA-B5-A11P-01	1583	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-B5-A11P	1583	0	days	1583	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	87			TCGA-B5-A11P-F37003	TCGA-B5-A11P	TCGA-B5-A11P-01B	Never Used	Stage IB	NO		-32047	979		0	1583				NO			2012-11-21	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A11P.77639636-9C18-4C81-9FCF-04BA2D92110E.pdf	A11P	20		TUMOR FREE			NO	4+		Never Used		NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5					Endometrial	B	LIVING	74	2008			TCGA-B5-A11P-01		TCGA-B5-A11P-01B-21-A18Q-20	4DB77D5F-8FE5-4079-B786-AC15D556A530									TCGA-B5-A11P-01	2d49f9b3-88bc-4e99-a2ea-ba900713563d	TCGA-B5-A11P-01B-11D-A14F-01		TCGA-B5-A11P-01B-11D-A14F-01	TCGA-B5-A11P-01	TCGA-B5-A11P-01	TCGA-B5-A11P-01B-11D-A14H-05		2d49f9b3-88bc-4e99-a2ea-ba900713563d
TCGA-B5-A11Q-01	MSS	0	TCGA-B5-A11Q-01	976	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-B5-A11Q	976	0	days	976	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64			TCGA-B5-A11Q-F17770	TCGA-B5-A11Q	TCGA-B5-A11Q-01A	Former User	Stage IIIA	NO		-23538	702		0	976						Scheduled Follow-up Submission	2011-10-25	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11Q.5117F490-9CE1-465F-BDF7-7B545B314703.pdf	A11Q	34	negative	TUMOR FREE				0	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	0		8	Endometrial	A	LIVING	88	2008			TCGA-B5-A11Q-01		TCGA-B5-A11Q-01A-21-A163-20	418EAA98-126B-4B44-B332-944D38386927					TCGA-B5-A11Q-01A-11D-A122-09	TCGA-B5-A11Q-01A-11D-A122-09			TCGA-B5-A11Q-01	3b8301c9-646f-43e7-9b8c-7690294d0356	TCGA-B5-A11Q-01A-11D-A120-01		TCGA-B5-A11Q-01A-11D-A120-01	TCGA-B5-A11Q-01	TCGA-B5-A11Q-01	TCGA-B5-A11Q-01A-11D-A123-05		3b8301c9-646f-43e7-9b8c-7690294d0356
TCGA-B5-A11R-01	MSS	0	TCGA-B5-A11R-01	2349	0	days	Iq		UCEC CIMP c18	cluster 2			miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-B5-A11R	2349	0	days	2349	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51			TCGA-B5-A11R-F72229	TCGA-B5-A11R	TCGA-B5-A11R-01A		Stage II	NO		-18878	734		0	2349						Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A11R.0AC5670B-7EA6-438C-9326-843BB7A6A81C.pdf	A11R	60	negative	TUMOR FREE			YES	2	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	B5	0	12	0	6	Endometrial	A	LIVING	89	2008	6152d141-ed7d-4c03-9af9-4647dc455c4f		TCGA-B5-A11R-01	6152d141-ed7d-4c03-9af9-4647dc455c4f					6152d141-ed7d-4c03-9af9-4647dc455c4f		TCGA-B5-A11R-01A-11D-A122-09	TCGA-B5-A11R-01A-11D-A122-09	6152d141-ed7d-4c03-9af9-4647dc455c4f		TCGA-B5-A11R-01		TCGA-B5-A11R-01A-11D-A120-01		TCGA-B5-A11R-01A-11D-A120-01	TCGA-B5-A11R-01	TCGA-B5-A11R-01	TCGA-B5-A11R-01A-11D-A123-05		
TCGA-B5-A11S-01	MSS	0	TCGA-B5-A11S-01	2229	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-B5-A11S	2229	0	days	2229	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			YES	Complete Response	63			TCGA-B5-A11S-F72230	TCGA-B5-A11S	TCGA-B5-A11S-01A	Never Used	Stage IA	NO	68	-23085	615		0	2229			41			Scheduled Follow-up Submission	2015-4-29	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	New Primary Tumor	Breast		NO	true	No	TCGA-B5-A11S.A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA.pdf	A11S	17	negative	TUMOR FREE			NO	2	Complete Remission/Response			NO	Surgical Resection				Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	2	0	28	Endometrial	A	LIVING	118	2009			TCGA-B5-A11S-01		TCGA-B5-A11S-01A-21-A163-20	69621795-517F-4376-81BC-4450BE17F9EF				TCGA-B5-A11S-01A-11D-A122-09	TCGA-B5-A11S-01A-11D-A122-09	TCGA-B5-A11S-01A-11D-A122-09			TCGA-B5-A11S-01	eb6cac23-997e-4d0b-82cf-f74fd5fb57d2	TCGA-B5-A11S-01A-11D-A120-01		TCGA-B5-A11S-01A-11D-A120-01	TCGA-B5-A11S-01	TCGA-B5-A11S-01	TCGA-B5-A11S-01A-11D-A123-05		eb6cac23-997e-4d0b-82cf-f74fd5fb57d2
TCGA-B5-A11U-01	MSI-H	0	TCGA-B5-A11U-01	509	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 13	TCGA-B5-A11U	509	0	days	509	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74			TCGA-B5-A11U-F17774	TCGA-B5-A11U	TCGA-B5-A11U-01A		Stage IVB	NO		-27160	371		0	509				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A11U.1EF2CB28-A515-4E9D-9148-CC1A2DF77F60.pdf	A11U	23		TUMOR FREE				2	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0				Endometrial	A	LIVING	61	2009			TCGA-B5-A11U-01		TCGA-B5-A11U-01A-21-A163-20	73AE6942-57B1-4104-8D42-3D5BA79480B2					TCGA-B5-A11U-01A-11D-A122-09	TCGA-B5-A11U-01A-11D-A122-09			TCGA-B5-A11U-01	714254dd-834a-4b70-8f88-c48bc7b4fdb8	TCGA-B5-A11U-01A-11D-A120-01		TCGA-B5-A11U-01A-11D-A120-01	TCGA-B5-A11U-01	TCGA-B5-A11U-01	TCGA-B5-A11U-01A-11D-A123-05		714254dd-834a-4b70-8f88-c48bc7b4fdb8
TCGA-B5-A11V-01	MSS	0	TCGA-B5-A11V-01	595	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-B5-A11V	595	0	days	595	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64			TCGA-B5-A11V-F17776	TCGA-B5-A11V	TCGA-B5-A11V-01A		Stage IA	NO		-23630	294		0	595				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	760	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11V.E1B5A941-5EEB-4207-84DC-F3BF22D5FC29.pdf	A11V	29	positive	TUMOR FREE				0	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	3	Endometrial	A	LIVING	71	2010		TCGA-B5-A11V-01	TCGA-B5-A11V-01		TCGA-B5-A11V-01A-21-A163-20	597AAFA9-8552-4364-ABB2-2B013C305A8B		TCGA-B5-A11V-01		TCGA-B5-A11V-01A-11D-A10M-09	TCGA-B5-A11V-01A-11D-A10M-09	TCGA-B5-A11V-01A-11D-A10M-09				986bddf6-4dde-4bfb-94c3-123674a4ca45	TCGA-B5-A11V-01A-11D-A10L-01		TCGA-B5-A11V-01A-11D-A10L-01		TCGA-B5-A11V-01	TCGA-B5-A11V-01A-11D-A10N-05		986bddf6-4dde-4bfb-94c3-123674a4ca45
TCGA-B5-A11W-01	MSS	0	TCGA-B5-A11W-01	593	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 7	TCGA-B5-A11W	593	0	days	593	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-B5-A11W-F17779	TCGA-B5-A11W	TCGA-B5-A11W-01A	Never Used	Stage IB			-22365	258		0	593				YES		Scheduled Follow-up Submission	2011-10-25	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	310	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A11W.C5762F7C-AB69-40D0-A9D0-71A6281F30AF.pdf	A11W	52	positive	TUMOR FREE				1	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	17	Endometrial	A	LIVING	102	2010			TCGA-B5-A11W-01		TCGA-B5-A11W-01A-21-A163-20	2868A3E3-9D6E-4F91-8E5D-EBDF6893272D					TCGA-B5-A11W-01A-12D-A122-09	TCGA-B5-A11W-01A-12D-A122-09			TCGA-B5-A11W-01	168116db-99c5-4d7a-9e9f-3858e1824298	TCGA-B5-A11W-01A-12D-A120-01		TCGA-B5-A11W-01A-12D-A120-01	TCGA-B5-A11W-01	TCGA-B5-A11W-01	TCGA-B5-A11W-01A-12D-A123-05		168116db-99c5-4d7a-9e9f-3858e1824298
TCGA-B5-A11X-01	MSI-L	0	TCGA-B5-A11X-01	596	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	RNA cluster 3	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-B5-A11X	397	1	days	596	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES		NO	Complete Response	66			TCGA-B5-A11X-F17790	TCGA-B5-A11X	TCGA-B5-A11X-01A		Stage IIIC2	NO		-24217	246		0	596			397			Scheduled Follow-up Submission	2011-10-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8020/3	C54.1	YES		Dilation and curettage procedure	530	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	lymph nodes		YES	true	No	TCGA-B5-A11X.89C9704E-F43C-440C-970F-872835910268.pdf	A11X	100	negative	TUMOR FREE				2				NO					Primary Tumor	01	open	2009	YES	NO	YES	B5	5	5	1	5	Endometrial	A	LIVING	71	2010		TCGA-B5-A11X-01	TCGA-B5-A11X-01		TCGA-B5-A11X-01A-21-A163-20	C94E9FFC-592E-41B8-9552-BAC7AE2F7404		TCGA-B5-A11X-01		TCGA-B5-A11X-01A-11D-A10M-09	TCGA-B5-A11X-01A-11D-A10M-09	TCGA-B5-A11X-01A-11D-A10M-09				bca7a3e6-57e9-44e6-b33f-a5e62011884d						TCGA-B5-A11X-01A-11D-A10N-05		bca7a3e6-57e9-44e6-b33f-a5e62011884d
TCGA-B5-A11Y-01	MSI-L	0	TCGA-B5-A11Y-01	560	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 6	TCGA-B5-A11Y	560	0	days	560	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59			TCGA-B5-A11Y-F17795	TCGA-B5-A11Y	TCGA-B5-A11Y-01A	Former User	Stage IB	NO		-21860	244		0	560						Scheduled Follow-up Submission	2011-10-25	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8382/3	C54.1	YES		Office Endometrial Biopsy	580	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11Y.4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1.pdf	A11Y	54	negative	TUMOR FREE				1	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5			0	8	Endometrial	A	LIVING	63	2010		TCGA-B5-A11Y-01	TCGA-B5-A11Y-01		TCGA-B5-A11Y-01A-31-A163-20	016DB1F0-DE63-48F1-9C2A-1C77E23306ED		TCGA-B5-A11Y-01			TCGA-B5-A11Y-01A-21D-A10M-09	TCGA-B5-A11Y-01A-21D-A10M-09				f192adcd-d613-400e-9737-725083638ee4	TCGA-B5-A11Y-01A-21D-A10L-01		TCGA-B5-A11Y-01A-21D-A10L-01		TCGA-B5-A11Y-01	TCGA-B5-A11Y-01A-21D-A10N-05		f192adcd-d613-400e-9737-725083638ee4
TCGA-B5-A11Z-01	MSS	0	TCGA-B5-A11Z-01	528	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-B5-A11Z	528	0	days	528	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-B5-A11Z-F17833	TCGA-B5-A11Z	TCGA-B5-A11Z-01A		Stage IA	NO		-22505	213		0	528				NO		Scheduled Follow-up Submission	2011-10-26	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A11Z.62C170A9-710F-45C0-B6BB-3F491A86A7E4.pdf	A11Z	0	negative	TUMOR FREE				3	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5		0		0	Endometrial	A	LIVING	84	2010			TCGA-B5-A11Z-01		TCGA-B5-A11Z-01A-21-A163-20	6CEE54D4-5FA9-4D01-82BF-C5B6A6341AB3				TCGA-B5-A11Z-01A-11D-A10M-09	TCGA-B5-A11Z-01A-11D-A10M-09	TCGA-B5-A11Z-01A-11D-A10M-09			TCGA-B5-A11Z-01	640190cd-cd16-4a1a-8e63-9e41db6c3f89	TCGA-B5-A11Z-01A-11D-A10L-01		TCGA-B5-A11Z-01A-11D-A10L-01	TCGA-B5-A11Z-01	TCGA-B5-A11Z-01	TCGA-B5-A11Z-01A-11D-A10N-05		640190cd-cd16-4a1a-8e63-9e41db6c3f89
TCGA-B5-A121-01	MSS	0	TCGA-B5-A121-01	504	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation c1uster 9	TCGA-B5-A121	504	0	days	504	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-B5-A121-F17838	TCGA-B5-A121	TCGA-B5-A121-01A		Stage IIIA	NO		-21018	188		0	504						Scheduled Follow-up Submission	2011-10-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-B5-A121.82B20A1F-99AC-4CC8-BAF2-B7132809D4F2.pdf	A121	48	negative	TUMOR FREE				2	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	0	0	0	Endometrial	A	LIVING	80	2010			TCGA-B5-A121-01		TCGA-B5-A121-01A-21-A163-20	A4DA0446-B32E-4A47-8D1D-F4934D134F1D					TCGA-B5-A121-01A-31D-A122-09	TCGA-B5-A121-01A-31D-A122-09			TCGA-B5-A121-01	3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3	TCGA-B5-A121-01A-31D-A120-01		TCGA-B5-A121-01A-31D-A120-01	TCGA-B5-A121-01	TCGA-B5-A121-01	TCGA-B5-A121-01A-31D-A123-05		3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3
TCGA-B5-A1MR-01	MSS	0	TCGA-B5-A1MR-01	6859	0	days	Kirc+		UCEC non-CIMP c3	cluster 2		LAML-like c13	miRNA cluster 4	cluster 2		TCGA-B5-A1MR	6859	0	days	6859	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65			TCGA-B5-A1MR-F72232	TCGA-B5-A1MR			Stage IIIA	NO		-24017			0	6859				NO		Scheduled Follow-up Submission	2015-4-29	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A1MR	4	negative	TUMOR FREE			NO	3	Complete Remission/Response	Never Used		YES					Primary Tumor	01	open	1988	NO	NO	YES	B5	0	7	0	15	Endometrial		LIVING	58	1995			TCGA-B5-A1MR-01												TCGA-B5-A1MR-01	a644742b-ae08-41e3-810e-800bf0eef8fe	TCGA-B5-A1MR-01A-31D-A14F-01		TCGA-B5-A1MR-01A-31D-A14F-01	TCGA-B5-A1MR-01	TCGA-B5-A1MR-01	TCGA-B5-A1MR-01A-31D-A14H-05		a644742b-ae08-41e3-810e-800bf0eef8fe
TCGA-B5-A1MS-01	MSS	1	TCGA-B5-A1MS-01	3112	1	days	BRCA-LUAD+		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-B5-A1MS	2706	1	days	3112	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES		Progressive Disease	60			TCGA-B5-A1MS-F44649	TCGA-B5-A1MS	TCGA-B5-A1MS-01B		Stage IC	NO		-22068	3117	3112	0				2706	NO			2013-8-20	FEMALE	166	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	440	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Supraclavicular Fossa	NO	YES	true	No	TCGA-B5-A1MS.5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B.pdf	A1MS	55	negative	WITH TUMOR			NO	4+	Partial Remission/Response	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	4	0	25	Endometrial	B	DECEASED	74	2003	6acf7672-ec9d-4765-85db-43c311d5f124		TCGA-B5-A1MS-01	6acf7672-ec9d-4765-85db-43c311d5f124	TCGA-B5-A1MS-01B-21-A23Z-20	02AB5130-5982-4EFB-9CA0-BE933CB5D453			6acf7672-ec9d-4765-85db-43c311d5f124				6acf7672-ec9d-4765-85db-43c311d5f124		TCGA-B5-A1MS-01		TCGA-B5-A1MS-01B-11D-A227-01		TCGA-B5-A1MS-01B-11D-A227-01	TCGA-B5-A1MS-01	TCGA-B5-A1MS-01	TCGA-B5-A1MS-01B-11D-A22B-05		
TCGA-B5-A1MU-01	MSS	1	TCGA-B5-A1MU-01	1548	1	days	BRCA-LUAD+	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 3	TCGA-B5-A1MU	1365	1	days	1548	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Progressive Disease	79			TCGA-B5-A1MU-F19109	TCGA-B5-A1MU	TCGA-B5-A1MU-01A		Stage IVB	NO	1374	-29027	1834	1548	0				1365	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	147	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	260	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	New Primary Tumor	Breast		YES	true	No	TCGA-B5-A1MU.FC3D9B79-4CAD-4F62-892C-C830B24E50DD.pdf	A1MU	100	positive	WITH TUMOR				3	Complete Remission/Response	Former User		NO	Surgical Resection				Primary Tumor	01	open	1988	NO	NO	YES	B5		0		0	Endometrial	A	DECEASED	44	2006			TCGA-B5-A1MU-01		TCGA-B5-A1MU-01A-21-A18Q-20	25E51246-A434-4281-90CE-E2577B8DC786				TCGA-B5-A1MU-01A-11D-A13L-09	TCGA-B5-A1MU-01A-11D-A13L-09	TCGA-B5-A1MU-01A-11D-A13L-09			TCGA-B5-A1MU-01	5afaa343-65f0-4499-a44d-c3c87106443a	TCGA-B5-A1MU-01A-11D-A13J-01		TCGA-B5-A1MU-01A-11D-A13J-01	TCGA-B5-A1MU-01	TCGA-B5-A1MU-01	TCGA-B5-A1MU-01A-11D-A13K-05		5afaa343-65f0-4499-a44d-c3c87106443a
TCGA-B5-A1MV-01	MSI-L	0	TCGA-B5-A1MV-01	1565	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4		TCGA-B5-A1MV	1565	0	days	1565	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	84			TCGA-B5-A1MV-F72234	TCGA-B5-A1MV	TCGA-B5-A1MV-01A	Former User	Stage IA	NO		-30926	226		0	1565						Scheduled Follow-up Submission	2015-4-29	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	470	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-B5-A1MV.E536759E-F47A-4EE9-B855-AFEC6BCF5EE0.pdf	A1MV	47	negative	TUMOR FREE			NO	2	Complete Remission/Response			NO					Primary Tumor	01	open	2009	NO	NO	YES	B5	0	7	0	19	Endometrial	A	LIVING	72	2010			TCGA-B5-A1MV-01		TCGA-B5-A1MV-01A-41-A18Q-20	F062FF19-5D49-4994-9952-F263FDB3B0B6									TCGA-B5-A1MV-01	ef62242e-872b-4bd3-ac3d-a6645f771020	TCGA-B5-A1MV-01A-31D-A14F-01		TCGA-B5-A1MV-01A-31D-A14F-01	TCGA-B5-A1MV-01	TCGA-B5-A1MV-01	TCGA-B5-A1MV-01A-31D-A14H-05		ef62242e-872b-4bd3-ac3d-a6645f771020
TCGA-B5-A1MW-01	MSI-H	0	TCGA-B5-A1MW-01	447	0	days	Kirc+		UCEC non-CIMP c3	cluster 2	UCEC-like c5		miRNA cluster 7	cluster 1		TCGA-B5-A1MW	311	1	days	447	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES		Complete Response	55			TCGA-B5-A1MW-F21619	TCGA-B5-A1MW	TCGA-B5-A1MW-01A	Former User	Stage IA	NO		-20183	148		0	447			311			Scheduled Follow-up Submission	2012-2-16	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	vaginal cuff		YES	true	No	TCGA-B5-A1MW.870882D8-D89A-4A89-B516-DADAB95BE285.pdf	A1MW	31	negative	TUMOR FREE				1	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5	0	8	0	31	Endometrial	A	LIVING	62	2010	7ad9720d-18e2-472f-a267-525f191a23ca		TCGA-B5-A1MW-01	7ad9720d-18e2-472f-a267-525f191a23ca	TCGA-B5-A1MW-01A-21-A18Q-20	ED0D19FF-3919-4938-943F-EF1CDB803193			7ad9720d-18e2-472f-a267-525f191a23ca				7ad9720d-18e2-472f-a267-525f191a23ca		TCGA-B5-A1MW-01		TCGA-B5-A1MW-01A-11D-A17C-01		TCGA-B5-A1MW-01A-11D-A17C-01	TCGA-B5-A1MW-01	TCGA-B5-A1MW-01	TCGA-B5-A1MW-01A-11D-A17F-05		
TCGA-B5-A1MX-01	MSI-H	0	TCGA-B5-A1MX-01	1473	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-B5-A1MX	1473	0	days	1473	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47			TCGA-B5-A1MX-F72235	TCGA-B5-A1MX	TCGA-B5-A1MX-01A	Never Used	Stage IB	NO		-17320	103		0	1473						Scheduled Follow-up Submission	2015-4-29	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	560	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	No	TCGA-B5-A1MX.C8962646-1A09-4EAA-8864-2539A0CCEC4C.pdf	A1MX	100		TUMOR FREE			YES	4+	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	0	2	0	14	Endometrial	A	LIVING	58	2010			TCGA-B5-A1MX-01		TCGA-B5-A1MX-01A-21-A18Q-20	FB207C5A-C3BE-44FF-85C1-9757F354DA68									TCGA-B5-A1MX-01	1cb61aae-c6d4-4afc-889e-4060d109c83e	TCGA-B5-A1MX-01A-11D-A141-01		TCGA-B5-A1MX-01A-11D-A141-01	TCGA-B5-A1MX-01	TCGA-B5-A1MX-01	TCGA-B5-A1MX-01A-11D-A145-05		1cb61aae-c6d4-4afc-889e-4060d109c83e
TCGA-B5-A1MY-01	MSS	1	TCGA-B5-A1MY-01	361	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-B5-A1MY	333	1	days	361	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	NO	Progressive Disease	62			TCGA-B5-A1MY-F22095	TCGA-B5-A1MY	TCGA-B5-A1MY-01A		Stage IIIC2	NO		-22805	128	361	0				333			Scheduled Follow-up Submission	2012-2-23	FEMALE	146	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	360	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	peritoneum		YES	true	No	TCGA-B5-A1MY.A5328E25-1433-4331-83B8-148780F6A6DA.pdf	A1MY	100	negative	WITH TUMOR				4+				YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5	2	5		0	Endometrial	A	DECEASED	67	2010			TCGA-B5-A1MY-01		TCGA-B5-A1MY-01A-21-A18Q-20	2CA50913-5945-4E8E-B67B-96BA996A7737				TCGA-B5-A1MY-01A-11D-A142-09	TCGA-B5-A1MY-01A-11D-A142-09	TCGA-B5-A1MY-01A-11D-A142-09			TCGA-B5-A1MY-01	fcb43e1a-3b34-4ff1-8d3e-849fbf901877	TCGA-B5-A1MY-01A-11D-A141-01		TCGA-B5-A1MY-01A-11D-A141-01	TCGA-B5-A1MY-01	TCGA-B5-A1MY-01	TCGA-B5-A1MY-01A-11D-A145-05		fcb43e1a-3b34-4ff1-8d3e-849fbf901877
TCGA-B5-A1MZ-01	MSI-L	0	TCGA-B5-A1MZ-01	1598	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1		TCGA-B5-A1MZ	613	1	days	1598	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES		Complete Response	54			TCGA-B5-A1MZ-F72236	TCGA-B5-A1MZ	TCGA-B5-A1MZ-01A		Stage IA	NO		-19955	114		0	1598			613			Scheduled Follow-up Submission	2015-4-29	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G1	Other, specify	Locoregional Recurrence	Vagina	NO	YES	true	No	TCGA-B5-A1MZ.071A53F9-6E40-4402-8353-BB963AFE5C33.pdf	A1MZ	31	negative	TUMOR FREE			NO	1	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	B5			0	32	Endometrial	A	LIVING	114	2010			TCGA-B5-A1MZ-01		TCGA-B5-A1MZ-01A-21-A18Q-20	96829880-88C7-4AC5-B779-1C3E985309FD									TCGA-B5-A1MZ-01	770fd2b7-24cf-432b-829d-39364a11277d	TCGA-B5-A1MZ-01A-11D-A141-01		TCGA-B5-A1MZ-01A-11D-A141-01	TCGA-B5-A1MZ-01	TCGA-B5-A1MZ-01	TCGA-B5-A1MZ-01A-11D-A145-05		770fd2b7-24cf-432b-829d-39364a11277d
TCGA-B5-A1N2-01	MSS	1	TCGA-B5-A1N2-01	954	1	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-B5-A1N2	804	1	days	954	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES		Progressive Disease	70			TCGA-B5-A1N2-F72237	TCGA-B5-A1N2	TCGA-B5-A1N2-01A	Former User	Stage IIIC1	NO		-25612	93	954	0	389			804	YES		Scheduled Follow-up Submission	2015-4-29	FEMALE	168	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	540	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Brain	Distant Metastasis			YES	true	No	TCGA-B5-A1N2.CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9.pdf	A1N2	12.5	positive	WITH TUMOR			YES	4+	Complete Remission/Response			YES					Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	B5			1	1	Endometrial	A	DECEASED	114	2010			TCGA-B5-A1N2-01		TCGA-B5-A1N2-01A-11-A18Q-20	C3866F58-D26C-4DF1-A522-125C0A4D12CE									TCGA-B5-A1N2-01	c45110ae-6ba6-44d7-8bff-5fa16c45d962	TCGA-B5-A1N2-01A-21D-A141-01		TCGA-B5-A1N2-01A-21D-A141-01	TCGA-B5-A1N2-01	TCGA-B5-A1N2-01	TCGA-B5-A1N2-01A-21D-A145-05		c45110ae-6ba6-44d7-8bff-5fa16c45d962
TCGA-B5-A3F9-01	MSS	0	TCGA-B5-A3F9-01	4155	0	days	Squamous		UCEC non-CIMP c3				miRNA c1uster 10			TCGA-B5-A3F9	4155	0	days	4155	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-B5-A3F9-F63391	TCGA-B5-A3F9	TCGA-B5-A3F9-01A		Stage IB			-20523	3159		0	4155							2014-8-7	FEMALE	166	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3F9.E4AD1574-653C-444D-BB43-B4DE701B109F.pdf	A3F9	6		TUMOR FREE			NO					NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0		0	Endometrial	A	LIVING	155	2003	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd		TCGA-B5-A3F9-01	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd					654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd				654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd		TCGA-B5-A3F9-01		TCGA-B5-A3F9-01A-21D-A227-01		TCGA-B5-A3F9-01A-21D-A227-01	TCGA-B5-A3F9-01	TCGA-B5-A3F9-01	TCGA-B5-A3F9-01A-21D-A22B-05		
TCGA-B5-A3FA-01	MSI-L	0	TCGA-B5-A3FA-01	2929	0	days	Quiet		UCEC Serous c4		UCEC-like c5		miRNA cluster 13			TCGA-B5-A3FA	2929	0	days	2929	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73			TCGA-B5-A3FA-F37049	TCGA-B5-A3FA	TCGA-B5-A3FA-01A		Stage IC			-26850	2679		0	2929							2012-11-21	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	510	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3FA.1CA1DEC3-AD70-40F7-859B-24A27F47C904.pdf	A3FA	52	negative	TUMOR FREE			NO	4+				NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5	0	2	0	11	Endometrial	A	LIVING	74	2004	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9		TCGA-B5-A3FA-01	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9	TCGA-B5-A3FA-01A-21-A23Z-20	B51FC044-B48F-43F6-B592-04C89D59A355			ae424bbe-6970-4afc-aa3b-7ae842f9a9d9				ae424bbe-6970-4afc-aa3b-7ae842f9a9d9		TCGA-B5-A3FA-01		TCGA-B5-A3FA-01A-11D-A19X-01		TCGA-B5-A3FA-01A-11D-A19X-01	TCGA-B5-A3FA-01	TCGA-B5-A3FA-01	TCGA-B5-A3FA-01A-11D-A19Z-05		
TCGA-B5-A3FB-01	MSS	0	TCGA-B5-A3FB-01	2844	0	days	Kirc+		UCEC Serous c4		squamous c3		miRNA cluster 12			TCGA-B5-A3FB	2844	0	days	2844	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73			TCGA-B5-A3FB-F63408	TCGA-B5-A3FB	TCGA-B5-A3FB-01A		Stage IB			-26779	2066		0	2844							2014-8-8	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	350	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3FB.FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B.pdf	A3FB	4	negative	TUMOR FREE			NO					NO					Primary Tumor	01	Minimally Invasive	1988		NO	YES	B5		0	0	33	Endometrial	A	LIVING	115	2006	0421d738-8236-46c5-8b98-6b261defb294		TCGA-B5-A3FB-01	0421d738-8236-46c5-8b98-6b261defb294	TCGA-B5-A3FB-01A-21-A23Z-20	296D37E4-A844-4792-869D-B1639FF420BE			0421d738-8236-46c5-8b98-6b261defb294				0421d738-8236-46c5-8b98-6b261defb294		TCGA-B5-A3FB-01		TCGA-B5-A3FB-01A-11D-A19X-01		TCGA-B5-A3FB-01A-11D-A19X-01	TCGA-B5-A3FB-01	TCGA-B5-A3FB-01	TCGA-B5-A3FB-01A-11D-A19Z-05		
TCGA-B5-A3FC-01	MSI-H	0	TCGA-B5-A3FC-01	2185	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FC	2185	0	days	2185	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-B5-A3FC-F37051	TCGA-B5-A3FC	TCGA-B5-A3FC-01A		Stage II			-19422	1814		0	2185							2012-11-21	FEMALE	169	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3FC.4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD.pdf	A3FC	0	negative	TUMOR FREE			NO					NO					Primary Tumor	01	open	1988		NO	YES	B5		0		0	Endometrial	A	LIVING	76	2006	cfc3065f-652c-458b-926f-24092edb803f		TCGA-B5-A3FC-01	cfc3065f-652c-458b-926f-24092edb803f	TCGA-B5-A3FC-01A-21-A23Z-20	17669455-F951-4491-992D-E8D3748C7A22			cfc3065f-652c-458b-926f-24092edb803f				cfc3065f-652c-458b-926f-24092edb803f		TCGA-B5-A3FC-01		TCGA-B5-A3FC-01A-11D-A227-01		TCGA-B5-A3FC-01A-11D-A227-01	TCGA-B5-A3FC-01	TCGA-B5-A3FC-01	TCGA-B5-A3FC-01A-11D-A22B-05		
TCGA-B5-A3FD-01	Indeterminate	1	TCGA-B5-A3FD-01	1197	1	days	Kirc+		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FD	992	1	days	1197	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	70			TCGA-B5-A3FD-F63409	TCGA-B5-A3FD	TCGA-B5-A3FD-01A		Stage IA			-25813	679	1197	0	796			992				2014-8-8	FEMALE	174	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	370	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3	Other, specify	Locoregional Recurrence	peritoneum	NO	YES	true	No	TCGA-B5-A3FD.7AC30D60-097A-4FED-A928-7A4BCAFB6C8D.pdf	A3FD	30	negative	TUMOR FREE			YES					NO	Other Method, Specify Below	thoracentesis			Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	7	0	34	Endometrial	A	DECEASED	115	2009	6fbe6214-bdfd-4688-bae3-d12a931f9989		TCGA-B5-A3FD-01	6fbe6214-bdfd-4688-bae3-d12a931f9989	TCGA-B5-A3FD-01A-21-A23Z-20	4DCFD79E-47D9-4223-B907-DA116D0015D8			6fbe6214-bdfd-4688-bae3-d12a931f9989				6fbe6214-bdfd-4688-bae3-d12a931f9989		TCGA-B5-A3FD-01		TCGA-B5-A3FD-01A-11D-A19X-01		TCGA-B5-A3FD-01A-11D-A19X-01	TCGA-B5-A3FD-01	TCGA-B5-A3FD-01	TCGA-B5-A3FD-01A-11D-A19Z-05		
TCGA-B5-A3FH-01	MSI-L	0	TCGA-B5-A3FH-01	841	0	days	Iq		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-B5-A3FH	841	0	days	841	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74			TCGA-B5-A3FH-F63411	TCGA-B5-A3FH	TCGA-B5-A3FH-01A		Stage IA			-27221	97		0	841				NO			2014-8-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	480	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3FH.05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E.pdf	A3FH	6	negative	TUMOR FREE			NO	3	Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	9	0	17	Endometrial	A	LIVING	85	2011	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7		TCGA-B5-A3FH-01	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7	TCGA-B5-A3FH-01A-21-A23Z-20	6FCB4E7F-DE11-4F45-8BEB-5D60942D06B7			2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7				2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7		TCGA-B5-A3FH-01		TCGA-B5-A3FH-01A-11D-A19X-01		TCGA-B5-A3FH-01A-11D-A19X-01	TCGA-B5-A3FH-01	TCGA-B5-A3FH-01	TCGA-B5-A3FH-01A-11D-A19Z-05		
TCGA-B5-A3S1-01	MSS	0	TCGA-B5-A3S1-01	902	0	days	High		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-B5-A3S1	902	0	days	902	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-B5-A3S1-F59469	TCGA-B5-A3S1	TCGA-B5-A3S1-01A	Former User	Stage IIIC1	NO		-26031	127		0	902				NO			2014-5-13	FEMALE	155	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-B5-A3S1.72F97A0D-1245-4C80-B2D2-B7B217BEC06B.pdf	A3S1	87.6	negative	WITH TUMOR			YES	1	Complete Remission/Response	Never Used		YES					Primary Tumor	01	Minimally Invasive	2009		NO	YES	B5	0	7	3	24	Endometrial	A	LIVING	68	2011	77db73b5-24ef-47a3-b54b-4457ae62d562		TCGA-B5-A3S1-01	77db73b5-24ef-47a3-b54b-4457ae62d562	TCGA-B5-A3S1-01A-21-A23Z-20	2F5C90A3-2306-4D8D-A5F3-DDAFD7B6E298			77db73b5-24ef-47a3-b54b-4457ae62d562				77db73b5-24ef-47a3-b54b-4457ae62d562		TCGA-B5-A3S1-01		TCGA-B5-A3S1-01A-11D-A227-01		TCGA-B5-A3S1-01A-11D-A227-01	TCGA-B5-A3S1-01	TCGA-B5-A3S1-01	TCGA-B5-A3S1-01A-11D-A22B-05		
TCGA-B5-A5OC-01	MSI-H	0	TCGA-B5-A5OC-01	1249	0	days										TCGA-B5-A5OC	1249	0	days	1249	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-B5-A5OC-F59471	TCGA-B5-A5OC	TCGA-B5-A5OC-01A	Never Used	Stage IIIB	NO		-26109	732		0	1249				YES			2014-5-13	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES			750	NO	NO		G3					NO	true	No	TCGA-B5-A5OC.2B1515A6-001A-46AF-952C-D393944DE57F.pdf	A5OC			TUMOR FREE			YES	3		Never Used		YES				R2	Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011	12be39a5-bbae-439a-84a9-28b790e89aa9		TCGA-B5-A5OC-01	12be39a5-bbae-439a-84a9-28b790e89aa9		22D396FC-0D94-4E2A-AFD0-4D2CCFB3872F			12be39a5-bbae-439a-84a9-28b790e89aa9				12be39a5-bbae-439a-84a9-28b790e89aa9		TCGA-B5-A5OC-01		TCGA-B5-A5OC-01A-21D-A27O-01		TCGA-B5-A5OC-01A-21D-A27O-01	TCGA-B5-A5OC-01	TCGA-B5-A5OC-01	TCGA-B5-A5OC-01A-21D-A27Y-05		
TCGA-B5-A5OD-01	MSS	0	TCGA-B5-A5OD-01	1038	0	days										TCGA-B5-A5OD	1038	0	days	1038	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-B5-A5OD-F59472	TCGA-B5-A5OD	TCGA-B5-A5OD-01A		Stage IIIC	NO		-24775	662		0	1038				NO			2014-5-13	FEMALE		Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES			370	NO	NO		G3					NO	true	No	TCGA-B5-A5OD.8A0B9737-98D2-4A61-95FF-18842056A6DE.pdf	A5OD			TUMOR FREE			YES	0		Never Used		YES					Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011	0dfc3298-73ab-4c7b-b4f5-1314a5713c92		TCGA-B5-A5OD-01	0dfc3298-73ab-4c7b-b4f5-1314a5713c92		16DD0C81-5825-4E38-8230-090E6783721B			0dfc3298-73ab-4c7b-b4f5-1314a5713c92				0dfc3298-73ab-4c7b-b4f5-1314a5713c92		TCGA-B5-A5OD-01		TCGA-B5-A5OD-01A-11D-A31T-01		TCGA-B5-A5OD-01A-11D-A31T-01	TCGA-B5-A5OD-01	TCGA-B5-A5OD-01	TCGA-B5-A5OD-01A-11D-A31V-05		
TCGA-B5-A5OE-01	MSS	0	TCGA-B5-A5OE-01	1063	0	days										TCGA-B5-A5OE	1063	0	days	1063	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-B5-A5OE-F59473	TCGA-B5-A5OE	TCGA-B5-A5OE-01A		Stage IIIC2	NO		-24905	609		0	1063				NO			2014-5-14	FEMALE		Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES			1540	NO	NO		G3					NO	true	No	TCGA-B5-A5OE.82A668E5-6B89-4C94-BEED-F4FF227BD0B1.pdf	A5OE			TUMOR FREE			YES	4+				NO					Primary Tumor	01		2009		YES	NO	B5					Endometrial	A	LIVING		2011	0595a9e2-f382-4f97-8d0e-69af86b9fb78		TCGA-B5-A5OE-01	0595a9e2-f382-4f97-8d0e-69af86b9fb78		300974AA-5FA7-4658-A7BD-95F64E650DCC			0595a9e2-f382-4f97-8d0e-69af86b9fb78				0595a9e2-f382-4f97-8d0e-69af86b9fb78		TCGA-B5-A5OE-01		TCGA-B5-A5OE-01A-11D-A31T-01		TCGA-B5-A5OE-01A-11D-A31T-01	TCGA-B5-A5OE-01	TCGA-B5-A5OE-01	TCGA-B5-A5OE-01A-11D-A31V-05		
TCGA-BG-A0LW-01	MSS	0	TCGA-BG-A0LW-01	566	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-BG-A0LW	566	0	days	566	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47			TCGA-BG-A0LW-F19329	TCGA-BG-A0LW	TCGA-BG-A0LW-01A	Never Used	Stage IA			-17369	107		0	566						Scheduled Follow-up Submission	2011-12-8	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Indeterminate (neither Pre or Postmenopausal)	G2					NO	true	No	TCGA-BG-A0LW.75A97BED-AB64-46CC-AE6B-59860673D53E.pdf	A0LW	5	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG		0	0	6	Endometrial	A	LIVING	141	2010		TCGA-BG-A0LW-01	TCGA-BG-A0LW-01		TCGA-BG-A0LW-01A-21-A163-20	1AF915C6-7503-4190-9013-EA95D556D6D2	TCGA-BG-A0LW-01	TCGA-BG-A0LW-01		TCGA-BG-A0LW-01A-11W-A062-09	TCGA-BG-A0LW-01A-11W-A062-09	TCGA-BG-A0LW-01A-11W-A062-09		TCGA-BG-A0LW-01		e91d204d-8790-4438-add0-52f520fa532b	TCGA-BG-A0LW-01A-11D-A042-01	TCGA-BG-A0LW-01A-11R-A040-07	TCGA-BG-A0LW-01A-11D-A042-01		TCGA-BG-A0LW-01		TCGA-BG-A0LW-01A-11D-A039-05	e91d204d-8790-4438-add0-52f520fa532b
TCGA-BG-A0LX-01	MSI-H	0	TCGA-BG-A0LX-01	614	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-BG-A0LX	614	0	days	614	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-BG-A0LX-F19323	TCGA-BG-A0LX	TCGA-BG-A0LX-01A	Never Used	Stage IB			-20928	120		0	614				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0LX.4306E592-FA36-4AB9-BF84-7232CC599A64.pdf	A0LX	90		TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG	0	7	0	15	Endometrial	A	LIVING	96	2010		TCGA-BG-A0LX-01	TCGA-BG-A0LX-01		TCGA-BG-A0LX-01A-21-A163-20	5F4E9178-6219-44BF-A4A2-D02F0AB33AD8		TCGA-BG-A0LX-01		TCGA-BG-A0LX-01A-11W-A062-09	TCGA-BG-A0LX-01A-11W-A062-09	TCGA-BG-A0LX-01A-11W-A062-09				7961370a-641d-4dc9-a530-99789e7d0036	TCGA-BG-A0LX-01A-11D-A042-01		TCGA-BG-A0LX-01A-11D-A042-01		TCGA-BG-A0LX-01		TCGA-BG-A0LX-01A-11D-A039-05	7961370a-641d-4dc9-a530-99789e7d0036
TCGA-BG-A0M0-01	MSI-H	0	TCGA-BG-A0M0-01	588	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0M0	588	0	days	588	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	66			TCGA-BG-A0M0-F19320	TCGA-BG-A0M0	TCGA-BG-A0M0-01A	Never Used	Stage IA			-24427	147		0	588				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	800	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0M0.BDDACDFC-E3D4-4EA7-9591-DB6371713E8E.pdf	A0M0	6	negative	TUMOR FREE	0	0			Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		0	0	1	Endometrial	A	LIVING	117	2010		TCGA-BG-A0M0-01	TCGA-BG-A0M0-01		TCGA-BG-A0M0-01A-21-A163-20	5007B1AB-8651-4B64-8777-885393A6A284		TCGA-BG-A0M0-01		TCGA-BG-A0M0-01A-11W-A10C-09	TCGA-BG-A0M0-01A-11W-A10C-09	TCGA-BG-A0M0-01A-11W-A10C-09				5343a292-c0ee-4764-8051-ee24716cf79d	TCGA-BG-A0M0-01A-11D-A102-01		TCGA-BG-A0M0-01A-11D-A102-01		TCGA-BG-A0M0-01		TCGA-BG-A0M0-01A-11D-A10Q-05	5343a292-c0ee-4764-8051-ee24716cf79d
TCGA-BG-A0M2-01	MSS	0	TCGA-BG-A0M2-01	637	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-BG-A0M2	637	0	days	637	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62	0	0	TCGA-BG-A0M2-F19319	TCGA-BG-A0M2	TCGA-BG-A0M2-01A	Never Used	Stage IB			-22822	185		0	637				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	510	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0M2.A0087300-81E9-4733-8497-95E0F95575B4.pdf	A0M2	59	negative	TUMOR FREE	0	0			Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG	0	1	0	8	Endometrial	A	LIVING	76	2009		TCGA-BG-A0M2-01	TCGA-BG-A0M2-01		TCGA-BG-A0M2-01A-21-A163-20	DD52C56D-2806-4F0F-906C-7518B5CC058F		TCGA-BG-A0M2-01		TCGA-BG-A0M2-01A-11D-A10O-09	TCGA-BG-A0M2-01A-11D-A10O-09	TCGA-BG-A0M2-01A-11D-A10O-09				4487eb24-a67d-4406-9a1f-b2c2fde39787	TCGA-BG-A0M2-01A-11D-A102-01		TCGA-BG-A0M2-01A-11D-A102-01		TCGA-BG-A0M2-01		TCGA-BG-A0M2-01A-11D-A10Q-05	4487eb24-a67d-4406-9a1f-b2c2fde39787
TCGA-BG-A0M3-01	MSS	0	TCGA-BG-A0M3-01	1071	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-BG-A0M3	1071	0	days	1071	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74	0	0	TCGA-BG-A0M3-F19332	TCGA-BG-A0M3	TCGA-BG-A0M3-01A	Never Used	Stage IB			-27183	597		0	1071				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0M3.19AABBD8-3DC5-418E-9B62-37CF7500F174.pdf	A0M3	53	positive	TUMOR FREE	0	0			Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	5	0	12	Endometrial	A	LIVING	75	2008		TCGA-BG-A0M3-01	TCGA-BG-A0M3-01		TCGA-BG-A0M3-01A-21-A163-20	00F34C1B-8B1B-47D2-9D64-12591734FAA1		TCGA-BG-A0M3-01		TCGA-BG-A0M3-01A-11W-A10C-09	TCGA-BG-A0M3-01A-11W-A10C-09	TCGA-BG-A0M3-01A-11W-A10C-09				e5b97796-bf64-458e-8ed8-246c2b303ce7	TCGA-BG-A0M3-01A-11D-A102-01		TCGA-BG-A0M3-01A-11D-A102-01		TCGA-BG-A0M3-01		TCGA-BG-A0M3-01A-11D-A10Q-05	e5b97796-bf64-458e-8ed8-246c2b303ce7
TCGA-BG-A0M4-01	MSI-H	0	TCGA-BG-A0M4-01	2167	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 6	TCGA-BG-A0M4	2167	0	days	2167	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-BG-A0M4-F71768	TCGA-BG-A0M4	TCGA-BG-A0M4-01A	Never Used	Stage IA			-22090	643		0	2167						Scheduled Follow-up Submission	2015-3-30	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-BG-A0M4.95002D96-C9D8-43BE-ADD1-072E93994194.pdf	A0M4	5	negative	TUMOR FREE	0	0	YES		Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	YES	YES	NO	BG	0	3	0	14	Endometrial	A	LIVING	97	2008		TCGA-BG-A0M4-01	TCGA-BG-A0M4-01		TCGA-BG-A0M4-01A-21-A163-20	57311FA8-C83F-4B62-8310-BE9A12E10B2E		TCGA-BG-A0M4-01		TCGA-BG-A0M4-01A-11W-A10C-09	TCGA-BG-A0M4-01A-11W-A10C-09	TCGA-BG-A0M4-01A-11W-A10C-09				174acfe1-d3ab-4912-9d05-7aa598ae1add	TCGA-BG-A0M4-01A-11D-A102-01		TCGA-BG-A0M4-01A-11D-A102-01		TCGA-BG-A0M4-01		TCGA-BG-A0M4-01A-11D-A10Q-05	174acfe1-d3ab-4912-9d05-7aa598ae1add
TCGA-BG-A0M6-01	MSS	1	TCGA-BG-A0M6-01	671	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-BG-A0M6	671	0	days	671	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	3	TCGA-BG-A0M6-F19331	TCGA-BG-A0M6	TCGA-BG-A0M6-01A	Never Used	Stage IIIC2			-26666	618	671	0	241				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection	320	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-BG-A0M6.39EC3673-5B31-403B-8328-9DEA5FF7CD1A.pdf	A0M6	100	positive	TUMOR FREE	0	5			Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	BG	3	5	5	16	Endometrial	A	DECEASED	55	2008		TCGA-BG-A0M6-01	TCGA-BG-A0M6-01		TCGA-BG-A0M6-01A-21-A163-20	61AE62D3-8662-47BB-B2A1-FE0A5D787E24		TCGA-BG-A0M6-01		TCGA-BG-A0M6-01A-31D-A10B-09	TCGA-BG-A0M6-01A-31D-A10B-09	TCGA-BG-A0M6-01A-31D-A10B-09				989bcd83-f8c2-4027-a10c-19ce3b67e348	TCGA-BG-A0M6-01A-31D-A102-01		TCGA-BG-A0M6-01A-31D-A102-01		TCGA-BG-A0M6-01		TCGA-BG-A0M6-01A-31D-A10Q-05	989bcd83-f8c2-4027-a10c-19ce3b67e348
TCGA-BG-A0M7-01	MSS	0	TCGA-BG-A0M7-01	1937	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-BG-A0M7	1937	0	days	1937	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60			TCGA-BG-A0M7-F71767	TCGA-BG-A0M7	TCGA-BG-A0M7-01A		Stage IIIC1			-22096	659		0	1937						Scheduled Follow-up Submission	2015-3-30	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	260	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0M7.F9128DAE-F3D0-4738-AC20-E665F22DDC63.pdf	A0M7	75	negative	TUMOR FREE			YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	BG					Endometrial	A	LIVING	102	2008		TCGA-BG-A0M7-01	TCGA-BG-A0M7-01		TCGA-BG-A0M7-01A-21-A163-20	7CEAF55F-FB25-46A2-B3B8-24CA17F2477D		TCGA-BG-A0M7-01		TCGA-BG-A0M7-01A-11W-A062-09	TCGA-BG-A0M7-01A-11W-A062-09	TCGA-BG-A0M7-01A-11W-A062-09				a832a6a6-1998-41c2-9dab-87076a1f11cf	TCGA-BG-A0M7-01A-11D-A042-01		TCGA-BG-A0M7-01A-11D-A042-01		TCGA-BG-A0M7-01		TCGA-BG-A0M7-01A-11D-A039-05	a832a6a6-1998-41c2-9dab-87076a1f11cf
TCGA-BG-A0M8-01	MSS	0	TCGA-BG-A0M8-01	2020	0	days	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 2	TCGA-BG-A0M8	2020	0	days	2020	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	50			TCGA-BG-A0M8-F71766	TCGA-BG-A0M8	TCGA-BG-A0M8-01A	Never Used	Stage IA			-18308	734		0	2020				NO		Scheduled Follow-up Submission	2015-3-30	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	630	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	true	Yes	TCGA-BG-A0M8.42DBC6F7-E413-41A6-994E-1391099818A0.pdf	A0M8	50	negative	TUMOR FREE			NO		Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG		0		0	Endometrial	A	LIVING	209	2008			TCGA-BG-A0M8-01		TCGA-BG-A0M8-01A-21-A163-20	E01A90AC-A64F-4AD2-8C5B-374D2F9FBF75				TCGA-BG-A0M8-01A-12D-A10B-09	TCGA-BG-A0M8-01A-12D-A10B-09	TCGA-BG-A0M8-01A-12D-A10B-09				90962783-12b4-434d-9b27-6c6f8f3b8d10	TCGA-BG-A0M8-01A-12D-A102-01		TCGA-BG-A0M8-01A-12D-A102-01		TCGA-BG-A0M8-01		TCGA-BG-A0M8-01A-12D-A10Q-05	90962783-12b4-434d-9b27-6c6f8f3b8d10
TCGA-BG-A0M9-01	MSS	0	TCGA-BG-A0M9-01	2270	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 1	TCGA-BG-A0M9	2270	0	days	2270	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	0	TCGA-BG-A0M9-F71764	TCGA-BG-A0M9	TCGA-BG-A0M9-01A	Never Used	Stage IB			-26708	772		0	2270				NO		Scheduled Follow-up Submission	2015-3-30	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0M9.08D832C7-9B5F-4B6E-9C3E-2F3E58305016.pdf	A0M9	75	negative	TUMOR FREE	0	0	NO		Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	4	0	5	Endometrial	A	LIVING	93	2008		TCGA-BG-A0M9-01	TCGA-BG-A0M9-01		TCGA-BG-A0M9-01A-11-A163-20	6AF1C2FB-89E2-4FCC-9774-858ED6CAC492		TCGA-BG-A0M9-01		TCGA-BG-A0M9-01A-21W-A10C-09	TCGA-BG-A0M9-01A-21W-A10C-09	TCGA-BG-A0M9-01A-21W-A10C-09				55874b54-441d-4a28-b2a7-a90e96774ff9	TCGA-BG-A0M9-01A-21D-A102-01		TCGA-BG-A0M9-01A-21D-A102-01		TCGA-BG-A0M9-01		TCGA-BG-A0M9-01A-21D-A10Q-05	55874b54-441d-4a28-b2a7-a90e96774ff9
TCGA-BG-A0MA-01	MSS	1	TCGA-BG-A0MA-01	326	1	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-BG-A0MA	70	1	days	326	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO	Progressive Disease	60	0	0	TCGA-BG-A0MA-F72174	TCGA-BG-A0MA	TCGA-BG-A0MA-01A		Stage IB			-22036	805	326	0				70			Scheduled Follow-up Submission	2015-4-22	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Distant Metastasis	lung		YES	true	No	TCGA-BG-A0MA.E5908692-5B04-407B-818A-D202756DD880.pdf	A0MA	78	negative	WITH TUMOR	0	0	NO	0	Progressive Disease			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	6	0	10	Endometrial	A	DECEASED	111	2008			TCGA-BG-A0MA-01		TCGA-BG-A0MA-01A-21-A18Q-20	26F8155B-BC23-4D3E-AE18-B9B538437680									TCGA-BG-A0MA-01	e93ac169-2fab-4312-9239-a9141d347763	TCGA-BG-A0MA-01A-11D-A17C-01		TCGA-BG-A0MA-01A-11D-A17C-01	TCGA-BG-A0MA-01	TCGA-BG-A0MA-01	TCGA-BG-A0MA-01A-11D-A17F-05		e93ac169-2fab-4312-9239-a9141d347763
TCGA-BG-A0MA-11	MSS	1	TCGA-BG-A0MA-11	326	1	days		C6-UCEC								TCGA-BG-A0MA	70	1	days	326	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO	Progressive Disease	60	0	0	TCGA-BG-A0MA-F72174	TCGA-BG-A0MA	TCGA-BG-A0MA-11A		Stage IB			-22036	1134	326	0				70			Scheduled Follow-up Submission	2015-4-22	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Distant Metastasis	lung		YES	true	No		A0MA	78	negative	WITH TUMOR	0	0	NO	0	Progressive Disease			NO				R0	Solid Tissue Normal	11	open	1988	NO	NO	YES	BG	0	6	0	10	Endometrial	A	DECEASED	111	2008																						TCGA-BG-A0MA-11A-11D-A17F-05		
TCGA-BG-A0MC-01	MSS	0	TCGA-BG-A0MC-01	1263	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 1	TCGA-BG-A0MC	1263	0	days	1263	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74			TCGA-BG-A0MC-F19280	TCGA-BG-A0MC	TCGA-BG-A0MC-01A	Never Used	Stage IA			-27136	779		0	1263				YES		Scheduled Follow-up Submission	2011-12-7	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	630	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0MC.100F4900-491A-438B-9704-51D4E016B325.pdf	A0MC	0	negative	TUMOR FREE					Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	BG		0		0	Endometrial	A	LIVING	135	2008		TCGA-BG-A0MC-01	TCGA-BG-A0MC-01		TCGA-BG-A0MC-01A-11-A163-20	27EBFA46-C09D-471B-A9D5-B3BA90EE832E		TCGA-BG-A0MC-01		TCGA-BG-A0MC-01A-21W-A062-09	TCGA-BG-A0MC-01A-21W-A062-09	TCGA-BG-A0MC-01A-21W-A062-09				1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9	TCGA-BG-A0MC-01A-21D-A042-01		TCGA-BG-A0MC-01A-21D-A042-01		TCGA-BG-A0MC-01		TCGA-BG-A0MC-01A-21D-A039-05	1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9
TCGA-BG-A0MG-01	MSS	0	TCGA-BG-A0MG-01	1477	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-BG-A0MG	1477	0	days	1477	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	0	TCGA-BG-A0MG-F19272	TCGA-BG-A0MG	TCGA-BG-A0MG-01A	Never Used	Stage IA	NO		-26957	980		0	1477				NO		Scheduled Follow-up Submission	2011-12-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0MG.65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B.pdf	A0MG	36	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	2	0	5	Endometrial	A	LIVING	61	2007		TCGA-BG-A0MG-01	TCGA-BG-A0MG-01		TCGA-BG-A0MG-01A-11-A163-20	107D6429-EC36-4D65-9820-23FF2EACE5E9		TCGA-BG-A0MG-01		TCGA-BG-A0MG-01A-21D-A10B-09	TCGA-BG-A0MG-01A-21D-A10B-09	TCGA-BG-A0MG-01A-21D-A10B-09				a21894d9-a459-4dbd-b9de-6c39f6fc61c2	TCGA-BG-A0MG-01A-21D-A102-01		TCGA-BG-A0MG-01A-21D-A102-01		TCGA-BG-A0MG-01		TCGA-BG-A0MG-01A-21D-A10Q-05	a21894d9-a459-4dbd-b9de-6c39f6fc61c2
TCGA-BG-A0MH-01	MSS	0	TCGA-BG-A0MH-01	1930	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 1		TCGA-BG-A0MH	1930	0	days	1930	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-BG-A0MH-F49548	TCGA-BG-A0MH	TCGA-BG-A0MH-01A		Stage IC			-22475	1000		0	1930							2013-10-3	FEMALE	154	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	790	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0MH.F641C526-7A0D-46C3-92EE-CD9CB0D13960.pdf	A0MH	90		TUMOR FREE		0	NO		Complete Remission/Response			YES					Primary Tumor	01	open	1988		NO	YES	BG				8	Endometrial	A	LIVING	136	2007			TCGA-BG-A0MH-01		TCGA-BG-A0MH-01A-21-A163-20	61CC9B5C-C646-4D6C-92FF-CEC57CD68FB7									TCGA-BG-A0MH-01	f73e7e5b-239b-4ac9-861e-c8f42e68188e				TCGA-BG-A0MH-01		TCGA-BG-A0MH-01A-11D-A123-05		f73e7e5b-239b-4ac9-861e-c8f42e68188e
TCGA-BG-A0MI-01	MSS	1	TCGA-BG-A0MI-01	714	1	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A0MI	714	0	days	714	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	83	0	0	TCGA-BG-A0MI-F17205	TCGA-BG-A0MI		Never Used	Stage IA	NO		-30334		714	0					NO		Scheduled Follow-up Submission	2011-10-4	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO		No		A0MI	13	negative	TUMOR FREE	0	0		3		Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG	0	2	0	13	Endometrial		DECEASED	101	2007		TCGA-BG-A0MI-01	TCGA-BG-A0MI-01				TCGA-BG-A0MI-01	TCGA-BG-A0MI-01		TCGA-BG-A0MI-01A-11W-A062-09	TCGA-BG-A0MI-01A-11W-A062-09	TCGA-BG-A0MI-01A-11W-A062-09		TCGA-BG-A0MI-01		c199bab3-c6e3-4123-811c-2c50e8d44fae	TCGA-BG-A0MI-01A-11D-A042-01	TCGA-BG-A0MI-01A-11R-A040-07	TCGA-BG-A0MI-01A-11D-A042-01		TCGA-BG-A0MI-01		TCGA-BG-A0MI-01A-11D-A039-05	c199bab3-c6e3-4123-811c-2c50e8d44fae
TCGA-BG-A0MK-01	Indeterminate	1	TCGA-BG-A0MK-01	1317	1	days	Quiet		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-BG-A0MK	1317	0	days	1317	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	52			TCGA-BG-A0MK-F39617	TCGA-BG-A0MK	TCGA-BG-A0MK-01A		Stage IIB			-19034	1399	1317	0								2013-1-28	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	1100	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	No	TCGA-BG-A0MK.9D631FCB-78A9-4CA9-A033-D66CB78D8CA3.pdf	A0MK		negative	WITH TUMOR			NO		Progressive Disease			YES				R0	Primary Tumor	01	Minimally Invasive	1995		YES	NO	BG					Endometrial	A	DECEASED		2006	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3		TCGA-BG-A0MK-01	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3	TCGA-BG-A0MK-01A-41-A23Z-20	4B3EF3BA-BF09-4B60-B976-73C9307C8D61			1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3				1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3		TCGA-BG-A0MK-01		TCGA-BG-A0MK-01A-51D-A19X-01		TCGA-BG-A0MK-01A-51D-A19X-01	TCGA-BG-A0MK-01	TCGA-BG-A0MK-01	TCGA-BG-A0MK-01A-51D-A19Z-05		
TCGA-BG-A0MO-01	MSS	0	TCGA-BG-A0MO-01	1309	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 1	mutation c1uster 9	TCGA-BG-A0MO	1309	0	days	1309	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-BG-A0MO-F19273	TCGA-BG-A0MO	TCGA-BG-A0MO-01A	Never Used	Stage IA	NO		-23287	854		0	1309				NO		Scheduled Follow-up Submission	2011-12-6	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0MO.C120AC98-36D2-49AD-84A1-6EA168D2A2BA.pdf	A0MO	35.7	negative	TUMOR FREE					Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG					Endometrial	A	LIVING	83	2008		TCGA-BG-A0MO-01	TCGA-BG-A0MO-01					TCGA-BG-A0MO-01		TCGA-BG-A0MO-01A-11W-A062-09	TCGA-BG-A0MO-01A-11W-A062-09	TCGA-BG-A0MO-01A-11W-A062-09				7fc96ce5-b529-4d89-8b27-5f8ba4e301e9	TCGA-BG-A0MO-01A-11D-A042-01		TCGA-BG-A0MO-01A-11D-A042-01		TCGA-BG-A0MO-01		TCGA-BG-A0MO-01A-11D-A039-05	7fc96ce5-b529-4d89-8b27-5f8ba4e301e9
TCGA-BG-A0MQ-01	MSI-H	0	TCGA-BG-A0MQ-01	1817	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-BG-A0MQ	1817	0	days	1817	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	71			TCGA-BG-A0MQ-F71765	TCGA-BG-A0MQ	TCGA-BG-A0MQ-01A	Never Used	Stage IA			-26284	692		0	1817				YES		Scheduled Follow-up Submission	2015-3-30	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0MQ.3252AEB3-3B0D-4066-B18E-31096F928D63.pdf	A0MQ	25	negative	WITH TUMOR			NO		Stable Disease	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BG					Endometrial	A	LIVING	101	2008		TCGA-BG-A0MQ-01	TCGA-BG-A0MQ-01					TCGA-BG-A0MQ-01		TCGA-BG-A0MQ-01A-11D-A10B-09	TCGA-BG-A0MQ-01A-11D-A10B-09	TCGA-BG-A0MQ-01A-11D-A10B-09				37d2da87-d591-440d-87d3-a34a038bef5b	TCGA-BG-A0MQ-01A-11D-A102-01		TCGA-BG-A0MQ-01A-11D-A102-01		TCGA-BG-A0MQ-01		TCGA-BG-A0MQ-01A-11D-A10Q-05	37d2da87-d591-440d-87d3-a34a038bef5b
TCGA-BG-A0MS-01	MSS	0	TCGA-BG-A0MS-01	1882	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A0MS	1882	0	days	1882	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-BG-A0MS-F71770	TCGA-BG-A0MS	TCGA-BG-A0MS-01A	Never Used	Stage IIIC1			-19547	420		0	1882				NO		Scheduled Follow-up Submission	2015-3-30	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	560	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-BG-A0MS.7BE89F2D-74E5-4D9E-8270-A216D79ADCD7.pdf	A0MS	44	negative	TUMOR FREE			YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	BG					Endometrial	A	LIVING	65	2009			TCGA-BG-A0MS-01		TCGA-BG-A0MS-01A-21-A163-20	C7A57035-FAC8-466B-B969-37A70C4D246F				TCGA-BG-A0MS-01A-11D-A10B-09	TCGA-BG-A0MS-01A-11D-A10B-09	TCGA-BG-A0MS-01A-11D-A10B-09				09b4aa83-d8e7-4615-bfad-da877df4fe7d	TCGA-BG-A0MS-01A-11D-A102-01		TCGA-BG-A0MS-01A-11D-A102-01		TCGA-BG-A0MS-01		TCGA-BG-A0MS-01A-11D-A10Q-05	09b4aa83-d8e7-4615-bfad-da877df4fe7d
TCGA-BG-A0MT-01	MSS	0	TCGA-BG-A0MT-01	644	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 10	TCGA-BG-A0MT	565	1	days	644	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium		YES		Partial Response	64			TCGA-BG-A0MT-F19318	TCGA-BG-A0MT	TCGA-BG-A0MT-01A	Never Used	Stage IA			-23574	344		0	644			565	NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	820	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	locally in the endometrium		YES	true	No	TCGA-BG-A0MT.89610F48-AC0D-431D-8A9E-FC9E51CF8FC0.pdf	A0MT	25	negative	TUMOR FREE					Partial Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG					Endometrial	A	LIVING	73	2009		TCGA-BG-A0MT-01	TCGA-BG-A0MT-01		TCGA-BG-A0MT-01A-21-A163-20	9170FA52-8CC4-465C-8DE7-94199FF1E4E4		TCGA-BG-A0MT-01		TCGA-BG-A0MT-01A-11D-A10B-09	TCGA-BG-A0MT-01A-11D-A10B-09	TCGA-BG-A0MT-01A-11D-A10B-09				578f3ec4-17e0-4cf9-bfa8-56624d174374	TCGA-BG-A0MT-01A-11D-A102-01		TCGA-BG-A0MT-01A-11D-A102-01		TCGA-BG-A0MT-01		TCGA-BG-A0MT-01A-11D-A10Q-05	578f3ec4-17e0-4cf9-bfa8-56624d174374
TCGA-BG-A0MU-01	MSS	0	TCGA-BG-A0MU-01	617	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-BG-A0MU	617	0	days	617	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	78	0	0	TCGA-BG-A0MU-F19322	TCGA-BG-A0MU	TCGA-BG-A0MU-01A	Never Used	Stage IIIA			-28621	121		0	617				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	860	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0MU.7162F7A7-7295-4736-B721-B13DAE006092.pdf	A0MU	76.9	negative	TUMOR FREE	0	0			Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	BG	0	1	0	8	Endometrial	A	LIVING	68	2010		TCGA-BG-A0MU-01	TCGA-BG-A0MU-01		TCGA-BG-A0MU-01A-21-A163-20	2220B369-D1D5-48E1-8F1D-2BF17726A5C9		TCGA-BG-A0MU-01		TCGA-BG-A0MU-01A-11D-A10B-09	TCGA-BG-A0MU-01A-11D-A10B-09	TCGA-BG-A0MU-01A-11D-A10B-09				06c39fc6-9167-4913-bf84-4fde036869a2	TCGA-BG-A0MU-01A-11D-A102-01		TCGA-BG-A0MU-01A-11D-A102-01		TCGA-BG-A0MU-01		TCGA-BG-A0MU-01A-11D-A10Q-05	06c39fc6-9167-4913-bf84-4fde036869a2
TCGA-BG-A0RY-01	MSS	0	TCGA-BG-A0RY-01	469	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-BG-A0RY	469	0	days	469	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68	0	0	TCGA-BG-A0RY-F19333	TCGA-BG-A0RY	TCGA-BG-A0RY-01A	Never Used	Stage IB			-24952	49		0	469				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	450	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0RY.170B34D7-94B3-4129-9B4D-E36AF7A09897.pdf	A0RY	96	negative	TUMOR FREE	0	0			Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	BG	0	0	0	9	Endometrial	A	LIVING	118	2010		TCGA-BG-A0RY-01	TCGA-BG-A0RY-01		TCGA-BG-A0RY-01A-21-A163-20	C6B6D0CE-40DE-4854-9839-31E44642187F		TCGA-BG-A0RY-01		TCGA-BG-A0RY-01A-11D-A10B-09	TCGA-BG-A0RY-01A-11D-A10B-09	TCGA-BG-A0RY-01A-11D-A10B-09				514a9fc3-0b51-41f3-8c94-f6c8d8c0911e	TCGA-BG-A0RY-01A-11D-A102-01		TCGA-BG-A0RY-01A-11D-A102-01		TCGA-BG-A0RY-01		TCGA-BG-A0RY-01A-11D-A10Q-05	514a9fc3-0b51-41f3-8c94-f6c8d8c0911e
TCGA-BG-A0VT-01	MSS	0	TCGA-BG-A0VT-01	1568	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation c1uster 9	TCGA-BG-A0VT	1568	0	days	1568	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-BG-A0VT-F71773	TCGA-BG-A0VT	TCGA-BG-A0VT-01A		Stage IIIA			-20602	87		0	1568							2015-3-30	FEMALE	170	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	true	No	TCGA-BG-A0VT.0BC38740-A7B9-4086-9F03-A139287B33CC.pdf	A0VT	20		TUMOR FREE		0	YES		Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	BG		3		3	Endometrial	A	LIVING	144	2010		TCGA-BG-A0VT-01	TCGA-BG-A0VT-01		TCGA-BG-A0VT-01A-31-A163-20	EA1D2D67-9237-433D-A6B5-D3918D8BF59A		TCGA-BG-A0VT-01		TCGA-BG-A0VT-01A-11D-A10M-09	TCGA-BG-A0VT-01A-11D-A10M-09	TCGA-BG-A0VT-01A-11D-A10M-09				666ecfed-75d2-412a-bd7f-24b9775db969	TCGA-BG-A0VT-01A-11D-A10L-01		TCGA-BG-A0VT-01A-11D-A10L-01		TCGA-BG-A0VT-01	TCGA-BG-A0VT-01A-11D-A10N-05		666ecfed-75d2-412a-bd7f-24b9775db969
TCGA-BG-A0VV-01	MSS	0	TCGA-BG-A0VV-01	1553	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0VV	1553	0	days	1553	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53		0	TCGA-BG-A0VV-F71775	TCGA-BG-A0VV	TCGA-BG-A0VV-01A		Stage IA			-19581	217		0	1553							2015-3-30	FEMALE	162	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	No	TCGA-BG-A0VV.42E7D5FF-18CD-4DEA-9518-9B9732BCA635.pdf	A0VV	50	negative	TUMOR FREE		0	NO		Complete Remission/Response			NO				R0	Primary Tumor	01	open	2009		NO	YES	BG		2		6	Endometrial	A	LIVING	147	2010			TCGA-BG-A0VV-01		TCGA-BG-A0VV-01A-11-A163-20	B296BC3F-3E22-46FD-AD09-8C08D18CC239					TCGA-BG-A0VV-01A-21D-A122-09	TCGA-BG-A0VV-01A-21D-A122-09			TCGA-BG-A0VV-01	34a66e0d-169f-4e39-89a2-78376bf741ae	TCGA-BG-A0VV-01A-21D-A120-01		TCGA-BG-A0VV-01A-21D-A120-01	TCGA-BG-A0VV-01	TCGA-BG-A0VV-01	TCGA-BG-A0VV-01A-21D-A123-05		34a66e0d-169f-4e39-89a2-78376bf741ae
TCGA-BG-A0VW-01	MSI-H	0	TCGA-BG-A0VW-01	1582	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 12	TCGA-BG-A0VW	1582	0	days	1582	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77		0	TCGA-BG-A0VW-F71776	TCGA-BG-A0VW	TCGA-BG-A0VW-01A		Stage IA			-28383	246		0	1582							2015-3-30	FEMALE	157	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0VW.7663D410-13EC-4A5B-B655-F7DCCC9C8E8D.pdf	A0VW	50	negative	TUMOR FREE		0	NO		Complete Remission/Response			NO				R0	Primary Tumor	01	open	2009		NO	YES	BG		2		10	Endometrial	A	LIVING	93	2010			TCGA-BG-A0VW-01								TCGA-BG-A0VW-01A-11D-A122-09	TCGA-BG-A0VW-01A-11D-A122-09			TCGA-BG-A0VW-01	818368c5-a7b6-40d2-a24f-39604ea80303	TCGA-BG-A0VW-01A-11D-A120-01		TCGA-BG-A0VW-01A-11D-A120-01	TCGA-BG-A0VW-01	TCGA-BG-A0VW-01	TCGA-BG-A0VW-01A-11D-A123-05		818368c5-a7b6-40d2-a24f-39604ea80303
TCGA-BG-A0VX-01	MSS	0	TCGA-BG-A0VX-01	1043	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 4	TCGA-BG-A0VX	1043	0	days	1043	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-BG-A0VX-F34087	TCGA-BG-A0VX			Stage IB	NO		-21425			0	1043				NO			2012-7-30	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A0VX	15		TUMOR FREE			NO		Complete Remission/Response			YES				RX	Primary Tumor	01	open	1988		NO	YES	BG					Endometrial		LIVING	157	2008			TCGA-BG-A0VX-01							TCGA-BG-A0VX-01A-11D-A122-09	TCGA-BG-A0VX-01A-11D-A122-09	TCGA-BG-A0VX-01A-11D-A122-09			TCGA-BG-A0VX-01	e6322f79-edd2-48f2-9712-82f7153b6e1e	TCGA-BG-A0VX-01A-11D-A120-01		TCGA-BG-A0VX-01A-11D-A120-01	TCGA-BG-A0VX-01	TCGA-BG-A0VX-01	TCGA-BG-A0VX-01A-11D-A123-05		e6322f79-edd2-48f2-9712-82f7153b6e1e
TCGA-BG-A0VZ-01	MSI-H	0	TCGA-BG-A0VZ-01	1601	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-BG-A0VZ	1601	0	days	1601	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-BG-A0VZ-F34091	TCGA-BG-A0VZ	TCGA-BG-A0VZ-01A		Stage IIIA	NO		-21414	876		0	1601				NO			2012-7-30	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0VZ.6CCCA758-AB3D-4260-BD25-16716E34B3BB.pdf	A0VZ	52	negative	TUMOR FREE			YES	1	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988		NO	YES	BG					Endometrial	A	LIVING	109	2008		TCGA-BG-A0VZ-01	TCGA-BG-A0VZ-01					TCGA-BG-A0VZ-01		TCGA-BG-A0VZ-01A-11D-A10G-09	TCGA-BG-A0VZ-01A-11D-A10G-09	TCGA-BG-A0VZ-01A-11D-A10G-09				740f4c64-0bc1-4691-8b37-7830ae67a080	TCGA-BG-A0VZ-01A-11D-A107-01		TCGA-BG-A0VZ-01A-11D-A107-01		TCGA-BG-A0VZ-01	TCGA-BG-A0VZ-01A-11D-A10A-05		740f4c64-0bc1-4691-8b37-7830ae67a080
TCGA-BG-A0W1-01	MSS	0	TCGA-BG-A0W1-01	1607	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0W1	1607	0	days	1607	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	89			TCGA-BG-A0W1-F34127	TCGA-BG-A0W1	TCGA-BG-A0W1-01A		Stage II	NO		-32750	1014		0	1607				NO			2012-7-30	FEMALE	130	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-BG-A0W1.BE7CC54D-8220-4AC6-9F8D-016DE4167B35.pdf	A0W1	45		TUMOR FREE		0	NO		Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988		NO	YES	BG				11	Endometrial	A	LIVING	56	2007		TCGA-BG-A0W1-01	TCGA-BG-A0W1-01		TCGA-BG-A0W1-01A-21-A163-20	882F0777-CF03-43CE-ACAD-42A6E98D7D64		TCGA-BG-A0W1-01		TCGA-BG-A0W1-01A-12D-A10G-09	TCGA-BG-A0W1-01A-12D-A10G-09	TCGA-BG-A0W1-01A-12D-A10G-09				85dd6956-38ee-4f12-9210-ffe2a8964aef	TCGA-BG-A0W1-01A-12D-A107-01		TCGA-BG-A0W1-01A-12D-A107-01		TCGA-BG-A0W1-01	TCGA-BG-A0W1-01A-12D-A10A-05		85dd6956-38ee-4f12-9210-ffe2a8964aef
TCGA-BG-A0W2-01	MSS	0	TCGA-BG-A0W2-01	1721	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BG-A0W2	1721	0	days	1721	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-BG-A0W2-F49543	TCGA-BG-A0W2	TCGA-BG-A0W2-01A		Stage IA			-20998	1073		0	1721							2013-10-3	FEMALE	165	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A0W2.D9BDB0FB-9205-4E41-9D7D-B12C206A608E.pdf	A0W2	0		TUMOR FREE			NO		Complete Remission/Response			NO				RX	Primary Tumor	01	open	1988		NO	YES	BG		0		0	Endometrial	A	LIVING	121	2007		TCGA-BG-A0W2-01	TCGA-BG-A0W2-01					TCGA-BG-A0W2-01		TCGA-BG-A0W2-01A-11D-A117-09	TCGA-BG-A0W2-01A-11D-A117-09	TCGA-BG-A0W2-01A-11D-A117-09				8f9d6b78-c294-4f11-99ea-dc834a7f1741	TCGA-BG-A0W2-01A-11D-A107-01		TCGA-BG-A0W2-01A-11D-A107-01		TCGA-BG-A0W2-01	TCGA-BG-A0W2-01A-11D-A10A-05		8f9d6b78-c294-4f11-99ea-dc834a7f1741
TCGA-BG-A0YU-01	MSS	0	TCGA-BG-A0YU-01	451	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BG-A0YU	451	0	days	451	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	37			TCGA-BG-A0YU-F19334	TCGA-BG-A0YU	TCGA-BG-A0YU-01A		Stage IA			-13644	166		0	451				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	pelvic wash specimen from PAP	Other method, specify:	310	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	true	No	TCGA-BG-A0YU.5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129.pdf	A0YU	50		TUMOR FREE					Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	BG					Endometrial	A	LIVING	107	2010		TCGA-BG-A0YU-01	TCGA-BG-A0YU-01		TCGA-BG-A0YU-01A-11-A163-20	3F6A7393-8558-4803-BC69-541FBB713CF3		TCGA-BG-A0YU-01		TCGA-BG-A0YU-01A-21D-A10M-09	TCGA-BG-A0YU-01A-21D-A10M-09	TCGA-BG-A0YU-01A-21D-A10M-09				6e00c57a-69e5-4b00-9e5e-97aa1d4933c7	TCGA-BG-A0YU-01A-21D-A10L-01		TCGA-BG-A0YU-01A-21D-A10L-01		TCGA-BG-A0YU-01	TCGA-BG-A0YU-01A-21D-A10N-05		6e00c57a-69e5-4b00-9e5e-97aa1d4933c7
TCGA-BG-A0YV-01	MSS	0	TCGA-BG-A0YV-01	382	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 13	TCGA-BG-A0YV	382	0	days	382	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-BG-A0YV-F19335	TCGA-BG-A0YV	TCGA-BG-A0YV-01A	Never Used	Stage IIIA			-24567	62		0	382				NO		Scheduled Follow-up Submission	2011-12-8	FEMALE	155	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-BG-A0YV.D037EFD1-22CB-43FE-BE0A-F2189C5FB202.pdf	A0YV			TUMOR FREE					Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	BG					Endometrial	A	LIVING	54	2010			TCGA-BG-A0YV-01		TCGA-BG-A0YV-01A-21-A163-20	5F0A557D-F6A8-4FFA-93C5-0236054DB568				TCGA-BG-A0YV-01A-11D-A10M-09	TCGA-BG-A0YV-01A-11D-A10M-09	TCGA-BG-A0YV-01A-11D-A10M-09			TCGA-BG-A0YV-01	9b120d0b-5e47-4428-8116-557fcb7edf8a	TCGA-BG-A0YV-01A-11D-A10L-01		TCGA-BG-A0YV-01A-11D-A10L-01	TCGA-BG-A0YV-01	TCGA-BG-A0YV-01	TCGA-BG-A0YV-01A-11D-A10N-05		9b120d0b-5e47-4428-8116-557fcb7edf8a
TCGA-BG-A186-01	MSS	0	TCGA-BG-A186-01	419	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BG-A186	419	0	days	419	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61		0	TCGA-BG-A186-F28644	TCGA-BG-A186	TCGA-BG-A186-01A		Stage IIIA	NO		-22370	104		0	419				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	162	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO			G2					NO	true	No	TCGA-BG-A186.76C588F1-ED43-485D-8FFF-32F4C5D92202.pdf	A186	28	positive	TUMOR FREE		0		2	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open	2009	YES	NO	YES	BG		6		23	Endometrial	A	LIVING	75	2010			TCGA-BG-A186-01		TCGA-BG-A186-01A-21-A164-20	F987438A-987D-4FB1-87B9-4FAA77E7AA3C				TCGA-BG-A186-01A-11D-A12J-09	TCGA-BG-A186-01A-11D-A12J-09	TCGA-BG-A186-01A-11D-A12J-09			TCGA-BG-A186-01	fcf451be-340a-4479-86ed-d6757d680386	TCGA-BG-A186-01A-11D-A12G-01		TCGA-BG-A186-01A-11D-A12G-01	TCGA-BG-A186-01	TCGA-BG-A186-01	TCGA-BG-A186-01A-11D-A12K-05		fcf451be-340a-4479-86ed-d6757d680386
TCGA-BG-A187-01	MSI-L	0	TCGA-BG-A187-01	448	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-BG-A187	448	0	days	448	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65			TCGA-BG-A187-F28645	TCGA-BG-A187	TCGA-BG-A187-01A		Stage IB	NO		-24099	97		0	448				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	360	NO			G2					NO	true	No	TCGA-BG-A187.CB8E915A-CE5D-4181-9303-22BD8CBCB80D.pdf	A187	80	negative	TUMOR FREE		0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		3		4	Endometrial	A	LIVING	61	2010			TCGA-BG-A187-01		TCGA-BG-A187-01A-21-A164-20	F00FE736-702F-4CFE-9019-012CFD2D2BA0				TCGA-BG-A187-01A-11D-A12J-09	TCGA-BG-A187-01A-11D-A12J-09	TCGA-BG-A187-01A-11D-A12J-09			TCGA-BG-A187-01	3486bd36-927d-46c7-8efe-5f2d6c80ac5e	TCGA-BG-A187-01A-11D-A12G-01		TCGA-BG-A187-01A-11D-A12G-01	TCGA-BG-A187-01	TCGA-BG-A187-01	TCGA-BG-A187-01A-11D-A12K-05		3486bd36-927d-46c7-8efe-5f2d6c80ac5e
TCGA-BG-A18A-01	MSS	0	TCGA-BG-A18A-01	426	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-BG-A18A	426	0	days	426	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74		0	TCGA-BG-A18A-F28647	TCGA-BG-A18A	TCGA-BG-A18A-01A	Former User	Stage IA	NO		-27086	146		0	426				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	true	No	TCGA-BG-A18A.099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA.pdf	A18A	50	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		2		11	Endometrial	A	LIVING	84	2010			TCGA-BG-A18A-01		TCGA-BG-A18A-01A-11-A163-20	A76C4656-73EF-4F33-AF5F-0278428FB79A				TCGA-BG-A18A-01A-21D-A12J-09	TCGA-BG-A18A-01A-21D-A12J-09	TCGA-BG-A18A-01A-21D-A12J-09			TCGA-BG-A18A-01	71679725-d65f-47d4-b851-e4467f9d3f62	TCGA-BG-A18A-01A-21D-A12G-01		TCGA-BG-A18A-01A-21D-A12G-01	TCGA-BG-A18A-01	TCGA-BG-A18A-01	TCGA-BG-A18A-01A-21D-A12K-05		71679725-d65f-47d4-b851-e4467f9d3f62
TCGA-BG-A18B-01	MSI-H	0	TCGA-BG-A18B-01	470	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-BG-A18B	470	0	days	470	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-BG-A18B-F28649	TCGA-BG-A18B	TCGA-BG-A18B-01A	Former User	Stage I	NO		-19550	56		0	470				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	480	NO		Peri (6-12 months since last menstrual period)	G2					NO	true	No	TCGA-BG-A18B.E7006FF4-33D9-4369-A4E0-42D124EAE1E0.pdf	A18B			TUMOR FREE		0		1	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	BG		0		5	Endometrial	A	LIVING	116	2010			TCGA-BG-A18B-01		TCGA-BG-A18B-01A-21-A164-20	8A7E6C09-E5B7-4C2E-B645-C88DB29F8318				TCGA-BG-A18B-01A-11D-A12J-09	TCGA-BG-A18B-01A-11D-A12J-09	TCGA-BG-A18B-01A-11D-A12J-09			TCGA-BG-A18B-01	5e981b2d-fef0-44c2-8228-8f5f7e9e3026	TCGA-BG-A18B-01A-11D-A12G-01		TCGA-BG-A18B-01A-11D-A12G-01	TCGA-BG-A18B-01	TCGA-BG-A18B-01	TCGA-BG-A18B-01A-11D-A12K-05		5e981b2d-fef0-44c2-8228-8f5f7e9e3026
TCGA-BG-A18C-01	MSS	0	TCGA-BG-A18C-01	470	0	days	High	C6-UCEC	Cluster 5	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-BG-A18C	470	0	days	470	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72		0	TCGA-BG-A18C-F28650	TCGA-BG-A18C	TCGA-BG-A18C-01A	Never Used	Stage IA	NO		-26602	52		0	470				YES		Scheduled Follow-up Submission	2012-2-22	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	340	NO			G2					NO	true	No	TCGA-BG-A18C.2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2.pdf	A18C	13		TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	BG		5		25	Endometrial	A	LIVING	96	2010			TCGA-BG-A18C-01		TCGA-BG-A18C-01A-21-A164-20	42648EF0-3A6A-4CF2-9A7B-E3AA008D4BEE				TCGA-BG-A18C-01A-11D-A12J-09	TCGA-BG-A18C-01A-11D-A12J-09	TCGA-BG-A18C-01A-11D-A12J-09			TCGA-BG-A18C-01	484a9564-c6dd-4e54-a319-4d826f308d0c	TCGA-BG-A18C-01A-11D-A12G-01		TCGA-BG-A18C-01A-11D-A12G-01	TCGA-BG-A18C-01	TCGA-BG-A18C-01	TCGA-BG-A18C-01A-11D-A12K-05		484a9564-c6dd-4e54-a319-4d826f308d0c
TCGA-BG-A220-01	MSI-H	0	TCGA-BG-A220-01	434	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11				TCGA-BG-A220	434	0	days	434	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69			TCGA-BG-A220-F28651	TCGA-BG-A220	TCGA-BG-A220-01A		Stage IA	NO		-25346	110		0	434				YES		Scheduled Follow-up Submission	2012-2-22	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO			G3					NO	true	Yes	TCGA-BG-A220.59CD459F-FB2B-4B0E-9E16-3E26BDF252E1.pdf	A220			TUMOR FREE				4+	Complete Remission/Response	Never Used		YES					Primary Tumor	01	open	2009	NO	NO	YES	BG		0		0	Endometrial	A	LIVING	127	2010			TCGA-BG-A220-01		TCGA-BG-A220-01A-21-A18R-20	3F856469-13FA-4F9E-957A-172BCD5064AE										f26378d3-9f18-4367-a553-1a6c02e72575	TCGA-BG-A220-01A-11D-A160-01		TCGA-BG-A220-01A-11D-A160-01		TCGA-BG-A220-01	TCGA-BG-A220-01A-11D-A161-05		f26378d3-9f18-4367-a553-1a6c02e72575
TCGA-BG-A221-01	MSI-H	0	TCGA-BG-A221-01	55	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-BG-A221	55	0	days	55	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	84		0	TCGA-BG-A221-F28653	TCGA-BG-A221	TCGA-BG-A221-01A		Stage IB	NO		-30960	99		0	55				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-BG-A221.58D68577-9022-4EF3-82E9-6EE159D41947.pdf	A221			TUMOR FREE		0		4+	Complete Remission/Response	Never Used		NO					Primary Tumor	01	open	2009	NO	NO	YES	BG		3		15	Endometrial	A	LIVING	62	2010			TCGA-BG-A221-01		TCGA-BG-A221-01A-11-A18R-20	8E13B416-DB5F-4D41-8126-0E55123579A2										58957940-d71f-4ad5-98a8-c8f2913801c5	TCGA-BG-A221-01A-21D-A160-01		TCGA-BG-A221-01A-21D-A160-01		TCGA-BG-A221-01	TCGA-BG-A221-01A-21D-A161-05		58957940-d71f-4ad5-98a8-c8f2913801c5
TCGA-BG-A222-01	MSI-H	0	TCGA-BG-A222-01	291	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-BG-A222	291	0	days	291	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	49		0	TCGA-BG-A222-F28654	TCGA-BG-A222	TCGA-BG-A222-01A		Stage IA	NO		-18220	50		0	291				NO		Scheduled Follow-up Submission	2012-2-22	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	630	NO			G3					NO	true	No	TCGA-BG-A222.32837D2C-0D2B-4A47-9E42-1A809CB4A25A.pdf	A222		negative	TUMOR FREE		0		1	Complete Remission/Response	Never Used		YES					Primary Tumor	01	open	2009	YES	NO	YES	BG		7		25	Endometrial	A	LIVING	132	2011			TCGA-BG-A222-01		TCGA-BG-A222-01A-21-A18R-20	0426C930-B68C-4971-A8C8-8449D94146BC									TCGA-BG-A222-01	0e8881cf-4745-4fb5-9842-dface6532da3	TCGA-BG-A222-01A-11D-A160-01		TCGA-BG-A222-01A-11D-A160-01	TCGA-BG-A222-01	TCGA-BG-A222-01	TCGA-BG-A222-01A-11D-A161-05		0e8881cf-4745-4fb5-9842-dface6532da3
TCGA-BG-A2AD-01	MSI-H	0	TCGA-BG-A2AD-01	609	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-BG-A2AD	609	0	days	609	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63		0	TCGA-BG-A2AD-F49552	TCGA-BG-A2AD	TCGA-BG-A2AD-01A		Stage IIIB			-23064	45		0	609							2013-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	770	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-BG-A2AD.E3FBF856-C09F-4F3A-975E-A1D07286A0EB.pdf	A2AD		positive	TUMOR FREE		0	YES		Complete Remission/Response			NO					Primary Tumor	01	Minimally Invasive	2009		NO	YES	BG		8		18	Endometrial	A	LIVING	80	2011			TCGA-BG-A2AD-01		TCGA-BG-A2AD-01A-11-A18R-20	90232DA4-577D-4CA4-9091-7C7BC7B16A08									TCGA-BG-A2AD-01	a6ed9981-f7df-4f36-be2e-da4c96722680	TCGA-BG-A2AD-01A-21D-A16C-01		TCGA-BG-A2AD-01A-21D-A16C-01	TCGA-BG-A2AD-01	TCGA-BG-A2AD-01	TCGA-BG-A2AD-01A-21D-A16G-05		a6ed9981-f7df-4f36-be2e-da4c96722680
TCGA-BG-A2AD-11	MSI-H	0	TCGA-BG-A2AD-11	609	0	days		C6-UCEC								TCGA-BG-A2AD	609	0	days	609	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63		0	TCGA-BG-A2AD-F49552	TCGA-BG-A2AD			Stage IIIB			-23064			0	609							2013-10-3	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A2AD		positive	TUMOR FREE		0	YES		Complete Remission/Response			NO					Solid Tissue Normal	11	Minimally Invasive	2009		NO	YES	BG		8		18	Endometrial		LIVING	80	2011	be03335f-81c9-4cdc-8805-c47c3e7756a1			be03335f-81c9-4cdc-8805-c47c3e7756a1					be03335f-81c9-4cdc-8805-c47c3e7756a1				be03335f-81c9-4cdc-8805-c47c3e7756a1		TCGA-BG-A2AD-11					TCGA-BG-A2AD-11		TCGA-BG-A2AD-11A-11D-A16G-05		
TCGA-BG-A2AE-01	MSS	0	TCGA-BG-A2AE-01	721	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-BG-A2AE	721	0	days	721	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-BG-A2AE-F49553	TCGA-BG-A2AE	TCGA-BG-A2AE-01A		Stage IB			-21069	50		0	721							2013-10-3	FEMALE	179	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	460	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true	No	TCGA-BG-A2AE.BA5BC88E-6A6C-425E-84B4-EC33DB9AC146.pdf	A2AE			TUMOR FREE		1	YES		Complete Remission/Response			YES					Primary Tumor	01	open	2009		NO	YES	BG				8	Endometrial	A	LIVING	135	2011			TCGA-BG-A2AE-01		TCGA-BG-A2AE-01A-21-A18R-20	F0576BE1-156D-4AB2-B139-A4AD29B28209				TCGA-BG-A2AE-01A-11D-A16D-09	TCGA-BG-A2AE-01A-11D-A16D-09	TCGA-BG-A2AE-01A-11D-A16D-09			TCGA-BG-A2AE-01	7a5dd0ca-549d-452a-beb8-ea8a3f5528ec	TCGA-BG-A2AE-01A-11D-A16C-01		TCGA-BG-A2AE-01A-11D-A16C-01	TCGA-BG-A2AE-01	TCGA-BG-A2AE-01	TCGA-BG-A2AE-01A-11D-A16G-05		7a5dd0ca-549d-452a-beb8-ea8a3f5528ec
TCGA-BG-A2AE-11	MSS	0	TCGA-BG-A2AE-11	721	0	days		C6-UCEC							mutation cluster 1	TCGA-BG-A2AE	721	0	days	721	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-BG-A2AE-F49553	TCGA-BG-A2AE	TCGA-BG-A2AE-11A		Stage IB			-21069	50		0	721							2013-10-3	FEMALE	179	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	40	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true	No		A2AE			TUMOR FREE		1	YES		Complete Remission/Response			YES					Solid Tissue Normal	11	open	2009		NO	YES	BG				8	Endometrial	A	LIVING	135	2011																						TCGA-BG-A2AE-11A-11D-A16G-05		
TCGA-BG-A2L7-01	MSI-H	0	TCGA-BG-A2L7-01	612	0	days	Quiet	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-BG-A2L7	612	0	days	612	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68		0	TCGA-BG-A2L7-F49554	TCGA-BG-A2L7	TCGA-BG-A2L7-01A		Stage IA			-25091	141		0	612							2013-10-3	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO	NO		G3					NO	true	No	TCGA-BG-A2L7.6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78.pdf	A2L7			TUMOR FREE		0	YES		Complete Remission/Response			YES				RX	Primary Tumor	01	open	2009		NO	YES	BG		1		15	Endometrial	A	LIVING		2011			TCGA-BG-A2L7-01		TCGA-BG-A2L7-01A-21-A23Z-20	9C365A47-24D5-4301-B47E-FD745ABBE8E7									TCGA-BG-A2L7-01	16ce8070-8c04-4cc7-b00a-c094a524b133	TCGA-BG-A2L7-01A-11D-A18N-01		TCGA-BG-A2L7-01A-11D-A18N-01	TCGA-BG-A2L7-01	TCGA-BG-A2L7-01	TCGA-BG-A2L7-01A-11D-A18O-05		16ce8070-8c04-4cc7-b00a-c094a524b133
TCGA-BG-A2L7-11	MSI-H	0	TCGA-BG-A2L7-11	612	0	days		C6-UCEC								TCGA-BG-A2L7	612	0	days	612	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68		0	TCGA-BG-A2L7-F49554	TCGA-BG-A2L7	TCGA-BG-A2L7-11A		Stage IA			-25091	141		0	612							2013-10-3	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	320	NO	NO		G3					NO	true	No		A2L7			TUMOR FREE		0	YES		Complete Remission/Response			YES				RX	Solid Tissue Normal	11	open	2009		NO	YES	BG		1		15	Endometrial	A	LIVING		2011																						TCGA-BG-A2L7-11A-11D-A18O-05		
TCGA-BG-A3EW-01	MSI-H	0	TCGA-BG-A3EW-01	344	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA c1uster 10			TCGA-BG-A3EW	344	0	days	344	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62		0	TCGA-BG-A3EW-F39618	TCGA-BG-A3EW	TCGA-BG-A3EW-01A		Stage III			-22705	24		0	344							2013-1-28	FEMALE	166	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-BG-A3EW.0463CA05-339C-4AB9-A236-CEAE733AD5F6.pdf	A3EW	12		TUMOR FREE		0	NO		Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BG		2		9	Endometrial	A	LIVING	126	2011	8b8048b4-fe60-45f4-97c5-662c45169334		TCGA-BG-A3EW-01	8b8048b4-fe60-45f4-97c5-662c45169334	TCGA-BG-A3EW-01A-21-A23Z-20	918C09B1-BCFE-4194-A61C-90B4A30DB902			8b8048b4-fe60-45f4-97c5-662c45169334				8b8048b4-fe60-45f4-97c5-662c45169334		TCGA-BG-A3EW-01		TCGA-BG-A3EW-01A-11D-A227-01		TCGA-BG-A3EW-01A-11D-A227-01	TCGA-BG-A3EW-01	TCGA-BG-A3EW-01	TCGA-BG-A3EW-01A-11D-A22B-05		
TCGA-BG-A3EW-11	MSI-H	0	TCGA-BG-A3EW-11	344	0	days										TCGA-BG-A3EW	344	0	days	344	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62		0	TCGA-BG-A3EW-F39618	TCGA-BG-A3EW			Stage III			-22705			0	344							2013-1-28	FEMALE	166	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A3EW	12		TUMOR FREE		0	NO		Complete Remission/Response			YES				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BG		2		9	Endometrial		LIVING	126	2011	a75c4597-041a-44ad-88e1-0466278f621c			a75c4597-041a-44ad-88e1-0466278f621c					a75c4597-041a-44ad-88e1-0466278f621c				a75c4597-041a-44ad-88e1-0466278f621c		TCGA-BG-A3EW-11					TCGA-BG-A3EW-11		TCGA-BG-A3EW-11A-22D-A22B-05		
TCGA-BG-A3PP-01	MSS	0	TCGA-BG-A3PP-01	681	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 5			TCGA-BG-A3PP	665	1	days	681	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	82			TCGA-BG-A3PP-F57825	TCGA-BG-A3PP	TCGA-BG-A3PP-01A		Stage II			-30227	143		0	681			665				2014-3-27	FEMALE		Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	320	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vagina apex		YES	true	No	TCGA-BG-A3PP.728D12CF-B846-49B7-8B16-463460CAD5C0.pdf	A3PP		positive	WITH TUMOR		0	YES		Progressive Disease			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BG				3	Endometrial	A	LIVING		2011	5ece050b-b22d-44b9-b920-257a351b5602		TCGA-BG-A3PP-01	5ece050b-b22d-44b9-b920-257a351b5602	TCGA-BG-A3PP-01A-21-A23Z-20	1EFCFA38-5D77-420A-A635-9657E138099C			5ece050b-b22d-44b9-b920-257a351b5602				5ece050b-b22d-44b9-b920-257a351b5602		TCGA-BG-A3PP-01		TCGA-BG-A3PP-01A-11D-A227-01		TCGA-BG-A3PP-01A-11D-A227-01	TCGA-BG-A3PP-01	TCGA-BG-A3PP-01	TCGA-BG-A3PP-01A-11D-A22B-05		
TCGA-BG-A3PP-11	MSS	0	TCGA-BG-A3PP-11	681	0	days										TCGA-BG-A3PP	665	1	days	681	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	82			TCGA-BG-A3PP-F57825	TCGA-BG-A3PP	TCGA-BG-A3PP-11A		Stage II			-30227	143		0	681			665				2014-3-27	FEMALE		Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vagina apex		YES	true	No		A3PP		positive	WITH TUMOR		0	YES		Progressive Disease			YES				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BG				3	Endometrial	A	LIVING		2011	02446b95-1e3f-474b-8123-f49117f58893			02446b95-1e3f-474b-8123-f49117f58893					02446b95-1e3f-474b-8123-f49117f58893				02446b95-1e3f-474b-8123-f49117f58893		TCGA-BG-A3PP-11					TCGA-BG-A3PP-11		TCGA-BG-A3PP-11A-11D-A22B-05		
TCGA-BK-A0C9-01	MSI-H	0	TCGA-BK-A0C9-01	1092	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 7	TCGA-BK-A0C9	1092	0	days	1092	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-BK-A0C9-F41805	TCGA-BK-A0C9	TCGA-BK-A0C9-01A	Never Used	Stage IB	NO		-20876	192		0	1092				NO			2013-3-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	490	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BK-A0C9.3E14F5F3-2C40-403F-A499-BE64857E8559.pdf	A0C9	40	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	YES	NO	BK	0	4	0	18	Endometrial	A	LIVING	127	2009		TCGA-BK-A0C9-01	TCGA-BK-A0C9-01		TCGA-BK-A0C9-01A-21-A162-20	FC84BD3F-BCE6-41AF-98D4-A4586B56F810	TCGA-BK-A0C9-01	TCGA-BK-A0C9-01		TCGA-BK-A0C9-01A-11W-A027-09	TCGA-BK-A0C9-01A-11W-A027-09	TCGA-BK-A0C9-01A-11W-A027-09		TCGA-BK-A0C9-01		71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7	TCGA-BK-A0C9-01A-11D-A00X-01	TCGA-BK-A0C9-01A-11R-A00V-07	TCGA-BK-A0C9-01A-11D-A00X-01		TCGA-BK-A0C9-01		TCGA-BK-A0C9-01A-11D-A00U-05	71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7
TCGA-BK-A0CA-01		0	TCGA-BK-A0CA-01	1064	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-BK-A0CA	1064	0	days	1064	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61		29	TCGA-BK-A0CA-F40261	TCGA-BK-A0CA	TCGA-BK-A0CA-01A		Stage IIIC	NO		-22378	86		0	1064				NO	FPPP		2013-2-14	FEMALE	163	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BK-A0CA.883D4832-75FB-495C-B93F-904FCA1AB18C.pdf	A0CA		negative	TUMOR FREE		9	YES	1	Complete Remission/Response	Never Used	TCGA	NO				RX	Primary Tumor	01	Minimally Invasive		YES	YES	NO	BK	29	32	9	14	Endometrial	A	LIVING		2010			TCGA-BK-A0CA-01		TCGA-BK-A0CA-01A-11-A162-20	30A62556-2260-4232-BA09-E3EFCA44EF7E				TCGA-BK-A0CA-01A-21D-A122-09	TCGA-BK-A0CA-01A-21D-A122-09	TCGA-BK-A0CA-01A-21D-A122-09			TCGA-BK-A0CA-01	20f433c2-0909-4b42-9429-215774b19604	TCGA-BK-A0CA-01A-21D-A275-01		TCGA-BK-A0CA-01A-21D-A275-01	TCGA-BK-A0CA-01	TCGA-BK-A0CA-01	TCGA-BK-A0CA-01A-21D-A27B-05,TCGA-BK-A0CA-01B-02D-A27B-05,TCGA-BK-A0CA-01A-21D-A123-05		20f433c2-0909-4b42-9429-215774b19604
TCGA-BK-A0CB-01	MSS	0	TCGA-BK-A0CB-01	1092	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11			mutation cluster 4	TCGA-BK-A0CB	1092	0	days	1092	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	2	TCGA-BK-A0CB-F39909	TCGA-BK-A0CB	TCGA-BK-A0CB-01A		Stage IIIC	NO		-21930	64		0	1092				YES			2013-2-13	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Incisional Biopsy	450	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-BK-A0CB.37923E3D-3CCB-41DB-8F30-C19FDE7407CB.pdf	A0CB	76	negative	TUMOR FREE	0	0	YES	0	Complete Remission/Response			NO				R0	Primary Tumor	01	open		YES	YES	NO	BK	2	8	0	13	Endometrial	A	LIVING	111	2010			TCGA-BK-A0CB-01		TCGA-BK-A0CB-01A-21-A162-20	248C77AA-3235-42DD-AE94-A1415F70AB72				TCGA-BK-A0CB-01A-32D-A10B-09	TCGA-BK-A0CB-01A-32D-A10B-09	TCGA-BK-A0CB-01A-32D-A10B-09				6b8a0d03-6a82-49ed-b3ee-66937dc06201	TCGA-BK-A0CB-01A-32D-A102-01		TCGA-BK-A0CB-01A-32D-A102-01		TCGA-BK-A0CB-01		TCGA-BK-A0CB-01A-32D-A10Q-05	6b8a0d03-6a82-49ed-b3ee-66937dc06201
TCGA-BK-A0CB-11	MSS	0	TCGA-BK-A0CB-11	1092	0	days		C6-UCEC							mutation cluster 4	TCGA-BK-A0CB	1092	0	days	1092	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	2	TCGA-BK-A0CB-F39909	TCGA-BK-A0CB	TCGA-BK-A0CB-11A		Stage IIIC	NO		-21930	64		0	1092				YES			2013-2-13	FEMALE	154	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Incisional Biopsy	420	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No		A0CB	76	negative	TUMOR FREE	0	0	YES	0	Complete Remission/Response			NO				R0	Solid Tissue Normal	11	open		YES	YES	NO	BK	2	8	0	13	Endometrial	A	LIVING	111	2010		TCGA-BK-A0CB-11						TCGA-BK-A0CB-11								7865a23a-f7a6-43b0-b395-16c8306cea2f							TCGA-BK-A0CB-11A-33D-A10Q-05	7865a23a-f7a6-43b0-b395-16c8306cea2f
TCGA-BK-A0CC-01		0	TCGA-BK-A0CC-01	1067	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	OV-like c4	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BK-A0CC	1010	1	days	1067	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	69	0	0	TCGA-BK-A0CC-F39535	TCGA-BK-A0CC	TCGA-BK-A0CC-01A		Stage IIIC	NO		-25479	52		0	1067			1010	YES	FPPP		2013-1-24	FEMALE	152	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Incisional Biopsy	310	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Right Pelvic Mass	NO	YES	false	No	TCGA-BK-A0CC.6A2AAC78-98B9-44D4-AF8D-9A132579CC2D.pdf	A0CC	54	negative	WITH TUMOR	0	2	YES	3	Complete Remission/Response	Never Used	TCGA	YES	Other Method, Specify Below	CT guided Fine Needle Aspiration		RX	Primary Tumor	01	open		YES	YES	NO	BK	0	5	2	12	Endometrial	A	LIVING	72	2010		TCGA-BK-A0CC-01	TCGA-BK-A0CC-01		TCGA-BK-A0CC-01A-11-A162-20	D106BF3B-A21D-465D-873E-DD7478086913	TCGA-BK-A0CC-01	TCGA-BK-A0CC-01		TCGA-BK-A0CC-01A-21W-A027-09	TCGA-BK-A0CC-01A-21W-A027-09	TCGA-BK-A0CC-01A-21W-A027-09		TCGA-BK-A0CC-01		ac44efb2-7079-49a7-8bc6-285ae009ad89	TCGA-BK-A0CC-01A-21D-A275-01	TCGA-BK-A0CC-01A-21R-A00V-07	TCGA-BK-A0CC-01A-21D-A275-01		TCGA-BK-A0CC-01	TCGA-BK-A0CC-01A-21D-A27B-05,TCGA-BK-A0CC-01B-04D-A27B-05	TCGA-BK-A0CC-01A-21D-A00U-05	ac44efb2-7079-49a7-8bc6-285ae009ad89
TCGA-BK-A139-01		1	TCGA-BK-A139-01	943	1	days	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 3	TCGA-BK-A139	684	1	days	943	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	74	0	0	TCGA-BK-A139-F39375	TCGA-BK-A139	TCGA-BK-A139-01A		Stage IB	NO		-27077	175	943	0	309		810	684	NO	FPPP	Scheduled Follow-up Submission	2013-1-21	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	770	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Paravaginal mass involving the bladder and rectal walls	YES	YES	false	No	TCGA-BK-A139.5F8C376B-31F8-4566-8EBF-21E7F4E6499D.pdf	A139			WITH TUMOR	0	0	NO	2	Complete Remission/Response	Never Used	TCGA	NO	Other Method, Specify Below	Total Pelvis Exenteration, mobilation of the splenic fexure, and sigmoid colostomy, ileal conduit diversion.		R0	Primary Tumor	01	Minimally Invasive		NO	YES	NO	BK	0	9	0	24	Endometrial	A	DECEASED	59	2010			TCGA-BK-A139-01		TCGA-BK-A139-01A-21-A163-20	1260487B-9CF7-43E6-8B3A-AD1B7CC40DEC					TCGA-BK-A139-01A-11D-A122-09	TCGA-BK-A139-01A-11D-A122-09			TCGA-BK-A139-01	4b398b99-8916-440b-9ed5-9ed67db19b9b	TCGA-BK-A139-01A-11D-A275-01		TCGA-BK-A139-01A-11D-A275-01	TCGA-BK-A139-01	TCGA-BK-A139-01	TCGA-BK-A139-01C-08D-A27B-05,TCGA-BK-A139-01A-11D-A123-05,TCGA-BK-A139-01A-11D-A27B-05		4b398b99-8916-440b-9ed5-9ed67db19b9b
TCGA-BK-A139-02		1	TCGA-BK-A139-02	943	1	days		C6-UCEC							mutation cluster 3	TCGA-BK-A139	684	1	days	943	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	74	0	0	TCGA-BK-A139-F39375	TCGA-BK-A139	TCGA-BK-A139-02A		Stage IB	NO		-27077	874	943	0	309		810	684	NO	FPPP	Scheduled Follow-up Submission	2013-1-21	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	430	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Paravaginal mass involving the bladder and rectal walls	YES	YES	false	No	TCGA-BK-A139.FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F.pdf	A139			WITH TUMOR	0	0	NO	2	Complete Remission/Response	Never Used	TCGA	NO	Other Method, Specify Below	Total Pelvis Exenteration, mobilation of the splenic fexure, and sigmoid colostomy, ileal conduit diversion.		R0	Recurrent Tumor	02	Minimally Invasive		NO	YES	NO	BK	0	9	0	24	Endometrial	A	DECEASED	59	2010	923217e0-602c-4cf7-b17a-37269d9371c4			923217e0-602c-4cf7-b17a-37269d9371c4					923217e0-602c-4cf7-b17a-37269d9371c4				923217e0-602c-4cf7-b17a-37269d9371c4		TCGA-BK-A139-02					TCGA-BK-A139-02		TCGA-BK-A139-02A-11D-A27Y-05		
TCGA-BK-A13B-01	MSI-H	0	TCGA-BK-A13B-01	966	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 7			TCGA-BK-A13B	760	1	days	966	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	58			TCGA-BK-A13B-F40746	TCGA-BK-A13B	TCGA-BK-A13B-01A		Stage IB	NO		-21493	140		0	966			760	YES		Scheduled Follow-up Submission	2013-3-14	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	830	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vaginal	NO	YES	false	No	TCGA-BK-A13B.F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E.pdf	A13B		negative	WITH TUMOR			NO	1	Complete Remission/Response	Never Used		YES	Other Method, Specify Below	Vaginal Biopsy			Primary Tumor	01		2009	NO	YES	NO	BK	0	10	0	15	Endometrial	A	LIVING	131	2010	ed2e8014-4042-45fe-ae9d-78606344955b		TCGA-BK-A13B-01	ed2e8014-4042-45fe-ae9d-78606344955b	TCGA-BK-A13B-01A-41-A23Z-20	B28F46F3-27E5-4A3D-9757-DB40F7859E76			ed2e8014-4042-45fe-ae9d-78606344955b				ed2e8014-4042-45fe-ae9d-78606344955b		TCGA-BK-A13B-01		TCGA-BK-A13B-01A-51D-A227-01		TCGA-BK-A13B-01A-51D-A227-01	TCGA-BK-A13B-01	TCGA-BK-A13B-01	TCGA-BK-A13B-01A-51D-A22B-05		
TCGA-BK-A13C-01	MSS	0	TCGA-BK-A13C-01	760	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 10	TCGA-BK-A13C	760	0	days	760	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47	0	0	TCGA-BK-A13C-F40813	TCGA-BK-A13C	TCGA-BK-A13C-01A		Stage IB	NO		-17317	146		0	760				NO		Scheduled Follow-up Submission	2013-3-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	310	NO	NO	Peri (6-12 months since last menstrual period)	G2					NO	false	No	TCGA-BK-A13C.2043D579-6785-4775-8A28-CDE3F1400BA2.pdf	A13C	17	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	YES	NO	BK	0	5	0	25	Endometrial	A	LIVING	93	2010			TCGA-BK-A13C-01		TCGA-BK-A13C-01A-21-A163-20	C833D378-9B97-4808-806E-A9DEE1298AE3					TCGA-BK-A13C-01A-11D-A122-09	TCGA-BK-A13C-01A-11D-A122-09			TCGA-BK-A13C-01	a7dc4fdb-a62d-4d84-b351-16d84ab202e3	TCGA-BK-A13C-01A-11D-A120-01		TCGA-BK-A13C-01A-11D-A120-01	TCGA-BK-A13C-01	TCGA-BK-A13C-01	TCGA-BK-A13C-01A-11D-A123-05		a7dc4fdb-a62d-4d84-b351-16d84ab202e3
TCGA-BK-A13C-11	MSS	0	TCGA-BK-A13C-11	760	0	days		C6-UCEC							mutation c1uster 10	TCGA-BK-A13C	760	0	days	760	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	47	0	0	TCGA-BK-A13C-F40813	TCGA-BK-A13C	TCGA-BK-A13C-11A		Stage IB	NO		-17317	146		0	760				NO		Scheduled Follow-up Submission	2013-3-1	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO	NO	Peri (6-12 months since last menstrual period)	G2					NO	false	No		A13C	17	negative	TUMOR FREE	0	0	NO	0	Complete Remission/Response	Never Used		NO				R0	Solid Tissue Normal	11	Minimally Invasive		NO	YES	NO	BK	0	5	0	25	Endometrial	A	LIVING	93	2010																a6ba27cf-7e06-4a44-a948-8575593272cb						TCGA-BK-A13C-11A-11D-A123-05		a6ba27cf-7e06-4a44-a948-8575593272cb
TCGA-BK-A26L-01		0	TCGA-BK-A26L-01	734	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-BK-A26L	734	0	days	734	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71	0	0	TCGA-BK-A26L-F40279	TCGA-BK-A26L	TCGA-BK-A26L-01A	Former User	Stage IIIC1	NO		-26002	131		0	734				NO	FPPP	Scheduled Follow-up Submission	2013-2-15	FEMALE	152	Serous endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	320	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BK-A26L.979388A8-CC61-4C03-BADC-BEF9EC50C40A.pdf	A26L	80	negative	TUMOR FREE	0	0	YES	3	Complete Remission/Response	Never Used	TCGA	YES				RX	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	BK	0	3	1	10	Endometrial	A	LIVING	75	2010			TCGA-BK-A26L-01		TCGA-BK-A26L-01A-21-A18R-20	E78FD774-2F02-41DA-BE47-D049CACC8560									TCGA-BK-A26L-01	80b16496-74bd-4fe7-967c-31058b2c022b	TCGA-BK-A26L-01A-11D-A275-01		TCGA-BK-A26L-01A-11D-A275-01	TCGA-BK-A26L-01	TCGA-BK-A26L-01	TCGA-BK-A26L-01A-11D-A16G-05,TCGA-BK-A26L-01C-04D-A27B-05,TCGA-BK-A26L-01A-11D-A27B-05		80b16496-74bd-4fe7-967c-31058b2c022b
TCGA-BK-A4ZD-01	MSS	0	TCGA-BK-A4ZD-01	506	0	days										TCGA-BK-A4ZD	506	0	days	506	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	42		0	TCGA-BK-A4ZD-F52698	TCGA-BK-A4ZD	TCGA-BK-A4ZD-01A		Stage IA	NO		-15536	92		0	506				YES			2013-12-5	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	No	TCGA-BK-A4ZD.388C7674-9CA2-446C-A67D-9639A28ADEB4.pdf	A4ZD	25	negative	TUMOR FREE		0	NO	3	Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BK	0	2	0	14	Endometrial	A	LIVING	142	2012	31bd06c7-98c1-4d2e-81ff-4e210e7bba75		TCGA-BK-A4ZD-01	31bd06c7-98c1-4d2e-81ff-4e210e7bba75		BD615DAC-024C-47F4-A6AE-99344CA93774			31bd06c7-98c1-4d2e-81ff-4e210e7bba75				31bd06c7-98c1-4d2e-81ff-4e210e7bba75		TCGA-BK-A4ZD-01		TCGA-BK-A4ZD-01A-11D-A27O-01		TCGA-BK-A4ZD-01A-11D-A27O-01	TCGA-BK-A4ZD-01	TCGA-BK-A4ZD-01	TCGA-BK-A4ZD-01A-11D-A27Y-05		
TCGA-BK-A4ZD-11	MSS	0	TCGA-BK-A4ZD-11	506	0	days										TCGA-BK-A4ZD	506	0	days	506	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	42		0	TCGA-BK-A4ZD-F52698	TCGA-BK-A4ZD			Stage IA	NO		-15536			0	506				YES			2013-12-5	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO		No		A4ZD	25	negative	TUMOR FREE		0	NO	3	Complete Remission/Response			NO				R0	Solid Tissue Normal	11	Minimally Invasive	2009		YES	NO	BK	0	2	0	14	Endometrial		LIVING	142	2012	babe74ee-b0dc-41c3-9968-2faac94addf2			babe74ee-b0dc-41c3-9968-2faac94addf2					babe74ee-b0dc-41c3-9968-2faac94addf2				babe74ee-b0dc-41c3-9968-2faac94addf2		TCGA-BK-A4ZD-11					TCGA-BK-A4ZD-11		TCGA-BK-A4ZD-11A-12D-A27Y-05		
TCGA-BK-A56F-01	MSS	0	TCGA-BK-A56F-01	401	0	days										TCGA-BK-A56F	401	0	days	401	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75			TCGA-BK-A56F-F49745	TCGA-BK-A56F	TCGA-BK-A56F-01A		Stage IB	NO		-27523	93		0	401				YES			2013-10-10	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	360	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BK-A56F.2778F3EE-0211-4B51-8FBE-050FC7A4D0FF.pdf	A56F	60	negative	TUMOR FREE			NO	4+	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	BK	0	3	0	10	Endometrial	A	LIVING	84	2012	5d83ceb3-a3f0-419e-945a-a5cf49d439e9		TCGA-BK-A56F-01	5d83ceb3-a3f0-419e-945a-a5cf49d439e9					5d83ceb3-a3f0-419e-945a-a5cf49d439e9				5d83ceb3-a3f0-419e-945a-a5cf49d439e9		TCGA-BK-A56F-01		TCGA-BK-A56F-01A-32D-A27O-01		TCGA-BK-A56F-01A-32D-A27O-01	TCGA-BK-A56F-01	TCGA-BK-A56F-01	TCGA-BK-A56F-01A-32D-A27Y-05		
TCGA-BK-A6W3-01	MSS	0	TCGA-BK-A6W3-01	305	0	days										TCGA-BK-A6W3	305	0	days	305	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	34			TCGA-BK-A6W3-F57503	TCGA-BK-A6W3	TCGA-BK-A6W3-01A		Stage II	NO		-12590	94		0	305				NO			2014-3-12	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	No	TCGA-BK-A6W3.15A94B35-48FD-4F94-94E4-25F8084F8B91.pdf	A6W3		negative	TUMOR FREE			NO	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01		2009		YES	NO	BK		0		0	Endometrial	A	LIVING	89	2013	abec519f-1747-400d-944d-7e53d12d6dea		TCGA-BK-A6W3-01	abec519f-1747-400d-944d-7e53d12d6dea		42DDB0FE-9C22-4E46-AF94-D56C01B6C949			abec519f-1747-400d-944d-7e53d12d6dea				abec519f-1747-400d-944d-7e53d12d6dea		TCGA-BK-A6W3-01		TCGA-BK-A6W3-01A-12D-A34P-01		TCGA-BK-A6W3-01A-12D-A34P-01	TCGA-BK-A6W3-01	TCGA-BK-A6W3-01	TCGA-BK-A6W3-01A-12D-A34S-05		
TCGA-BK-A6W4-01	MSS	0	TCGA-BK-A6W4-01	300	0	days										TCGA-BK-A6W4	300	0	days	300	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62			TCGA-BK-A6W4-F57489	TCGA-BK-A6W4	TCGA-BK-A6W4-01A		Stage IA	NO		-22766	118		0	300				YES			2014-3-12	FEMALE	157	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-BK-A6W4.5F25185F-4F80-4137-A07C-230FB3ACE3AE.pdf	A6W4	32		TUMOR FREE			NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009		YES	NO	BK		0		0	Endometrial	A	LIVING	107	2013	1073a603-5546-48b8-b6aa-9a16f909547b		TCGA-BK-A6W4-01	1073a603-5546-48b8-b6aa-9a16f909547b					1073a603-5546-48b8-b6aa-9a16f909547b				1073a603-5546-48b8-b6aa-9a16f909547b		TCGA-BK-A6W4-01		TCGA-BK-A6W4-01A-12D-A34P-01		TCGA-BK-A6W4-01A-12D-A34P-01	TCGA-BK-A6W4-01	TCGA-BK-A6W4-01	TCGA-BK-A6W4-01A-12D-A34S-05		
TCGA-BS-A0T9-01	MSS	1	TCGA-BS-A0T9-01	1428	1	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-BS-A0T9			days	1428	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	YES	Progressive Disease	39	0	0	TCGA-BS-A0T9-F9188	TCGA-BS-A0T9	TCGA-BS-A0T9-01A	Never Used	Stage IVB	NO	922	-14253	2009	1428	0				634	NO			2010-11-19	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	600	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	No	TCGA-BS-A0T9.C9151621-D012-48F9-B7E1-F540567E791C.pdf	A0T9	67	positive	WITH TUMOR	0	0		0	Complete Remission/Response	Never Used		NO	Surgical Resection		R2	R2	Primary Tumor	01	open	1988	YES	NO	YES	BS	1	2	2	2	Endometrial	A	DECEASED	109	2005			TCGA-BS-A0T9-01		TCGA-BS-A0T9-01A-21-A163-20	BA865E56-EF20-4543-AE3B-465967C47508				TCGA-BS-A0T9-01A-11D-A12J-09	TCGA-BS-A0T9-01A-11D-A12J-09	TCGA-BS-A0T9-01A-11D-A12J-09			TCGA-BS-A0T9-01	8947d611-8c3f-4096-9479-063660ee8607	TCGA-BS-A0T9-01A-11D-A12G-01		TCGA-BS-A0T9-01A-11D-A12G-01	TCGA-BS-A0T9-01	TCGA-BS-A0T9-01	TCGA-BS-A0T9-01A-11D-A12K-05		8947d611-8c3f-4096-9479-063660ee8607
TCGA-BS-A0TA-01	MSI-H	1	TCGA-BS-A0TA-01	740	1	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation c1uster 10	TCGA-BS-A0TA	581	1	days	740	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	NO	Progressive Disease	58	0	0	TCGA-BS-A0TA-F68985	TCGA-BS-A0TA	TCGA-BS-A0TA-01A	Never Used	Stage IVB	NO		-21505	1788	740	0	714			581	YES			2014-12-24	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Fine needle aspiration biopsy	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	Right Adrenal Gland	NO	YES	false	No	TCGA-BS-A0TA.5F009A9A-549F-4EEB-BB6D-C67353C7A292.pdf	A0TA	88	negative	WITH TUMOR	0	0	YES	0	Stable Disease	Never Used		YES				RX	Primary Tumor	01	open	1988	YES	NO	YES	BS	1	1	2	14	Endometrial	A	DECEASED	90	2005		TCGA-BS-A0TA-01	TCGA-BS-A0TA-01		TCGA-BS-A0TA-01A-21-A163-20	9553C69B-1FB7-4D93-9B62-19E9A7AE9C62		TCGA-BS-A0TA-01		TCGA-BS-A0TA-01A-11D-A10B-09	TCGA-BS-A0TA-01A-11D-A10B-09	TCGA-BS-A0TA-01A-11D-A10B-09				c1621135-fa9b-4043-8168-356402d45f01	TCGA-BS-A0TA-01A-11D-A102-01		TCGA-BS-A0TA-01A-11D-A102-01		TCGA-BS-A0TA-01		TCGA-BS-A0TA-01A-11D-A10Q-05	c1621135-fa9b-4043-8168-356402d45f01
TCGA-BS-A0TC-01	MSS	0	TCGA-BS-A0TC-01	2602	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-BS-A0TC			days	2602	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					69	0	0	TCGA-BS-A0TC-F4391	TCGA-BS-A0TC	TCGA-BS-A0TC-01A	Never Used	Stage IB	NO		-25560	2227		0	2602				YES			2010-11-19	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.3	8380/3	C54.3	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	No	TCGA-BS-A0TC.8AA64402-A062-410D-85B8-24DAD320916D.pdf	A0TC	9	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	03	0	20	Endometrial	A	LIVING	68	2004		TCGA-BS-A0TC-01	TCGA-BS-A0TC-01		TCGA-BS-A0TC-01A-21-A163-20	5F9C0254-8925-4A04-A019-C001594FF615		TCGA-BS-A0TC-01			TCGA-BS-A0TC-01A-11D-A10B-09	TCGA-BS-A0TC-01A-11D-A10B-09				0b2aa3d5-f8cd-4047-91cf-295e6b4c8891	TCGA-BS-A0TC-01A-11D-A102-01		TCGA-BS-A0TC-01A-11D-A102-01		TCGA-BS-A0TC-01		TCGA-BS-A0TC-01A-11D-A10Q-05	0b2aa3d5-f8cd-4047-91cf-295e6b4c8891
TCGA-BS-A0TD-01	MSS	0	TCGA-BS-A0TD-01	2379	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-BS-A0TD			days	2379	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					65			TCGA-BS-A0TD-F4393	TCGA-BS-A0TD	TCGA-BS-A0TD-01A	Former User	Stage IB	NO		-23950	2004		0	2379				YES			2010-11-19	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.9	YES		Tumor resection	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1						false	No	TCGA-BS-A0TD.51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0.pdf	A0TD	3	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0	0	13	Endometrial	A	LIVING	85	2005		TCGA-BS-A0TD-01	TCGA-BS-A0TD-01		TCGA-BS-A0TD-01A-21-A163-20	930AAB77-0151-4616-8E43-674B780895E3		TCGA-BS-A0TD-01		TCGA-BS-A0TD-01A-11D-A10B-09	TCGA-BS-A0TD-01A-11D-A10B-09	TCGA-BS-A0TD-01A-11D-A10B-09				ca81a393-ec7d-4538-a64a-417ed188a320	TCGA-BS-A0TD-01A-11D-A102-01		TCGA-BS-A0TD-01A-11D-A102-01		TCGA-BS-A0TD-01		TCGA-BS-A0TD-01A-11D-A10Q-05	ca81a393-ec7d-4538-a64a-417ed188a320
TCGA-BS-A0TE-01	MSI-H	1	TCGA-BS-A0TE-01	146	1	days	High	C1-LUAD-enriched	Cluster 5	cluster 3		COADREAD-like c15	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BS-A0TE			days	146	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Progressive Disease	35			TCGA-BS-A0TE-F4407	TCGA-BS-A0TE	TCGA-BS-A0TE-01A	Former User	Stage IVB	NO		-12983	1835	146	0				58	NO			2010-11-19	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.9	8380/3	C54.9	YES	biopsy of cervical tissue	Other method, specify:	50	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	No	TCGA-BS-A0TE.8FD57BC9-19A1-4427-B68F-3E58639FEA40.pdf	A0TE	100	positive	WITH TUMOR	4	0		1	Progressive Disease	Never Used		NO				R2	Primary Tumor	01	open	1988	YES	NO	YES	BS		0	0	6	Endometrial	A	DECEASED	91	2005		TCGA-BS-A0TE-01	TCGA-BS-A0TE-01					TCGA-BS-A0TE-01		TCGA-BS-A0TE-01A-11D-A10B-09	TCGA-BS-A0TE-01A-11D-A10B-09	TCGA-BS-A0TE-01A-11D-A10B-09				8edc23c4-43f8-4dd3-8c40-257297393492	TCGA-BS-A0TE-01A-11D-A102-01		TCGA-BS-A0TE-01A-11D-A102-01		TCGA-BS-A0TE-01		TCGA-BS-A0TE-01A-11D-A10Q-05	8edc23c4-43f8-4dd3-8c40-257297393492
TCGA-BS-A0TG-01	MSS	0	TCGA-BS-A0TG-01	2371	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 1	TCGA-BS-A0TG			days	2371	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					60	0	0	TCGA-BS-A0TG-F4395	TCGA-BS-A0TG	TCGA-BS-A0TG-01A	Former User	Stage IIIA	NO		-22043	1996		0	2371				NO			2010-11-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	No	TCGA-BS-A0TG.7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8.pdf	A0TG	40	positive	WITH TUMOR	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	07	Endometrial	A	LIVING	64	2005		TCGA-BS-A0TG-01	TCGA-BS-A0TG-01		TCGA-BS-A0TG-01A-21-A163-20	70DE1BC1-F8A6-49A4-B2B2-22905D8C2A48		TCGA-BS-A0TG-01		TCGA-BS-A0TG-01A-32D-A10B-09	TCGA-BS-A0TG-01A-32D-A10B-09	TCGA-BS-A0TG-01A-32D-A10B-09				5fcefe73-6ed0-42f2-beda-3afc67aba867	TCGA-BS-A0TG-01A-32D-A102-01		TCGA-BS-A0TG-01A-32D-A102-01		TCGA-BS-A0TG-01		TCGA-BS-A0TG-01A-32D-A10Q-05	5fcefe73-6ed0-42f2-beda-3afc67aba867
TCGA-BS-A0TI-01	MSS	0	TCGA-BS-A0TI-01	1882	0	days	High	C6-UCEC	UCEC Serous c4	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 5	TCGA-BS-A0TI			days	1882	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					64	0	0	TCGA-BS-A0TI-F4406	TCGA-BS-A0TI	TCGA-BS-A0TI-01A	Former User	Stage IC	NO		-23705	1507		0	1882				NO			2010-11-19	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-BS-A0TI.60212550-2757-4AB0-B778-723AE046F6BE.pdf	A0TI	92	negative	TUMOR FREE	0	0		0	Complete Remission/Response			NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	14	Endometrial	A	LIVING	59	2006		TCGA-BS-A0TI-01	TCGA-BS-A0TI-01		TCGA-BS-A0TI-01A-21-A163-20	03D002A0-05DE-4B9B-99B9-0DD455E3BAD7		TCGA-BS-A0TI-01		TCGA-BS-A0TI-01A-11D-A10B-09	TCGA-BS-A0TI-01A-11D-A10B-09	TCGA-BS-A0TI-01A-11D-A10B-09				4fefb750-f793-4c1f-92cc-bd8fd9998cc6	TCGA-BS-A0TI-01A-11D-A102-01		TCGA-BS-A0TI-01A-11D-A102-01		TCGA-BS-A0TI-01		TCGA-BS-A0TI-01A-11D-A10Q-05	4fefb750-f793-4c1f-92cc-bd8fd9998cc6
TCGA-BS-A0TJ-01	MSI-H	0	TCGA-BS-A0TJ-01	2068	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 1	TCGA-BS-A0TJ			days	2068	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					59	0	0	TCGA-BS-A0TJ-F4441	TCGA-BS-A0TJ	TCGA-BS-A0TJ-01A	Former User	Stage IC	NO		-21663	1431		0	2068				NO			2010-11-19	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-BS-A0TJ.17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0.pdf	A0TJ	58	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	9	0	34	Endometrial	A	LIVING	88	2006		TCGA-BS-A0TJ-01	TCGA-BS-A0TJ-01		TCGA-BS-A0TJ-01A-21-A163-20	6DA84EAF-5E8E-48C1-B7D2-BC98EB76E31A		TCGA-BS-A0TJ-01		TCGA-BS-A0TJ-01A-11D-A10B-09	TCGA-BS-A0TJ-01A-11D-A10B-09	TCGA-BS-A0TJ-01A-11D-A10B-09				3ecbfdb2-c75a-47ce-9db6-ae7d36eab559	TCGA-BS-A0TJ-01A-11D-A102-01		TCGA-BS-A0TJ-01A-11D-A102-01		TCGA-BS-A0TJ-01		TCGA-BS-A0TJ-01A-11D-A10Q-05	3ecbfdb2-c75a-47ce-9db6-ae7d36eab559
TCGA-BS-A0U5-01	MSS	0	TCGA-BS-A0U5-01	2935	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-BS-A0U5	2935	0	days	2935	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					76	0	0	TCGA-BS-A0U5-F16697	TCGA-BS-A0U5	TCGA-BS-A0U5-01A		Stage IA	NO		-27945	2525		0	2935				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BS-A0U5.8024498D-449C-45C6-B57D-846DDBA3FF30.pdf	A0U5	0		TUMOR FREE	0	0			Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	10	Endometrial	A	LIVING	59	2003		TCGA-BS-A0U5-01	TCGA-BS-A0U5-01					TCGA-BS-A0U5-01		TCGA-BS-A0U5-01A-11D-A10G-09	TCGA-BS-A0U5-01A-11D-A10G-09	TCGA-BS-A0U5-01A-11D-A10G-09				2bb7d230-0982-4ce5-908a-a04064cb7665	TCGA-BS-A0U5-01A-11D-A107-01		TCGA-BS-A0U5-01A-11D-A107-01		TCGA-BS-A0U5-01	TCGA-BS-A0U5-01A-11D-A10A-05		2bb7d230-0982-4ce5-908a-a04064cb7665
TCGA-BS-A0U7-01	MSI-L	1	TCGA-BS-A0U7-01	935	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 14	TCGA-BS-A0U7	935	0	days	935	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					63	0	0	TCGA-BS-A0U7-F16698	TCGA-BS-A0U7	TCGA-BS-A0U7-01A		Stage IC	NO		-23166	2466	935	0					NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-BS-A0U7.BE83021F-D4D5-4ECA-8484-8A37B2FE67C0.pdf	A0U7	51		TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	14	0	13	Endometrial	A	DECEASED	66	2003		TCGA-BS-A0U7-01	TCGA-BS-A0U7-01		TCGA-BS-A0U7-01A-11-A163-20	D35AAF56-A418-4154-BF07-5E0F655276D1		TCGA-BS-A0U7-01		TCGA-BS-A0U7-01A-21D-A10B-09	TCGA-BS-A0U7-01A-21D-A10B-09	TCGA-BS-A0U7-01A-21D-A10B-09				cf1bf8d7-3971-4919-93ef-2ef85b3dc61d	TCGA-BS-A0U7-01A-21D-A102-01		TCGA-BS-A0U7-01A-21D-A102-01		TCGA-BS-A0U7-01		TCGA-BS-A0U7-01A-21D-A10Q-05	cf1bf8d7-3971-4919-93ef-2ef85b3dc61d
TCGA-BS-A0U8-01	MSI-H	0	TCGA-BS-A0U8-01	2963	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 12	TCGA-BS-A0U8	2963	0	days	2963	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					55	0	0	TCGA-BS-A0U8-F16703	TCGA-BS-A0U8	TCGA-BS-A0U8-01A		Stage IIIC	NO		-20402	2432		0	2963				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BS-A0U8.EAE30BBB-B895-42B9-8AAB-937278A3EBB0.pdf	A0U8	100	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES					Primary Tumor	01	open	1988	YES	NO	YES	BS	0	1	3	4	Endometrial	A	LIVING	82	2004		TCGA-BS-A0U8-01	TCGA-BS-A0U8-01		TCGA-BS-A0U8-01A-21-A163-20	0A9A4E64-690F-4D6D-AA72-633B924E0ADF		TCGA-BS-A0U8-01		TCGA-BS-A0U8-01A-11D-A10B-09	TCGA-BS-A0U8-01A-11D-A10B-09	TCGA-BS-A0U8-01A-11D-A10B-09				6fc8c938-15ec-452d-9cf7-16b97e0a2c8f	TCGA-BS-A0U8-01A-11D-A102-01		TCGA-BS-A0U8-01A-11D-A102-01		TCGA-BS-A0U8-01		TCGA-BS-A0U8-01A-11D-A10Q-05	6fc8c938-15ec-452d-9cf7-16b97e0a2c8f
TCGA-BS-A0U9-01	MSS	0	TCGA-BS-A0U9-01	2825	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-BS-A0U9	2825	0	days	2825	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59	0	0	TCGA-BS-A0U9-F68986	TCGA-BS-A0U9	TCGA-BS-A0U9-01B	Never Used	Stage IIA	NO		-21580	1637		0	2825				YES		Scheduled Follow-up Submission	2014-12-24	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	430	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BS-A0U9.029B0BBB-D88D-4492-AC9A-9094E0DD101C.pdf	A0U9	5	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	3	0	34	Endometrial	B	LIVING	99	2006		TCGA-BS-A0U9-01	TCGA-BS-A0U9-01		TCGA-BS-A0U9-01B-11-A163-20	F2D7C005-5AB3-44EC-954F-D0CDFB98C51F		TCGA-BS-A0U9-01		TCGA-BS-A0U9-01B-21D-A10M-09	TCGA-BS-A0U9-01B-21D-A10M-09	TCGA-BS-A0U9-01B-21D-A10M-09				b280c179-336d-4638-9309-0f51426f8054	TCGA-BS-A0U9-01B-21D-A10L-01		TCGA-BS-A0U9-01B-21D-A10L-01		TCGA-BS-A0U9-01	TCGA-BS-A0U9-01B-21D-A10N-05		b280c179-336d-4638-9309-0f51426f8054
TCGA-BS-A0UA-01	MSI-H	0	TCGA-BS-A0UA-01	3495	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 4	TCGA-BS-A0UA	3495	0	days	3495	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Complete Response	68			TCGA-BS-A0UA-F68987	TCGA-BS-A0UA	TCGA-BS-A0UA-01A		Stage IB	NO		-24872	2361		0	3495			520	NO		Scheduled Follow-up Submission	2014-12-24	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	Locoregional Disease	endometrium		NO	false	No	TCGA-BS-A0UA.58DC7332-5100-408B-9A1E-F0282B013648.pdf	A0UA	26	negative	TUMOR FREE			NO	1	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	right vaginal cuff biopsy		R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	64	2004			TCGA-BS-A0UA-01								TCGA-BS-A0UA-01A-11D-A122-09	TCGA-BS-A0UA-01A-11D-A122-09			TCGA-BS-A0UA-01	97ffaeb2-3ff9-41ff-9552-27f622469460	TCGA-BS-A0UA-01A-11D-A120-01		TCGA-BS-A0UA-01A-11D-A120-01	TCGA-BS-A0UA-01	TCGA-BS-A0UA-01	TCGA-BS-A0UA-01A-11D-A123-05		97ffaeb2-3ff9-41ff-9552-27f622469460
TCGA-BS-A0UF-01	MSS	0	TCGA-BS-A0UF-01	2611	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 11	TCGA-BS-A0UF	2611	0	days	2611	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					65	0	0	TCGA-BS-A0UF-F16712	TCGA-BS-A0UF	TCGA-BS-A0UF-01A	Never Used	Stage IB	NO		-23771	2285		0	2611				NO		Scheduled Follow-up Submission	2011-3-28	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BS-A0UF.719E2A48-0E04-4EAD-A5CC-6416450FC68F.pdf	A0UF	30	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	9	Endometrial	A	LIVING	57	2004		TCGA-BS-A0UF-01	TCGA-BS-A0UF-01		TCGA-BS-A0UF-01A-21-A163-20	27E906A3-706B-43A0-B6B4-46A029C7AB11		TCGA-BS-A0UF-01			TCGA-BS-A0UF-01A-11D-A10B-09	TCGA-BS-A0UF-01A-11D-A10B-09				2ae9f382-fd01-4707-8dae-3ec3c527a226	TCGA-BS-A0UF-01A-11D-A102-01		TCGA-BS-A0UF-01A-11D-A102-01		TCGA-BS-A0UF-01		TCGA-BS-A0UF-01A-11D-A10Q-05	2ae9f382-fd01-4707-8dae-3ec3c527a226
TCGA-BS-A0UJ-01	MSI-H	0	TCGA-BS-A0UJ-01	2506	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 11	TCGA-BS-A0UJ	2506	0	days	2506	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					68			TCGA-BS-A0UJ-F16700	TCGA-BS-A0UJ	TCGA-BS-A0UJ-01A		Stage IA	NO		-25149	2180		0	2506				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	155	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BS-A0UJ.DEE9AA2E-DA73-4074-9588-C75DDEC4D29B.pdf	A0UJ	0	negative	TUMOR FREE				4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	52	2004		TCGA-BS-A0UJ-01	TCGA-BS-A0UJ-01		TCGA-BS-A0UJ-01A-21-A163-20	8B861700-DD5C-42DE-AD5C-357CE568B427		TCGA-BS-A0UJ-01			TCGA-BS-A0UJ-01A-12D-A10B-09	TCGA-BS-A0UJ-01A-12D-A10B-09				835f4f9a-3c90-45d5-809c-6b4316a972b9	TCGA-BS-A0UJ-01A-12D-A102-01		TCGA-BS-A0UJ-01A-12D-A102-01		TCGA-BS-A0UJ-01		TCGA-BS-A0UJ-01A-12D-A10Q-05	835f4f9a-3c90-45d5-809c-6b4316a972b9
TCGA-BS-A0UL-01	MSI-H	0	TCGA-BS-A0UL-01	2481	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-BS-A0UL	2481	0	days	2481	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					54			TCGA-BS-A0UL-F16702	TCGA-BS-A0UL	TCGA-BS-A0UL-01A		Stage IA	NO		-19982	2155		0	2481				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	170	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	70	NO		Peri (6-12 months since last menstrual period)	G1					NO	false	No	TCGA-BS-A0UL.323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9.pdf	A0UL	0	negative	TUMOR FREE				2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS		0		0	Endometrial	A	LIVING	114	2004		TCGA-BS-A0UL-01	TCGA-BS-A0UL-01					TCGA-BS-A0UL-01		TCGA-BS-A0UL-01A-11D-A10G-09	TCGA-BS-A0UL-01A-11D-A10G-09	TCGA-BS-A0UL-01A-11D-A10G-09				954c9805-885f-481a-9dac-024d4481256b	TCGA-BS-A0UL-01A-11D-A107-01		TCGA-BS-A0UL-01A-11D-A107-01		TCGA-BS-A0UL-01	TCGA-BS-A0UL-01A-11D-A10A-05		954c9805-885f-481a-9dac-024d4481256b
TCGA-BS-A0UM-01	MSI-H	0	TCGA-BS-A0UM-01	2644	0	days			UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-BS-A0UM	1454	1	days	2644	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO		64	0	0	TCGA-BS-A0UM-F17016	TCGA-BS-A0UM	TCGA-BS-A0UM-01A		Stage IB	NO		-23400	2072		0	2644			1454	NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Brain	Metastatic			YES	false	No	TCGA-BS-A0UM.97354B28-9E9A-4DBD-B0C7-79C1165AD1CA.pdf	A0UM	22	negative	WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		NO	Other Method, Specify Below	lef lung biopsy		R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	4	0	5	Endometrial	A	LIVING	90	2005		TCGA-BS-A0UM-01	TCGA-BS-A0UM-01					TCGA-BS-A0UM-01		TCGA-BS-A0UM-01A-11W-A10C-09	TCGA-BS-A0UM-01A-11W-A10C-09	TCGA-BS-A0UM-01A-11W-A10C-09				40c2c93a-81a9-4baa-91b3-3c950042475a							TCGA-BS-A0UM-01A-11D-A10Q-05	40c2c93a-81a9-4baa-91b3-3c950042475a
TCGA-BS-A0UT-01	MSS	0	TCGA-BS-A0UT-01	2212	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-BS-A0UT	2212	0	days	2212	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					62	0	0	TCGA-BS-A0UT-F16711	TCGA-BS-A0UT		Never Used	Stage IIB	NO		-22775			0	2212				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO		No		A0UT	33	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	5	0	22	Endometrial		LIVING	65	2005		TCGA-BS-A0UT-01	TCGA-BS-A0UT-01					TCGA-BS-A0UT-01		TCGA-BS-A0UT-01A-11D-A10B-09	TCGA-BS-A0UT-01A-11D-A10B-09	TCGA-BS-A0UT-01A-11D-A10B-09				ece7dac4-4f09-45c9-8a63-e4375ebf4c88	TCGA-BS-A0UT-01A-11D-A102-01		TCGA-BS-A0UT-01A-11D-A102-01		TCGA-BS-A0UT-01		TCGA-BS-A0UT-01A-11D-A10Q-05	ece7dac4-4f09-45c9-8a63-e4375ebf4c88
TCGA-BS-A0UV-01	MSI-L	0	TCGA-BS-A0UV-01	2228	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 11	TCGA-BS-A0UV	2228	0	days	2228	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					55	0	0	TCGA-BS-A0UV-F16696	TCGA-BS-A0UV	TCGA-BS-A0UV-01A	Former User	Stage IIIC	NO		-20266	1902		0	2228				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BS-A0UV.9414D0B9-3126-42E9-8189-7C1EC38B2AAB.pdf	A0UV	65	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	8	1	8	Endometrial	A	LIVING	112	2005		TCGA-BS-A0UV-01	TCGA-BS-A0UV-01					TCGA-BS-A0UV-01			TCGA-BS-A0UV-01A-11D-A10B-09	TCGA-BS-A0UV-01A-11D-A10B-09				08890bb3-7ad1-41c2-8774-b10bf86ee047	TCGA-BS-A0UV-01A-11D-A102-01		TCGA-BS-A0UV-01A-11D-A102-01		TCGA-BS-A0UV-01		TCGA-BS-A0UV-01A-11D-A10Q-05	08890bb3-7ad1-41c2-8774-b10bf86ee047
TCGA-BS-A0V4-01	MSI-H	0	TCGA-BS-A0V4-01	1810	0	days	Iq		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 7	cluster 1		TCGA-BS-A0V4	1810	0	days	1810	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					56	0	0	TCGA-BS-A0V4-F16710	TCGA-BS-A0V4	TCGA-BS-A0V4-01A	Never Used	Stage IB	NO		-20777	1576		0	1810				NO		Scheduled Follow-up Submission	2011-3-25	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	310	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-BS-A0V4.AA0FFBF8-693C-484E-A29D-02F859E1E4C5.pdf	A0V4	4	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO					Primary Tumor	01	open	1988	NO	NO	YES	BS	0	2	0	33	Endometrial	A	LIVING	96	2006	5deaf911-f777-4c38-95bf-19af647e7806		TCGA-BS-A0V4-01	5deaf911-f777-4c38-95bf-19af647e7806	TCGA-BS-A0V4-01A-21-A18Q-20	3B2AACBD-F667-4B5E-A678-B3E0A5542839			5deaf911-f777-4c38-95bf-19af647e7806				5deaf911-f777-4c38-95bf-19af647e7806		TCGA-BS-A0V4-01		TCGA-BS-A0V4-01A-11D-A14F-01		TCGA-BS-A0V4-01A-11D-A14F-01	TCGA-BS-A0V4-01	TCGA-BS-A0V4-01	TCGA-BS-A0V4-01A-11D-A14H-05		
TCGA-BS-A0V6-01	MSS	0	TCGA-BS-A0V6-01	2725	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 4	mutation cluster 4	TCGA-BS-A0V6	2725	0	days	2725	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55	0	0	TCGA-BS-A0V6-F68988	TCGA-BS-A0V6		Never Used	Stage IB	NO		-20369			0	2725				NO		Scheduled Follow-up Submission	2014-12-24	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO		No		A0V6	5.6	negative	TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	8	0	22	Endometrial		LIVING	83	2006			TCGA-BS-A0V6-01							TCGA-BS-A0V6-01A-11D-A122-09	TCGA-BS-A0V6-01A-11D-A122-09	TCGA-BS-A0V6-01A-11D-A122-09			TCGA-BS-A0V6-01	a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a	TCGA-BS-A0V6-01A-11D-A120-01		TCGA-BS-A0V6-01A-11D-A120-01	TCGA-BS-A0V6-01	TCGA-BS-A0V6-01	TCGA-BS-A0V6-01A-11D-A123-05		a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a
TCGA-BS-A0V7-01	MSS	0	TCGA-BS-A0V7-01	1934	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5		miRNA cluster 5	cluster 4	mutation cluster 1	TCGA-BS-A0V7	1934	0	days	1934	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					48	0	0	TCGA-BS-A0V7-F17014	TCGA-BS-A0V7	TCGA-BS-A0V7-01A	Never Used	Stage IB	NO		-17810	1455		0	1934				YES		Scheduled Follow-up Submission	2011-3-28	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	suction using pipelle	Other method, specify:	130	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	false	No	TCGA-BS-A0V7.A4515806-9888-48E8-8F9E-491527FFC29C.pdf	A0V7	36.7	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	26	Endometrial	A	LIVING	102	2006	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c		TCGA-BS-A0V7-01	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c	TCGA-BS-A0V7-01A-11-A163-20	E32601C9-C3CF-4923-93AA-40DDFA630978			0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c		TCGA-BS-A0V7-01A-21D-A122-09	TCGA-BS-A0V7-01A-21D-A122-09	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c		TCGA-BS-A0V7-01		TCGA-BS-A0V7-01A-21D-A120-01		TCGA-BS-A0V7-01A-21D-A120-01	TCGA-BS-A0V7-01	TCGA-BS-A0V7-01	TCGA-BS-A0V7-01A-21D-A123-05		
TCGA-BS-A0V8-01	MSS	0	TCGA-BS-A0V8-01	2544	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 5	TCGA-BS-A0V8	2544	0	days	2544	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68	0	0	TCGA-BS-A0V8-F68989	TCGA-BS-A0V8	TCGA-BS-A0V8-01A	Never Used	Stage IIB	NO		-24981	1410		0	2544				YES		Scheduled Follow-up Submission	2014-12-24	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-BS-A0V8.A024F121-F6C9-4CDF-B0ED-B58708DB6DFE.pdf	A0V8	75	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		YES				R1	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	5	0	13	Endometrial	A	LIVING	85	2006			TCGA-BS-A0V8-01								TCGA-BS-A0V8-01A-11D-A122-09	TCGA-BS-A0V8-01A-11D-A122-09			TCGA-BS-A0V8-01	1c908135-7fdf-4257-8b9e-92e6aa0850a6	TCGA-BS-A0V8-01A-11D-A120-01		TCGA-BS-A0V8-01A-11D-A120-01	TCGA-BS-A0V8-01	TCGA-BS-A0V8-01	TCGA-BS-A0V8-01A-11D-A123-05		1c908135-7fdf-4257-8b9e-92e6aa0850a6
TCGA-BS-A0VI-01	MSI-H	0	TCGA-BS-A0VI-01	2646	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-BS-A0VI	2646	0	days	2646	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-BS-A0VI-F68993	TCGA-BS-A0VI	TCGA-BS-A0VI-01A	Never Used	Stage IIB	NO		-21198	1514		0	2646				NO		Scheduled Follow-up Submission	2014-12-24	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-BS-A0VI.EC10AA0B-A597-4224-8807-52F7228C6D07.pdf	A0VI	93		TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	1	0	23	Endometrial	A	LIVING	91	2006			TCGA-BS-A0VI-01		TCGA-BS-A0VI-01A-21-A18Q-20	98BED513-3C0E-4D93-95BC-5F6736F69ADC									TCGA-BS-A0VI-01	eb32a70b-8e73-4c44-8a44-c623158e87b1	TCGA-BS-A0VI-01A-11D-A14F-01		TCGA-BS-A0VI-01A-11D-A14F-01	TCGA-BS-A0VI-01	TCGA-BS-A0VI-01	TCGA-BS-A0VI-01A-11D-A14H-05		eb32a70b-8e73-4c44-8a44-c623158e87b1
TCGA-BS-A0WQ-01	MSS	0	TCGA-BS-A0WQ-01	2022	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-BS-A0WQ	2022	0	days	2022	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					55	0	0	TCGA-BS-A0WQ-F16701	TCGA-BS-A0WQ	TCGA-BS-A0WQ-01A		Stage IA	NO		-20131	1696		0	2022				YES		Scheduled Follow-up Submission	2011-3-25	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-BS-A0WQ.207B2565-ABB2-4F05-8B54-2280DAC57AD3.pdf	A0WQ	0	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Former User		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	BS	0	11	0	14	Endometrial	A	LIVING	93	2006		TCGA-BS-A0WQ-01	TCGA-BS-A0WQ-01					TCGA-BS-A0WQ-01		TCGA-BS-A0WQ-01A-21D-A10G-09	TCGA-BS-A0WQ-01A-21D-A10G-09	TCGA-BS-A0WQ-01A-21D-A10G-09				432f025e-4ece-432e-b573-01a8e6f9a1e5	TCGA-BS-A0WQ-01A-21D-A107-01		TCGA-BS-A0WQ-01A-21D-A107-01		TCGA-BS-A0WQ-01	TCGA-BS-A0WQ-01A-21D-A10A-05		432f025e-4ece-432e-b573-01a8e6f9a1e5
TCGA-D1-A0ZN-01	MSS	0	TCGA-D1-A0ZN-01	512	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 1	mutation cluster 4	TCGA-D1-A0ZN	448	1	days	512	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Complete Response	60	0	0	TCGA-D1-A0ZN-F17736	TCGA-D1-A0ZN	TCGA-D1-A0ZN-01A		Stage IA	NO		-22026	567		0	512			448	NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	120	NO		Peri (6-12 months since last menstrual period)	G1	Other, specify	New Primary Tumor	Breast left		YES	false	No	TCGA-D1-A0ZN.53DB2270-9308-47F5-BD1F-4D4C737F98AC.pdf	A0ZN	0	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	82	2009			TCGA-D1-A0ZN-01								TCGA-D1-A0ZN-01A-11D-A122-09	TCGA-D1-A0ZN-01A-11D-A122-09			TCGA-D1-A0ZN-01	2d12622b-f828-43b0-a63f-fc542af894db	TCGA-D1-A0ZN-01A-11D-A120-01		TCGA-D1-A0ZN-01A-11D-A120-01	TCGA-D1-A0ZN-01	TCGA-D1-A0ZN-01	TCGA-D1-A0ZN-01A-11D-A123-05		2d12622b-f828-43b0-a63f-fc542af894db
TCGA-D1-A0ZO-01	MSI-H	0	TCGA-D1-A0ZO-01	602	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A0ZO	602	0	days	602	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75	0	0	TCGA-D1-A0ZO-F17744	TCGA-D1-A0ZO	TCGA-D1-A0ZO-01A		Stage IB	NO		-27482	586		0	602				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	Yes	TCGA-D1-A0ZO.13826E23-2184-4D03-B67C-B312BF4FA87E.pdf	A0ZO	30	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	18	Endometrial	A	LIVING	110	2009			TCGA-D1-A0ZO-01							TCGA-D1-A0ZO-01A-11D-A122-09	TCGA-D1-A0ZO-01A-11D-A122-09	TCGA-D1-A0ZO-01A-11D-A122-09			TCGA-D1-A0ZO-01	0e70ff34-799d-4e88-9911-85357f2bb0a2	TCGA-D1-A0ZO-01A-11D-A120-01		TCGA-D1-A0ZO-01A-11D-A120-01	TCGA-D1-A0ZO-01	TCGA-D1-A0ZO-01	TCGA-D1-A0ZO-01A-11D-A123-05		0e70ff34-799d-4e88-9911-85357f2bb0a2
TCGA-D1-A0ZP-01	MSI-L	0	TCGA-D1-A0ZP-01	911	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 4	TCGA-D1-A0ZP	629	1	days	911	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	59	0	0	TCGA-D1-A0ZP-F17745	TCGA-D1-A0ZP	TCGA-D1-A0ZP-01A		Stage IVA	NO	783	-21581	552		0	911			629	NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	161	Serous endometrial adenocarcinoma	No		NO	C54.1	8441/3	C54.1	YES		Tumor resection	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Disease	Recurrent endometrial carcinoma in retriponeal lymphnodes		YES	false	No	TCGA-D1-A0ZP.FD46BB74-914F-4B4E-819A-5AD5F4548672.pdf	A0ZP	30	positive	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		YES	Excisional Biopsy		R0	RX	Primary Tumor	01	open		YES	NO	YES	D1	0	19	0	51	Endometrial	A	LIVING	58	2009		TCGA-D1-A0ZP-01	TCGA-D1-A0ZP-01		TCGA-D1-A0ZP-01A-11-A163-20	A0FF554C-EDC0-4E64-B073-E447DB25593B		TCGA-D1-A0ZP-01		TCGA-D1-A0ZP-01A-21D-A10M-09	TCGA-D1-A0ZP-01A-21D-A10M-09	TCGA-D1-A0ZP-01A-21D-A10M-09				2188d23d-209d-4d3c-b737-f48892e08d31	TCGA-D1-A0ZP-01A-21D-A10L-01		TCGA-D1-A0ZP-01A-21D-A10L-01		TCGA-D1-A0ZP-01	TCGA-D1-A0ZP-01A-21D-A10N-05		2188d23d-209d-4d3c-b737-f48892e08d31
TCGA-D1-A0ZQ-01	MSS	0	TCGA-D1-A0ZQ-01	260	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2		UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 4	TCGA-D1-A0ZQ	260	0	days	260	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	90	0	0	TCGA-D1-A0ZQ-F17747	TCGA-D1-A0ZQ	TCGA-D1-A0ZQ-01A	Never Used	Stage IB	NO		-32873	540		0	260				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A0ZQ.BAC6E925-0499-41AD-9F58-2CB8E3EE058E.pdf	A0ZQ	60		TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	69	2009			TCGA-D1-A0ZQ-01							TCGA-D1-A0ZQ-01A-11D-A122-09	TCGA-D1-A0ZQ-01A-11D-A122-09	TCGA-D1-A0ZQ-01A-11D-A122-09			TCGA-D1-A0ZQ-01	650687c0-616b-41a5-ae29-322ba9cfc462	TCGA-D1-A0ZQ-01A-11D-A120-01		TCGA-D1-A0ZQ-01A-11D-A120-01	TCGA-D1-A0ZQ-01	TCGA-D1-A0ZQ-01	TCGA-D1-A0ZQ-01A-11D-A123-05		650687c0-616b-41a5-ae29-322ba9cfc462
TCGA-D1-A0ZR-01	MSS	0	TCGA-D1-A0ZR-01	17	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation c1uster 10	TCGA-D1-A0ZR	17	0	days	17	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-D1-A0ZR-F17748	TCGA-D1-A0ZR	TCGA-D1-A0ZR-01A		Stage IB	NO		-21157	537		0	17				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Indeterminate (neither Pre or Postmenopausal)	G2					NO	false	No	TCGA-D1-A0ZR.ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D.pdf	A0ZR	12	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	10	0	48	Endometrial	A	LIVING	117	2009		TCGA-D1-A0ZR-01	TCGA-D1-A0ZR-01		TCGA-D1-A0ZR-01A-11-A163-20	B7CAE504-6F63-49DF-8575-2409EEAD4418		TCGA-D1-A0ZR-01		TCGA-D1-A0ZR-01A-21D-A10M-09	TCGA-D1-A0ZR-01A-21D-A10M-09	TCGA-D1-A0ZR-01A-21D-A10M-09				41f4268d-a222-4d6b-b4aa-515bb8765c6c	TCGA-D1-A0ZR-01A-21D-A10L-01		TCGA-D1-A0ZR-01A-21D-A10L-01		TCGA-D1-A0ZR-01	TCGA-D1-A0ZR-01A-21D-A10N-05		41f4268d-a222-4d6b-b4aa-515bb8765c6c
TCGA-D1-A0ZS-01	MSI-H	0	TCGA-D1-A0ZS-01	148	0	days	Quiet	C11-small-various	UCEC CIMP c18	cluster 2		GBM-like c6	miRNA cluster 5	cluster 4	mutation cluster 1	TCGA-D1-A0ZS	148	0	days	148	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54	0	0	TCGA-D1-A0ZS-F17755	TCGA-D1-A0ZS			Stage IB	NO		-19821			0	148				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A0ZS	40		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	19	0	27	Endometrial		LIVING	62	2009			TCGA-D1-A0ZS-01							TCGA-D1-A0ZS-01A-11D-A122-09	TCGA-D1-A0ZS-01A-11D-A122-09	TCGA-D1-A0ZS-01A-11D-A122-09			TCGA-D1-A0ZS-01	f35db751-0250-4045-9faf-2c0f1158b354	TCGA-D1-A0ZS-01A-11D-A120-01		TCGA-D1-A0ZS-01A-11D-A120-01	TCGA-D1-A0ZS-01	TCGA-D1-A0ZS-01	TCGA-D1-A0ZS-01A-11D-A123-05		f35db751-0250-4045-9faf-2c0f1158b354
TCGA-D1-A0ZU-01	MSS	0	TCGA-D1-A0ZU-01	872	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A0ZU	872	0	days	872	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	34	0	0	TCGA-D1-A0ZU-F17749	TCGA-D1-A0ZU	TCGA-D1-A0ZU-01A		Stage IB	NO		-12458	508		0	872				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8382/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	No	TCGA-D1-A0ZU.D0BC0903-390B-4344-A613-48ABF71CF08D.pdf	A0ZU	5	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive		YES	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	94	2009		TCGA-D1-A0ZU-01	TCGA-D1-A0ZU-01		TCGA-D1-A0ZU-01A-21-A163-20	8C9B9C6B-D8EB-4609-AAF6-8C92BA431FEF		TCGA-D1-A0ZU-01		TCGA-D1-A0ZU-01A-11D-A10M-09	TCGA-D1-A0ZU-01A-11D-A10M-09	TCGA-D1-A0ZU-01A-11D-A10M-09				8708462d-d090-4fa2-95a6-f6021ce0489b	TCGA-D1-A0ZU-01A-11D-A10L-01		TCGA-D1-A0ZU-01A-11D-A10L-01		TCGA-D1-A0ZU-01	TCGA-D1-A0ZU-01A-11D-A10N-05		8708462d-d090-4fa2-95a6-f6021ce0489b
TCGA-D1-A0ZV-01	MSS	0	TCGA-D1-A0ZV-01	728	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-D1-A0ZV	728	0	days	728	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-D1-A0ZV-F19531	TCGA-D1-A0ZV	TCGA-D1-A0ZV-01A		Stage IB	NO		-21374	324		0	728				NO		Scheduled Follow-up Submission	2011-12-13	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A0ZV.C9AE2762-705F-4061-B3B6-325426D0C0C8.pdf	A0ZV	30		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	23	Endometrial	A	LIVING	77	2009		TCGA-D1-A0ZV-01	TCGA-D1-A0ZV-01					TCGA-D1-A0ZV-01		TCGA-D1-A0ZV-01A-11D-A10M-09	TCGA-D1-A0ZV-01A-11D-A10M-09	TCGA-D1-A0ZV-01A-11D-A10M-09				45676252-677e-45f6-a1e3-3052d3615472	TCGA-D1-A0ZV-01A-11D-A10L-01		TCGA-D1-A0ZV-01A-11D-A10L-01		TCGA-D1-A0ZV-01	TCGA-D1-A0ZV-01A-11D-A10N-05		45676252-677e-45f6-a1e3-3052d3615472
TCGA-D1-A0ZZ-01	MSS	0	TCGA-D1-A0ZZ-01	686	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2	mutation cluster 13	TCGA-D1-A0ZZ	686	0	days	686	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	80	0	0	TCGA-D1-A0ZZ-F17753	TCGA-D1-A0ZZ	TCGA-D1-A0ZZ-01A		Stage IB	NO		-29420	349		0	686				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	154	Mixed serous and endometrioid	No		NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A0ZZ.4339EAC6-F56E-49E6-8EF9-2256165CADB5.pdf	A0ZZ	11	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open		YES	NO	YES	D1	0	12	0	26	Endometrial	A	LIVING	51	2009		TCGA-D1-A0ZZ-01	TCGA-D1-A0ZZ-01		TCGA-D1-A0ZZ-01A-21-A163-20	9AD5DB69-7DCA-4BE6-BA19-74509C89A963		TCGA-D1-A0ZZ-01		TCGA-D1-A0ZZ-01A-11D-A10M-09	TCGA-D1-A0ZZ-01A-11D-A10M-09	TCGA-D1-A0ZZ-01A-11D-A10M-09				b50b6ebf-8b11-47db-803b-e2739e7dd005	TCGA-D1-A0ZZ-01A-11D-A10L-01		TCGA-D1-A0ZZ-01A-11D-A10L-01		TCGA-D1-A0ZZ-01	TCGA-D1-A0ZZ-01A-11D-A10N-05		b50b6ebf-8b11-47db-803b-e2739e7dd005
TCGA-D1-A101-01	MSI-H	0	TCGA-D1-A101-01	53	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A101	53	0	days	53	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-D1-A101-F17752	TCGA-D1-A101	TCGA-D1-A101-01A		Stage IB	NO		-22078	349		0	53				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	150	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A101.2D6287C8-9C22-4046-8F14-3886DDE62695.pdf	A101	10	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	82	2009		TCGA-D1-A101-01	TCGA-D1-A101-01		TCGA-D1-A101-01A-21-A163-20	AF6EEC20-46D9-4B44-989E-B36509847182		TCGA-D1-A101-01		TCGA-D1-A101-01A-12D-A10M-09	TCGA-D1-A101-01A-12D-A10M-09	TCGA-D1-A101-01A-12D-A10M-09				df97f5e0-e49a-4f34-911c-92502e7df570	TCGA-D1-A101-01A-12D-A10L-01		TCGA-D1-A101-01A-12D-A10L-01		TCGA-D1-A101-01	TCGA-D1-A101-01A-12D-A10N-05		df97f5e0-e49a-4f34-911c-92502e7df570
TCGA-D1-A102-01	MSS	0	TCGA-D1-A102-01	135	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1	mutation cluster 4	TCGA-D1-A102	135	0	days	135	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	49	0	0	TCGA-D1-A102-F17750	TCGA-D1-A102	TCGA-D1-A102-01A		Stage IB	NO		-17991	380		0	135				YES		Scheduled Follow-up Submission	2011-10-24	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	Yes	TCGA-D1-A102.9983D576-706A-48D2-93EE-70EABB3BD77C.pdf	A102	13	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	45	Endometrial	A	LIVING	122	2009			TCGA-D1-A102-01		TCGA-D1-A102-01A-21-A163-20	E113E37B-D85D-48E7-9AE4-DD3FDF12155C				TCGA-D1-A102-01A-11D-A10M-09	TCGA-D1-A102-01A-11D-A10M-09	TCGA-D1-A102-01A-11D-A10M-09			TCGA-D1-A102-01	120e984a-ef3b-4240-8990-20aeadce8226	TCGA-D1-A102-01A-11D-A10L-01		TCGA-D1-A102-01A-11D-A10L-01	TCGA-D1-A102-01	TCGA-D1-A102-01	TCGA-D1-A102-01A-11D-A10N-05		120e984a-ef3b-4240-8990-20aeadce8226
TCGA-D1-A103-01	MSI-L	0	TCGA-D1-A103-01	669	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 3	mutation cluster 11	TCGA-D1-A103	669	0	days	669	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	87	0	0	TCGA-D1-A103-F17751	TCGA-D1-A103	TCGA-D1-A103-01A		Stage IB	NO		-31841	376		0	669				NO		Scheduled Follow-up Submission	2011-10-24	FEMALE	150	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A103.AE2FAD3D-FA6A-4648-90A5-2D2C442796AF.pdf	A103	0		TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open		NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	60	2009			TCGA-D1-A103-01		TCGA-D1-A103-01A-21-A163-20	93FD8223-7024-4A46-88F8-922B00C25EFA					TCGA-D1-A103-01A-11D-A10M-09	TCGA-D1-A103-01A-11D-A10M-09			TCGA-D1-A103-01	ba50902a-fcf9-4023-bdbc-3e7d61c7011b	TCGA-D1-A103-01A-11D-A10L-01		TCGA-D1-A103-01A-11D-A10L-01	TCGA-D1-A103-01	TCGA-D1-A103-01	TCGA-D1-A103-01A-11D-A10N-05		ba50902a-fcf9-4023-bdbc-3e7d61c7011b
TCGA-D1-A15V-01	MSS	0	TCGA-D1-A15V-01	1201	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-D1-A15V	1201	0	days	1201	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68	0	0	TCGA-D1-A15V-F18453	TCGA-D1-A15V	TCGA-D1-A15V-01A		Stage IB	NO		-24886	895		0	1201				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A15V.597F20F2-AE36-4A9F-A7AF-1647CB56B453.pdf	A15V	20	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	16	0	38	Endometrial	A	LIVING	69	2008			TCGA-D1-A15V-01		TCGA-D1-A15V-01A-21-A163-20	034BEF37-E51A-43DC-8C33-A8D8423EBE75					TCGA-D1-A15V-01A-11D-A122-09	TCGA-D1-A15V-01A-11D-A122-09			TCGA-D1-A15V-01	30f27799-c311-47c4-ad9e-6c80863a3cd2	TCGA-D1-A15V-01A-11D-A120-01		TCGA-D1-A15V-01A-11D-A120-01	TCGA-D1-A15V-01	TCGA-D1-A15V-01	TCGA-D1-A15V-01A-11D-A123-05		30f27799-c311-47c4-ad9e-6c80863a3cd2
TCGA-D1-A15W-01	MSS	0	TCGA-D1-A15W-01	915	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4	mutation cluster 7	TCGA-D1-A15W	915	0	days	915	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58	0	0	TCGA-D1-A15W-F18462	TCGA-D1-A15W	TCGA-D1-A15W-01A		Stage IIIC	NO		-21545	906		0	915				YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A15W.1C938760-9492-4F4E-87CE-85CE3C15BBCA.pdf	A15W	38	negative	TUMOR FREE	0	1		0	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	8	1	34	Endometrial	A	LIVING	126	2008			TCGA-D1-A15W-01		TCGA-D1-A15W-01A-21-A164-20	CAFD3FC6-B826-40D0-BDA1-E66AB5BFA073				TCGA-D1-A15W-01A-11D-A122-09	TCGA-D1-A15W-01A-11D-A122-09	TCGA-D1-A15W-01A-11D-A122-09			TCGA-D1-A15W-01	9def1496-a891-431c-b5c2-75d258e7ec29	TCGA-D1-A15W-01A-11D-A120-01		TCGA-D1-A15W-01A-11D-A120-01	TCGA-D1-A15W-01	TCGA-D1-A15W-01	TCGA-D1-A15W-01A-11D-A123-05		9def1496-a891-431c-b5c2-75d258e7ec29
TCGA-D1-A15X-01	MSI-L	0	TCGA-D1-A15X-01	909	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 11	TCGA-D1-A15X	909	0	days	909	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	45	0	0	TCGA-D1-A15X-F18473	TCGA-D1-A15X	TCGA-D1-A15X-01A	Current User	Stage IA	NO		-16532	897		0	909				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	169	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	High Grade					NO	false	No	TCGA-D1-A15X.F32EB1C9-4802-4873-8F0E-E10724DA9C15.pdf	A15X	0	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	16	0	29	Endometrial	A	LIVING	72	2008			TCGA-D1-A15X-01		TCGA-D1-A15X-01A-21-A164-20	D5DF60B0-AEC5-44E0-BB4C-99DF11B9AE51					TCGA-D1-A15X-01A-11D-A122-09	TCGA-D1-A15X-01A-11D-A122-09			TCGA-D1-A15X-01	51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1	TCGA-D1-A15X-01A-11D-A120-01		TCGA-D1-A15X-01A-11D-A120-01	TCGA-D1-A15X-01	TCGA-D1-A15X-01	TCGA-D1-A15X-01A-11D-A123-05		51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1
TCGA-D1-A15Z-01	MSI-L	1	TCGA-D1-A15Z-01	58	1	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation c1uster 9	TCGA-D1-A15Z	58	0	days	58	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72	0	0	TCGA-D1-A15Z-F18475	TCGA-D1-A15Z	TCGA-D1-A15Z-01A		Stage IB	NO		-26638	884	58	0					YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A15Z.280F86BF-4834-4FA9-B153-DE7BE312E619.pdf	A15Z	30		TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	5	0	28	Endometrial	A	DECEASED	125	2008			TCGA-D1-A15Z-01		TCGA-D1-A15Z-01A-21-A163-20	9589DF72-D456-456F-8B39-94E788ADCC03				TCGA-D1-A15Z-01A-11D-A122-09	TCGA-D1-A15Z-01A-11D-A122-09	TCGA-D1-A15Z-01A-11D-A122-09			TCGA-D1-A15Z-01	0ca45a1d-6cdc-48f5-8bde-633cfd15d687	TCGA-D1-A15Z-01A-11D-A120-01		TCGA-D1-A15Z-01A-11D-A120-01	TCGA-D1-A15Z-01	TCGA-D1-A15Z-01	TCGA-D1-A15Z-01A-11D-A123-05		0ca45a1d-6cdc-48f5-8bde-633cfd15d687
TCGA-D1-A160-01	MSI-H	0	TCGA-D1-A160-01	112	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-D1-A160	112	0	days	112	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70	0	0	TCGA-D1-A160-F18477	TCGA-D1-A160	TCGA-D1-A160-01A		Stage IB	NO		-25673	895		0	112				YES		Scheduled Follow-up Submission	2011-11-17	FEMALE	172	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A160.F349C87E-F324-4A8E-81E1-153C99173E21.pdf	A160	20	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	13	0	29	Endometrial	A	LIVING	122	2008			TCGA-D1-A160-01		TCGA-D1-A160-01A-21-A163-20	A35BF473-635A-43CF-8507-E4328B2155FC					TCGA-D1-A160-01A-11D-A122-09	TCGA-D1-A160-01A-11D-A122-09			TCGA-D1-A160-01	ac9c8753-ae35-4367-9aef-d42522bc8db7	TCGA-D1-A160-01A-11D-A120-01		TCGA-D1-A160-01A-11D-A120-01	TCGA-D1-A160-01	TCGA-D1-A160-01	TCGA-D1-A160-01A-11D-A123-05		ac9c8753-ae35-4367-9aef-d42522bc8db7
TCGA-D1-A161-01	MSS	0	TCGA-D1-A161-01	892	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A161	892	0	days	892	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	78	0	0	TCGA-D1-A161-F18478	TCGA-D1-A161	TCGA-D1-A161-01A		Stage IC	NO		-28695	864		0	892				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A161.E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD.pdf	A161	70	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	9	0	21	Endometrial	A	LIVING	71	2008			TCGA-D1-A161-01		TCGA-D1-A161-01A-21-A163-20	E9312DE7-7981-4E1C-864B-5C4273A4C04B					TCGA-D1-A161-01A-11D-A122-09	TCGA-D1-A161-01A-11D-A122-09			TCGA-D1-A161-01	9336e8ea-7afe-45b3-b9e7-add7141ecca0	TCGA-D1-A161-01A-11D-A120-01		TCGA-D1-A161-01A-11D-A120-01	TCGA-D1-A161-01	TCGA-D1-A161-01	TCGA-D1-A161-01A-11D-A123-05		9336e8ea-7afe-45b3-b9e7-add7141ecca0
TCGA-D1-A162-01	MSS	0	TCGA-D1-A162-01	1145	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A162	1145	0	days	1145	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69	0	0	TCGA-D1-A162-F18479	TCGA-D1-A162	TCGA-D1-A162-01A		Stage IB	NO		-25543	874		0	1145				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	170	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A162.CB5E7FA1-33EE-492F-B2B0-F4C9332640A9.pdf	A162	50	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	16	0	45	Endometrial	A	LIVING	100	2008			TCGA-D1-A162-01		TCGA-D1-A162-01A-21-A163-20	192B1720-C24A-43FE-9F8B-D9164E4C37C0									TCGA-D1-A162-01	4f440484-1605-442b-b1e5-b3534277b9c2				TCGA-D1-A162-01		TCGA-D1-A162-01A-11D-A123-05		4f440484-1605-442b-b1e5-b3534277b9c2
TCGA-D1-A163-01	MSI-H	0	TCGA-D1-A163-01	991	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-D1-A163	223	1	days	991	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	50	0	0	TCGA-D1-A163-F18485	TCGA-D1-A163	TCGA-D1-A163-01A		Stage IIIC	NO	327	-18604	854		0	991			223	NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	170	NO		Peri (6-12 months since last menstrual period)	G2	Other, specify	Metastatic	Paraaortic retroperitoneal lymphnode		YES	false	No	TCGA-D1-A163.993B9CE9-7D25-4B2B-B246-F642550C70CD.pdf	A163	12	negative	TUMOR FREE	0	2		1	Complete Remission/Response	Never Used		YES	Surgical Resection		R0	R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	38	2	53	Endometrial	A	LIVING	109	2008			TCGA-D1-A163-01		TCGA-D1-A163-01A-21-A163-20	78CB9680-D489-4ED4-BFDF-56CF4E9B2C9C				TCGA-D1-A163-01A-11D-A12J-09	TCGA-D1-A163-01A-11D-A12J-09	TCGA-D1-A163-01A-11D-A12J-09			TCGA-D1-A163-01	b9d45e58-d758-4aa0-a282-1366dc00f833	TCGA-D1-A163-01A-11D-A12G-01		TCGA-D1-A163-01A-11D-A12G-01	TCGA-D1-A163-01	TCGA-D1-A163-01	TCGA-D1-A163-01A-11D-A12K-05		b9d45e58-d758-4aa0-a282-1366dc00f833
TCGA-D1-A165-01	MSS	0	TCGA-D1-A165-01	20	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A165	20	0	days	20	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-D1-A165-F18493	TCGA-D1-A165	TCGA-D1-A165-01A		Stage IIIA	NO		-23526	848		0	20				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	181	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A165.476F8219-DAAE-4DB3-BA31-C64AC24ACF65.pdf	A165	25	positive	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	13	0	30	Endometrial	A	LIVING	87	2008			TCGA-D1-A165-01		TCGA-D1-A165-01A-21-A163-20	2DC14A00-8265-4379-A0FD-EB8E9E199B59				TCGA-D1-A165-01A-11D-A12J-09	TCGA-D1-A165-01A-11D-A12J-09	TCGA-D1-A165-01A-11D-A12J-09			TCGA-D1-A165-01	6d1d9284-004e-4ed7-91dd-71f4fa919632	TCGA-D1-A165-01A-11D-A12G-01		TCGA-D1-A165-01A-11D-A12G-01	TCGA-D1-A165-01	TCGA-D1-A165-01	TCGA-D1-A165-01A-11D-A12K-05		6d1d9284-004e-4ed7-91dd-71f4fa919632
TCGA-D1-A167-01	MSI-H	0	TCGA-D1-A167-01	478	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 11	TCGA-D1-A167	478	0	days	478	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70	0	0	TCGA-D1-A167-F18494	TCGA-D1-A167	TCGA-D1-A167-01A		Stage IC	NO		-25575	841		0	478				NO		Scheduled Follow-up Submission	2011-11-17	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A167.4E67EAA4-3069-4B62-A403-9300A9FA494C.pdf	A167	60	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	20	0	52	Endometrial	A	LIVING	72	2008			TCGA-D1-A167-01		TCGA-D1-A167-01A-21-A163-20	8ABC7390-66A1-4E32-B8B5-747673551370					TCGA-D1-A167-01A-11D-A12J-09	TCGA-D1-A167-01A-11D-A12J-09			TCGA-D1-A167-01	09807f16-30aa-47b0-ace0-0dfb6a5342c2	TCGA-D1-A167-01A-11D-A12G-01		TCGA-D1-A167-01A-11D-A12G-01	TCGA-D1-A167-01	TCGA-D1-A167-01	TCGA-D1-A167-01A-11D-A12K-05		09807f16-30aa-47b0-ace0-0dfb6a5342c2
TCGA-D1-A168-01	MSS	0	TCGA-D1-A168-01	1098	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	BLCA nonsquamous-like c1	miRNA cluster 12	cluster 4	mutation cluster 1	TCGA-D1-A168	1098	0	days	1098	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67	0	0	TCGA-D1-A168-F18501	TCGA-D1-A168	TCGA-D1-A168-01A		Stage IB	NO		-24586	821		0	1098				NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A168.B9D9D808-17B1-415F-9E58-4FDBC1BF30C0.pdf	A168	35	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	19	0	49	Endometrial	A	LIVING	76	2008			TCGA-D1-A168-01		TCGA-D1-A168-01A-21-A163-20	770C564F-5591-4122-9855-BA6C3CE96517				TCGA-D1-A168-01A-31D-A12J-09	TCGA-D1-A168-01A-31D-A12J-09	TCGA-D1-A168-01A-31D-A12J-09			TCGA-D1-A168-01	9ca7ed26-2a2c-47cd-8423-f9b100beccc3	TCGA-D1-A168-01A-31D-A12G-01		TCGA-D1-A168-01A-31D-A12G-01	TCGA-D1-A168-01	TCGA-D1-A168-01	TCGA-D1-A168-01A-31D-A12K-05		9ca7ed26-2a2c-47cd-8423-f9b100beccc3
TCGA-D1-A169-01	MSS	0	TCGA-D1-A169-01	1135	0	days	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 3	TCGA-D1-A169	519	1	days	1135	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Stable Disease	63	0	0	TCGA-D1-A169-F18503	TCGA-D1-A169	TCGA-D1-A169-01A		Stage IV	NO	519	-23238	800		0	1135			519	NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Metastatic	Bladder nodule		YES	false	No	TCGA-D1-A169.F7B4C0DC-2259-4A0A-81D3-E145EFA91279.pdf	A169	45	positive	WITH TUMOR	0	0		0	Complete Remission/Response	Never Used		NO	Excisional Biopsy		R2	R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	23	0	29	Endometrial	A	LIVING	102	2008			TCGA-D1-A169-01		TCGA-D1-A169-01A-21-A163-20	EED70D33-031C-4464-A665-1E4B090ECAE8				TCGA-D1-A169-01A-11D-A12J-09	TCGA-D1-A169-01A-11D-A12J-09	TCGA-D1-A169-01A-11D-A12J-09			TCGA-D1-A169-01	7a487d4e-9e11-4adc-86a1-cf6a7bde4f67	TCGA-D1-A169-01A-11D-A12G-01		TCGA-D1-A169-01A-11D-A12G-01	TCGA-D1-A169-01	TCGA-D1-A169-01	TCGA-D1-A169-01A-11D-A12K-05		7a487d4e-9e11-4adc-86a1-cf6a7bde4f67
TCGA-D1-A16B-01	MSS	0	TCGA-D1-A16B-01	1106	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 4	TCGA-D1-A16B	1106	0	days	1106	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-D1-A16B-F18508	TCGA-D1-A16B	TCGA-D1-A16B-01A		Stage IC	NO		-23450	793		0	1106				NO		Scheduled Follow-up Submission	2011-11-18	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A16B.1B9ED459-4046-4DD9-ABA5-E815A90601A3.pdf	A16B	56	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1995	NO	NO	YES	D1	0	12	0	18	Endometrial	A	LIVING	86	2008			TCGA-D1-A16B-01		TCGA-D1-A16B-01A-21-A163-20	FAAC5466-A988-4DF3-8098-C4208C4D0453				TCGA-D1-A16B-01A-11D-A12J-09	TCGA-D1-A16B-01A-11D-A12J-09	TCGA-D1-A16B-01A-11D-A12J-09			TCGA-D1-A16B-01	90250b43-5a36-42c0-886f-32a0ed39bea6	TCGA-D1-A16B-01A-11D-A12G-01		TCGA-D1-A16B-01A-11D-A12G-01	TCGA-D1-A16B-01	TCGA-D1-A16B-01	TCGA-D1-A16B-01A-11D-A12K-05		90250b43-5a36-42c0-886f-32a0ed39bea6
TCGA-D1-A16D-01	MSS	0	TCGA-D1-A16D-01	1141	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-D1-A16D	1141	0	days	1141	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	49	0	0	TCGA-D1-A16D-F18509	TCGA-D1-A16D	TCGA-D1-A16D-01A		Stage IC	NO		-17933	799		0	1141				YES		Scheduled Follow-up Submission	2011-11-18	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	No	TCGA-D1-A16D.795A5264-493A-498D-A731-87ECB0A7F612.pdf	A16D	86	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	0	0	34	Endometrial	A	LIVING	151	2008			TCGA-D1-A16D-01		TCGA-D1-A16D-01A-21-A164-20	5F2C5422-2513-4C05-9668-74E46BCA6563				TCGA-D1-A16D-01A-11D-A12J-09	TCGA-D1-A16D-01A-11D-A12J-09	TCGA-D1-A16D-01A-11D-A12J-09			TCGA-D1-A16D-01	619e7a96-8900-484b-b1e2-54ef91b9109d	TCGA-D1-A16D-01A-11D-A12G-01		TCGA-D1-A16D-01A-11D-A12G-01	TCGA-D1-A16D-01	TCGA-D1-A16D-01	TCGA-D1-A16D-01A-11D-A12K-05		619e7a96-8900-484b-b1e2-54ef91b9109d
TCGA-D1-A16E-01	MSS	0	TCGA-D1-A16E-01	1119	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A16E	1119	0	days	1119	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73	0	0	TCGA-D1-A16E-F18558	TCGA-D1-A16E	TCGA-D1-A16E-01A		Stage IB	NO		-26859	790		0	1119				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	154	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A16E.DF926973-D344-48AE-A6F6-5901A4A8C846.pdf	A16E	25		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	60	2008			TCGA-D1-A16E-01		TCGA-D1-A16E-01A-11-A164-20	564E1D1E-8143-473D-B49A-A701458F6516				TCGA-D1-A16E-01A-22D-A12J-09	TCGA-D1-A16E-01A-22D-A12J-09	TCGA-D1-A16E-01A-22D-A12J-09			TCGA-D1-A16E-01	abe099ed-caea-4903-aa4a-2729d2b28da2	TCGA-D1-A16E-01A-22D-A12G-01		TCGA-D1-A16E-01A-22D-A12G-01	TCGA-D1-A16E-01	TCGA-D1-A16E-01	TCGA-D1-A16E-01A-22D-A12K-05		abe099ed-caea-4903-aa4a-2729d2b28da2
TCGA-D1-A16F-01	MSI-H	0	TCGA-D1-A16F-01	80	0	days		C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 7	TCGA-D1-A16F	80	0	days	80	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-D1-A16F-F18559	TCGA-D1-A16F	TCGA-D1-A16F-01A		Stage IB	NO		-22242	783		0	80				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A16F.E89C4CBF-45D5-405D-A673-F67186C206B3.pdf	A16F	25	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995	NO	NO	YES	D1	0	6	0	15	Endometrial	A	LIVING	90	2008			TCGA-D1-A16F-01		TCGA-D1-A16F-01A-21-A164-20	2D4EB2C7-4E8D-4D10-B6D7-C6EE8965053E					TCGA-D1-A16F-01A-11D-A12J-09	TCGA-D1-A16F-01A-11D-A12J-09			TCGA-D1-A16F-01	7eab3a7a-c66e-4289-8fb4-ae751b2103e6				TCGA-D1-A16F-01		TCGA-D1-A16F-01A-11D-A12K-05		7eab3a7a-c66e-4289-8fb4-ae751b2103e6
TCGA-D1-A16G-01	MSS	1	TCGA-D1-A16G-01	834	1	days	Squamous	C7-COAD/READ	UCEC non-CIMP c3	cluster 4	squamous c3	COADREAD-like c15	miRNA cluster 8	cluster 2	mutation cluster 3	TCGA-D1-A16G	642	1	days	834	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	74	0	0	TCGA-D1-A16G-F18560	TCGA-D1-A16G	TCGA-D1-A16G-01A		Stage IV	NO		-27065	769	834	0				642	NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Other, specify	Locoregional Disease	Lymph nodes		YES	false	No	TCGA-D1-A16G.778F9F58-841E-48F3-B6EA-7CF58463808B.pdf	A16G	100	positive	WITH TUMOR	0	0		3	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	15	0	30	Endometrial	A	DECEASED	75	2008			TCGA-D1-A16G-01		TCGA-D1-A16G-01A-21-A164-20	D63DB6BF-75DA-431D-947C-1609C481A48A				TCGA-D1-A16G-01A-31D-A12J-09	TCGA-D1-A16G-01A-31D-A12J-09	TCGA-D1-A16G-01A-31D-A12J-09			TCGA-D1-A16G-01	deeb2238-8ed6-4651-8b63-428c76914c94	TCGA-D1-A16G-01A-31D-A12G-01		TCGA-D1-A16G-01A-31D-A12G-01	TCGA-D1-A16G-01	TCGA-D1-A16G-01	TCGA-D1-A16G-01A-31D-A12K-05		deeb2238-8ed6-4651-8b63-428c76914c94
TCGA-D1-A16I-01	MSS	1	TCGA-D1-A16I-01	350	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 5	TCGA-D1-A16I	350	0	days	350	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62	0	0	TCGA-D1-A16I-F18573	TCGA-D1-A16I	TCGA-D1-A16I-01A		Stage IC	NO		-22836	763	350	0					NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	false	No	TCGA-D1-A16I.3D30B053-444A-4F4D-B451-EB8746A157A2.pdf	A16I	66		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1995	YES	NO	YES	D1	0	22	0	29	Endometrial	A	DECEASED	84	2008			TCGA-D1-A16I-01		TCGA-D1-A16I-01A-21-A164-20	86D661F5-6386-4735-B9F1-04B2B4B96418				TCGA-D1-A16I-01A-11D-A12J-09	TCGA-D1-A16I-01A-11D-A12J-09	TCGA-D1-A16I-01A-11D-A12J-09			TCGA-D1-A16I-01	21e840d7-f768-45b3-8a3a-bf228f7227e7	TCGA-D1-A16I-01A-11D-A12G-01		TCGA-D1-A16I-01A-11D-A12G-01	TCGA-D1-A16I-01	TCGA-D1-A16I-01	TCGA-D1-A16I-01A-11D-A12K-05		21e840d7-f768-45b3-8a3a-bf228f7227e7
TCGA-D1-A16J-01	MSS	0	TCGA-D1-A16J-01	910	0	days	COAD-READ	C1-LUAD-enriched	Cluster 6	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 7	cluster 2	mutation cluster 1	TCGA-D1-A16J	910	0	days	910	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61	0	0	TCGA-D1-A16J-F18579	TCGA-D1-A16J	TCGA-D1-A16J-01A		Stage IIB	NO		-22319	735		0	910				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A16J.7A1F7567-5D17-4074-B099-1E60C8069FA1.pdf	A16J	100	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	13	0	50	Endometrial	A	LIVING	130	2008			TCGA-D1-A16J-01		TCGA-D1-A16J-01A-21-A164-20	6C745697-65BC-44B8-8F15-B8482F902E85				TCGA-D1-A16J-01A-11D-A12J-09	TCGA-D1-A16J-01A-11D-A12J-09	TCGA-D1-A16J-01A-11D-A12J-09			TCGA-D1-A16J-01	43ae3721-059e-467e-a8a3-7875e738ccef	TCGA-D1-A16J-01A-11D-A12G-01		TCGA-D1-A16J-01A-11D-A12G-01	TCGA-D1-A16J-01	TCGA-D1-A16J-01	TCGA-D1-A16J-01A-11D-A12K-05		43ae3721-059e-467e-a8a3-7875e738ccef
TCGA-D1-A16N-01	MSI-H	0	TCGA-D1-A16N-01	945	0	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 3	TCGA-D1-A16N	945	0	days	945	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51	0	0	TCGA-D1-A16N-F18584	TCGA-D1-A16N	TCGA-D1-A16N-01A		Stage IIIA	NO		-18787	629		0	945				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Peri (6-12 months since last menstrual period)	G3					NO	false	No	TCGA-D1-A16N.81CFA07C-5FCE-41F3-88D1-FFD17840B293.pdf	A16N	42	positive	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1995	YES	NO	YES	D1	0	10	0	49	Endometrial	A	LIVING	89	2009			TCGA-D1-A16N-01		TCGA-D1-A16N-01A-21-A164-20	4C1FD9BC-7AE2-4325-B08F-56075E677662				TCGA-D1-A16N-01A-11D-A12J-09	TCGA-D1-A16N-01A-11D-A12J-09	TCGA-D1-A16N-01A-11D-A12J-09			TCGA-D1-A16N-01	55b006ca-aacf-4ed5-a0bc-7238eacfb23e	TCGA-D1-A16N-01A-11D-A12G-01		TCGA-D1-A16N-01A-11D-A12G-01	TCGA-D1-A16N-01	TCGA-D1-A16N-01	TCGA-D1-A16N-01A-11D-A12K-05		55b006ca-aacf-4ed5-a0bc-7238eacfb23e
TCGA-D1-A16O-01	MSS	0	TCGA-D1-A16O-01	1023	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 1	TCGA-D1-A16O	1023	0	days	1023	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	44	0	0	TCGA-D1-A16O-F18652	TCGA-D1-A16O	TCGA-D1-A16O-01A		Stage IB	NO		-16114	756		0	1023				NO		Scheduled Follow-up Submission	2011-11-21	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A16O.B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0.pdf	A16O	12	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	0	0	0	Endometrial	A	LIVING	102	2008			TCGA-D1-A16O-01		TCGA-D1-A16O-01A-21-A164-20	641D2D76-4BC1-4A7F-8F59-87BF90319D4F				TCGA-D1-A16O-01A-11D-A12J-09	TCGA-D1-A16O-01A-11D-A12J-09	TCGA-D1-A16O-01A-11D-A12J-09			TCGA-D1-A16O-01	3581b34d-0e76-4feb-a872-b510effff12a	TCGA-D1-A16O-01A-11D-A12G-01		TCGA-D1-A16O-01A-11D-A12G-01	TCGA-D1-A16O-01	TCGA-D1-A16O-01	TCGA-D1-A16O-01A-11D-A12K-05		3581b34d-0e76-4feb-a872-b510effff12a
TCGA-D1-A16Q-01	MSS	0	TCGA-D1-A16Q-01	324	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D1-A16Q	324	0	days	324	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54	0	0	TCGA-D1-A16Q-F18653	TCGA-D1-A16Q	TCGA-D1-A16Q-01A		Stage II	NO		-19873	136		0	324				YES		Scheduled Follow-up Submission	2011-11-21	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A16Q.60635568-D27E-4C72-BFF2-238CF2992925.pdf	A16Q	77	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	19	0	74	Endometrial	A	LIVING	117	2010			TCGA-D1-A16Q-01		TCGA-D1-A16Q-01A-21-A164-20	088C67D6-5A80-407A-BA4A-2F02C25C7A65				TCGA-D1-A16Q-01A-12D-A12J-09	TCGA-D1-A16Q-01A-12D-A12J-09	TCGA-D1-A16Q-01A-12D-A12J-09			TCGA-D1-A16Q-01	6f456a65-f075-469d-a0f9-365cae129564	TCGA-D1-A16Q-01A-12D-A12G-01		TCGA-D1-A16Q-01A-12D-A12G-01	TCGA-D1-A16Q-01	TCGA-D1-A16Q-01	TCGA-D1-A16Q-01A-12D-A12K-05		6f456a65-f075-469d-a0f9-365cae129564
TCGA-D1-A16R-01	MSS	0	TCGA-D1-A16R-01	21	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A16R	21	0	days	21	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	39	0	0	TCGA-D1-A16R-F20316	TCGA-D1-A16R	TCGA-D1-A16R-01A		Stage IA	NO		-14465	161		0	21				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	290	NO		Indeterminate (neither Pre or Postmenopausal)	G1					NO	false	No	TCGA-D1-A16R.D9641375-D204-4469-989A-ED08DDE66408.pdf	A16R	19	negative	TUMOR FREE	0	0		1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	0	0	49	Endometrial	A	LIVING	105	2010			TCGA-D1-A16R-01		TCGA-D1-A16R-01A-21-A164-20	B11290FB-906E-40FD-BB7C-B6F5660388EB				TCGA-D1-A16R-01A-11D-A12J-09	TCGA-D1-A16R-01A-11D-A12J-09	TCGA-D1-A16R-01A-11D-A12J-09			TCGA-D1-A16R-01	16c07e59-0ad4-4a8d-82a0-a77c78119175	TCGA-D1-A16R-01A-11D-A12G-01		TCGA-D1-A16R-01A-11D-A12G-01	TCGA-D1-A16R-01	TCGA-D1-A16R-01	TCGA-D1-A16R-01A-11D-A12K-05		16c07e59-0ad4-4a8d-82a0-a77c78119175
TCGA-D1-A16S-01	MSS	0	TCGA-D1-A16S-01	568	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2	mutation cluster 3	TCGA-D1-A16S	568	0	days	568	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70	0	0	TCGA-D1-A16S-F20314	TCGA-D1-A16S	TCGA-D1-A16S-01A		Stage IIIC	NO		-25690	177		0	568				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	false	No	TCGA-D1-A16S.D69D2E09-B195-4F3F-B5A1-821A87852266.pdf	A16S	100	negative	TUMOR FREE	0	1		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	20	1	35	Endometrial	A	LIVING	59	2010			TCGA-D1-A16S-01		TCGA-D1-A16S-01A-21-A164-20	70A0402E-460F-443A-8851-58C7A2D0BD97				TCGA-D1-A16S-01A-11D-A12J-09	TCGA-D1-A16S-01A-11D-A12J-09	TCGA-D1-A16S-01A-11D-A12J-09			TCGA-D1-A16S-01	7c0fca0e-60ff-4c7e-a337-fb7489f69151	TCGA-D1-A16S-01A-11D-A12G-01		TCGA-D1-A16S-01A-11D-A12G-01	TCGA-D1-A16S-01	TCGA-D1-A16S-01	TCGA-D1-A16S-01A-11D-A12K-05		7c0fca0e-60ff-4c7e-a337-fb7489f69151
TCGA-D1-A16V-01	MSS	1	TCGA-D1-A16V-01	120	1	days	Squamous	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-D1-A16V	120	0	days	120	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	78	0	7	TCGA-D1-A16V-F20230	TCGA-D1-A16V	TCGA-D1-A16V-01A		Stage IIIC	NO		-28635	609	120	0	43				YES		Scheduled Follow-up Submission	2012-1-8	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A16V.92EA83B6-8041-4449-BAE6-5060C32966D0.pdf	A16V	73		TUMOR FREE	0	15		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	7	30	15	35	Endometrial	A	DECEASED	105	2009			TCGA-D1-A16V-01		TCGA-D1-A16V-01A-21-A164-20	C3D27B98-8016-4388-9F04-B07D6389F0EF									TCGA-D1-A16V-01	860613bc-72b2-47bb-90ac-2b272e549860	TCGA-D1-A16V-01A-11D-A12G-01		TCGA-D1-A16V-01A-11D-A12G-01	TCGA-D1-A16V-01	TCGA-D1-A16V-01	TCGA-D1-A16V-01A-11D-A12K-05		860613bc-72b2-47bb-90ac-2b272e549860
TCGA-D1-A16X-01	MSS	0	TCGA-D1-A16X-01	111	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 11	TCGA-D1-A16X	111	0	days	111	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54	0	0	TCGA-D1-A16X-F20231	TCGA-D1-A16X	TCGA-D1-A16X-01A		Stage IB	NO		-19799	618		0	111				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A16X.0C395D2C-1864-448E-8FB7-09BFE5FF4C50.pdf	A16X	18	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	26	0	46	Endometrial	A	LIVING	101	2009			TCGA-D1-A16X-01		TCGA-D1-A16X-01A-21-A164-20	3845198C-CE52-4BAC-936E-CB1FC79D2176					TCGA-D1-A16X-01A-11D-A12J-09	TCGA-D1-A16X-01A-11D-A12J-09			TCGA-D1-A16X-01	4468bb31-bb94-4353-9d13-556d4b8a892a	TCGA-D1-A16X-01A-11D-A12G-01		TCGA-D1-A16X-01A-11D-A12G-01	TCGA-D1-A16X-01	TCGA-D1-A16X-01	TCGA-D1-A16X-01A-11D-A12K-05		4468bb31-bb94-4353-9d13-556d4b8a892a
TCGA-D1-A16Y-01	MSI-L	0	TCGA-D1-A16Y-01	532	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-D1-A16Y	532	0	days	532	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56	0	0	TCGA-D1-A16Y-F20232	TCGA-D1-A16Y	TCGA-D1-A16Y-01A		Stage IB	NO		-20455	610		0	532				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A16Y.0A0451C4-2A58-4404-934E-3517443E4CEE.pdf	A16Y	8	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	6	0	20	Endometrial	A	LIVING	87	2009			TCGA-D1-A16Y-01		TCGA-D1-A16Y-01A-21-A164-20	B3D6CAEC-CBFC-4417-8810-8CB3BF4AE37B					TCGA-D1-A16Y-01A-31D-A12J-09	TCGA-D1-A16Y-01A-31D-A12J-09			TCGA-D1-A16Y-01	486755e1-9b18-4310-a1bb-ddd325f212b0	TCGA-D1-A16Y-01A-31D-A12G-01		TCGA-D1-A16Y-01A-31D-A12G-01	TCGA-D1-A16Y-01	TCGA-D1-A16Y-01	TCGA-D1-A16Y-01A-31D-A12K-05		486755e1-9b18-4310-a1bb-ddd325f212b0
TCGA-D1-A174-01	MSI-H	0	TCGA-D1-A174-01	594	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 6	cluster 1	mutation cluster 11	TCGA-D1-A174	594	0	days	594	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51	0	0	TCGA-D1-A174-F20312	TCGA-D1-A174	TCGA-D1-A174-01A		Stage IA	NO		-18702	219		0	594				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO		Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	No	TCGA-D1-A174.E45B2436-C0B2-44C3-B400-49C668114B01.pdf	A174	8	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1	0	9	0	19	Endometrial	A	LIVING	65	2010			TCGA-D1-A174-01							TCGA-D1-A174-01A-11D-A12J-09	TCGA-D1-A174-01A-11D-A12J-09	TCGA-D1-A174-01A-11D-A12J-09			TCGA-D1-A174-01	67f6f0d9-6581-4946-a9c7-a6629da86888	TCGA-D1-A174-01A-11D-A12G-01		TCGA-D1-A174-01A-11D-A12G-01	TCGA-D1-A174-01	TCGA-D1-A174-01	TCGA-D1-A174-01A-11D-A12K-05		67f6f0d9-6581-4946-a9c7-a6629da86888
TCGA-D1-A175-01	MSI-H	0	TCGA-D1-A175-01	202	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-D1-A175	202	0	days	202	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	48	0	0	TCGA-D1-A175-F20245	TCGA-D1-A175	TCGA-D1-A175-01A		Stage IC	NO		-17802	566		0	202				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	No	TCGA-D1-A175.4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE.pdf	A175	90	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	17	0	23	Endometrial	A	LIVING	64	2009			TCGA-D1-A175-01		TCGA-D1-A175-01A-21-A164-20	E0B67C97-4029-436E-9E17-2A5595C3CF03									TCGA-D1-A175-01	5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8	TCGA-D1-A175-01A-11D-A12G-01		TCGA-D1-A175-01A-11D-A12G-01	TCGA-D1-A175-01	TCGA-D1-A175-01	TCGA-D1-A175-01A-11D-A12K-05		5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8
TCGA-D1-A176-01	MSI-H	0	TCGA-D1-A176-01	917	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-D1-A176	917	0	days	917	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67		0	TCGA-D1-A176-F20248	TCGA-D1-A176	TCGA-D1-A176-01A		Stage IB	NO		-24521	555		0	917				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A176.6F361A45-F13E-44F7-8F3C-00C8B30ACB7A.pdf	A176	13	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	33	0	57	Endometrial	A	LIVING	94	2009			TCGA-D1-A176-01		TCGA-D1-A176-01A-21-A164-20	CF18931D-E2F9-4E89-A78D-93E5DE195854				TCGA-D1-A176-01A-11D-A12J-09	TCGA-D1-A176-01A-11D-A12J-09	TCGA-D1-A176-01A-11D-A12J-09			TCGA-D1-A176-01	8e075c0e-43b4-48b0-9bdc-b27b6d6568b3	TCGA-D1-A176-01A-11D-A12G-01		TCGA-D1-A176-01A-11D-A12G-01	TCGA-D1-A176-01	TCGA-D1-A176-01	TCGA-D1-A176-01A-11D-A12K-05		8e075c0e-43b4-48b0-9bdc-b27b6d6568b3
TCGA-D1-A177-01	MSI-H	0	TCGA-D1-A177-01	548	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 12	TCGA-D1-A177	347	1	days	548	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	YES	Complete Response	70		0	TCGA-D1-A177-F20307	TCGA-D1-A177	TCGA-D1-A177-01A		Stage IB	NO	347	-25602	227		0	548			347	NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	190	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	paraaortic lymph nodes		YES	false	No	TCGA-D1-A177.28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337.pdf	A177	93	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1	0	15	0	45	Endometrial	A	LIVING	53	2010			TCGA-D1-A177-01		TCGA-D1-A177-01A-11-A164-20	10E516C6-19DC-483A-ABA2-471E8FB9CB7E				TCGA-D1-A177-01A-21D-A12J-09	TCGA-D1-A177-01A-21D-A12J-09	TCGA-D1-A177-01A-21D-A12J-09			TCGA-D1-A177-01	75b0fdbd-9670-468e-b426-410c95d84426	TCGA-D1-A177-01A-21D-A12G-01		TCGA-D1-A177-01A-21D-A12G-01	TCGA-D1-A177-01	TCGA-D1-A177-01	TCGA-D1-A177-01A-21D-A12K-05		75b0fdbd-9670-468e-b426-410c95d84426
TCGA-D1-A179-01	MSS	1	TCGA-D1-A179-01	448	1	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	OV-like c4	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-D1-A179	427	1	days	448	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium			NO	Progressive Disease	76		6	TCGA-D1-A179-F20304	TCGA-D1-A179	TCGA-D1-A179-01A		Stage IIIC	NO		-28037	230	448	0	206			427	YES		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	250	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade	Lung	Metastatic			YES	false	No	TCGA-D1-A179.F8F4C024-B723-424C-B98D-AA885C38CDFB.pdf	A179	25	negative	WITH TUMOR		2		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	D1	6	9	2	21	Endometrial	A	DECEASED	95	2010			TCGA-D1-A179-01		TCGA-D1-A179-01A-21-A164-20	1DBC4EDF-4733-486E-9F7E-FE0BFF8A4428									TCGA-D1-A179-01	c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09	TCGA-D1-A179-01A-11D-A12G-01		TCGA-D1-A179-01A-11D-A12G-01	TCGA-D1-A179-01	TCGA-D1-A179-01	TCGA-D1-A179-01A-11D-A12K-05		c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09
TCGA-D1-A17A-01	MSI-H	0	TCGA-D1-A17A-01	48	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 1	TCGA-D1-A17A	48	0	days	48	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59		0	TCGA-D1-A17A-F20250	TCGA-D1-A17A	TCGA-D1-A17A-01A		Stage IIA	NO		-21560	553		0	48				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	176	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A17A.9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472.pdf	A17A	41	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	23	0	40	Endometrial	A	LIVING	102	2009			TCGA-D1-A17A-01							TCGA-D1-A17A-01A-11D-A12J-09	TCGA-D1-A17A-01A-11D-A12J-09	TCGA-D1-A17A-01A-11D-A12J-09			TCGA-D1-A17A-01	88aec124-1462-4fd5-b209-b0dadf1138bc	TCGA-D1-A17A-01A-11D-A12G-01		TCGA-D1-A17A-01A-11D-A12G-01	TCGA-D1-A17A-01	TCGA-D1-A17A-01	TCGA-D1-A17A-01A-11D-A12K-05		88aec124-1462-4fd5-b209-b0dadf1138bc
TCGA-D1-A17B-01	MSI-H	0	TCGA-D1-A17B-01	213	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 12	cluster 2	mutation cluster 4	TCGA-D1-A17B	213	0	days	213	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69			TCGA-D1-A17B-F20251	TCGA-D1-A17B	TCGA-D1-A17B-01A		Stage IB	NO		-25504	685		0	213				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A17B.FBE330EA-52BC-4B16-A046-3858318348F5.pdf	A17B	8	negative	TUMOR FREE		0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1			0	42	Endometrial	A	LIVING	110	2009			TCGA-D1-A17B-01		TCGA-D1-A17B-01A-31-A164-20	B0A6109A-AA31-450B-AD32-4B07EB833EC4				TCGA-D1-A17B-01A-22D-A12J-09	TCGA-D1-A17B-01A-22D-A12J-09	TCGA-D1-A17B-01A-22D-A12J-09			TCGA-D1-A17B-01	7dc8574f-d39c-4a7d-be83-e326a577b5bb	TCGA-D1-A17B-01A-22D-A12G-01		TCGA-D1-A17B-01A-22D-A12G-01	TCGA-D1-A17B-01	TCGA-D1-A17B-01	TCGA-D1-A17B-01A-22D-A12K-05		7dc8574f-d39c-4a7d-be83-e326a577b5bb
TCGA-D1-A17C-01	MSS	0	TCGA-D1-A17C-01	30	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 4	TCGA-D1-A17C	30	0	days	30	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	78			TCGA-D1-A17C-F20302	TCGA-D1-A17C	TCGA-D1-A17C-01A		Stage IA	NO		-28571	249		0	30				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A17C.213A073E-C5E1-4BA8-B4D5-23C92E539FA5.pdf	A17C	14	negative	TUMOR FREE				3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	81	2010			TCGA-D1-A17C-01		TCGA-D1-A17C-01A-21-A164-20	1EA520E6-0092-4DEB-992A-8CA0BB2B9B6C				TCGA-D1-A17C-01A-11D-A12J-09	TCGA-D1-A17C-01A-11D-A12J-09	TCGA-D1-A17C-01A-11D-A12J-09			TCGA-D1-A17C-01	1f3910ae-d1c0-4815-836b-25f2926f9258	TCGA-D1-A17C-01A-11D-A12G-01		TCGA-D1-A17C-01A-11D-A12G-01	TCGA-D1-A17C-01	TCGA-D1-A17C-01	TCGA-D1-A17C-01A-11D-A12K-05		1f3910ae-d1c0-4815-836b-25f2926f9258
TCGA-D1-A17D-01	MSI-H	0	TCGA-D1-A17D-01	926	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 6	TCGA-D1-A17D	926	0	days	926	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58		0	TCGA-D1-A17D-F20254	TCGA-D1-A17D	TCGA-D1-A17D-01A		Stage IB	NO		-21441	541		0	926				YES		Scheduled Follow-up Submission	2012-1-9	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A17D.1042404C-E963-4620-BC02-E33751FDB96C.pdf	A17D	67	negative	TUMOR FREE		0		1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	D1	0	36	0	23	Endometrial	A	LIVING	68	2009			TCGA-D1-A17D-01		TCGA-D1-A17D-01A-21-A164-20	AD75151C-839F-4245-9F2C-94BF67FC993D				TCGA-D1-A17D-01A-12D-A12J-09	TCGA-D1-A17D-01A-12D-A12J-09	TCGA-D1-A17D-01A-12D-A12J-09			TCGA-D1-A17D-01	ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9	TCGA-D1-A17D-01A-12D-A12G-01		TCGA-D1-A17D-01A-12D-A12G-01	TCGA-D1-A17D-01	TCGA-D1-A17D-01	TCGA-D1-A17D-01A-12D-A12K-05		ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9
TCGA-D1-A17F-01	MSI-H	0	TCGA-D1-A17F-01	39	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-D1-A17F	39	0	days	39	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-D1-A17F-F20300	TCGA-D1-A17F	TCGA-D1-A17F-01A		Stage IA	NO		-25116	269		0	39				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A17F.62F464EA-9410-4511-8DE8-F0E62AB1E482.pdf	A17F	21	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	42	Endometrial	A	LIVING	79	2010			TCGA-D1-A17F-01		TCGA-D1-A17F-01A-21-A164-20	4F996645-41F2-42CA-9D4E-F34184B6F95F				TCGA-D1-A17F-01A-11D-A12J-09	TCGA-D1-A17F-01A-11D-A12J-09	TCGA-D1-A17F-01A-11D-A12J-09			TCGA-D1-A17F-01	67a8a629-6001-48cb-99b1-588a69f49ecc	TCGA-D1-A17F-01A-11D-A12G-01		TCGA-D1-A17F-01A-11D-A12G-01	TCGA-D1-A17F-01	TCGA-D1-A17F-01	TCGA-D1-A17F-01A-11D-A12K-05		67a8a629-6001-48cb-99b1-588a69f49ecc
TCGA-D1-A17H-01	MSI-H	0	TCGA-D1-A17H-01	852	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 7	TCGA-D1-A17H	852	0	days	852	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-D1-A17H-F20263	TCGA-D1-A17H	TCGA-D1-A17H-01A	Never Used	Stage IB	NO		-22389	531		0	852				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	167	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A17H.E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4.pdf	A17H	57	negative	TUMOR FREE		0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	28	Endometrial	A	LIVING	96	2009			TCGA-D1-A17H-01		TCGA-D1-A17H-01A-21-A164-20	E8A0F2A3-5323-48FE-BE8B-D1782EC2CB1E				TCGA-D1-A17H-01A-11D-A12J-09	TCGA-D1-A17H-01A-11D-A12J-09	TCGA-D1-A17H-01A-11D-A12J-09			TCGA-D1-A17H-01	e9e9ace8-7686-48a6-9e1b-91899268bd11	TCGA-D1-A17H-01A-11D-A12G-01		TCGA-D1-A17H-01A-11D-A12G-01	TCGA-D1-A17H-01	TCGA-D1-A17H-01	TCGA-D1-A17H-01A-11D-A12K-05		e9e9ace8-7686-48a6-9e1b-91899268bd11
TCGA-D1-A17K-01	MSS	0	TCGA-D1-A17K-01	854	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-D1-A17K	815	1	days	854	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES	Progressive Disease	74			TCGA-D1-A17K-F20268	TCGA-D1-A17K	TCGA-D1-A17K-01A		Stage IA	NO	832	-27283	513		0	854			815	NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Disease	Vagina, apex		YES	false	No	TCGA-D1-A17K.C9E1B85A-8637-4421-A8CD-2E4BB28B3A73.pdf	A17K	0		TUMOR FREE				2	Complete Remission/Response	Never Used		NO	Surgical Resection		R2	R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	97	2009			TCGA-D1-A17K-01		TCGA-D1-A17K-01A-21-A164-20	0C2F85CC-EEFA-46BA-ADF8-A437B7CFDC8E				TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-01A-11D-A12J-09			TCGA-D1-A17K-01	de485b7d-cd88-4889-aff4-e290027f26bb	TCGA-D1-A17K-01A-11D-A12G-01		TCGA-D1-A17K-01A-11D-A12G-01	TCGA-D1-A17K-01	TCGA-D1-A17K-01	TCGA-D1-A17K-01A-11D-A12K-05		de485b7d-cd88-4889-aff4-e290027f26bb
TCGA-D1-A17L-01	MSS	0	TCGA-D1-A17L-01	802	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 1	TCGA-D1-A17L	802	0	days	802	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	81			TCGA-D1-A17L-F20271	TCGA-D1-A17L	TCGA-D1-A17L-01A		Stage IA	NO		-29899	493		0	802				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	172	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A17L.BCF17C02-8F6E-419F-AEDF-3AC03AA883E7.pdf	A17L	22	negative	TUMOR FREE		0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	34	Endometrial	A	LIVING	123	2009			TCGA-D1-A17L-01		TCGA-D1-A17L-01A-21-A164-20	3D47AB97-2F85-4789-82B6-82268ABB08AC				TCGA-D1-A17L-01A-11D-A12J-09	TCGA-D1-A17L-01A-11D-A12J-09	TCGA-D1-A17L-01A-11D-A12J-09			TCGA-D1-A17L-01	1622de43-ddd8-4a57-a89c-70c427d0a9f6	TCGA-D1-A17L-01A-11D-A12G-01		TCGA-D1-A17L-01A-11D-A12G-01	TCGA-D1-A17L-01	TCGA-D1-A17L-01	TCGA-D1-A17L-01A-11D-A12K-05		1622de43-ddd8-4a57-a89c-70c427d0a9f6
TCGA-D1-A17M-01	MSI-H	0	TCGA-D1-A17M-01	311	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A17M	311	0	days	311	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-D1-A17M-F20272	TCGA-D1-A17M	TCGA-D1-A17M-01A		Stage II	NO		-20685	454		0	311				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A17M.E69EF984-AF58-4EB0-93D2-CADE53DF0A6D.pdf	A17M	24	negative	TUMOR FREE		0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	14	Endometrial	A	LIVING	142	2009			TCGA-D1-A17M-01		TCGA-D1-A17M-01A-11-A164-20	C86897DA-DA1F-47F9-9C4C-3922E75EBE55				TCGA-D1-A17M-01A-21D-A12J-09	TCGA-D1-A17M-01A-21D-A12J-09	TCGA-D1-A17M-01A-21D-A12J-09			TCGA-D1-A17M-01	7e8a4ecc-07b0-4765-a8da-5868523736f5	TCGA-D1-A17M-01A-21D-A12G-01		TCGA-D1-A17M-01A-21D-A12G-01	TCGA-D1-A17M-01	TCGA-D1-A17M-01	TCGA-D1-A17M-01A-21D-A12K-05		7e8a4ecc-07b0-4765-a8da-5868523736f5
TCGA-D1-A17N-01	MSS	0	TCGA-D1-A17N-01	46	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 4	mutation c1uster 9	TCGA-D1-A17N	46	0	days	46	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	46			TCGA-D1-A17N-F20274	TCGA-D1-A17N	TCGA-D1-A17N-01A		Stage IA	NO		-17045	451		0	46				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	No	TCGA-D1-A17N.AD892375-1A50-4D9E-8235-A9A495C35B97.pdf	A17N	0	negative	TUMOR FREE				1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	134	2009			TCGA-D1-A17N-01		TCGA-D1-A17N-01A-21-A164-20	2CC2A0B7-B673-4572-94CA-C7FEDD1DB0AC				TCGA-D1-A17N-01A-11D-A12J-09	TCGA-D1-A17N-01A-11D-A12J-09	TCGA-D1-A17N-01A-11D-A12J-09			TCGA-D1-A17N-01	ab241aac-4962-4ccd-919c-140031a13dba	TCGA-D1-A17N-01A-11D-A12G-01		TCGA-D1-A17N-01A-11D-A12G-01	TCGA-D1-A17N-01	TCGA-D1-A17N-01	TCGA-D1-A17N-01A-11D-A12K-05		ab241aac-4962-4ccd-919c-140031a13dba
TCGA-D1-A17Q-01	MSI-L	0	TCGA-D1-A17Q-01	54	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-D1-A17Q	54	0	days	54	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54			TCGA-D1-A17Q-F20277	TCGA-D1-A17Q	TCGA-D1-A17Q-01A		Stage IA	NO		-20015	434		0	54				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	169	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Peri (6-12 months since last menstrual period)	G2					NO	false	No	TCGA-D1-A17Q.698079B6-EB07-4491-9672-4BDE4E5DAC49.pdf	A17Q	12	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	29	Endometrial	A	LIVING	68	2009			TCGA-D1-A17Q-01		TCGA-D1-A17Q-01A-21-A164-20	5518E1C8-0CB5-4944-B0CD-C80DE1E1B87F					TCGA-D1-A17Q-01A-11D-A12J-09	TCGA-D1-A17Q-01A-11D-A12J-09			TCGA-D1-A17Q-01	85b22bad-9b11-474f-9c87-5ddb98c76ccb	TCGA-D1-A17Q-01A-11D-A12G-01		TCGA-D1-A17Q-01A-11D-A12G-01	TCGA-D1-A17Q-01	TCGA-D1-A17Q-01	TCGA-D1-A17Q-01A-11D-A12K-05		85b22bad-9b11-474f-9c87-5ddb98c76ccb
TCGA-D1-A17R-01	MSI-H	1	TCGA-D1-A17R-01	339	1	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 4	TCGA-D1-A17R	339	0	days	339	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58			TCGA-D1-A17R-F20285	TCGA-D1-A17R	TCGA-D1-A17R-01A		Stage IA	NO		-21382	443	339	0					NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	No	TCGA-D1-A17R.51598364-A609-4EBC-8500-53042C9E79E9.pdf	A17R	5	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	11	Endometrial	A	DECEASED	126	2009			TCGA-D1-A17R-01		TCGA-D1-A17R-01A-21-A164-20	B75B6784-2F5F-4900-8541-D7AD05DA5233				TCGA-D1-A17R-01A-11D-A12J-09	TCGA-D1-A17R-01A-11D-A12J-09	TCGA-D1-A17R-01A-11D-A12J-09			TCGA-D1-A17R-01	e500f620-089f-4e15-ba8c-25c91e88e7e2	TCGA-D1-A17R-01A-11D-A12G-01		TCGA-D1-A17R-01A-11D-A12G-01	TCGA-D1-A17R-01	TCGA-D1-A17R-01	TCGA-D1-A17R-01A-11D-A12K-05		e500f620-089f-4e15-ba8c-25c91e88e7e2
TCGA-D1-A17S-01	MSS	0	TCGA-D1-A17S-01	739	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 4	TCGA-D1-A17S	739	0	days	739	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	59			TCGA-D1-A17S-F20288	TCGA-D1-A17S	TCGA-D1-A17S-01A		Stage IA	NO		-21794	419		0	739				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A17S.54337BED-9366-4CB6-BA95-BB5999CBF342.pdf	A17S	18	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	52	Endometrial	A	LIVING	109	2009			TCGA-D1-A17S-01		TCGA-D1-A17S-01A-21-A164-20	3A7C1301-5B80-4043-97F5-99E5B02456A1				TCGA-D1-A17S-01A-11D-A12J-09	TCGA-D1-A17S-01A-11D-A12J-09	TCGA-D1-A17S-01A-11D-A12J-09			TCGA-D1-A17S-01	dcd43fa2-2529-47e6-9d9f-931cbf8d4da5	TCGA-D1-A17S-01A-11D-A12G-01		TCGA-D1-A17S-01A-11D-A12G-01	TCGA-D1-A17S-01	TCGA-D1-A17S-01	TCGA-D1-A17S-01A-11D-A12K-05		dcd43fa2-2529-47e6-9d9f-931cbf8d4da5
TCGA-D1-A17T-01	MSS	0	TCGA-D1-A17T-01	71	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3	mutation cluster 4	TCGA-D1-A17T	71	0	days	71	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67			TCGA-D1-A17T-F20289	TCGA-D1-A17T	TCGA-D1-A17T-01A		Stage IA	NO		-24652	318		0	71				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A17T.D5927418-5A2B-477D-9917-7CE912628CA4.pdf	A17T	25		TUMOR FREE		0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0	0	24	Endometrial	A	LIVING	83	2010			TCGA-D1-A17T-01		TCGA-D1-A17T-01A-21-A164-20	A27DCED7-D683-4251-A4A8-A087059D6F19				TCGA-D1-A17T-01A-11D-A12J-09	TCGA-D1-A17T-01A-11D-A12J-09	TCGA-D1-A17T-01A-11D-A12J-09			TCGA-D1-A17T-01	2ede539e-5856-4781-bb6f-b1c6efbdf23d	TCGA-D1-A17T-01A-11D-A12G-01		TCGA-D1-A17T-01A-11D-A12G-01	TCGA-D1-A17T-01	TCGA-D1-A17T-01	TCGA-D1-A17T-01A-11D-A12K-05		2ede539e-5856-4781-bb6f-b1c6efbdf23d
TCGA-D1-A17U-01	MSI-H	0	TCGA-D1-A17U-01	697	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4	mutation cluster 1	TCGA-D1-A17U	697	0	days	697	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53		4	TCGA-D1-A17U-F20293	TCGA-D1-A17U	TCGA-D1-A17U-01A		Stage IIIC2	NO		-19544	314		0	697				NO		Scheduled Follow-up Submission	2012-1-9	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-D1-A17U.A0A4164D-FD8D-4472-BAFA-A036469E22CC.pdf	A17U	100	negative	TUMOR FREE		0		0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	4	9	0	3	Endometrial	A	LIVING	87	2010			TCGA-D1-A17U-01		TCGA-D1-A17U-01A-11-A164-20	0D4EB4B1-2250-4BFE-A2B0-CDC6AA7E7247				TCGA-D1-A17U-01A-21D-A12J-09	TCGA-D1-A17U-01A-21D-A12J-09	TCGA-D1-A17U-01A-21D-A12J-09			TCGA-D1-A17U-01	07508c27-8f79-414e-af9d-e78240df5c48	TCGA-D1-A17U-01A-21D-A12G-01		TCGA-D1-A17U-01A-21D-A12G-01	TCGA-D1-A17U-01	TCGA-D1-A17U-01	TCGA-D1-A17U-01A-21D-A12K-05		07508c27-8f79-414e-af9d-e78240df5c48
TCGA-D1-A1NS-01	MSI-H	0	TCGA-D1-A1NS-01	43	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-D1-A1NS	43	0	days	43	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	53			TCGA-D1-A1NS-F21633	TCGA-D1-A1NS	TCGA-D1-A1NS-01A		Stage IA	NO		-19638	92		0	43				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	178	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A1NS.FE397385-B600-4450-AE73-3CB62D5FEA3B.pdf	A1NS	17	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	41	Endometrial	A	LIVING	126	2010			TCGA-D1-A1NS-01		TCGA-D1-A1NS-01A-21-A18Q-20	00339539-4450-4AD5-90AC-FDFE11DD167B									TCGA-D1-A1NS-01	48ade293-84c9-41cf-97aa-c28bb4ac4ca6	TCGA-D1-A1NS-01A-11D-A14F-01		TCGA-D1-A1NS-01A-11D-A14F-01	TCGA-D1-A1NS-01	TCGA-D1-A1NS-01	TCGA-D1-A1NS-01A-11D-A14H-05		48ade293-84c9-41cf-97aa-c28bb4ac4ca6
TCGA-D1-A1NU-01	MSS	0	TCGA-D1-A1NU-01	402	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 3	TCGA-D1-A1NU	402	0	days	402	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74	0	0	TCGA-D1-A1NU-F21638	TCGA-D1-A1NU	TCGA-D1-A1NU-01A		Stage IA	NO		-27272	87		0	402				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	151	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A1NU.08AE92E6-EDAB-4059-AF51-4A8522EDD463.pdf	A1NU	16	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	8	0	37	Endometrial	A	LIVING	93	2010			TCGA-D1-A1NU-01		TCGA-D1-A1NU-01A-21-A18Q-20	8E2D8E73-9940-4E05-8463-D5174A602B15				TCGA-D1-A1NU-01A-11D-A14G-09	TCGA-D1-A1NU-01A-11D-A14G-09	TCGA-D1-A1NU-01A-11D-A14G-09			TCGA-D1-A1NU-01	543b9907-bf2a-4f64-b83f-13cc4289310b	TCGA-D1-A1NU-01A-11D-A14F-01		TCGA-D1-A1NU-01A-11D-A14F-01	TCGA-D1-A1NU-01	TCGA-D1-A1NU-01	TCGA-D1-A1NU-01A-11D-A14H-05		543b9907-bf2a-4f64-b83f-13cc4289310b
TCGA-D1-A1NW-01	MSI-L	0	TCGA-D1-A1NW-01	22	0	days	Squamous		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A1NW	22	0	days	22	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72	0	2	TCGA-D1-A1NW-F21642	TCGA-D1-A1NW	TCGA-D1-A1NW-01A		Stage IVB	NO		-26556	199		0	22				NO		Scheduled Follow-up Submission	2012-2-12	FEMALE	160	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	80	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A1NW.10E1E872-408C-458D-9438-00F5ECA3083A.pdf	A1NW	0	positive	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	2	26	0	36	Endometrial	A	LIVING	98	2010			TCGA-D1-A1NW-01												TCGA-D1-A1NW-01	35759844-0020-4b37-bd5a-ede870b7f0ab	TCGA-D1-A1NW-01A-11D-A14J-01		TCGA-D1-A1NW-01A-11D-A14J-01	TCGA-D1-A1NW-01	TCGA-D1-A1NW-01	TCGA-D1-A1NW-01A-11D-A14N-05		35759844-0020-4b37-bd5a-ede870b7f0ab
TCGA-D1-A1NX-01	MSS	0	TCGA-D1-A1NX-01	555	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 3	TCGA-D1-A1NX	476	1	days	555	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium		YES	NO	Partial Response	66	0	13	TCGA-D1-A1NX-F21565	TCGA-D1-A1NX			Stage IIIC	NO		-24441			0	555			476	NO		Scheduled Follow-up Submission	2012-2-15	FEMALE	159	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	Supraclavicular lymphnodes		YES		No		A1NX	95	positive	WITH TUMOR	0	8		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	13	23	8	39	Endometrial		LIVING	87	2010			TCGA-D1-A1NX-01								TCGA-D1-A1NX-01A-11D-A16D-09	TCGA-D1-A1NX-01A-11D-A16D-09			TCGA-D1-A1NX-01	d04855a8-fdd2-464c-967d-1a58e530539f	TCGA-D1-A1NX-01A-11D-A16C-01		TCGA-D1-A1NX-01A-11D-A16C-01	TCGA-D1-A1NX-01	TCGA-D1-A1NX-01	TCGA-D1-A1NX-01A-11D-A16G-05		d04855a8-fdd2-464c-967d-1a58e530539f
TCGA-D1-A1NY-01	MSI-H	0	TCGA-D1-A1NY-01	513	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-D1-A1NY	513	0	days	513	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67	0	0	TCGA-D1-A1NY-F21629	TCGA-D1-A1NY	TCGA-D1-A1NY-01A		Stage IB	NO		-24683	199		0	513				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A1NY.8F963009-F6C3-4F45-B714-0E96F5D5E526.pdf	A1NY	85	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	YES	NO	YES	D1	0	10	0	17	Endometrial	A	LIVING	97	2010			TCGA-D1-A1NY-01		TCGA-D1-A1NY-01A-21-A18Q-20	D5F226EC-8A5F-4393-B698-AF727D23D16C									TCGA-D1-A1NY-01	e0397750-69a4-41ef-bcb0-70bc4b2d7c87	TCGA-D1-A1NY-01A-11D-A16C-01		TCGA-D1-A1NY-01A-11D-A16C-01	TCGA-D1-A1NY-01	TCGA-D1-A1NY-01	TCGA-D1-A1NY-01A-11D-A16G-05		e0397750-69a4-41ef-bcb0-70bc4b2d7c87
TCGA-D1-A1NZ-01	MSI-H	0	TCGA-D1-A1NZ-01	548	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	squamous c3	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-D1-A1NZ	548	0	days	548	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60			TCGA-D1-A1NZ-F17383	TCGA-D1-A1NZ	TCGA-D1-A1NZ-01A		Stage IA	NO		-22027	191		0	548				NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	Yes, I am currently taking menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A1NZ.0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25.pdf	A1NZ	33	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	34	Endometrial	A	LIVING	90	2010			TCGA-D1-A1NZ-01		TCGA-D1-A1NZ-01A-11-A18Q-20	C38FA373-FEA7-4076-BBAA-5E7D6F2443AC									TCGA-D1-A1NZ-01	e947ba64-793a-4462-9447-5c02a4a9ff39	TCGA-D1-A1NZ-01A-21D-A14F-01		TCGA-D1-A1NZ-01A-21D-A14F-01	TCGA-D1-A1NZ-01	TCGA-D1-A1NZ-01	TCGA-D1-A1NZ-01A-21D-A14H-05		e947ba64-793a-4462-9447-5c02a4a9ff39
TCGA-D1-A1O0-01	MSS	0	TCGA-D1-A1O0-01	63	0	days	BRCA-LUAD+		UCEC non-CIMP c3	cluster 3		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-D1-A1O0	63	0	days	63	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77	0	0	TCGA-D1-A1O0-F21636	TCGA-D1-A1O0	TCGA-D1-A1O0-01A		Stage IA	NO		-28162	195		0	63				YES		Scheduled Follow-up Submission	2012-2-16	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A1O0.2F5CADA5-176C-4B9D-9660-53BE86B1CD39.pdf	A1O0	5	negative	TUMOR FREE	0	0		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1	0	5	0	38	Endometrial	A	LIVING	117	2010			TCGA-D1-A1O0-01												TCGA-D1-A1O0-01	6eefe77a-d312-44fc-9b9e-7c3b439a7e23	TCGA-D1-A1O0-01A-11D-A17C-01		TCGA-D1-A1O0-01A-11D-A17C-01	TCGA-D1-A1O0-01	TCGA-D1-A1O0-01	TCGA-D1-A1O0-01A-11D-A17F-05		6eefe77a-d312-44fc-9b9e-7c3b439a7e23
TCGA-D1-A1O5-01	MSS	0	TCGA-D1-A1O5-01	458	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-D1-A1O5	458	0	days	458	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-D1-A1O5-F21574	TCGA-D1-A1O5	TCGA-D1-A1O5-01A		Stage IA	NO		-22580	174		0	458				NO		Scheduled Follow-up Submission	2012-2-15	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A1O5.F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D.pdf	A1O5	8	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	0	20	Endometrial	A	LIVING	80	2010			TCGA-D1-A1O5-01		TCGA-D1-A1O5-01A-21-A18Q-20	E9F2117D-AFD1-418A-8580-70586444AB0A									TCGA-D1-A1O5-01	7bc83c49-3fd8-4048-adf4-b461fcffcc00	TCGA-D1-A1O5-01A-11D-A14F-01		TCGA-D1-A1O5-01A-11D-A14F-01	TCGA-D1-A1O5-01	TCGA-D1-A1O5-01	TCGA-D1-A1O5-01A-11D-A14H-05		7bc83c49-3fd8-4048-adf4-b461fcffcc00
TCGA-D1-A1O7-01	MSI-H	0	TCGA-D1-A1O7-01	32	0	days	Quiet		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A1O7	32	0	days	32	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60			TCGA-D1-A1O7-F21637	TCGA-D1-A1O7	TCGA-D1-A1O7-01A		Stage IA	NO		-22037	154		0	32				YES		Scheduled Follow-up Submission	2012-2-16	FEMALE	148	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	50	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-D1-A1O7.37C25226-AD56-487E-969B-1538E6E00A5D.pdf	A1O7	5		TUMOR FREE				2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	D1		0		0	Endometrial	A	LIVING	96	2010			TCGA-D1-A1O7-01												TCGA-D1-A1O7-01	00ea54c2-1043-4a7f-ae62-e2851eb94ba1	TCGA-D1-A1O7-01A-11D-A14F-01		TCGA-D1-A1O7-01A-11D-A14F-01	TCGA-D1-A1O7-01	TCGA-D1-A1O7-01	TCGA-D1-A1O7-01A-11D-A14H-05		00ea54c2-1043-4a7f-ae62-e2851eb94ba1
TCGA-D1-A1O8-01	MSS	1	TCGA-D1-A1O8-01	120	1	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	RNA cluster 3	miRNA cluster 6	cluster 1		TCGA-D1-A1O8	120	0	days	120	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70			TCGA-D1-A1O8-F21635	TCGA-D1-A1O8	TCGA-D1-A1O8-01A		Stage IIIC	NO		-25789	147	120	0					NO		Scheduled Follow-up Submission	2012-2-16	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-D1-A1O8.8E7FDFD5-892F-4671-8172-FC2BFB800AE9.pdf	A1O8	85	negative	TUMOR FREE	0	3		0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	D1		0	3	3	Endometrial	A	DECEASED	85	2010			TCGA-D1-A1O8-01		TCGA-D1-A1O8-01A-21-A18Q-20	B02713DD-EA3F-4965-B8E7-EF2B40F7A599									TCGA-D1-A1O8-01	980faf04-5313-4f74-99b7-ca004f698a93	TCGA-D1-A1O8-01A-11D-A14F-01		TCGA-D1-A1O8-01A-11D-A14F-01	TCGA-D1-A1O8-01	TCGA-D1-A1O8-01	TCGA-D1-A1O8-01A-11D-A14H-05		980faf04-5313-4f74-99b7-ca004f698a93
TCGA-D1-A2G0-01	MSI-H	0	TCGA-D1-A2G0-01	1484	0	days	Kirc+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA c1uster 10	cluster 3		TCGA-D1-A2G0			days	1484	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					70	0	0	TCGA-D1-A2G0-F41534	TCGA-D1-A2G0	TCGA-D1-A2G0-01A		Stage IB	NO		-25573	1416		0	1484				NO			2015-5-18	FEMALE	171	Mixed serous and endometrioid	No		NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	90	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-D1-A2G0.02872006-6F7E-4FB7-B1C2-1C5DD3199FE3.pdf	A2G0	17	negative	TUMOR FREE	0	0		2								R0	Primary Tumor	01	open	1995		NO	YES	D1	0	13	0	37	Endometrial	A	LIVING	73	2007	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229		TCGA-D1-A2G0-01	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229	TCGA-D1-A2G0-01A-21-A18Q-20	AF037631-DDA4-417C-9104-816BFE0B456F			ca1b7ca7-5c8b-442d-ab3d-29bd16de1229				ca1b7ca7-5c8b-442d-ab3d-29bd16de1229		TCGA-D1-A2G0-01		TCGA-D1-A2G0-01A-11D-A17C-01		TCGA-D1-A2G0-01A-11D-A17C-01	TCGA-D1-A2G0-01	TCGA-D1-A2G0-01	TCGA-D1-A2G0-01A-11D-A17F-05		
TCGA-D1-A2G5-01	MSI-H	0	TCGA-D1-A2G5-01	1455	0	days	Iq		UCEC CIMP c18	cluster 2		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A2G5	1122	1	days	1455	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES			50	0	0	TCGA-D1-A2G5-F41443	TCGA-D1-A2G5			Stage IB	NO		-18322			0	1455		1122	1122	NO			2013-3-19	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	omentum	YES	YES		Yes		A2G5	20	negative	WITH TUMOR	0	1	NO	0	Complete Remission/Response	Never Used		YES	Excisional Biopsy		R0	R0	Primary Tumor	01	open	1995		NO	YES	D1	0	15	1	37	Endometrial		LIVING	143	2007			TCGA-D1-A2G5-01												TCGA-D1-A2G5-01	c890843b-4712-4d9f-998d-8ddcb2c39c3c	TCGA-D1-A2G5-01A-11D-A17C-01		TCGA-D1-A2G5-01A-11D-A17C-01	TCGA-D1-A2G5-01	TCGA-D1-A2G5-01	TCGA-D1-A2G5-01A-11D-A17F-05		c890843b-4712-4d9f-998d-8ddcb2c39c3c
TCGA-D1-A2G6-01	MSI-H	1	TCGA-D1-A2G6-01	258	1	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 4		TCGA-D1-A2G6			days	258	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					53	0	0		TCGA-D1-A2G6	TCGA-D1-A2G6-01A		Stage IIIC			-19547	1350	258	0								2011-6-2	FEMALE	168	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-D1-A2G6.3375E2AF-173B-4263-84A8-8535DF33BA69.pdf	A2G6	94	positive	WITH TUMOR	0	2										R0	Primary Tumor	01	open	1995		NO	YES	D1	0	20	2	30	Endometrial	A	DECEASED	80	2007			TCGA-D1-A2G6-01		TCGA-D1-A2G6-01A-21-A18Q-20	02777737-0116-4B62-95A0-2A2EBD4426B8									TCGA-D1-A2G6-01	ccc7b7d6-f3a1-48b7-a266-73080858257d	TCGA-D1-A2G6-01A-11D-A17C-01		TCGA-D1-A2G6-01A-11D-A17C-01	TCGA-D1-A2G6-01	TCGA-D1-A2G6-01	TCGA-D1-A2G6-01A-11D-A17F-05		ccc7b7d6-f3a1-48b7-a266-73080858257d
TCGA-D1-A2G7-01	MSS	1	TCGA-D1-A2G7-01	1793	1	days	Squamous	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-D1-A2G7	1793	0	days	1793	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65	0	0	TCGA-D1-A2G7-F41607	TCGA-D1-A2G7	TCGA-D1-A2G7-01A	Never Used	Stage IB			-23913	1339	1793	0	1365				YES			2015-5-18	FEMALE	164	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	true	No	TCGA-D1-A2G7.5D25FD0B-EEE9-435C-82C7-BC44B0758A14.pdf	A2G7	8	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1995		NO	YES	D1	0	23	0	48	Endometrial	A	DECEASED	133	2007			TCGA-D1-A2G7-01		TCGA-D1-A2G7-01A-12-A18R-20	4874B9A7-5E58-4F1A-B972-582F6E39C71B									TCGA-D1-A2G7-01	bddd28d0-8d22-4949-b890-9cd54a4a0f29	TCGA-D1-A2G7-01A-21D-A17U-01		TCGA-D1-A2G7-01A-21D-A17U-01	TCGA-D1-A2G7-01	TCGA-D1-A2G7-01	TCGA-D1-A2G7-01A-21D-A17Z-05		bddd28d0-8d22-4949-b890-9cd54a4a0f29
TCGA-D1-A3DA-01	MSI-L	0	TCGA-D1-A3DA-01	483	0	days	Iq		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 13			TCGA-D1-A3DA	483	0	days	483	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	77			TCGA-D1-A3DA-F41456	TCGA-D1-A3DA	TCGA-D1-A3DA-01A		Stage IIIC1	NO		-28142	128		0	483				NO			2013-3-27	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-D1-A3DA.8F3D4AFC-2E70-4633-A58F-C98ED00A8964.pdf	A3DA	17	positive	TUMOR FREE			YES	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	D1	0	19	1	34	Endometrial	A	LIVING	57	2011	21fd1035-30e0-4851-88c6-35d2693e6dcd		TCGA-D1-A3DA-01	21fd1035-30e0-4851-88c6-35d2693e6dcd	TCGA-D1-A3DA-01A-21-A23Z-20	9555CB48-3997-46E2-B1A5-228F8FCFA62E			21fd1035-30e0-4851-88c6-35d2693e6dcd				21fd1035-30e0-4851-88c6-35d2693e6dcd		TCGA-D1-A3DA-01		TCGA-D1-A3DA-01A-12D-A20R-01		TCGA-D1-A3DA-01A-12D-A20R-01	TCGA-D1-A3DA-01	TCGA-D1-A3DA-01	TCGA-D1-A3DA-01A-12D-A212-05		
TCGA-D1-A3DG-01	MSS	1	TCGA-D1-A3DG-01	130	1	days	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-D1-A3DG	130	0	days	130	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					81			TCGA-D1-A3DG-F41478	TCGA-D1-A3DG	TCGA-D1-A3DG-01A		Stage IVB	NO		-29771	49	130	0	130				NO			2015-5-18	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-D1-A3DG.97C44FFC-8D88-43DC-BCC9-F634151C7098.pdf	A3DG	41	positive	TUMOR FREE			NO	3		Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	D1		0		0	Endometrial	A	DECEASED	86	2011	11a0e295-f45e-4979-8317-10429d515d34		TCGA-D1-A3DG-01	11a0e295-f45e-4979-8317-10429d515d34	TCGA-D1-A3DG-01A-21-A23Z-20	F12A529F-E468-486B-8B4E-A1EBC92C1A73			11a0e295-f45e-4979-8317-10429d515d34				11a0e295-f45e-4979-8317-10429d515d34		TCGA-D1-A3DG-01		TCGA-D1-A3DG-01A-11D-A19X-01		TCGA-D1-A3DG-01A-11D-A19X-01	TCGA-D1-A3DG-01	TCGA-D1-A3DG-01	TCGA-D1-A3DG-01A-11D-A19Z-05		
TCGA-D1-A3DH-01	MSS	0	TCGA-D1-A3DH-01	573	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 9			TCGA-D1-A3DH	573	0	days	573	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-D1-A3DH-F41531	TCGA-D1-A3DH	TCGA-D1-A3DH-01A		Stage IA	NO		-25935	43		0	573				YES			2015-5-18	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Excisional Biopsy	150	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-D1-A3DH.C63CF985-CF78-42EE-A7A2-22083FED571D.pdf	A3DH	11	negative	TUMOR FREE			NO	4+	Complete Remission/Response			YES				R0	Primary Tumor	01	open	2009		NO	YES	D1	0	14	0	48	Endometrial	A	LIVING	76	2011	8576f260-e8fb-4fbf-81ad-34fb4af302fd		TCGA-D1-A3DH-01	8576f260-e8fb-4fbf-81ad-34fb4af302fd	TCGA-D1-A3DH-01A-21-A23Z-20	2EFDF91C-E96E-4A86-BF0C-A275A9FF2BA0			8576f260-e8fb-4fbf-81ad-34fb4af302fd				8576f260-e8fb-4fbf-81ad-34fb4af302fd		TCGA-D1-A3DH-01		TCGA-D1-A3DH-01A-11D-A19X-01		TCGA-D1-A3DH-01A-11D-A19X-01	TCGA-D1-A3DH-01	TCGA-D1-A3DH-01	TCGA-D1-A3DH-01A-11D-A19Z-05		
TCGA-D1-A3JP-01	MSS	0	TCGA-D1-A3JP-01	515	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-D1-A3JP	515	0	days	515	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					61				TCGA-D1-A3JP	TCGA-D1-A3JP-01A		Stage IA	NO		-22538	101		0	515				NO			2013-3-20	FEMALE	159	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	170	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-D1-A3JP.62290E86-409F-4590-AA2C-D3D2F77148FF.pdf	A3JP	0	negative	TUMOR FREE			NO	2	Partial Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	D1	0	18	0	56	Endometrial	A	LIVING	59	2011	f579f0dc-d6e3-4960-9769-5038e69aa712		TCGA-D1-A3JP-01	f579f0dc-d6e3-4960-9769-5038e69aa712	TCGA-D1-A3JP-01A-21-A240-20	881675F5-0526-4D86-B58F-40868B7B36B1			f579f0dc-d6e3-4960-9769-5038e69aa712				f579f0dc-d6e3-4960-9769-5038e69aa712				TCGA-D1-A3JP-01A-31D-A227-01		TCGA-D1-A3JP-01A-31D-A227-01		TCGA-D1-A3JP-01	TCGA-D1-A3JP-01A-31D-A22B-05		
TCGA-D1-A3JQ-01	MSS	0	TCGA-D1-A3JQ-01	526	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-D1-A3JQ	526	0	days	526	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-D1-A3JQ-F41416	TCGA-D1-A3JQ	TCGA-D1-A3JQ-01A		Stage IIIC	NO		-22297	77		0	526				NO			2013-3-19	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-D1-A3JQ.2001A1EC-1385-4EB3-BC9E-7E48143FD663.pdf	A3JQ	32	negative	TUMOR FREE			YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	D1	0	20	1	28	Endometrial	A	LIVING	121	2011	10c76952-15aa-44e9-8197-26529889bb6a		TCGA-D1-A3JQ-01	10c76952-15aa-44e9-8197-26529889bb6a	TCGA-D1-A3JQ-01A-21-A23Z-20	1EE04796-47C3-4BC2-8316-36ED0C56C6BB			10c76952-15aa-44e9-8197-26529889bb6a				10c76952-15aa-44e9-8197-26529889bb6a		TCGA-D1-A3JQ-01		TCGA-D1-A3JQ-01A-11D-A227-01		TCGA-D1-A3JQ-01A-11D-A227-01	TCGA-D1-A3JQ-01	TCGA-D1-A3JQ-01	TCGA-D1-A3JQ-01A-11D-A22B-05		
TCGA-DF-A2KN-01	MSI-H	0	TCGA-DF-A2KN-01	67	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-DF-A2KN	67	0	days	67	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response				TCGA-DF-A2KN-F51114	TCGA-DF-A2KN	TCGA-DF-A2KN-01A		Stage IC	NO						67							2013-11-7	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DF-A2KN.A61CE064-B18B-429E-93F1-BA0FC06AB310.pdf	A2KN			TUMOR FREE			NO		Complete Remission/Response							RX	Primary Tumor	01				NO	YES	DF		0	0	20	Endometrial	A	LIVING	77		291167cc-8f00-47e1-abe2-72388c98170d		TCGA-DF-A2KN-01	291167cc-8f00-47e1-abe2-72388c98170d	TCGA-DF-A2KN-01A-21-A18R-20	B215AA1E-6DD0-48DE-BFED-181FC2612DBD			291167cc-8f00-47e1-abe2-72388c98170d				291167cc-8f00-47e1-abe2-72388c98170d		TCGA-DF-A2KN-01		TCGA-DF-A2KN-01A-11D-A17U-01		TCGA-DF-A2KN-01A-11D-A17U-01	TCGA-DF-A2KN-01	TCGA-DF-A2KN-01	TCGA-DF-A2KN-01A-11D-A17Z-05		
TCGA-DF-A2KR-01	MSS	0	TCGA-DF-A2KR-01	2178	0	days	High		UCEC non-CIMP c3				miRNA c1uster 10	cluster 2		TCGA-DF-A2KR	2113	1	days	2178	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES		Complete Response	84			TCGA-DF-A2KR-F49885	TCGA-DF-A2KR			Stage IIIC	NO		-31007				2178			2113	NO			2013-10-14	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	endometrial biopsy, not otherwise specified	Other method, specify:			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	New Primary Tumor		NO	YES		No		A2KR	70		TUMOR FREE	0	1	NO	0	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open			NO	YES	DF			1	7	Endometrial		LIVING			b8e18fd7-ff5d-44b9-b977-945622d2a59e		TCGA-DF-A2KR-01	b8e18fd7-ff5d-44b9-b977-945622d2a59e					b8e18fd7-ff5d-44b9-b977-945622d2a59e				b8e18fd7-ff5d-44b9-b977-945622d2a59e		TCGA-DF-A2KR-01		TCGA-DF-A2KR-01A-11D-A17U-01		TCGA-DF-A2KR-01A-11D-A17U-01	TCGA-DF-A2KR-01	TCGA-DF-A2KR-01	TCGA-DF-A2KR-01A-11D-A17Z-05		
TCGA-DF-A2KS-01	MSS	0	TCGA-DF-A2KS-01	3318	0	days	High	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-DF-A2KS	2277	1	days	3318	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Complete Response	69			TCGA-DF-A2KS-F72048	TCGA-DF-A2KS	TCGA-DF-A2KS-01A		Stage IB	NO		-25313				3318			2277	YES			2015-4-2	FEMALE		Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES	endometrial biopsy not otherwise specified	Other method, specify:	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	New Primary Tumor	colorectal	YES	YES	false	No	TCGA-DF-A2KS.C6638C17-4F05-491F-86ED-6D7DDB1B8FDE.pdf	A2KS	31	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		YES	Surgical Resection			RX	Primary Tumor	01	Minimally Invasive			NO	YES	DF		0	0	18	Endometrial	A	LIVING	66				TCGA-DF-A2KS-01		TCGA-DF-A2KS-01A-21-A23Z-20	905BD3B7-05F2-4DE8-B4A2-4D839BC28908									TCGA-DF-A2KS-01	05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2	TCGA-DF-A2KS-01A-11D-A18N-01		TCGA-DF-A2KS-01A-11D-A18N-01	TCGA-DF-A2KS-01	TCGA-DF-A2KS-01	TCGA-DF-A2KS-01A-11D-A18O-05		05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2
TCGA-DF-A2KU-01	MSI-L	0	TCGA-DF-A2KU-01	3067	0	days	Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-DF-A2KU	3067	0	days	3067	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response				TCGA-DF-A2KU-F72047	TCGA-DF-A2KU	TCGA-DF-A2KU-01A		Stage IB	NO						3067				NO			2015-4-2	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	380	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DF-A2KU.6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98.pdf	A2KU	8	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open			NO	YES	DF		0	0	9	Endometrial	A	LIVING			ee0873f1-b89d-44ef-9aad-d40c5a8999f1		TCGA-DF-A2KU-01	ee0873f1-b89d-44ef-9aad-d40c5a8999f1	TCGA-DF-A2KU-01A-21-A18R-20	E3626449-4A3F-4515-972E-CBCB111BE320			ee0873f1-b89d-44ef-9aad-d40c5a8999f1				ee0873f1-b89d-44ef-9aad-d40c5a8999f1		TCGA-DF-A2KU-01		TCGA-DF-A2KU-01A-11D-A17U-01		TCGA-DF-A2KU-01A-11D-A17U-01	TCGA-DF-A2KU-01	TCGA-DF-A2KU-01	TCGA-DF-A2KU-01A-11D-A17Z-05		
TCGA-DF-A2KV-01	MSS	0	TCGA-DF-A2KV-01	2717	0	days	Quiet		UCEC non-CIMP c3		UCEC-like c5		miRNA c1uster 10			TCGA-DF-A2KV	2717	0	days	2717	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					55			TCGA-DF-A2KV-F66260	TCGA-DF-A2KV	TCGA-DF-A2KV-01A		Stage IB	NO		-20160			0	2717				NO			2014-10-7	FEMALE		Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	580	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DF-A2KV.5717937B-AC81-452E-9B4D-3301FDA7CD0B.pdf	A2KV	21	negative	TUMOR FREE	0	0		0								RX	Primary Tumor	01	open			NO	YES	DF		0	0	21	Endometrial	A	LIVING			5378bbbf-3ddf-43bf-824d-fcb46028f571		TCGA-DF-A2KV-01	5378bbbf-3ddf-43bf-824d-fcb46028f571	TCGA-DF-A2KV-01A-21-A18R-20	6A4B246D-F732-4F90-8197-0BE951D9C954			5378bbbf-3ddf-43bf-824d-fcb46028f571				5378bbbf-3ddf-43bf-824d-fcb46028f571		TCGA-DF-A2KV-01		TCGA-DF-A2KV-01A-11D-A17U-01		TCGA-DF-A2KV-01A-11D-A17U-01	TCGA-DF-A2KV-01	TCGA-DF-A2KV-01	TCGA-DF-A2KV-01A-11D-A17Z-05		
TCGA-DF-A2KY-01	MSI-H	0	TCGA-DF-A2KY-01	332	0	days	Kirc+		BRCA CIMP c7		BRCA basal-like c6		miRNA c1uster 9			TCGA-DF-A2KY			days	332	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					49	0	0		TCGA-DF-A2KY	TCGA-DF-A2KY-01A		Stage IVA			-18086			0	332							2014-6-20	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES	Hysteroscopy and endometrial ablation	Other method, specify:	960	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3						false	No	TCGA-DF-A2KY.8A35F74A-AFA4-4B2D-931B-FA2DE895F010.pdf	A2KY	73.3		WITH TUMOR	0	1	YES					NO				R1	Primary Tumor	01	open	2009		NO	YES	DF	0	0	1	12	Endometrial	A	LIVING			872ef409-1ec0-4856-859c-37be70ebce35		TCGA-DF-A2KY-01	872ef409-1ec0-4856-859c-37be70ebce35	TCGA-DF-A2KY-01A-41-A23Z-20	2CC0B84B-C141-4904-9895-9906F40CFB08			872ef409-1ec0-4856-859c-37be70ebce35				872ef409-1ec0-4856-859c-37be70ebce35		TCGA-DF-A2KY-01		TCGA-DF-A2KY-01A-21D-A20R-01		TCGA-DF-A2KY-01A-21D-A20R-01	TCGA-DF-A2KY-01	TCGA-DF-A2KY-01	TCGA-DF-A2KY-01A-21D-A212-05		
TCGA-DF-A2KZ-01	MSI-H	0	TCGA-DF-A2KZ-01	826	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-DF-A2KZ	826	0	days	826	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					87	0	0		TCGA-DF-A2KZ	TCGA-DF-A2KZ-01A		Stage IB			-31973			0	826							2014-6-11	FEMALE		Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Tumor resection	450	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DF-A2KZ.D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38.pdf	A2KZ	25	negative	TUMOR FREE	0	0	NO					YES				RX	Primary Tumor	01	open	2009		NO	YES	DF	0	0	0	0	Endometrial	A	LIVING			dff76521-f81c-4de8-9a80-d75d18fe7982		TCGA-DF-A2KZ-01	dff76521-f81c-4de8-9a80-d75d18fe7982	TCGA-DF-A2KZ-01A-21-A23Z-20	16936733-EEF7-44F7-9DC0-C1C8922C8ACA			dff76521-f81c-4de8-9a80-d75d18fe7982				dff76521-f81c-4de8-9a80-d75d18fe7982		TCGA-DF-A2KZ-01		TCGA-DF-A2KZ-01A-11D-A20R-01		TCGA-DF-A2KZ-01A-11D-A20R-01	TCGA-DF-A2KZ-01	TCGA-DF-A2KZ-01	TCGA-DF-A2KZ-01A-11D-A212-05		
TCGA-DF-A2L0-01	MSS	1	TCGA-DF-A2L0-01	788	1	days	High		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5			TCGA-DF-A2L0	523	1	days	788	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	60			TCGA-DF-A2L0-F49841	TCGA-DF-A2L0	TCGA-DF-A2L0-01A		Stage IIIC	NO		-22200		788					523	NO			2013-10-11	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES	endometrial biopsy not otherwise specified	Other method, specify:	520	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	lymph nodes and retroperitoneal tissue	NO	YES	false	No	TCGA-DF-A2L0.1679CA2C-86BF-41D1-96E1-62FC89D9AAA7.pdf	A2L0	86		WITH TUMOR	0	5	YES	3	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	open			NO	YES	DF		0	5	17	Endometrial	A	DECEASED	95		60fc2e50-f36c-4074-879b-b5773d75a466		TCGA-DF-A2L0-01	60fc2e50-f36c-4074-879b-b5773d75a466	TCGA-DF-A2L0-01A-21-A18R-20	D58633C4-B72E-41B7-B8DC-2BBED3A4CD0C			60fc2e50-f36c-4074-879b-b5773d75a466				60fc2e50-f36c-4074-879b-b5773d75a466		TCGA-DF-A2L0-01		TCGA-DF-A2L0-01A-11D-A17U-01		TCGA-DF-A2L0-01A-11D-A17U-01	TCGA-DF-A2L0-01	TCGA-DF-A2L0-01	TCGA-DF-A2L0-01A-11D-A17Z-05		
TCGA-DI-A0WH-01	MSI-H	0	TCGA-DI-A0WH-01	496	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1	mutation cluster 1	TCGA-DI-A0WH	496	0	days	496	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-DI-A0WH-F16112	TCGA-DI-A0WH	TCGA-DI-A0WH-01A	Former User	Stage IB	NO		-23692	244		0	496				YES		Scheduled Follow-up Submission	2011-9-13	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	180	NO			G3					NO	false	No	TCGA-DI-A0WH.3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF.pdf	A0WH	15.6		TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009	NO	NO	YES	DI	0	2	0	18	Endometrial	A	LIVING	107	2010			TCGA-DI-A0WH-01		TCGA-DI-A0WH-01A-21-A163-20	3F62FDDF-883B-41E2-8BA6-226563893CE0				TCGA-DI-A0WH-01A-12D-A12J-09	TCGA-DI-A0WH-01A-12D-A12J-09	TCGA-DI-A0WH-01A-12D-A12J-09			TCGA-DI-A0WH-01	46b06f7a-18ed-42a6-9cb9-75e6dc98b30e	TCGA-DI-A0WH-01A-12D-A12G-01		TCGA-DI-A0WH-01A-12D-A12G-01	TCGA-DI-A0WH-01	TCGA-DI-A0WH-01	TCGA-DI-A0WH-01A-12D-A12K-05		46b06f7a-18ed-42a6-9cb9-75e6dc98b30e
TCGA-DI-A1BU-01	MSI-H	0	TCGA-DI-A1BU-01	1195	0	days	Quiet		UCEC non-CIMP c3	cluster 2	UCEC-like c5		miRNA cluster 6	cluster 1		TCGA-DI-A1BU	1195	0	days	1195	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55	0	0	TCGA-DI-A1BU-F20903	TCGA-DI-A1BU	TCGA-DI-A1BU-01A	Former User	Stage IIB	NO		-20114	903		0	1195				NO		Scheduled Follow-up Submission	2012-1-24	FEMALE	171	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	endometrial biopsy	Other method, specify:	140	NO			G3					NO	false	No	TCGA-DI-A1BU.18A286FD-E85B-48FC-B193-456AB10D24B9.pdf	A1BU	15.8		TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009	YES	NO	YES	DI	0	6	0	25	Endometrial	A	LIVING	93	2008	60728ff8-1098-4ed9-9cc0-b3d5523736d3		TCGA-DI-A1BU-01	60728ff8-1098-4ed9-9cc0-b3d5523736d3	TCGA-DI-A1BU-01A-21-A18Q-20	11A1BC6D-8970-4733-A5F1-EE1D9E0821C3			60728ff8-1098-4ed9-9cc0-b3d5523736d3				60728ff8-1098-4ed9-9cc0-b3d5523736d3		TCGA-DI-A1BU-01		TCGA-DI-A1BU-01A-11D-A134-01		TCGA-DI-A1BU-01A-11D-A134-01	TCGA-DI-A1BU-01	TCGA-DI-A1BU-01	TCGA-DI-A1BU-01A-11D-A138-05		
TCGA-DI-A1BY-01	MSS	0	TCGA-DI-A1BY-01	1114	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 4		TCGA-DI-A1BY	1114	0	days	1114	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-DI-A1BY-F20963	TCGA-DI-A1BY	TCGA-DI-A1BY-01A	Never Used	Stage IIB	NO		-23113	989		0	1114				YES		Scheduled Follow-up Submission	2012-1-25	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Uterine scrapings	Other method, specify:	140	NO			G2					NO	false	No	TCGA-DI-A1BY.8B96371D-5E42-461B-B7A2-AB9641D842CD.pdf	A1BY	17	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009	NO	NO	YES	DI		0	0	6	Endometrial	A	LIVING	125	2008			TCGA-DI-A1BY-01		TCGA-DI-A1BY-01A-31-A18Q-20	F17216D8-4293-45BC-8FA3-73C8A69EA573									TCGA-DI-A1BY-01	4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e	TCGA-DI-A1BY-01A-21D-A134-01		TCGA-DI-A1BY-01A-21D-A134-01	TCGA-DI-A1BY-01	TCGA-DI-A1BY-01	TCGA-DI-A1BY-01A-21D-A138-05		4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e
TCGA-DI-A1C3-01	MSS	0	TCGA-DI-A1C3-01	739	0	days	Quiet		UCEC non-CIMP c3	cluster 4			miRNA cluster 13	cluster 4		TCGA-DI-A1C3	739	0	days	739	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	38			TCGA-DI-A1C3-F20968	TCGA-DI-A1C3	TCGA-DI-A1C3-01A	Never Used	Stage IB	NO		-13885	755		0	739				YES		Scheduled Follow-up Submission	2012-1-25	FEMALE	171	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	polyp removal	Other method, specify:	170	NO			G2					NO	false	No	TCGA-DI-A1C3.63A6706E-823B-456E-A3BC-65755C07CF62.pdf	A1C3	8.6		TUMOR FREE				0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01		2009	NO	NO	YES	DI		0		0	Endometrial	A	LIVING	144	2008	016f584a-453b-4e91-a311-0c0120e127d0		TCGA-DI-A1C3-01	016f584a-453b-4e91-a311-0c0120e127d0					016f584a-453b-4e91-a311-0c0120e127d0				016f584a-453b-4e91-a311-0c0120e127d0		TCGA-DI-A1C3-01		TCGA-DI-A1C3-01A-41D-A134-01		TCGA-DI-A1C3-01A-41D-A134-01	TCGA-DI-A1C3-01	TCGA-DI-A1C3-01	TCGA-DI-A1C3-01A-41D-A138-05		
TCGA-DI-A1NN-01	MSS	0	TCGA-DI-A1NN-01	1076	0	days	High	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-DI-A1NN	1023	1	days	1076	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	63	0	2	TCGA-DI-A1NN-F19104	TCGA-DI-A1NN	TCGA-DI-A1NN-01A		Stage IIIC	NO	1023	-23026	813		0	1076			1023	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vagina		YES	false	No	TCGA-DI-A1NN.EBBDE504-29C9-4662-8D06-44E8CBAD0741.pdf	A1NN	3		WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		NO	Excisional Biopsy		R2	R0	Primary Tumor	01	Minimally Invasive	1988	YES	NO	YES	DI	2	9	0	10	Endometrial	A	LIVING	71	2008			TCGA-DI-A1NN-01		TCGA-DI-A1NN-01A-21-A18Q-20	CF1A7C5B-632B-4792-AA34-E10E967EC882				TCGA-DI-A1NN-01A-11D-A16D-09	TCGA-DI-A1NN-01A-11D-A16D-09	TCGA-DI-A1NN-01A-11D-A16D-09			TCGA-DI-A1NN-01	1857cddd-76d1-403b-a14e-f14d0781f68b	TCGA-DI-A1NN-01A-11D-A16C-01		TCGA-DI-A1NN-01A-11D-A16C-01	TCGA-DI-A1NN-01	TCGA-DI-A1NN-01	TCGA-DI-A1NN-01A-11D-A16G-05		1857cddd-76d1-403b-a14e-f14d0781f68b
TCGA-DI-A1NN-11	MSS	0	TCGA-DI-A1NN-11	1076	0	days		C6-UCEC							mutation cluster 5	TCGA-DI-A1NN	1023	1	days	1076	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Complete Response	63	0	2	TCGA-DI-A1NN-F19104	TCGA-DI-A1NN	TCGA-DI-A1NN-11A		Stage IIIC	NO	1023	-23026	813		0	1076			1023	NO		Scheduled Follow-up Submission	2011-12-2	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vagina		YES	false	No		A1NN	3		WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		NO	Excisional Biopsy		R2	R0	Solid Tissue Normal	11	Minimally Invasive	1988	YES	NO	YES	DI	2	9	0	10	Endometrial	A	LIVING	71	2008																						TCGA-DI-A1NN-11A-21D-A16G-05		
TCGA-DI-A1NO-01	MSS	1	TCGA-DI-A1NO-01	285	1	days	Squamous	C6-UCEC	OV-like c1	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-DI-A1NO	285	0	days	285	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	68	0	0	TCGA-DI-A1NO-F20801	TCGA-DI-A1NO	TCGA-DI-A1NO-01A	Never Used	Stage IIIA	NO		-24996	688	285	0					YES		Scheduled Follow-up Submission	2012-1-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	270	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DI-A1NO.11CEAAB6-3853-48EB-94CE-1B11FEF45B4C.pdf	A1NO	1.03		WITH TUMOR	0	0		1	Complete Remission/Response	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	DI	0	0	0	2	Endometrial	A	DECEASED	122	2009			TCGA-DI-A1NO-01		TCGA-DI-A1NO-01A-21-A18Q-20	6DFFF5AA-3B22-4F41-9A2F-4F6E84237EF6									TCGA-DI-A1NO-01	272f94bc-ce8b-46ff-b13f-827bba6071d5	TCGA-DI-A1NO-01A-31D-A160-01		TCGA-DI-A1NO-01A-31D-A160-01	TCGA-DI-A1NO-01	TCGA-DI-A1NO-01	TCGA-DI-A1NO-01A-31D-A161-05		272f94bc-ce8b-46ff-b13f-827bba6071d5
TCGA-DI-A1NO-11	MSS	1	TCGA-DI-A1NO-11	285	1	days		C6-UCEC								TCGA-DI-A1NO	285	0	days	285	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	68	0	0	TCGA-DI-A1NO-F20801	TCGA-DI-A1NO	TCGA-DI-A1NO-11A	Never Used	Stage IIIA	NO		-24996	688	285	0					YES		Scheduled Follow-up Submission	2012-1-23	FEMALE	166	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A1NO	1.03		WITH TUMOR	0	0		1	Complete Remission/Response	Never Used		NO				RX	Solid Tissue Normal	11	Minimally Invasive	2009	NO	NO	YES	DI	0	0	0	2	Endometrial	A	DECEASED	122	2009																						TCGA-DI-A1NO-11A-11D-A161-05		
TCGA-DI-A2QT-01	MSS	1	TCGA-DI-A2QT-01	377	1	days	BRCA-LUAD+		UCEC Serous c4		squamous c3		miRNA cluster 14			TCGA-DI-A2QT			days	377	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					51	0	10		TCGA-DI-A2QT	TCGA-DI-A2QT-01A		Stage IIIC			-18835	1186	377	0								2011-8-26	FEMALE	156	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-DI-A2QT.416DF035-67B0-4461-9523-EB4A4A1FBA5B.pdf	A2QT	96		WITH TUMOR	0	7										R2	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI	10	10	7	15	Endometrial	A	DECEASED	62	2008	859fec54-ae79-44fa-8021-b6dd66d529da		TCGA-DI-A2QT-01	859fec54-ae79-44fa-8021-b6dd66d529da	TCGA-DI-A2QT-01A-21-A23Z-20	155C8C74-6540-4D84-B87D-F7619D143457			859fec54-ae79-44fa-8021-b6dd66d529da				859fec54-ae79-44fa-8021-b6dd66d529da		TCGA-DI-A2QT-01		TCGA-DI-A2QT-01A-12D-A19X-01		TCGA-DI-A2QT-01A-12D-A19X-01	TCGA-DI-A2QT-01	TCGA-DI-A2QT-01	TCGA-DI-A2QT-01A-12D-A19Z-05		
TCGA-DI-A2QU-01	MSS	1	TCGA-DI-A2QU-01	946	1	days	Squamous	C6-UCEC	UCEC Serous c4		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-DI-A2QU			days	946	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67				TCGA-DI-A2QU	TCGA-DI-A2QU-01A		Stage IVB			-24488	2296	946	0								2011-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	240	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-DI-A2QU.43F1EE09-6F10-4BCE-A55C-147084A26999.pdf	A2QU	0		WITH TUMOR	0	0										RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI		0	0	6	Endometrial	A	DECEASED	93	2005			TCGA-DI-A2QU-01		TCGA-DI-A2QU-01A-21-A23Z-20	051E4CE2-ABE2-443D-B2A6-E030EF7A01BF									TCGA-DI-A2QU-01	94746e57-a703-4b53-bcdc-11107424eb23	TCGA-DI-A2QU-01A-11D-A18N-01		TCGA-DI-A2QU-01A-11D-A18N-01	TCGA-DI-A2QU-01	TCGA-DI-A2QU-01	TCGA-DI-A2QU-01A-11D-A18O-05		94746e57-a703-4b53-bcdc-11107424eb23
TCGA-DI-A2QU-11	MSS	1	TCGA-DI-A2QU-11	946	1	days		C6-UCEC								TCGA-DI-A2QU			days	946	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					67				TCGA-DI-A2QU	TCGA-DI-A2QU-11A		Stage IVB			-24488	2296	946	0								2011-8-26	FEMALE	160	Endometrioid endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	230	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No		A2QU	0		WITH TUMOR	0	0										RX	Solid Tissue Normal	11	Minimally Invasive	1988		NO	YES	DI		0	0	6	Endometrial	A	DECEASED	93	2005															TCGA-DI-A2QU-11	8fefb116-ef42-4566-a5e3-8793ca8b7cda				TCGA-DI-A2QU-11		TCGA-DI-A2QU-11A-11D-A18O-05		8fefb116-ef42-4566-a5e3-8793ca8b7cda
TCGA-DI-A2QY-01	MSS	1	TCGA-DI-A2QY-01	3349	1	days	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-DI-A2QY	3349	0	days	3349	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-DI-A2QY-F60669	TCGA-DI-A2QY	TCGA-DI-A2QY-01A	Never Used	Stage IIB	NO		-23398	2957	3349	0	2797				NO			2014-6-13	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES	endocervical smear	Other method, specify:	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-DI-A2QY.C78D0C27-34C3-44C4-9814-94EEE8A8AB95.pdf	A2QY	50	positive	TUMOR FREE	0	0	YES	2	Complete Remission/Response	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive	1988		NO	YES	DI	0	3	0	6	Endometrial	A	DECEASED	85	2003	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927		TCGA-DI-A2QY-01	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927	TCGA-DI-A2QY-01A-21-A23Z-20	3DD87696-1FE4-464E-8359-535C2AD8A78D			ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927				ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927		TCGA-DI-A2QY-01		TCGA-DI-A2QY-01A-12D-A19X-01		TCGA-DI-A2QY-01A-12D-A19X-01	TCGA-DI-A2QY-01	TCGA-DI-A2QY-01	TCGA-DI-A2QY-01A-12D-A19Z-05		
TCGA-DI-A2QY-11	MSS	1	TCGA-DI-A2QY-11	3349	1	days										TCGA-DI-A2QY	3349	0	days	3349	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-DI-A2QY-F60669	TCGA-DI-A2QY	TCGA-DI-A2QY-11A	Never Used	Stage IIB	NO		-23398	2957	3349	0	2797				NO			2014-6-13	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES	endocervical smear	Other method, specify:	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A2QY	50	positive	TUMOR FREE	0	0	YES	2	Complete Remission/Response	Never Used		YES				RX	Solid Tissue Normal	11	Minimally Invasive	1988		NO	YES	DI	0	3	0	6	Endometrial	A	DECEASED	85	2003	9ba4d4d3-4640-40b7-8a67-72f384858b93			9ba4d4d3-4640-40b7-8a67-72f384858b93					9ba4d4d3-4640-40b7-8a67-72f384858b93				9ba4d4d3-4640-40b7-8a67-72f384858b93		TCGA-DI-A2QY-11					TCGA-DI-A2QY-11		TCGA-DI-A2QY-11A-11D-A19Z-05		
TCGA-E6-A1LX-01	MSI-L	0	TCGA-E6-A1LX-01	711	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-E6-A1LX	711	0	days	711	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	40		0	TCGA-E6-A1LX-F20265	TCGA-E6-A1LX	TCGA-E6-A1LX-01A	Never Used	Stage IB	NO		-14731	1539		0	711				NO		Scheduled Follow-up Submission	2011-12-28	FEMALE	163	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	190	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	No	TCGA-E6-A1LX.73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0.pdf	A1LX	14	negative	TUMOR FREE				1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	NO	NO	YES	E6	0	3		0	Endometrial	A	LIVING		2006			TCGA-E6-A1LX-01		TCGA-E6-A1LX-01A-21-A18Q-20	88FC93D5-1A22-484D-9087-828750CCE453									TCGA-E6-A1LX-01	ca056af5-cdea-498c-adaf-9550e8fb4336	TCGA-E6-A1LX-01A-11D-A14F-01		TCGA-E6-A1LX-01A-11D-A14F-01	TCGA-E6-A1LX-01	TCGA-E6-A1LX-01	TCGA-E6-A1LX-01A-11D-A14H-05		ca056af5-cdea-498c-adaf-9550e8fb4336
TCGA-E6-A1LZ-01	MSS	0	TCGA-E6-A1LZ-01	2406	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	BRCA basal-like c6	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-E6-A1LZ	2406	0	days	2406	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	76		0	TCGA-E6-A1LZ-F69830	TCGA-E6-A1LZ	TCGA-E6-A1LZ-01A	Never Used	Stage IA	NO		-28054	1233		0	2406				NO		Scheduled Follow-up Submission	2015-1-21	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Tumor resection	350	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-E6-A1LZ.55F7B7D0-D30A-4E78-B91A-CE794784CA3C.pdf	A1LZ		negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	1988	YES	NO	YES	E6	0	5	0	26	Endometrial	A	LIVING	65	2007			TCGA-E6-A1LZ-01		TCGA-E6-A1LZ-01A-21-A18Q-20	89C5BBA0-431E-4A89-9FC5-A03ABB721615				TCGA-E6-A1LZ-01A-11D-A142-09	TCGA-E6-A1LZ-01A-11D-A142-09	TCGA-E6-A1LZ-01A-11D-A142-09			TCGA-E6-A1LZ-01	4f4a8bd9-c07f-4930-8600-349ab60a37a7	TCGA-E6-A1LZ-01A-11D-A141-01		TCGA-E6-A1LZ-01A-11D-A141-01	TCGA-E6-A1LZ-01	TCGA-E6-A1LZ-01	TCGA-E6-A1LZ-01A-11D-A145-05		4f4a8bd9-c07f-4930-8600-349ab60a37a7
TCGA-E6-A1M0-01	MSS	0	TCGA-E6-A1M0-01	1793	0	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-E6-A1M0	1793	0	days	1793	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-E6-A1M0-F69833	TCGA-E6-A1M0	TCGA-E6-A1M0-01A	Never Used	Stage IIIC	NO		-20629	360		0	1793				NO		Scheduled Follow-up Submission	2015-1-21	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	160	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-E6-A1M0.F1AF61FE-BF05-49E2-85DA-F4CE37596DEA.pdf	A1M0	90	negative	TUMOR FREE		2	YES	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	E6	0	5	2	13	Endometrial	A	LIVING	114	2010			TCGA-E6-A1M0-01		TCGA-E6-A1M0-01A-21-A18Q-20	95236C17-EA65-447B-A665-5EA84796E305									TCGA-E6-A1M0-01	e527020e-6b3f-4837-87d1-8f7ba68c19d6	TCGA-E6-A1M0-01A-11D-A141-01		TCGA-E6-A1M0-01A-11D-A141-01	TCGA-E6-A1M0-01	TCGA-E6-A1M0-01	TCGA-E6-A1M0-01A-11D-A145-05		e527020e-6b3f-4837-87d1-8f7ba68c19d6
TCGA-E6-A1M0-11	MSS	0	TCGA-E6-A1M0-11	1793	0	days		C6-UCEC								TCGA-E6-A1M0	1793	0	days	1793	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-E6-A1M0-F69833	TCGA-E6-A1M0		Never Used	Stage IIIC	NO		-20629			0	1793				NO		Scheduled Follow-up Submission	2015-1-21	FEMALE	174	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A1M0	90	negative	TUMOR FREE		2	YES	3	Complete Remission/Response	Never Used		NO				R0	Solid Tissue Normal	11	open	2009	YES	NO	YES	E6	0	5	2	13	Endometrial		LIVING	114	2010															TCGA-E6-A1M0-11	a0c84298-852b-454f-aab8-fb64656834dc				TCGA-E6-A1M0-11		TCGA-E6-A1M0-11A-11D-A145-05		a0c84298-852b-454f-aab8-fb64656834dc
TCGA-E6-A2P8-01	MSI-H	1	TCGA-E6-A2P8-01	72	1	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-E6-A2P8	60	1	days	72	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	NO	Progressive Disease	53		0	TCGA-E6-A2P8-F33518	TCGA-E6-A2P8	TCGA-E6-A2P8-01A		Stage IV	NO		-19448	254	72	0				60	NO		Scheduled Follow-up Submission	2012-6-29	FEMALE	156	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Metastatic			YES	true	No	TCGA-E6-A2P8.B67CD692-73B4-4A61-A65B-65964AA3ACF4.pdf	A2P8	89.1	negative	WITH TUMOR		1		2	Progressive Disease			NO					Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	E6	0	0	1	1	Endometrial	A	DECEASED	76	2010	db3429ba-32b0-40ef-bc81-ad0a8b097610		TCGA-E6-A2P8-01	db3429ba-32b0-40ef-bc81-ad0a8b097610	TCGA-E6-A2P8-01A-21-A23Z-20	10DEABF1-C72A-400C-9CDF-E2CE69F8E2CA			db3429ba-32b0-40ef-bc81-ad0a8b097610				db3429ba-32b0-40ef-bc81-ad0a8b097610		TCGA-E6-A2P8-01		TCGA-E6-A2P8-01A-11D-A19X-01		TCGA-E6-A2P8-01A-11D-A19X-01	TCGA-E6-A2P8-01	TCGA-E6-A2P8-01	TCGA-E6-A2P8-01A-11D-A19Z-05		
TCGA-E6-A2P9-01	MSI-H	0	TCGA-E6-A2P9-01	1386	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 7			TCGA-E6-A2P9	1386	0	days	1386	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	65		0	TCGA-E6-A2P9-F68580	TCGA-E6-A2P9	TCGA-E6-A2P9-01A		Stage IA	NO		-24088	189		0	1386				NO		Scheduled Follow-up Submission	2014-12-1	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	230	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-E6-A2P9.EF7B01C4-0952-4FE8-B128-2A43FA31E6F5.pdf	A2P9	20	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			YES				RX	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	E6	0	1	0	7	Endometrial	A	LIVING	125	2011	08576085-2f37-41fc-82f6-39d396d75862		TCGA-E6-A2P9-01	08576085-2f37-41fc-82f6-39d396d75862	TCGA-E6-A2P9-01A-21-A23Z-20	EB9A5DA6-7AD0-44F1-83F5-9389E73B6319			08576085-2f37-41fc-82f6-39d396d75862				08576085-2f37-41fc-82f6-39d396d75862		TCGA-E6-A2P9-01		TCGA-E6-A2P9-01A-11D-A19X-01		TCGA-E6-A2P9-01A-11D-A19X-01	TCGA-E6-A2P9-01	TCGA-E6-A2P9-01	TCGA-E6-A2P9-01A-11D-A19Z-05		
TCGA-E6-A8L9-01	MSS	0	TCGA-E6-A8L9-01	1013	0	days										TCGA-E6-A8L9	1013	0	days	1013	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61		0	TCGA-E6-A8L9-F69832	TCGA-E6-A8L9	TCGA-E6-A8L9-01A	Never Used	Stage IB	NO		-22333	657		0	1013				YES			2015-1-21	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-E6-A8L9.40CB57C1-7E8C-45B0-BEDD-DFE531C9201E.pdf	A8L9	1.92	negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	E6	0	5	0	15	Endometrial	A	LIVING	78	2012	916cf47a-0100-4e01-a912-2e884777186f		TCGA-E6-A8L9-01	916cf47a-0100-4e01-a912-2e884777186f		9B18D6BD-ECE6-49B4-A70E-92E1B8BC3153			916cf47a-0100-4e01-a912-2e884777186f				916cf47a-0100-4e01-a912-2e884777186f		TCGA-E6-A8L9-01		TCGA-E6-A8L9-01A-21D-A37M-01		TCGA-E6-A8L9-01A-21D-A37M-01	TCGA-E6-A8L9-01	TCGA-E6-A8L9-01	TCGA-E6-A8L9-01A-21D-A37Q-05		
TCGA-EC-A1NJ-01	MSI-H	0	TCGA-EC-A1NJ-01	488	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EC-A1NJ	488	0	days	488	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73			TCGA-EC-A1NJ-F55852	TCGA-EC-A1NJ	TCGA-EC-A1NJ-01A	Never Used	Stage IA	NO		-27002	60		0	488				NO		Scheduled Follow-up Submission	2014-2-18	FEMALE	153	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	620	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-EC-A1NJ.8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141.pdf	A1NJ	33	negative	TUMOR FREE				1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	EC		0		0	Endometrial	A	LIVING	62	2010			TCGA-EC-A1NJ-01		TCGA-EC-A1NJ-01A-21-A18Q-20	42820F72-E240-43CF-B375-31A1021BB55A									TCGA-EC-A1NJ-01	838b151f-4608-4981-89f3-0cba9ec540fb	TCGA-EC-A1NJ-01A-31D-A14F-01		TCGA-EC-A1NJ-01A-31D-A14F-01	TCGA-EC-A1NJ-01	TCGA-EC-A1NJ-01	TCGA-EC-A1NJ-01A-31D-A14H-05		838b151f-4608-4981-89f3-0cba9ec540fb
TCGA-EC-A1QX-01	MSI-H	0	TCGA-EC-A1QX-01	224	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 2	squamous c3	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-EC-A1QX	219	1	days	224	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES	Complete Response	71			TCGA-EC-A1QX-F48708	TCGA-EC-A1QX	TCGA-EC-A1QX-01A	Never Used	Stage IB	NO	219	-26259	81		0	224			219	YES		Scheduled Follow-up Submission	2013-9-19	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	560	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	No	TCGA-EC-A1QX.0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12.pdf	A1QX		negative	TUMOR FREE				2	Progressive Disease	Never Used		YES	Surgical Resection		RX	R0	Primary Tumor	01		2009	YES	YES	NO	EC		0		0	Endometrial	A	LIVING	90	2010			TCGA-EC-A1QX-01		TCGA-EC-A1QX-01A-21-A18Q-20	F29B5B7A-0EA1-4AE8-B1FD-5D48D671F757									TCGA-EC-A1QX-01	bfa1d102-0917-407f-a158-3125d4219c6c	TCGA-EC-A1QX-01A-31D-A16C-01		TCGA-EC-A1QX-01A-31D-A16C-01	TCGA-EC-A1QX-01	TCGA-EC-A1QX-01	TCGA-EC-A1QX-01A-31D-A16G-05		bfa1d102-0917-407f-a158-3125d4219c6c
TCGA-EC-A24G-01	MSI-H	0	TCGA-EC-A24G-01	511	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-EC-A24G	511	0	days	511	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57	0	0	TCGA-EC-A24G-F40428	TCGA-EC-A24G	TCGA-EC-A24G-01A	Never Used	Stage II	NO		-20857	78		0	511				NO		Scheduled Follow-up Submission	2013-2-20	FEMALE	148	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	410	NO	YES	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	true	No	TCGA-EC-A24G.5DE142C5-7A0D-4C5E-8EF6-2809B10378C4.pdf	A24G	50		TUMOR FREE	0	0	YES	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01		2009	YES	YES	NO	EC	0	0	0	15	Endometrial	A	LIVING	93	2011			TCGA-EC-A24G-01		TCGA-EC-A24G-01A-21-A18R-20	98AB1F54-6633-42A9-B751-785CD6E9260C									TCGA-EC-A24G-01	92f1d13e-3dbb-4a41-aac4-5887b50bc19f	TCGA-EC-A24G-01A-11D-A16C-01		TCGA-EC-A24G-01A-11D-A16C-01	TCGA-EC-A24G-01	TCGA-EC-A24G-01	TCGA-EC-A24G-01A-11D-A16G-05		92f1d13e-3dbb-4a41-aac4-5887b50bc19f
TCGA-EO-A1Y5-01	MSS	0	TCGA-EO-A1Y5-01	327	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 2	cluster 2	mutation cluster 13	TCGA-EO-A1Y5	327	0	days	327	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63		1	TCGA-EO-A1Y5-F56547	TCGA-EO-A1Y5	TCGA-EO-A1Y5-01A	Never Used	Stage IIIC2	NO		-23251	223		0	327				NO			2014-2-12	FEMALE	161	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A1Y5.B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F.pdf	A1Y5	100		TUMOR FREE		8	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	EO	1	1	8	17	Endometrial	A	LIVING	79	2010			TCGA-EO-A1Y5-01		TCGA-EO-A1Y5-01A-21-A18Q-20	C19E3960-24A6-4C23-8543-E58F9FD8338B				TCGA-EO-A1Y5-01A-11D-A159-09	TCGA-EO-A1Y5-01A-11D-A159-09	TCGA-EO-A1Y5-01A-11D-A159-09			TCGA-EO-A1Y5-01	fd13e02a-4bfb-4aaa-bbf7-488660106a31	TCGA-EO-A1Y5-01A-11D-A160-01		TCGA-EO-A1Y5-01A-11D-A160-01	TCGA-EO-A1Y5-01	TCGA-EO-A1Y5-01	TCGA-EO-A1Y5-01A-11D-A161-05		fd13e02a-4bfb-4aaa-bbf7-488660106a31
TCGA-EO-A1Y7-01	MSS	0	TCGA-EO-A1Y7-01	1495	0	days	High		UCEC non-CIMP c3	cluster 4	UCEC-like c5		miRNA cluster 12	cluster 5		TCGA-EO-A1Y7	880	1	days	1495	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Stable Disease	65		0	TCGA-EO-A1Y7-F68567	TCGA-EO-A1Y7	TCGA-EO-A1Y7-01A	Never Used	Stage IB	NO		-24085	196		0	1495			880	NO			2014-11-26	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Distant Metastasis		NO	YES	false	No	TCGA-EO-A1Y7.88AABD4B-ECB4-4748-B59F-BD4AE0621BFB.pdf	A1Y7	60		WITH TUMOR		0	YES	4+	Stable Disease	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EO	0	8	0	3	Endometrial	A	LIVING	95	2010	4da7543e-f58a-46f1-bf94-834d4ce4cbff		TCGA-EO-A1Y7-01	4da7543e-f58a-46f1-bf94-834d4ce4cbff	TCGA-EO-A1Y7-01A-21-A18Q-20	F45FB2AE-1B5C-4470-8986-8E69124A46F2			4da7543e-f58a-46f1-bf94-834d4ce4cbff				4da7543e-f58a-46f1-bf94-834d4ce4cbff		TCGA-EO-A1Y7-01		TCGA-EO-A1Y7-01A-11D-A160-01		TCGA-EO-A1Y7-01A-11D-A160-01	TCGA-EO-A1Y7-01	TCGA-EO-A1Y7-01	TCGA-EO-A1Y7-01A-11D-A161-05		
TCGA-EO-A1Y8-01	MSS	0	TCGA-EO-A1Y8-01	1147	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-EO-A1Y8	1147	0	days	1147	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	87			TCGA-EO-A1Y8-F56552	TCGA-EO-A1Y8	TCGA-EO-A1Y8-01A	Never Used	Stage IA	NO		-31971	204		0	1147				NO			2014-2-12	FEMALE	146	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	170	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A1Y8.61143E14-52BD-499F-901C-4BD1EA83DAC1.pdf	A1Y8	40		TUMOR FREE		0	NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EO		0	0	16	Endometrial	A	LIVING	58	2010			TCGA-EO-A1Y8-01		TCGA-EO-A1Y8-01A-21-A18Q-20	838C4AC7-EF01-4F07-A1BC-A8165A744583				TCGA-EO-A1Y8-01A-11D-A159-09	TCGA-EO-A1Y8-01A-11D-A159-09	TCGA-EO-A1Y8-01A-11D-A159-09			TCGA-EO-A1Y8-01	a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c	TCGA-EO-A1Y8-01A-11D-A160-01		TCGA-EO-A1Y8-01A-11D-A160-01	TCGA-EO-A1Y8-01	TCGA-EO-A1Y8-01	TCGA-EO-A1Y8-01A-11D-A161-05		a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c
TCGA-EO-A22R-01	MSI-L	0	TCGA-EO-A22R-01	1878	0	days	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA c1uster 10			TCGA-EO-A22R	1878	0	days	1878	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-EO-A22R-F62603	TCGA-EO-A22R	TCGA-EO-A22R-01A		Stage IB	NO		-20604	925		0	1878				YES			2014-9-25	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A22R.5B97D87A-5D28-417F-A942-21775156B46C.pdf	A22R	51	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO			0	18	Endometrial	A	LIVING	88	2008			TCGA-EO-A22R-01		TCGA-EO-A22R-01A-21-A23Z-20	F7096155-7582-491D-BC2C-4C28A7AC90B3									TCGA-EO-A22R-01	21aa44a9-e23e-4ab9-aa35-6942b118b066	TCGA-EO-A22R-01A-11D-A18N-01		TCGA-EO-A22R-01A-11D-A18N-01	TCGA-EO-A22R-01	TCGA-EO-A22R-01	TCGA-EO-A22R-01A-11D-A18O-05		21aa44a9-e23e-4ab9-aa35-6942b118b066
TCGA-EO-A22R-11	MSI-L	0	TCGA-EO-A22R-11	1878	0	days		C6-UCEC								TCGA-EO-A22R	1878	0	days	1878	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56			TCGA-EO-A22R-F62603	TCGA-EO-A22R	TCGA-EO-A22R-11A		Stage IB	NO		-20604	1058		0	1878				YES			2014-9-25	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A22R	51	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO			0	18	Endometrial	A	LIVING	88	2008																						TCGA-EO-A22R-11A-11D-A18O-05		
TCGA-EO-A22S-01	MSI-H	0	TCGA-EO-A22S-01	1872	0	days	Quiet	C6-UCEC	UCEC CIMP c18		squamous c3	UCEC-like c11	miRNA cluster 12			TCGA-EO-A22S	1872	0	days	1872	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58		0	TCGA-EO-A22S-F62595	TCGA-EO-A22S	TCGA-EO-A22S-01A		Stage IB	NO		-21328	919		0	1872				NO			2014-8-13	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A22S.DB26485C-BE5C-4874-B79D-7FCFFFF70C4E.pdf	A22S	51		TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		5		25	Endometrial	A	LIVING	84	2008			TCGA-EO-A22S-01		TCGA-EO-A22S-01A-21-A23Z-20	A71C8254-A31B-460C-8920-65EA0E6BE583									TCGA-EO-A22S-01	b8177a01-9ec3-47dc-a776-1794f693d9e7	TCGA-EO-A22S-01A-11D-A18N-01		TCGA-EO-A22S-01A-11D-A18N-01	TCGA-EO-A22S-01	TCGA-EO-A22S-01	TCGA-EO-A22S-01A-11D-A18O-05		b8177a01-9ec3-47dc-a776-1794f693d9e7
TCGA-EO-A22S-11	MSI-H	0	TCGA-EO-A22S-11	1872	0	days		C6-UCEC								TCGA-EO-A22S	1872	0	days	1872	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	58		0	TCGA-EO-A22S-F62595	TCGA-EO-A22S	TCGA-EO-A22S-11A		Stage IB	NO		-21328	1052		0	1872				NO			2014-8-13	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A22S	51		TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO		5		25	Endometrial	A	LIVING	84	2008																						TCGA-EO-A22S-11A-11D-A18O-05		
TCGA-EO-A22T-01	MSI-H	0	TCGA-EO-A22T-01	2035	0	days	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 5			TCGA-EO-A22T	2035	0	days	2035	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-EO-A22T-F62605	TCGA-EO-A22T	TCGA-EO-A22T-01A		Stage II	NO		-20608	916		0	2035				NO			2014-9-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A22T.1D5567D9-3015-452E-9888-2E67F91D6B20.pdf	A22T	49		TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		11	0	19	Endometrial	A	LIVING	53	2008			TCGA-EO-A22T-01		TCGA-EO-A22T-01A-11-A23Z-20	DFC6F069-E4BA-4BD0-BBB4-4A40A3C98A0E									TCGA-EO-A22T-01	fe8a344f-fc0b-415c-b388-c71e82b64703	TCGA-EO-A22T-01A-21D-A18N-01		TCGA-EO-A22T-01A-21D-A18N-01	TCGA-EO-A22T-01	TCGA-EO-A22T-01	TCGA-EO-A22T-01A-21D-A18O-05		fe8a344f-fc0b-415c-b388-c71e82b64703
TCGA-EO-A22T-11	MSI-H	0	TCGA-EO-A22T-11	2035	0	days		C6-UCEC								TCGA-EO-A22T	2035	0	days	2035	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-EO-A22T-F62605	TCGA-EO-A22T	TCGA-EO-A22T-11A		Stage II	NO		-20608	1049		0	2035				NO			2014-9-25	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	180	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No		A22T	49		TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Solid Tissue Normal	11	open	2009		NO	YES	EO		11	0	19	Endometrial	A	LIVING	53	2008																						TCGA-EO-A22T-11A-11D-A18O-05		
TCGA-EO-A22U-01	MSI-H	0	TCGA-EO-A22U-01	1407	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12	cluster 4		TCGA-EO-A22U	1407	0	days	1407	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	83			TCGA-EO-A22U-F62597	TCGA-EO-A22U	TCGA-EO-A22U-01A	Former User	Stage IB	NO		-30557	758		0	1407				NO			2014-9-25	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A22U.DB7D72BC-F9C7-4726-98F4-A4F642B125C6.pdf	A22U	51	negative	TUMOR FREE			NO	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		0	Endometrial	A	LIVING	59	2009	3513c95d-9ea0-4c3b-9e8e-0f148231bc83		TCGA-EO-A22U-01	3513c95d-9ea0-4c3b-9e8e-0f148231bc83	TCGA-EO-A22U-01A-21-A18R-20	451C5655-3310-4746-895F-9038D36FE619			3513c95d-9ea0-4c3b-9e8e-0f148231bc83				3513c95d-9ea0-4c3b-9e8e-0f148231bc83		TCGA-EO-A22U-01		TCGA-EO-A22U-01A-11D-A17U-01		TCGA-EO-A22U-01A-11D-A17U-01	TCGA-EO-A22U-01	TCGA-EO-A22U-01	TCGA-EO-A22U-01A-11D-A17Z-05		
TCGA-EO-A22X-01	MSS	0	TCGA-EO-A22X-01	1752	0	days	Kirc+		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5	cluster 4		TCGA-EO-A22X	1752	0	days	1752	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	36		0	TCGA-EO-A22X-F56587	TCGA-EO-A22X	TCGA-EO-A22X-01A	Never Used	Stage IIIA	NO		-13245	842		0	1752							2014-2-13	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.		C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO	false	No	TCGA-EO-A22X.4D919902-FBCE-4AAC-ACD2-38A2F1D8E901.pdf	A22X	100	negative	TUMOR FREE		0	YES		Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	NO	YES	EO	0	10	0	26	Endometrial	A	LIVING	56	2008	ca6bff3c-e95e-42e6-8eff-76d66e8031b0		TCGA-EO-A22X-01	ca6bff3c-e95e-42e6-8eff-76d66e8031b0	TCGA-EO-A22X-01A-21-A18R-20	38F062A0-F499-4E30-A858-EC1133DD37E4			ca6bff3c-e95e-42e6-8eff-76d66e8031b0				ca6bff3c-e95e-42e6-8eff-76d66e8031b0		TCGA-EO-A22X-01		TCGA-EO-A22X-01A-11D-A17U-01		TCGA-EO-A22X-01A-11D-A17U-01	TCGA-EO-A22X-01	TCGA-EO-A22X-01	TCGA-EO-A22X-01A-11D-A17Z-05		
TCGA-EO-A22Y-01	MSS	0	TCGA-EO-A22Y-01	1567	0	days	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5	cluster 4		TCGA-EO-A22Y	1567	0	days	1567	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-EO-A22Y-F56824	TCGA-EO-A22Y	TCGA-EO-A22Y-01A	Never Used	Stage IA	NO		-25127	692		0	1567				NO			2014-2-24	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A22Y.44F2A17C-265B-4C2A-9AA0-42C55A23B592.pdf	A22Y	51	negative	TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	EO			0	33	Endometrial	A	LIVING		2009	24ee58d3-60c9-4808-b35a-2767594b83f8		TCGA-EO-A22Y-01	24ee58d3-60c9-4808-b35a-2767594b83f8	TCGA-EO-A22Y-01A-21-A18R-20	90125C27-8268-4C34-B4B1-3CA0B40FD3A5			24ee58d3-60c9-4808-b35a-2767594b83f8				24ee58d3-60c9-4808-b35a-2767594b83f8		TCGA-EO-A22Y-01		TCGA-EO-A22Y-01A-11D-A17U-01		TCGA-EO-A22Y-01A-11D-A17U-01	TCGA-EO-A22Y-01	TCGA-EO-A22Y-01	TCGA-EO-A22Y-01A-11D-A17Z-05		
TCGA-EO-A2CG-01	MSS	0	TCGA-EO-A2CG-01	1564	0	days	High		OV-like c1			UCEC-like c11	miRNA cluster 5			TCGA-EO-A2CG	1564	0	days	1564	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	69		0	TCGA-EO-A2CG-F56877	TCGA-EO-A2CG	TCGA-EO-A2CG-01A	Never Used	Stage IA	NO		-25279	643		0	1564				NO			2014-2-25	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	60	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A2CG.CAF671DB-2DD1-43D5-99C8-185253775B37.pdf	A2CG	49	negative	TUMOR FREE		0	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES		YES	EO	0	11	0	8	Endometrial	A	LIVING	68	2009			TCGA-EO-A2CG-01												TCGA-EO-A2CG-01	5f65a8b5-2460-4544-be71-5e7b7347b0fa	TCGA-EO-A2CG-01A-12D-A17U-01		TCGA-EO-A2CG-01A-12D-A17U-01	TCGA-EO-A2CG-01	TCGA-EO-A2CG-01	TCGA-EO-A2CG-01A-12D-A17Z-05		5f65a8b5-2460-4544-be71-5e7b7347b0fa
TCGA-EO-A2CH-01	MSS	1	TCGA-EO-A2CH-01	590	1	days	Squamous	C6-UCEC	UCEC non-CIMP c3		UCEC-like c5	UCEC-like c11	miRNA cluster 1			TCGA-EO-A2CH	413	1	days	590	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Progressive Disease	73			TCGA-EO-A2CH-F70417	TCGA-EO-A2CH	TCGA-EO-A2CH-01A	Never Used	Stage IVB	NO		-26966	802	590	0				413	YES			2015-2-12	FEMALE	152	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	80	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Distant Metastasis		NO	YES	false	No	TCGA-EO-A2CH.B4A5577E-C043-4D25-8D53-77A43C5EC0CC.pdf	A2CH	51		WITH TUMOR			YES	1	Progressive Disease	Never Used		NO				R2	Primary Tumor	01	open	2009	YES	NO	YES	EO		0		0	Endometrial	A	DECEASED	66	2009			TCGA-EO-A2CH-01		TCGA-EO-A2CH-01A-21-A18R-20	3CF90784-6646-4288-8671-ACE67B983808									TCGA-EO-A2CH-01	f9814b3c-60f3-4d83-885e-1e1a88e520a9	TCGA-EO-A2CH-01A-11D-A17U-01		TCGA-EO-A2CH-01A-11D-A17U-01	TCGA-EO-A2CH-01	TCGA-EO-A2CH-01	TCGA-EO-A2CH-01A-11D-A17Z-05		f9814b3c-60f3-4d83-885e-1e1a88e520a9
TCGA-EO-A3AS-01	MSS	0	TCGA-EO-A3AS-01	1046	0	days	Squamous		UCEC non-CIMP c3				miRNA cluster 4			TCGA-EO-A3AS	1046	0	days	1046	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	86			TCGA-EO-A3AS-F38250	TCGA-EO-A3AS	TCGA-EO-A3AS-01A	Never Used	Stage IA	NO		-31450	850		0	1046				NO			2013-1-31	FEMALE	147	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3AS.844799B1-4C96-473A-8ECB-71ACB080F95E.pdf	A3AS	49		TUMOR FREE			NO	3	Complete Remission/Response	Never Used		NO					Primary Tumor	01	open	2009			YES	EO		0		0	Endometrial	A	LIVING	58	2009	0ce294d7-8111-474c-be3a-19195f5d49ab		TCGA-EO-A3AS-01	0ce294d7-8111-474c-be3a-19195f5d49ab					0ce294d7-8111-474c-be3a-19195f5d49ab				0ce294d7-8111-474c-be3a-19195f5d49ab		TCGA-EO-A3AS-01		TCGA-EO-A3AS-01A-11D-A19X-01		TCGA-EO-A3AS-01A-11D-A19X-01	TCGA-EO-A3AS-01	TCGA-EO-A3AS-01	TCGA-EO-A3AS-01A-11D-A19Z-05		
TCGA-EO-A3AU-01	MSI-H	0	TCGA-EO-A3AU-01	1543	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 11			TCGA-EO-A3AU	1178	1	days	1543	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Complete Response	72		0	TCGA-EO-A3AU-F71141	TCGA-EO-A3AU	TCGA-EO-A3AU-01A		Stage II	NO		-26406	393		0	1543		1178	1178	YES			2015-3-18	FEMALE	150	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES	Endocervical curettage	Other method, specify:	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	New Primary Tumor		YES	YES	false	No	TCGA-EO-A3AU.B1D13355-6346-4FA4-950A-84114901515C.pdf	A3AU	51	negative	TUMOR FREE		1	YES	4+	Complete Remission/Response	Never Used		YES	Surgical Resection		R0		Primary Tumor	01	Minimally Invasive	2009			YES	EO		1		14	Endometrial	A	LIVING	78	2010	f6c13e4d-5a10-48cc-8ce1-a535565b6006		TCGA-EO-A3AU-01	f6c13e4d-5a10-48cc-8ce1-a535565b6006	TCGA-EO-A3AU-01A-11-A23Z-20	6DB1614D-F39D-4DF2-9293-232B3CA6A975			f6c13e4d-5a10-48cc-8ce1-a535565b6006				f6c13e4d-5a10-48cc-8ce1-a535565b6006		TCGA-EO-A3AU-01		TCGA-EO-A3AU-01A-21D-A19X-01		TCGA-EO-A3AU-01A-21D-A19X-01	TCGA-EO-A3AU-01	TCGA-EO-A3AU-01	TCGA-EO-A3AU-01A-21D-A19Z-05		
TCGA-EO-A3AV-01	MSS	0	TCGA-EO-A3AV-01	1069	0	days	Kirc+		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 4			TCGA-EO-A3AV	1069	0	days	1069	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51		0	TCGA-EO-A3AV-F48634	TCGA-EO-A3AV	TCGA-EO-A3AV-01A		Stage IIIC1	NO		-18713	407		0	1069				NO			2013-9-18	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	130	NO	NO	Peri (6-12 months since last menstrual period)	G3					NO	false	No	TCGA-EO-A3AV.9FF6FADC-4F38-41A2-8B96-24CB1EB2010E.pdf	A3AV	51	negative	TUMOR FREE		6	YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		3	6	33	Endometrial	A	LIVING	45	2010	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f		TCGA-EO-A3AV-01	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f	TCGA-EO-A3AV-01A-21-A23Z-20	CAEF23A5-BEC8-4033-9A45-A2620497D282			ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f				ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f		TCGA-EO-A3AV-01		TCGA-EO-A3AV-01A-12D-A19X-01		TCGA-EO-A3AV-01A-12D-A19X-01	TCGA-EO-A3AV-01	TCGA-EO-A3AV-01	TCGA-EO-A3AV-01A-12D-A19Z-05		
TCGA-EO-A3AY-01	MSS	0	TCGA-EO-A3AY-01	1158	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 4			TCGA-EO-A3AY	1163	1	days	1158	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	58			TCGA-EO-A3AY-F71142	TCGA-EO-A3AY	TCGA-EO-A3AY-01A		Stage IB	NO		-21291	227		0	1158			1163	NO			2015-3-18	FEMALE	164	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Vaginal Vault		YES	false	No	TCGA-EO-A3AY.330AEFE0-D564-4799-8928-B05280BACA91.pdf	A3AY	50	negative	WITH TUMOR		0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009			YES	EO		0		25	Endometrial	A	LIVING	76	2011	8025c2b5-a137-4c88-9ac4-cc4be43e4f25		TCGA-EO-A3AY-01	8025c2b5-a137-4c88-9ac4-cc4be43e4f25	TCGA-EO-A3AY-01A-21-A23Z-20	018AE6E3-62FC-46D9-95F5-F114322C89D4			8025c2b5-a137-4c88-9ac4-cc4be43e4f25				8025c2b5-a137-4c88-9ac4-cc4be43e4f25		TCGA-EO-A3AY-01		TCGA-EO-A3AY-01A-12D-A19X-01		TCGA-EO-A3AY-01A-12D-A19X-01	TCGA-EO-A3AY-01	TCGA-EO-A3AY-01	TCGA-EO-A3AY-01A-12D-A19Z-05		
TCGA-EO-A3AZ-01	MSI-H	0	TCGA-EO-A3AZ-01	826	0	days	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 5			TCGA-EO-A3AZ	826	0	days	826	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	80			TCGA-EO-A3AZ-F48635	TCGA-EO-A3AZ	TCGA-EO-A3AZ-01A	Never Used	Stage IB	NO		-29234	241		0	826				NO			2013-9-18	FEMALE	140	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3AZ.EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46.pdf	A3AZ	51	negative	TUMOR FREE			NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		0	Endometrial	A	LIVING	78	2011	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f		TCGA-EO-A3AZ-01	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f	TCGA-EO-A3AZ-01A-21-A23Z-20	FBF232C4-9838-4991-8623-DC86F7A60FC8			78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f				78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f		TCGA-EO-A3AZ-01		TCGA-EO-A3AZ-01A-12D-A19X-01		TCGA-EO-A3AZ-01A-12D-A19X-01	TCGA-EO-A3AZ-01	TCGA-EO-A3AZ-01	TCGA-EO-A3AZ-01A-12D-A19Z-05		
TCGA-EO-A3B0-01	MSS	0	TCGA-EO-A3B0-01	1412	0	days	Kirc+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 5			TCGA-EO-A3B0	1412	0	days	1412	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	43		2	TCGA-EO-A3B0-F71143	TCGA-EO-A3B0	TCGA-EO-A3B0-01A	Former User	Stage IIIC2	NO		-15954	196		0	1412				NO			2015-3-18	FEMALE	152	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO	NO	Indeterminate (neither Pre or Postmenopausal)	G3					NO	false	No	TCGA-EO-A3B0.5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28.pdf	A3B0			TUMOR FREE		5	NO	2	[Discrepancy]	Never Used		NO				RX	Primary Tumor	01	open	2009			YES	EO		3		7	Endometrial	A	LIVING	53	2011	cad7a685-cb28-44bf-ad8e-e4528a73f0b6		TCGA-EO-A3B0-01	cad7a685-cb28-44bf-ad8e-e4528a73f0b6	TCGA-EO-A3B0-01A-21-A23Z-20	31CAA926-B4B8-4574-A03C-893D2ED156B5			cad7a685-cb28-44bf-ad8e-e4528a73f0b6				cad7a685-cb28-44bf-ad8e-e4528a73f0b6		TCGA-EO-A3B0-01		TCGA-EO-A3B0-01A-12D-A19X-01		TCGA-EO-A3B0-01A-12D-A19X-01	TCGA-EO-A3B0-01	TCGA-EO-A3B0-01	TCGA-EO-A3B0-01A-12D-A19Z-05		
TCGA-EO-A3B1-01	MSS	0	TCGA-EO-A3B1-01	820	0	days	High		UCEC Serous c4		squamous c3		miRNA cluster 4			TCGA-EO-A3B1	820	0	days	820	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63			TCGA-EO-A3B1-F48637	TCGA-EO-A3B1	TCGA-EO-A3B1-01A	Never Used	Stage IB	NO		-23162	163		0	820				NO			2013-9-18	FEMALE	170	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	90	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3B1.D3309430-5427-4FAD-BDD6-A6E9BABE29D2.pdf	A3B1	51		TUMOR FREE		0	YES		Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		13	Endometrial	A	LIVING	93	2011	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f		TCGA-EO-A3B1-01	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f	TCGA-EO-A3B1-01A-21-A23Z-20	266FC9A2-C102-471E-B05A-2A596507E0FB			2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f				2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f		TCGA-EO-A3B1-01		TCGA-EO-A3B1-01A-12D-A19X-01		TCGA-EO-A3B1-01A-12D-A19X-01	TCGA-EO-A3B1-01	TCGA-EO-A3B1-01	TCGA-EO-A3B1-01A-12D-A19Z-05		
TCGA-EO-A3KU-01	MSS	0	TCGA-EO-A3KU-01	677	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA c1uster 10			TCGA-EO-A3KU	677	0	days	677	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68		0	TCGA-EO-A3KU-F48646	TCGA-EO-A3KU	TCGA-EO-A3KU-01A	Never Used	Stage II	NO		-25116	93		0	677							2013-9-18	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3KU.B6945BE4-FA4A-4ED4-9233-B32123F41C95.pdf	A3KU	0		TUMOR FREE		0	YES	3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		9		6	Endometrial	A	LIVING	65	2011	91238210-9f8d-4c09-8016-fd0a7d135023		TCGA-EO-A3KU-01	91238210-9f8d-4c09-8016-fd0a7d135023	TCGA-EO-A3KU-01A-21-A23Z-20	9615A8B1-9358-4C26-A89B-10112848D993			91238210-9f8d-4c09-8016-fd0a7d135023				91238210-9f8d-4c09-8016-fd0a7d135023		TCGA-EO-A3KU-01		TCGA-EO-A3KU-01A-11D-A227-01		TCGA-EO-A3KU-01A-11D-A227-01	TCGA-EO-A3KU-01	TCGA-EO-A3KU-01	TCGA-EO-A3KU-01A-11D-A22B-05		
TCGA-EO-A3KW-01	MSS	0	TCGA-EO-A3KW-01	497	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-EO-A3KW	497	0	days	497	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72			TCGA-EO-A3KW-F39967	TCGA-EO-A3KW	TCGA-EO-A3KW-01A		Stage IA	NO		-26492	205		0	497				NO			2013-2-7	FEMALE	153	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3KW.C1CFE3DE-628B-4C0F-881B-588C613498DA.pdf	A3KW			TUMOR FREE		0	YES	2	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		21	Endometrial	A	LIVING	62	2011	eb279337-8251-4442-905c-8a4be743f057		TCGA-EO-A3KW-01	eb279337-8251-4442-905c-8a4be743f057	TCGA-EO-A3KW-01A-21-A23Z-20	E6BEBDFC-AE99-42FA-A673-C64C518F0EEA			eb279337-8251-4442-905c-8a4be743f057				eb279337-8251-4442-905c-8a4be743f057		TCGA-EO-A3KW-01		TCGA-EO-A3KW-01A-11D-A227-01		TCGA-EO-A3KW-01A-11D-A227-01	TCGA-EO-A3KW-01	TCGA-EO-A3KW-01	TCGA-EO-A3KW-01A-11D-A22B-05		
TCGA-EO-A3KX-01	MSI-H	0	TCGA-EO-A3KX-01	1170	0	days	Quiet		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-EO-A3KX	1170	0	days	1170	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	80			TCGA-EO-A3KX-F71144	TCGA-EO-A3KX	TCGA-EO-A3KX-01A		Stage IA			-29260	184		0	1170				YES			2015-3-18	FEMALE	145	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	150	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3KX.BB1CD473-0D98-414E-801B-09037E1BF43E.pdf	A3KX			TUMOR FREE		0	NO		Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EO		0		3	Endometrial	A	LIVING	44	2011	babc3b9e-a99f-490b-a277-ab4e6f6b5449		TCGA-EO-A3KX-01	babc3b9e-a99f-490b-a277-ab4e6f6b5449	TCGA-EO-A3KX-01A-21-A23Z-20	B61C7ED5-D259-4A39-BA2A-4E31ECB0BFB7			babc3b9e-a99f-490b-a277-ab4e6f6b5449				babc3b9e-a99f-490b-a277-ab4e6f6b5449		TCGA-EO-A3KX-01		TCGA-EO-A3KX-01A-11D-A227-01		TCGA-EO-A3KX-01A-11D-A227-01	TCGA-EO-A3KX-01	TCGA-EO-A3KX-01	TCGA-EO-A3KX-01A-11D-A22B-05		
TCGA-EO-A3L0-01	MSS	0	TCGA-EO-A3L0-01	1554	0	days	Kirc+		UCEC CIMP c18		squamous c3		miRNA c1uster 10			TCGA-EO-A3L0	1554	0	days	1554	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	76		0	TCGA-EO-A3L0-F71161	TCGA-EO-A3L0	TCGA-EO-A3L0-01A		Stage IA	NO		-28003	422		0	1554							2015-3-19	FEMALE	159	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EO-A3L0.AD1F0EEC-20B6-416B-9728-BC103D2B3B87.pdf	A3L0	49		TUMOR FREE		0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	EO		2		11	Endometrial	A	LIVING	110	2010	4383201e-ca97-4192-8e89-c63b10caaa0c		TCGA-EO-A3L0-01	4383201e-ca97-4192-8e89-c63b10caaa0c	TCGA-EO-A3L0-01A-21-A23Z-20	BA066AC9-3E99-41B7-913A-E6E05347406E			4383201e-ca97-4192-8e89-c63b10caaa0c				4383201e-ca97-4192-8e89-c63b10caaa0c		TCGA-EO-A3L0-01		TCGA-EO-A3L0-01A-11D-A227-01		TCGA-EO-A3L0-01A-11D-A227-01	TCGA-EO-A3L0-01	TCGA-EO-A3L0-01	TCGA-EO-A3L0-01A-11D-A22B-05		
TCGA-EY-A1G7-01	MSS	1	TCGA-EY-A1G7-01	189	1	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-EY-A1G7			days	189	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	YES	NO	Partial Response	86			TCGA-EY-A1G7-F10982	TCGA-EY-A1G7	TCGA-EY-A1G7-01A	Never Used	Stage II	NO		-31603	1002	189	0				95	NO			2011-5-2	FEMALE	151	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2						false	Yes	TCGA-EY-A1G7.2803014E-7E68-463F-BF3C-C5E4DF9FA421.pdf	A1G7	96	negative	WITH TUMOR				4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	EY		0		0	Endometrial	A	DECEASED	85	2008			TCGA-EY-A1G7-01		TCGA-EY-A1G7-01A-21-A18Q-20	73D5F538-13D4-4E09-B7EF-0746A72B4BC0										c3c8ccb3-db16-4cc6-b790-204473be0f25	TCGA-EY-A1G7-01A-11D-A13J-01		TCGA-EY-A1G7-01A-11D-A13J-01		TCGA-EY-A1G7-01	TCGA-EY-A1G7-01A-11D-A13K-05		c3c8ccb3-db16-4cc6-b790-204473be0f25
TCGA-EY-A1G8-01	MSS	1	TCGA-EY-A1G8-01	456	1	days	Kirc+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 6		TCGA-EY-A1G8			days	456	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					83			TCGA-EY-A1G8-F10562	TCGA-EY-A1G8	TCGA-EY-A1G8-01A		Stage IB	NO		-30517	771	456	0					NO			2011-4-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Tumor resection	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-EY-A1G8.2454950F-8B3D-4690-98CA-B94C79F99552.pdf	A1G8	38	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	EY		0		40	Endometrial	A	DECEASED	49	2008			TCGA-EY-A1G8-01		TCGA-EY-A1G8-01A-21-A18Q-20	70FDD3EE-9591-401A-8AE0-EACA0BDE0FFA										d653b50c-d568-48a1-bbed-5e36fbf525ac	TCGA-EY-A1G8-01A-11D-A13J-01		TCGA-EY-A1G8-01A-11D-A13J-01		TCGA-EY-A1G8-01	TCGA-EY-A1G8-01A-11D-A13K-05		d653b50c-d568-48a1-bbed-5e36fbf525ac
TCGA-EY-A1GC-01	MSS	0	TCGA-EY-A1GC-01	1647	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 3		TCGA-EY-A1GC	1647	0	days	1647	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62			TCGA-EY-A1GC-F70253	TCGA-EY-A1GC	TCGA-EY-A1GC-01A		Stage IB	NO		-22656	519		0	1647				NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	167	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Tumor resection	290	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A1GC.62D18250-0D82-43AB-AADE-E152D6FF74BB.pdf	A1GC	5	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY		0	0	24	Endometrial	A	LIVING	96	2009			TCGA-EY-A1GC-01		TCGA-EY-A1GC-01A-21-A18Q-20	58118A63-3A3A-4625-A75E-D8EDA915269A									TCGA-EY-A1GC-01	b408b777-f98b-4660-b01b-89fa0c607c3b	TCGA-EY-A1GC-01A-11D-A13J-01		TCGA-EY-A1GC-01A-11D-A13J-01	TCGA-EY-A1GC-01	TCGA-EY-A1GC-01	TCGA-EY-A1GC-01A-11D-A13K-05		b408b777-f98b-4660-b01b-89fa0c607c3b
TCGA-EY-A1GD-01	MSS	0	TCGA-EY-A1GD-01	1639	0	days	Iq	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-EY-A1GD	1639	0	days	1639	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51		0	TCGA-EY-A1GD-F70252	TCGA-EY-A1GD	TCGA-EY-A1GD-01A	Former User	Stage IA	NO		-18638	511		0	1639				NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Tumor resection	230	NO	NO	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1					NO	false	No	TCGA-EY-A1GD.65C636F7-B24D-479C-A607-FEFEE7D7E30D.pdf	A1GD	0	negative	TUMOR FREE		0	NO	3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	3	0	20	Endometrial	A	LIVING	79	2009			TCGA-EY-A1GD-01		TCGA-EY-A1GD-01A-21-A18Q-20	482B940B-57EA-48B1-97D5-1F5F105A5829									TCGA-EY-A1GD-01	5d109d0e-7bc8-4d3e-898b-a48ab288a5ee	TCGA-EY-A1GD-01A-11D-A13J-01		TCGA-EY-A1GD-01A-11D-A13J-01	TCGA-EY-A1GD-01	TCGA-EY-A1GD-01	TCGA-EY-A1GD-01A-11D-A13K-05		5d109d0e-7bc8-4d3e-898b-a48ab288a5ee
TCGA-EY-A1GE-01	MSS	0	TCGA-EY-A1GE-01	741	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 4	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 1		TCGA-EY-A1GE	741	0	days	741	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67		0	TCGA-EY-A1GE-F19724	TCGA-EY-A1GE	TCGA-EY-A1GE-01A	Never Used	Stage IA	NO		-24667	506		0	741				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-EY-A1GE.432813D0-4B52-4941-940C-5725BCE4211A.pdf	A1GE	0	negative	TUMOR FREE		0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	10	0	27	Endometrial	A	LIVING	103	2009			TCGA-EY-A1GE-01		TCGA-EY-A1GE-01A-21-A18Q-20	D3FF0165-3783-4EA1-83CF-9A312E3A8EC0									TCGA-EY-A1GE-01	d2a5585a-76fe-4e69-bf8a-36553bf282fb	TCGA-EY-A1GE-01A-11D-A13J-01		TCGA-EY-A1GE-01A-11D-A13J-01	TCGA-EY-A1GE-01	TCGA-EY-A1GE-01	TCGA-EY-A1GE-01A-11D-A13K-05		d2a5585a-76fe-4e69-bf8a-36553bf282fb
TCGA-EY-A1GF-01	MSI-H	0	TCGA-EY-A1GF-01	826	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GF	826	0	days	826	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75		0	TCGA-EY-A1GF-F19725	TCGA-EY-A1GF	TCGA-EY-A1GF-01A	Never Used	Stage IA	NO		-27450	504		0	826				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-EY-A1GF.0C63BAC2-FD3E-49CB-A352-0B1653B78BDD.pdf	A1GF	11	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY	0	9	0	16	Endometrial	A	LIVING	71	2009			TCGA-EY-A1GF-01		TCGA-EY-A1GF-01A-21-A18Q-20	EE015F30-256C-40B7-9FEF-3545593179BB									TCGA-EY-A1GF-01	e8d79b43-6ed3-40f4-854e-5fd23204381f	TCGA-EY-A1GF-01A-11D-A13J-01		TCGA-EY-A1GF-01A-11D-A13J-01	TCGA-EY-A1GF-01	TCGA-EY-A1GF-01	TCGA-EY-A1GF-01A-11D-A13K-05		e8d79b43-6ed3-40f4-854e-5fd23204381f
TCGA-EY-A1GH-01	MSS	0	TCGA-EY-A1GH-01	710	0	days	BRCA-LUAD+	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 3		TCGA-EY-A1GH	710	0	days	710	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70			TCGA-EY-A1GH-F19726	TCGA-EY-A1GH	TCGA-EY-A1GH-01A	Never Used	Stage IA	NO		-25802	452		0	710				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	280	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-EY-A1GH.29D738E9-2F8D-4909-A427-7C056859B89A.pdf	A1GH	33	negative	TUMOR FREE				2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	NO	YES	EY		0			Endometrial	A	LIVING	117	2009			TCGA-EY-A1GH-01		TCGA-EY-A1GH-01A-21-A18Q-20	18E9DF4D-A21E-449E-8EE8-C2AD19BD4491									TCGA-EY-A1GH-01	55f89e0e-bb6b-40e0-bc85-602a011c764b	TCGA-EY-A1GH-01A-11D-A13J-01		TCGA-EY-A1GH-01A-11D-A13J-01	TCGA-EY-A1GH-01	TCGA-EY-A1GH-01	TCGA-EY-A1GH-01A-11D-A13K-05		55f89e0e-bb6b-40e0-bc85-602a011c764b
TCGA-EY-A1GI-01	MSS	0	TCGA-EY-A1GI-01	710	0	days	Quiet	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA cluster 13	cluster 4		TCGA-EY-A1GI	710	0	days	710	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	52			TCGA-EY-A1GI-F19727	TCGA-EY-A1GI	TCGA-EY-A1GI-01A	Never Used	Stage IB	NO		-19117	444		0	710				NO		Scheduled Follow-up Submission	2011-12-21	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Excisional Biopsy	150	NO		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2					NO	false	No	TCGA-EY-A1GI.1D56F7CA-A3F0-4078-B8E3-A10CD97873D4.pdf	A1GI	76	negative	TUMOR FREE		0		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	NO	YES	EY		0	0	23	Endometrial	A	LIVING	69	2009			TCGA-EY-A1GI-01		TCGA-EY-A1GI-01A-21-A18Q-20	27280176-FA3E-4547-BC14-810694C91270									TCGA-EY-A1GI-01	e505cac9-a568-42db-bc67-d90af57e5265	TCGA-EY-A1GI-01A-11D-A13J-01		TCGA-EY-A1GI-01A-11D-A13J-01	TCGA-EY-A1GI-01	TCGA-EY-A1GI-01	TCGA-EY-A1GI-01A-11D-A13K-05		e505cac9-a568-42db-bc67-d90af57e5265
TCGA-EY-A1GJ-01	MSS	0	TCGA-EY-A1GJ-01	727	0	days	High		UCEC Serous c4	cluster 3	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-EY-A1GJ	727	0	days	727	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73		0	TCGA-EY-A1GJ-F19728	TCGA-EY-A1GJ	TCGA-EY-A1GJ-01A	Never Used	Stage IA	NO		-26715	434		0	727				YES		Scheduled Follow-up Submission	2011-12-21	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A1GJ.505FE0B0-068C-4B2A-AA40-4657FB2E0425.pdf	A1GJ	0	negative	TUMOR FREE		0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	10	0	15	Endometrial	A	LIVING	85	2009					TCGA-EY-A1GJ-01A-21-A18Q-20	FC904AB6-4B55-45A7-896A-02CAD12E1C69									TCGA-EY-A1GJ-01		TCGA-EY-A1GJ-01A-12D-A141-01		TCGA-EY-A1GJ-01A-12D-A141-01	TCGA-EY-A1GJ-01		TCGA-EY-A1GJ-01A-12D-A145-05		
TCGA-EY-A1GK-01	MSI-H	0	TCGA-EY-A1GK-01	693	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 4		TCGA-EY-A1GK	693	0	days	693	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74		0	TCGA-EY-A1GK-F19756	TCGA-EY-A1GK	TCGA-EY-A1GK-01A	Never Used	Stage IB	NO		-27127	409		0	693				NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A1GK.B5024D10-E23D-4B3B-8C54-13EBAA423A04.pdf	A1GK	58	negative	TUMOR FREE		0		3	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	12	0	14	Endometrial	A	LIVING	105	2009			TCGA-EY-A1GK-01		TCGA-EY-A1GK-01A-21-A18Q-20	FE0AC1DE-B750-4B82-9B56-EE722A7064F0									TCGA-EY-A1GK-01	bfbb3c82-87b0-44b2-bf2c-5c9bdc318460	TCGA-EY-A1GK-01A-11D-A13J-01		TCGA-EY-A1GK-01A-11D-A13J-01	TCGA-EY-A1GK-01	TCGA-EY-A1GK-01	TCGA-EY-A1GK-01A-11D-A13K-05		bfbb3c82-87b0-44b2-bf2c-5c9bdc318460
TCGA-EY-A1GL-01	MSS	0	TCGA-EY-A1GL-01	1014	0	days	Kirc+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA cluster 11	cluster 2		TCGA-EY-A1GL	1014	0	days	1014	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	51		0	TCGA-EY-A1GL-F70250	TCGA-EY-A1GL	TCGA-EY-A1GL-01A	Never Used	Stage II	NO		-18761	366		0	1014				NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	173	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	300	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-EY-A1GL.449C1D9F-6A1F-4523-8C86-AFED911D95D4.pdf	A1GL	83	negative	TUMOR FREE		0	NO	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009	NO	YES	NO	EY	0	6	0	13	Endometrial	A	LIVING	73	2010	94120972-002e-4dbd-8bb1-7f41f05f2b0f		TCGA-EY-A1GL-01	94120972-002e-4dbd-8bb1-7f41f05f2b0f	TCGA-EY-A1GL-01A-21-A18Q-20	C3D4EF49-BDA0-4723-90CB-311EDDE0C900			94120972-002e-4dbd-8bb1-7f41f05f2b0f				94120972-002e-4dbd-8bb1-7f41f05f2b0f		TCGA-EY-A1GL-01		TCGA-EY-A1GL-01A-11D-A13J-01		TCGA-EY-A1GL-01A-11D-A13J-01	TCGA-EY-A1GL-01	TCGA-EY-A1GL-01	TCGA-EY-A1GL-01A-11D-A13K-05		
TCGA-EY-A1GM-01	MSS	1	TCGA-EY-A1GM-01	995	1	days	COAD-READ	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-EY-A1GM	791	1	days	995	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO		Progressive Disease	60		0	TCGA-EY-A1GM-F70249	TCGA-EY-A1GM	TCGA-EY-A1GM-01A	Never Used	Stage IIIA	NO		-22010	323	995	0	210			791	NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	157	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	140	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3		Locoregional Recurrence		NO	YES	false	No	TCGA-EY-A1GM.C3599CB9-3B69-4083-AA2E-5BB52CF1ED93.pdf	A1GM	33	positive	WITH TUMOR		0	YES	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	13	0	11	Endometrial	A	DECEASED	71	2010			TCGA-EY-A1GM-01		TCGA-EY-A1GM-01A-21-A18Q-20	2C36E07A-174A-4CBC-8CCD-AD830A4BB1DF									TCGA-EY-A1GM-01	9713963c-c7c7-47a0-ba01-6710bd4e9fea	TCGA-EY-A1GM-01A-12D-A14F-01		TCGA-EY-A1GM-01A-12D-A14F-01	TCGA-EY-A1GM-01	TCGA-EY-A1GM-01	TCGA-EY-A1GM-01A-12D-A14H-05		9713963c-c7c7-47a0-ba01-6710bd4e9fea
TCGA-EY-A1GO-01	MSI-H	0	TCGA-EY-A1GO-01	586	0	days	Squamous		UCEC Serous c4	cluster 4	UCEC-like c5		miRNA c1uster 10	cluster 3		TCGA-EY-A1GO	517	1	days	586	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	YES	Progressive Disease	65		0	TCGA-EY-A1GO-F19759	TCGA-EY-A1GO	TCGA-EY-A1GO-01A	Former User	Stage IIIC1	NO	517	-23853	259		0	586			517	NO		Scheduled Follow-up Submission	2011-12-22	FEMALE	156	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	NO	C54.1	8380/3	C54.1	YES		Tumor resection	100	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Lung	Metastatic			YES	false	No	TCGA-EY-A1GO.82216372-E1EF-47F2-B57A-25C1DCB24E5E.pdf	A1GO	98	negative	WITH TUMOR		1		2	Complete Remission/Response	Never Used		YES	Other Method, Specify Below	VATS Wedge resection	RX	R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	6	1	17	Endometrial	A	LIVING	76	2010	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7		TCGA-EY-A1GO-01	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7	TCGA-EY-A1GO-01A-21-A18Q-20	DFCAEDA6-D463-4CE3-B9BD-66CC4B3F2C82			8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7				8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7		TCGA-EY-A1GO-01		TCGA-EY-A1GO-01A-11D-A14F-01		TCGA-EY-A1GO-01A-11D-A14F-01	TCGA-EY-A1GO-01	TCGA-EY-A1GO-01	TCGA-EY-A1GO-01A-11D-A14H-05		
TCGA-EY-A1GP-01	MSS	0	TCGA-EY-A1GP-01	573	0	days	BRCA-LUAD+		UCEC Serous c4	cluster 3	UCEC-like c5		miRNA cluster 13	cluster 6		TCGA-EY-A1GP	573	0	days	573	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	54			TCGA-EY-A1GP-F19766	TCGA-EY-A1GP	TCGA-EY-A1GP-01A	Never Used	Stage IA	NO		-20011	262		0	573				YES		Scheduled Follow-up Submission	2011-12-22	FEMALE	158	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-EY-A1GP.D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1.pdf	A1GP	32	negative	TUMOR FREE				0	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY		0		0	Endometrial	A	LIVING	72	2010	c3740105-aee5-42ef-94e9-50f6b242b7c8		TCGA-EY-A1GP-01	c3740105-aee5-42ef-94e9-50f6b242b7c8	TCGA-EY-A1GP-01A-21-A18Q-20	24AA478A-20A3-4B5D-BC07-A92892908608			c3740105-aee5-42ef-94e9-50f6b242b7c8				c3740105-aee5-42ef-94e9-50f6b242b7c8		TCGA-EY-A1GP-01		TCGA-EY-A1GP-01A-11D-A13J-01		TCGA-EY-A1GP-01A-11D-A13J-01	TCGA-EY-A1GP-01	TCGA-EY-A1GP-01	TCGA-EY-A1GP-01A-11D-A13K-05		
TCGA-EY-A1GQ-01	MSI-H	0	TCGA-EY-A1GQ-01	544	0	days	BRCA-LUAD+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 5	cluster 4		TCGA-EY-A1GQ	334	1	days	544	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES		NO	Partial Response	76			TCGA-EY-A1GQ-F13192	TCGA-EY-A1GQ	TCGA-EY-A1GQ-01A		Stage IB	NO		-27905	274		0	544			334	NO		Additional New Tumor Event	2011-12-22	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	160	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	R external iliac node, presacral peritoneal implant, ascitic fluid		YES	false	Yes	TCGA-EY-A1GQ.9A8D1D19-18D8-483B-BD87-B686D25C617F.pdf	A1GQ	98	negative	WITH TUMOR		0		4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY		0	0	29	Endometrial	A	LIVING	81	2010			TCGA-EY-A1GQ-01		TCGA-EY-A1GQ-01A-11-A18Q-20	9901D7A2-131B-47A0-A143-80885513AFF8									TCGA-EY-A1GQ-01	afceaea6-337b-4ac4-a7fb-773c98d95547	TCGA-EY-A1GQ-01A-21D-A13J-01		TCGA-EY-A1GQ-01A-21D-A13J-01	TCGA-EY-A1GQ-01	TCGA-EY-A1GQ-01	TCGA-EY-A1GQ-01A-21D-A13K-05		afceaea6-337b-4ac4-a7fb-773c98d95547
TCGA-EY-A1GR-01	MSS	0	TCGA-EY-A1GR-01	536	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GR	536	0	days	536	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67		0	TCGA-EY-A1GR-F19769	TCGA-EY-A1GR	TCGA-EY-A1GR-01A	Never Used	Stage IA	NO		-24784	263		0	536				YES		Scheduled Follow-up Submission	2011-12-22	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A1GR.1C53C957-1A0A-46AF-A53B-0287683D52F6.pdf	A1GR	33	negative	TUMOR FREE		0		3	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	YES	NO	EY	0	9	0	16	Endometrial	A	LIVING	93	2010			TCGA-EY-A1GR-01		TCGA-EY-A1GR-01A-21-A18Q-20	8F1450F5-22BC-4D32-AB5E-5D64396EB05D									TCGA-EY-A1GR-01	64b366d1-dfb2-4488-9fd1-e6b26998bb9d	TCGA-EY-A1GR-01A-11D-A13J-01		TCGA-EY-A1GR-01A-11D-A13J-01	TCGA-EY-A1GR-01	TCGA-EY-A1GR-01	TCGA-EY-A1GR-01A-11D-A13K-05		64b366d1-dfb2-4488-9fd1-e6b26998bb9d
TCGA-EY-A1GS-01	MSS	1	TCGA-EY-A1GS-01	670	1	days	High	C6-UCEC	BRCA CIMP c7	cluster 2	BRCA basal-like c6	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 2	TCGA-EY-A1GS	670	0	days	670	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	71			TCGA-EY-A1GS-F70247	TCGA-EY-A1GS	TCGA-EY-A1GS-01A		Stage IVB			-26012	211	670	0	459				NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	161	Serous endometrial adenocarcinoma	No		YES	C54.1	8441/3	C54.1	YES		Tumor resection	270	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A1GS.3F953015-45DC-4678-A8B3-DC55339DE717.pdf	A1GS	50		WITH TUMOR		7	YES	0	Stable Disease			NO				R2	Primary Tumor	01	open	2009	YES	YES	NO	EY		0	7	9	Endometrial	A	DECEASED	62	2010			TCGA-EY-A1GS-01		TCGA-EY-A1GS-01A-21-A18Q-20	D6E48E59-4576-413C-B2EB-6EE828E54AB1					TCGA-EY-A1GS-01A-11D-A13L-09	TCGA-EY-A1GS-01A-11D-A13L-09			TCGA-EY-A1GS-01	7348f1f9-8bcf-41e2-bcb0-743823cac926	TCGA-EY-A1GS-01A-11D-A13J-01		TCGA-EY-A1GS-01A-11D-A13J-01	TCGA-EY-A1GS-01	TCGA-EY-A1GS-01	TCGA-EY-A1GS-01A-11D-A13K-05		7348f1f9-8bcf-41e2-bcb0-743823cac926
TCGA-EY-A1GT-01	MSS	0	TCGA-EY-A1GT-01	490	0	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-EY-A1GT	490	0	days	490	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-EY-A1GT-F19877	TCGA-EY-A1GT	TCGA-EY-A1GT-01A	Former User	Stage IIIA	NO		-25151	225		0	490				NO		Scheduled Follow-up Submission	2012-1-3	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	Yes, I have taken menopausal hormone therapy in the past, but no longer do.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	380	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-EY-A1GT.2F5AE4E7-9411-461D-ACD9-EB7D51CEF872.pdf	A1GT	10	positive	TUMOR FREE		0		1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY		0	0	25	Endometrial	A	LIVING	70	2010			TCGA-EY-A1GT-01		TCGA-EY-A1GT-01A-21-A18Q-20	ECED1752-B536-431E-AB4E-255B1046711A									TCGA-EY-A1GT-01	654f3e2f-00c7-4db6-b092-e2d0d50845da	TCGA-EY-A1GT-01A-11D-A13J-01		TCGA-EY-A1GT-01A-11D-A13J-01	TCGA-EY-A1GT-01	TCGA-EY-A1GT-01	TCGA-EY-A1GT-01A-11D-A13K-05		654f3e2f-00c7-4db6-b092-e2d0d50845da
TCGA-EY-A1GU-01	MSI-H	1	TCGA-EY-A1GU-01	997	1	days	Iq	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 7	cluster 1		TCGA-EY-A1GU	997	0	days	997	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	66		0	TCGA-EY-A1GU-F70245	TCGA-EY-A1GU	TCGA-EY-A1GU-01A	Never Used	Stage IB	NO		-24304	189	997	0	378				YES		Scheduled Follow-up Submission	2015-2-2	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	380	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-EY-A1GU.7A06A8F8-416F-41CD-B546-95DEA06996D0.pdf	A1GU	94	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	5	0	11	Endometrial	A	DECEASED	90	2010			TCGA-EY-A1GU-01		TCGA-EY-A1GU-01A-21-A18Q-20	1B18AB0C-DC27-4B01-8E6A-7E890F1207DE									TCGA-EY-A1GU-01	02302c44-fe54-4b39-9bef-c56db229c2ac	TCGA-EY-A1GU-01A-11D-A13J-01		TCGA-EY-A1GU-01A-11D-A13J-01	TCGA-EY-A1GU-01	TCGA-EY-A1GU-01	TCGA-EY-A1GU-01A-11D-A13K-05		02302c44-fe54-4b39-9bef-c56db229c2ac
TCGA-EY-A1GV-01	MSS	0	TCGA-EY-A1GV-01	481	0	days	High	C6-UCEC	OV-like c1	cluster 3	BRCA basal-like c6	UCEC-like c11	miRNA cluster 13	cluster 2		TCGA-EY-A1GV	481	0	days	481	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75		0	TCGA-EY-A1GV-F19882	TCGA-EY-A1GV	TCGA-EY-A1GV-01A		Stage IIIC1	NO		-27581	156		0	481				YES		Scheduled Follow-up Submission	2012-1-3	FEMALE	165	Mixed serous and endometrioid	No		YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	300	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A1GV.87A6A698-71B7-41D8-AE28-C2FCC92F9A94.pdf	A1GV	59	negative	TUMOR FREE		1		4+	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	11	1	17	Endometrial	A	LIVING	79	2010			TCGA-EY-A1GV-01		TCGA-EY-A1GV-01A-21-A18Q-20	BE92B05E-43B1-4ED5-AEE9-E7781D431237									TCGA-EY-A1GV-01	2b56219d-b0d0-4107-acdf-b2ad9c18f090	TCGA-EY-A1GV-01A-11D-A13J-01		TCGA-EY-A1GV-01A-11D-A13J-01	TCGA-EY-A1GV-01	TCGA-EY-A1GV-01	TCGA-EY-A1GV-01A-11D-A13K-05		2b56219d-b0d0-4107-acdf-b2ad9c18f090
TCGA-EY-A1GW-01	MSS	1	TCGA-EY-A1GW-01	337	1	days	Squamous	C6-UCEC	UCEC non-CIMP c3	cluster 2	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A1GW	190	1	days	337	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	73			TCGA-EY-A1GW-F12151	TCGA-EY-A1GW	TCGA-EY-A1GW-01A	Never Used	Stage IVB	NO		-26979	155	337	0	260			190	NO		Additional New Tumor Event	2012-1-3	FEMALE	149	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	410	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Metastatic			YES	false	No	TCGA-EY-A1GW.52C26330-540E-4409-ACDF-4D56EA1E7D7F.pdf	A1GW	62	positive	WITH TUMOR				2	Progressive Disease	Never Used		NO				R1	Primary Tumor	01	open	2009	YES	YES	NO	EY		0		0	Endometrial	A	DECEASED	81	2010			TCGA-EY-A1GW-01		TCGA-EY-A1GW-01A-11-A18Q-20	F4D2FE5C-7742-4751-B59D-E7907F5F90A2									TCGA-EY-A1GW-01	4e6ddf28-1fb2-4527-b415-30c714ecde09	TCGA-EY-A1GW-01A-22D-A13J-01		TCGA-EY-A1GW-01A-22D-A13J-01	TCGA-EY-A1GW-01	TCGA-EY-A1GW-01	TCGA-EY-A1GW-01A-22D-A13K-05		4e6ddf28-1fb2-4527-b415-30c714ecde09
TCGA-EY-A1GX-01	MSS	1	TCGA-EY-A1GX-01	1127	1	days	BRCA-LUAD+		UCEC CIMP c18	cluster 1	UCEC-like c5		miRNA c1uster 10	cluster 1		TCGA-EY-A1GX	743	1	days	1127	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium		YES		Progressive Disease	76		0	TCGA-EY-A1GX-F70244	TCGA-EY-A1GX	TCGA-EY-A1GX-01A		Stage IIIA	NO		-27962	172	1127	0	197			743	NO		Scheduled Follow-up Submission	2015-2-2	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	Locoregional Recurrence	pelvic mass	NO	YES	false	No	TCGA-EY-A1GX.4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B.pdf	A1GX	25	negative	TUMOR FREE		0	NO	2	Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	6	0	8	Endometrial	A	DECEASED	69	2010	253d79e4-6505-4704-8cd4-aafa5d36b4a4		TCGA-EY-A1GX-01	253d79e4-6505-4704-8cd4-aafa5d36b4a4	TCGA-EY-A1GX-01A-21-A18Q-20	E64F4415-7FA9-481E-8BD3-89FE5AB640D9			253d79e4-6505-4704-8cd4-aafa5d36b4a4				253d79e4-6505-4704-8cd4-aafa5d36b4a4		TCGA-EY-A1GX-01		TCGA-EY-A1GX-01A-12D-A13J-01		TCGA-EY-A1GX-01A-12D-A13J-01	TCGA-EY-A1GX-01	TCGA-EY-A1GX-01	TCGA-EY-A1GX-01A-12D-A13K-05		
TCGA-EY-A1H0-01	MSI-H	0	TCGA-EY-A1H0-01	588	0	days	Kirc+	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-EY-A1H0	588	0	days	588	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	57		1	TCGA-EY-A1H0-F19894	TCGA-EY-A1H0	TCGA-EY-A1H0-01A		Stage IIIC2	NO		-20937	262		0	588				YES		Scheduled Follow-up Submission	2012-1-3	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-EY-A1H0.CE7F1184-9FFC-4A30-926B-0008915893F2.pdf	A1H0	23	negative	WITH TUMOR		3		1	Partial Remission/Response			YES				R0	Primary Tumor	01	open	2009	YES	YES	NO	EY	1	4	3	8	Endometrial	A	LIVING	90	2010			TCGA-EY-A1H0-01		TCGA-EY-A1H0-01A-21-A18Q-20	690B02E6-1CAD-4909-B674-32A3843EE797									TCGA-EY-A1H0-01	8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01	TCGA-EY-A1H0-01A-11D-A13J-01		TCGA-EY-A1H0-01A-11D-A13J-01	TCGA-EY-A1H0-01	TCGA-EY-A1H0-01	TCGA-EY-A1H0-01A-11D-A13K-05		8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01
TCGA-EY-A210-01	MSI-L	0	TCGA-EY-A210-01	383	0	days	High		UCEC non-CIMP c3	cluster 3	UCEC-like c5		miRNA cluster 12	cluster 5		TCGA-EY-A210	383	0	days	383	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	82		7	TCGA-EY-A210-F21703	TCGA-EY-A210	TCGA-EY-A210-01A	Never Used	Stage IIIC2	NO		-30095	70		0	383				NO		Scheduled Follow-up Submission	2012-2-17	FEMALE	155	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	840	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A210.51A98C43-6A6A-4027-8E92-B3B9AA1A63D4.pdf	A210	38	positive	TUMOR FREE		6		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	7	8	6	20	Endometrial	A	LIVING	63	2011	4547d0d6-21ed-4128-9be9-34555bff3b83		TCGA-EY-A210-01	4547d0d6-21ed-4128-9be9-34555bff3b83	TCGA-EY-A210-01A-21-A18Q-20	CD95626D-05E0-4A37-A046-AFB888D11C6E			4547d0d6-21ed-4128-9be9-34555bff3b83				4547d0d6-21ed-4128-9be9-34555bff3b83		TCGA-EY-A210-01		TCGA-EY-A210-01A-11D-A160-01		TCGA-EY-A210-01A-11D-A160-01	TCGA-EY-A210-01	TCGA-EY-A210-01	TCGA-EY-A210-01A-11D-A161-05		
TCGA-EY-A212-01	MSS	1	TCGA-EY-A212-01	310	1	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 5	TCGA-EY-A212	310	0	days	310	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Partial Response	83		0	TCGA-EY-A212-F21719	TCGA-EY-A212	TCGA-EY-A212-01A		Stage IIIC1	YES		-30680	112	310	0	110				YES		Scheduled Follow-up Submission	2012-2-17	FEMALE	159	Serous endometrial adenocarcinoma	No		YES	C54.1	8460/3	C54.1	YES		Office Endometrial Biopsy	290	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A212.3E8012E3-97F1-48A2-B1C0-5C814DF8EE01.pdf	A212	45	positive	WITH TUMOR		1		4+	Partial Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	19	1	33	Endometrial	A	DECEASED	81	2010			TCGA-EY-A212-01		TCGA-EY-A212-01A-21-A18R-20	0AD26348-0444-4AA1-B64C-57F26CD91A94					TCGA-EY-A212-01A-11D-A14K-09	TCGA-EY-A212-01A-11D-A14K-09			TCGA-EY-A212-01	6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23	TCGA-EY-A212-01A-11D-A14J-01		TCGA-EY-A212-01A-11D-A14J-01	TCGA-EY-A212-01	TCGA-EY-A212-01	TCGA-EY-A212-01A-11D-A14N-05		6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23
TCGA-EY-A214-01	MSS	0	TCGA-EY-A214-01	438	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-EY-A214	438	0	days	438	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	66		0	TCGA-EY-A214-F22091	TCGA-EY-A214	TCGA-EY-A214-01A	Former User	Stage IIIC1	NO		-24136	160		0	438				NO		Scheduled Follow-up Submission	2012-2-23	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	330	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A214.90B0CBB0-3AC0-44F8-9C49-310CFFE0370C.pdf	A214	72	negative	TUMOR FREE		1		2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009	YES	YES	NO	EY	0	19	1	31	Endometrial	A	LIVING	94	2010			TCGA-EY-A214-01		TCGA-EY-A214-01A-21-A18R-20	8BD01A29-72D8-46DD-BE1A-444403EB2F4C									TCGA-EY-A214-01	32d0d293-ce07-487a-b914-062548072260	TCGA-EY-A214-01A-12D-A160-01		TCGA-EY-A214-01A-12D-A160-01	TCGA-EY-A214-01	TCGA-EY-A214-01	TCGA-EY-A214-01A-12D-A161-05		32d0d293-ce07-487a-b914-062548072260
TCGA-EY-A215-01	MSI-H	0	TCGA-EY-A215-01	574	0	days	Quiet	C6-UCEC	UCEC CIMP c18	cluster 1	UCEC-like c5	COADREAD-like c15	miRNA c1uster 10	cluster 3		TCGA-EY-A215	574	0	days	574	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60		0	TCGA-EY-A215-F21735	TCGA-EY-A215	TCGA-EY-A215-01A		Stage IB	NO		-22076	293		0	574				NO		Scheduled Follow-up Submission	2012-2-17	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	210	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A215.C0F970E3-E534-4A34-B87A-4383FD261B53.pdf	A215	50	negative	TUMOR FREE		0		2	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009	NO	YES	NO	EY	0	14	0	7	Endometrial	A	LIVING	49	2010			TCGA-EY-A215-01		TCGA-EY-A215-01A-21-A18R-20	10A2C6D4-0F10-43F9-A5DD-9A61D34FA5B6									TCGA-EY-A215-01	9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab	TCGA-EY-A215-01A-11D-A14J-01		TCGA-EY-A215-01A-11D-A14J-01	TCGA-EY-A215-01	TCGA-EY-A215-01	TCGA-EY-A215-01A-11D-A14N-05		9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab
TCGA-EY-A2OM-01	MSI-H	0	TCGA-EY-A2OM-01	694	0	days	Kirc+	C6-UCEC	UCEC CIMP c18		UCEC-like c5	UCEC-like c11	miRNA cluster 12			TCGA-EY-A2OM	694	0	days	694	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55			TCGA-EY-A2OM-F44823	TCGA-EY-A2OM	TCGA-EY-A2OM-01A		Stage IA			-20398	176		0	694							2013-6-27	FEMALE	152	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	640	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A2OM.7C46CE28-FC96-47FD-A133-B95EA93E1D8B.pdf	A2OM	20	negative	TUMOR FREE		0	YES					YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0	0	13	Endometrial	A	LIVING	110	2011			TCGA-EY-A2OM-01		TCGA-EY-A2OM-01A-21-A23Z-20	B6FE1435-A4DC-48E9-A92E-B7D599544F66									TCGA-EY-A2OM-01	0c622763-f905-4eaa-a05b-ea27dbd49888	TCGA-EY-A2OM-01A-11D-A18N-01		TCGA-EY-A2OM-01A-11D-A18N-01	TCGA-EY-A2OM-01	TCGA-EY-A2OM-01	TCGA-EY-A2OM-01A-11D-A18O-05		0c622763-f905-4eaa-a05b-ea27dbd49888
TCGA-EY-A2ON-01	MSS	1	TCGA-EY-A2ON-01	610	1	days	High		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 14			TCGA-EY-A2ON			days	610	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	61			TCGA-EY-A2ON-F34164	TCGA-EY-A2ON	TCGA-EY-A2ON-01A		Stage IVB			-22624	80	610	0	171			226				2013-6-20	FEMALE	165	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	650	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3				NO		false	No	TCGA-EY-A2ON.AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134.pdf	A2ON		positive	WITH TUMOR			YES		Progressive Disease			NO				R2	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0		0	Endometrial	A	DECEASED	100	2011	10a6bc01-f811-400f-a205-caf7879008fe		TCGA-EY-A2ON-01	10a6bc01-f811-400f-a205-caf7879008fe	TCGA-EY-A2ON-01A-11-A23Z-20	D85F0679-8CFA-4EA3-B9DA-02CC32C4E01B			10a6bc01-f811-400f-a205-caf7879008fe				10a6bc01-f811-400f-a205-caf7879008fe		TCGA-EY-A2ON-01		TCGA-EY-A2ON-01A-21D-A18N-01		TCGA-EY-A2ON-01A-21D-A18N-01	TCGA-EY-A2ON-01	TCGA-EY-A2ON-01	TCGA-EY-A2ON-01A-21D-A18O-05		
TCGA-EY-A2OO-01	MSS	0	TCGA-EY-A2OO-01	1392	0	days	BRCA-LUAD+		UCEC CIMP c18		UCEC-like c5		miRNA cluster 13			TCGA-EY-A2OO	1392	0	days	1392	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	56		0	TCGA-EY-A2OO-F44827	TCGA-EY-A2OO	TCGA-EY-A2OO-01A		Stage IB			-20797	715		0	1392							2013-6-27	FEMALE	175	Mixed serous and endometrioid	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A2OO.CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8.pdf	A2OO	14	negative	TUMOR FREE		0	YES					YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	EY	0	3	0	21	Endometrial	A	LIVING	79	2009	060787cf-a4a0-402f-8534-742157bb4a2c		TCGA-EY-A2OO-01	060787cf-a4a0-402f-8534-742157bb4a2c	TCGA-EY-A2OO-01A-21-A23Z-20	71B9F996-932C-46AD-B6B1-C5ECEB19A332			060787cf-a4a0-402f-8534-742157bb4a2c				060787cf-a4a0-402f-8534-742157bb4a2c		TCGA-EY-A2OO-01		TCGA-EY-A2OO-01A-11D-A19X-01		TCGA-EY-A2OO-01A-11D-A19X-01	TCGA-EY-A2OO-01	TCGA-EY-A2OO-01	TCGA-EY-A2OO-01A-11D-A19Z-05		
TCGA-EY-A2OP-01	MSI-H	0	TCGA-EY-A2OP-01	944	0	days	Iq		UCEC CIMP c18		UCEC-like c5		miRNA cluster 12			TCGA-EY-A2OP	944	0	days	944	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	63		0	TCGA-EY-A2OP-F44831	TCGA-EY-A2OP	TCGA-EY-A2OP-01A		Stage IA			-23090	521		0	944							2013-6-27	FEMALE	150	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A2OP.E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7.pdf	A2OP	10	negative	TUMOR FREE		0	NO					NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	7	0	12	Endometrial	A	LIVING	57	2010	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f		TCGA-EY-A2OP-01	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f	TCGA-EY-A2OP-01A-21-A23Z-20	88434549-A691-4715-AD3D-4B3B7F2F6842			48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f				48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f		TCGA-EY-A2OP-01		TCGA-EY-A2OP-01A-11D-A19X-01		TCGA-EY-A2OP-01A-11D-A19X-01	TCGA-EY-A2OP-01	TCGA-EY-A2OP-01	TCGA-EY-A2OP-01A-11D-A19Z-05		
TCGA-EY-A2OQ-01	MSS	0	TCGA-EY-A2OQ-01	885	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-EY-A2OQ	885	0	days	885	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61		0	TCGA-EY-A2OQ-F44835	TCGA-EY-A2OQ	TCGA-EY-A2OQ-01A		Stage IA			-22309	217		0	885							2013-6-27	FEMALE	155	Endometrioid endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A2OQ.BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2.pdf	A2OQ	29	negative	TUMOR FREE		0	NO					NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	15	0	22	Endometrial	A	LIVING	79	2011	fe9055e4-f25c-4b7b-9479-a8468c36310f		TCGA-EY-A2OQ-01	fe9055e4-f25c-4b7b-9479-a8468c36310f	TCGA-EY-A2OQ-01A-21-A23Z-20	6075ABA3-3438-4ABE-9C56-BD9A57640AB8			fe9055e4-f25c-4b7b-9479-a8468c36310f				fe9055e4-f25c-4b7b-9479-a8468c36310f		TCGA-EY-A2OQ-01		TCGA-EY-A2OQ-01A-11D-A19X-01		TCGA-EY-A2OQ-01A-11D-A19X-01	TCGA-EY-A2OQ-01	TCGA-EY-A2OQ-01	TCGA-EY-A2OQ-01A-11D-A19Z-05		
TCGA-EY-A3L3-01	MSS	0	TCGA-EY-A3L3-01	832	0	days	High		UCEC Serous c4		BRCA basal-like c6		miRNA c1uster 10			TCGA-EY-A3L3	832	0	days	832	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	82		0	TCGA-EY-A3L3-F50665	TCGA-EY-A3L3	TCGA-EY-A3L3-01A		Stage IA			-30138	198		0	832							2013-10-28	FEMALE	161	Serous endometrial adenocarcinoma	No			C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	1020	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A3L3.DBCC8E6F-3AB9-41B2-8266-341509A9FDB3.pdf	A3L3	28	negative	TUMOR FREE		0	YES		Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	3	0	14	Endometrial	A	LIVING	92	2011	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8		TCGA-EY-A3L3-01	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8	TCGA-EY-A3L3-01A-21-A23Z-20	560982E6-96AF-414D-A20B-5F136CB71629			eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8				eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8		TCGA-EY-A3L3-01		TCGA-EY-A3L3-01A-11D-A227-01		TCGA-EY-A3L3-01A-11D-A227-01	TCGA-EY-A3L3-01	TCGA-EY-A3L3-01	TCGA-EY-A3L3-01A-11D-A22B-05		
TCGA-EY-A3QX-01	MSS	1	TCGA-EY-A3QX-01	989	1	days	Squamous		UCEC non-CIMP c3		UCEC-like c5		miRNA cluster 4			TCGA-EY-A3QX	896	1	days	989	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	64			TCGA-EY-A3QX-F66590	TCGA-EY-A3QX	TCGA-EY-A3QX-01A		Stage IVB			-23663	112	989	0	162			896				2014-10-21	FEMALE	168	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	659	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	Peritoneum	NO	YES	false	No	TCGA-EY-A3QX.8AED036E-FB86-42D1-B840-FB4AD6E8D0EF.pdf	A3QX	95	positive	WITH TUMOR			YES		Complete Remission/Response			NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY		0		0	Endometrial	A	DECEASED	63	2011	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3		TCGA-EY-A3QX-01	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3	TCGA-EY-A3QX-01A-21-A23Z-20	FCB39116-72F7-4722-B691-A8D39DC71BFE			cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3				cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3		TCGA-EY-A3QX-01		TCGA-EY-A3QX-01A-11D-A227-01		TCGA-EY-A3QX-01A-11D-A227-01	TCGA-EY-A3QX-01	TCGA-EY-A3QX-01	TCGA-EY-A3QX-01A-11D-A22B-05		
TCGA-EY-A4KR-01	MSS	1	TCGA-EY-A4KR-01	346	1	days										TCGA-EY-A4KR	346	0	days	346	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	56			TCGA-EY-A4KR-F44431	TCGA-EY-A4KR	TCGA-EY-A4KR-01A		Stage IIIC1	NO		-20669	147	346	0	196				NO			2013-6-19	FEMALE	164	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	610	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A4KR.D8669681-B1D2-4D39-B7BB-5207F901A937.pdf	A4KR	99	positive	WITH TUMOR		7	YES	2	Progressive Disease	Never Used		YES				RX	Primary Tumor	01	Minimally Invasive			YES	NO	EY		0	7	9	Endometrial	A	DECEASED	114	2012	8bc81bd5-9814-4a83-b78d-6d5722a1a53d		TCGA-EY-A4KR-01	8bc81bd5-9814-4a83-b78d-6d5722a1a53d		1B4E7519-3FE8-4F74-9497-D50B1985669F			8bc81bd5-9814-4a83-b78d-6d5722a1a53d				8bc81bd5-9814-4a83-b78d-6d5722a1a53d		TCGA-EY-A4KR-01		TCGA-EY-A4KR-01A-11D-A27O-01		TCGA-EY-A4KR-01A-11D-A27O-01	TCGA-EY-A4KR-01	TCGA-EY-A4KR-01	TCGA-EY-A4KR-01A-11D-A27Y-05		
TCGA-EY-A547-01	Indeterminate	0	TCGA-EY-A547-01	545	0	days										TCGA-EY-A547	545	0	days	545	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	75		0	TCGA-EY-A547-F55805	TCGA-EY-A547	TCGA-EY-A547-01A		Stage IA	NO		-27686	645		0	545				YES			2014-1-15	FEMALE	166	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	610	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A547.59662419-D77B-4C25-A888-CE993D412FD1.pdf	A547	14	negative	TUMOR FREE		0	NO	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY	0	8	0	10	Endometrial	A	LIVING	108	2011	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87		TCGA-EY-A547-01	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87		C1DA4818-1742-461D-934C-4D1CFD051585			cc3bf52b-7b69-40c9-9358-f66cb7b1dd87				cc3bf52b-7b69-40c9-9358-f66cb7b1dd87		TCGA-EY-A547-01		TCGA-EY-A547-01A-11D-A27O-01		TCGA-EY-A547-01A-11D-A27O-01	TCGA-EY-A547-01	TCGA-EY-A547-01	TCGA-EY-A547-01A-11D-A27Y-05		
TCGA-EY-A548-01	MSI-H	0	TCGA-EY-A548-01	430	0	days										TCGA-EY-A548	430	0	days	430	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	83			TCGA-EY-A548-F55806	TCGA-EY-A548	TCGA-EY-A548-01A	Never Used	Stage IA	NO		-30544	169		0	430				NO			2014-1-15	FEMALE	157	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	850	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-EY-A548.A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5.pdf	A548	0	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY		0	0	12	Endometrial	A	LIVING	67	2012	32b29d34-5d28-4b68-9d64-61290448fca5		TCGA-EY-A548-01	32b29d34-5d28-4b68-9d64-61290448fca5		38F71989-9140-4D94-A813-CB38482A0CC3			32b29d34-5d28-4b68-9d64-61290448fca5				32b29d34-5d28-4b68-9d64-61290448fca5		TCGA-EY-A548-01		TCGA-EY-A548-01A-11D-A27O-01		TCGA-EY-A548-01A-11D-A27O-01	TCGA-EY-A548-01	TCGA-EY-A548-01	TCGA-EY-A548-01A-11D-A27Y-05		
TCGA-EY-A549-01	MSI-H	0	TCGA-EY-A549-01	605	0	days										TCGA-EY-A549	605	0	days	605	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	78		0	TCGA-EY-A549-F55760	TCGA-EY-A549	TCGA-EY-A549-01A	Never Used	Stage IA	YES		-28570	191		0	605				NO			2014-1-14	FEMALE	165	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.9	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A549.F6D1F090-C601-4212-951E-BEE086DDD24F.pdf	A549	33		TUMOR FREE		0	NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive			YES	NO	EY	0	18	0	22	Endometrial	A	LIVING	74	2012	4cbce4ad-3208-4463-a06d-75edce32ed3f		TCGA-EY-A549-01	4cbce4ad-3208-4463-a06d-75edce32ed3f		E18E8B7F-FB1D-4E71-99AF-81A632FC381A			4cbce4ad-3208-4463-a06d-75edce32ed3f				4cbce4ad-3208-4463-a06d-75edce32ed3f		TCGA-EY-A549-01		TCGA-EY-A549-01A-11D-A27O-01		TCGA-EY-A549-01A-11D-A27O-01	TCGA-EY-A549-01	TCGA-EY-A549-01	TCGA-EY-A549-01A-11D-A27Y-05		
TCGA-EY-A54A-01	Indeterminate	0	TCGA-EY-A54A-01	447	0	days										TCGA-EY-A54A	447	0	days	447	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	67		1	TCGA-EY-A54A-F57555	TCGA-EY-A54A	TCGA-EY-A54A-01A	Former User	Stage IIIC2	NO		-24822	105		0	447				YES			2014-3-17	FEMALE	161	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.9	8380/3	C54.9	YES		Office Endometrial Biopsy	500	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A54A.E3C3D3B8-550A-4652-9B17-122BC64A437A.pdf	A54A	41		TUMOR FREE		4	YES	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	1	8	4	16	Endometrial	A	LIVING	70	2012	a7c691a2-a91d-44d0-8e91-0234cddb1e92		TCGA-EY-A54A-01	a7c691a2-a91d-44d0-8e91-0234cddb1e92		2CD53475-9ADE-4981-95CF-286418DBBAF4			a7c691a2-a91d-44d0-8e91-0234cddb1e92				a7c691a2-a91d-44d0-8e91-0234cddb1e92		TCGA-EY-A54A-01		TCGA-EY-A54A-01A-11D-A27O-01		TCGA-EY-A54A-01A-11D-A27O-01	TCGA-EY-A54A-01	TCGA-EY-A54A-01	TCGA-EY-A54A-01A-11D-A27Y-05		
TCGA-EY-A5W2-01	MSI-H	0	TCGA-EY-A5W2-01	516	0	days										TCGA-EY-A5W2	516	0	days	516	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72		0	TCGA-EY-A5W2-F58696	TCGA-EY-A5W2	TCGA-EY-A5W2-01A		Stage IB	NO		-26498	105		0	516				NO			2014-4-22	FEMALE	161	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	870	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-EY-A5W2.C09EED3C-50CC-47CB-BA81-96D05E53D9F0.pdf	A5W2	52	negative	TUMOR FREE		0	NO	4+	Complete Remission/Response			YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	EY	0	7	0	16	Endometrial	A	LIVING	83	2012	894b867a-591d-4d05-b008-db1a90b18a60		TCGA-EY-A5W2-01	894b867a-591d-4d05-b008-db1a90b18a60		7F27E4E1-84E6-4CD1-A925-56A28A53D371			894b867a-591d-4d05-b008-db1a90b18a60				894b867a-591d-4d05-b008-db1a90b18a60		TCGA-EY-A5W2-01		TCGA-EY-A5W2-01A-11D-A31T-01		TCGA-EY-A5W2-01A-11D-A31T-01	TCGA-EY-A5W2-01	TCGA-EY-A5W2-01	TCGA-EY-A5W2-01A-11D-A31V-05		
TCGA-EY-A72D-01	MSS	0	TCGA-EY-A72D-01	179	0	days										TCGA-EY-A72D	179	0	days	179	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	87			TCGA-EY-A72D-F63789	TCGA-EY-A72D	TCGA-EY-A72D-01A	Never Used	Stage II	NO		-31818	120		0	179				NO			2014-8-18	FEMALE	162	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	340	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	Yes	TCGA-EY-A72D.6F2C081B-8D36-4DB4-9846-67DC1D3964E0.pdf	A72D	22.5		TUMOR FREE			NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		YES	NO	EY		0		0	Endometrial	A	LIVING	106	2013	051469db-cfa9-4907-ae54-13c060ad2958		TCGA-EY-A72D-01	051469db-cfa9-4907-ae54-13c060ad2958		C1F2DA4B-8F02-437C-9A58-E1E9E3362666			051469db-cfa9-4907-ae54-13c060ad2958				051469db-cfa9-4907-ae54-13c060ad2958		TCGA-EY-A72D-01		TCGA-EY-A72D-01A-12D-A34P-01		TCGA-EY-A72D-01A-12D-A34P-01	TCGA-EY-A72D-01	TCGA-EY-A72D-01	TCGA-EY-A72D-01A-12D-A34S-05		
TCGA-FI-A2CX-01	MSS	0	TCGA-FI-A2CX-01	2031	0	days	Kirc+		OV-like c1	cluster 3		LAML-like c13	miRNA c1uster 9	cluster 2		TCGA-FI-A2CX	2031	0	days	2031	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	82	0	0	TCGA-FI-A2CX-F71662	TCGA-FI-A2CX		Never Used	Stage IB	NO		-30224			0	2031				NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	155	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		Yes		A2CX	33		TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	1988	NO	NO	YES	FI	0	3	0	7	Endometrial		LIVING	52	2008			TCGA-FI-A2CX-01												TCGA-FI-A2CX-01	ab3e5a04-9d4c-4289-93ed-38dba3e619b2	TCGA-FI-A2CX-01A-11D-A17C-01		TCGA-FI-A2CX-01A-11D-A17C-01	TCGA-FI-A2CX-01	TCGA-FI-A2CX-01	TCGA-FI-A2CX-01A-11D-A17F-05		ab3e5a04-9d4c-4289-93ed-38dba3e619b2
TCGA-FI-A2CY-01	MSS	0	TCGA-FI-A2CY-01	2080	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 4	cluster 2		TCGA-FI-A2CY	2080	0	days	2080	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	60	0	0	TCGA-FI-A2CY-F71663	TCGA-FI-A2CY	TCGA-FI-A2CY-01A	Never Used	Stage IA	NO		-22098	1067		0	2080				NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	145	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-FI-A2CY.2C4CE5F5-AD46-427E-A787-529DF9FA891A.pdf	A2CY	0	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	2	0	15	Endometrial	A	LIVING	100	2008			TCGA-FI-A2CY-01		TCGA-FI-A2CY-01A-21-A18R-20	40294F1C-B9EC-4486-87DB-8973840F9238									TCGA-FI-A2CY-01	4bcff10b-20ad-4635-bbcd-855826277b8a	TCGA-FI-A2CY-01A-11D-A17C-01		TCGA-FI-A2CY-01A-11D-A17C-01	TCGA-FI-A2CY-01	TCGA-FI-A2CY-01	TCGA-FI-A2CY-01A-11D-A17F-05		4bcff10b-20ad-4635-bbcd-855826277b8a
TCGA-FI-A2D0-01	MSI-H	0	TCGA-FI-A2D0-01	1023	0	days	Quiet		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA cluster 12	cluster 2		TCGA-FI-A2D0	1023	0	days	1023	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55	0	0	TCGA-FI-A2D0-F71665	TCGA-FI-A2D0		Never Used	Stage IA	NO		-20393			0	1023				NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	158	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy			NO	Peri (6-12 months since last menstrual period)	G3					NO		No		A2D0	0	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	FI	0	7	0	21	Endometrial		LIVING	135	2008			TCGA-FI-A2D0-01												TCGA-FI-A2D0-01	e8736e4d-6e9b-49b0-a321-0e42740a11c1	TCGA-FI-A2D0-01A-11D-A17C-01		TCGA-FI-A2D0-01A-11D-A17C-01	TCGA-FI-A2D0-01	TCGA-FI-A2D0-01	TCGA-FI-A2D0-01A-11D-A17F-05		e8736e4d-6e9b-49b0-a321-0e42740a11c1
TCGA-FI-A2D2-01	MSS	1	TCGA-FI-A2D2-01	2352	1	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 2	mutation cluster 3	TCGA-FI-A2D2	1917	1	days	2352	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Progressive Disease	66			TCGA-FI-A2D2-F71666	TCGA-FI-A2D2	TCGA-FI-A2D2-01A		Stage IB	NO		-24260	975	2352	0	1215			1917	NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	168	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	Locoregional Recurrence	Liver	NO	YES	true	No	TCGA-FI-A2D2.75FB8F31-5C30-48C2-B4A5-2DA184DC039C.pdf	A2D2	33	negative	WITH TUMOR			YES	2	[Discrepancy]	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI		0		0	Endometrial	A	DECEASED	166	2008			TCGA-FI-A2D2-01							TCGA-FI-A2D2-01A-11D-A17D-09	TCGA-FI-A2D2-01A-11D-A17D-09	TCGA-FI-A2D2-01A-11D-A17D-09			TCGA-FI-A2D2-01	941d70e7-2ac8-4809-baa4-7752df3c2ee3	TCGA-FI-A2D2-01A-11D-A17C-01		TCGA-FI-A2D2-01A-11D-A17C-01	TCGA-FI-A2D2-01	TCGA-FI-A2D2-01	TCGA-FI-A2D2-01A-11D-A17F-05		941d70e7-2ac8-4809-baa4-7752df3c2ee3
TCGA-FI-A2D4-01	MSI-H	1	TCGA-FI-A2D4-01	243	1	days	Kirc+		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA cluster 12	cluster 5		TCGA-FI-A2D4	243	0	days	243	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Partial Response	44			TCGA-FI-A2D4-F31734	TCGA-FI-A2D4			Stage IIIC	NO		-16163		243	0					NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3					NO		No		A2D4	100		WITH TUMOR	0	1			Partial Remission/Response	Never Used		NO				R2	Primary Tumor	01	open	1988	YES	NO	YES	FI		0	1	1	Endometrial		DECEASED	112	2009			TCGA-FI-A2D4-01												TCGA-FI-A2D4-01	c3c9142f-d5c8-44ef-90c2-9ae69846dc60	TCGA-FI-A2D4-01A-12D-A17C-01		TCGA-FI-A2D4-01A-12D-A17C-01	TCGA-FI-A2D4-01	TCGA-FI-A2D4-01	TCGA-FI-A2D4-01A-12D-A17F-05		c3c9142f-d5c8-44ef-90c2-9ae69846dc60
TCGA-FI-A2D5-01	MSS	1	TCGA-FI-A2D5-01	421	1	days	Quiet		UCEC non-CIMP c3	cluster 4		UCEC-like c11	miRNA c1uster 9	cluster 4		TCGA-FI-A2D5	280	1	days	421	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	YES	NO	Progressive Disease	56			TCGA-FI-A2D5-F31743	TCGA-FI-A2D5	TCGA-FI-A2D5-01A	Never Used	Stage IVB	NO		-20666	702	421	0				280	NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	160	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Metastatic	vaginal cuff		YES	true	Yes	TCGA-FI-A2D5.A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C.pdf	A2D5	100	positive	WITH TUMOR	0	1		1	Partial Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	FI		0	1	2	Endometrial	A	DECEASED	92	2009			TCGA-FI-A2D5-01												TCGA-FI-A2D5-01	33655926-ef2e-4e77-8be7-3f9c921db77c	TCGA-FI-A2D5-01A-11D-A17C-01		TCGA-FI-A2D5-01A-11D-A17C-01	TCGA-FI-A2D5-01	TCGA-FI-A2D5-01	TCGA-FI-A2D5-01A-11D-A17F-05		33655926-ef2e-4e77-8be7-3f9c921db77c
TCGA-FI-A2D6-01	MSI-H	1	TCGA-FI-A2D6-01	767	1	days	Kirc+		BRCA CIMP c7	cluster 1		GBM-like c6	miRNA cluster 13	cluster 6		TCGA-FI-A2D6	767	0	days	767	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74			TCGA-FI-A2D6-F71667	TCGA-FI-A2D6			Stage IB	NO		-27060		767	0	263				NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO		No		A2D6	74	negative	TUMOR FREE			NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	FI		0		0	Endometrial		DECEASED	95	2009			TCGA-FI-A2D6-01												TCGA-FI-A2D6-01	fffc5da3-ed33-4f8d-982e-e75b2d707c4b	TCGA-FI-A2D6-01A-11D-A17C-01		TCGA-FI-A2D6-01A-11D-A17C-01	TCGA-FI-A2D6-01	TCGA-FI-A2D6-01	TCGA-FI-A2D6-01A-11D-A17F-05		fffc5da3-ed33-4f8d-982e-e75b2d707c4b
TCGA-FI-A2EU-01	MSS	0	TCGA-FI-A2EU-01	2941	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA c1uster 10	cluster 2		TCGA-FI-A2EU	2941	0	days	2941	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68	0	0	TCGA-FI-A2EU-F31382	TCGA-FI-A2EU	TCGA-FI-A2EU-01A		Stage IA	NO		-24837	2779		0	2941				YES		Scheduled Follow-up Submission	2012-5-1	FEMALE	168	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-FI-A2EU.95F8FB60-A533-4A37-8B4B-FC6811A77636.pdf	A2EU	0	negative	TUMOR FREE	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	2	0	11	Endometrial	A	LIVING	93	2003			TCGA-FI-A2EU-01		TCGA-FI-A2EU-01A-21-A18Q-20	98F272A2-B83C-4E44-ACCC-BD15049DA4C3									TCGA-FI-A2EU-01	1d3ec463-a3c0-4aa5-8fc0-d221be3a0700	TCGA-FI-A2EU-01A-11D-A17C-01		TCGA-FI-A2EU-01A-11D-A17C-01	TCGA-FI-A2EU-01	TCGA-FI-A2EU-01	TCGA-FI-A2EU-01A-11D-A17F-05		1d3ec463-a3c0-4aa5-8fc0-d221be3a0700
TCGA-FI-A2EW-01	Indeterminate	0	TCGA-FI-A2EW-01	1462	0	days	High	C6-UCEC	UCEC Serous c4	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 13	TCGA-FI-A2EW	1169	1	days	1462	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES		NO	[Discrepancy]	71	0	0	TCGA-FI-A2EW-F31518	TCGA-FI-A2EW	TCGA-FI-A2EW-01A	Never Used	Stage IIB	NO		-26267	2321		0	1462			1169	NO		Scheduled Follow-up Submission	2012-5-4	FEMALE	160	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Liver	Metastatic			YES	true	No	TCGA-FI-A2EW.3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1.pdf	A2EW	75	negative	TUMOR FREE	0	0		4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	8	0	29	Endometrial	A	LIVING	83	2005			TCGA-FI-A2EW-01		TCGA-FI-A2EW-01A-21-A18Q-20	2C665CF4-C3ED-4579-9050-4064E3AE281C				TCGA-FI-A2EW-01A-11D-A17D-09	TCGA-FI-A2EW-01A-11D-A17D-09	TCGA-FI-A2EW-01A-11D-A17D-09			TCGA-FI-A2EW-01	e3abb7cf-945d-496f-8bf0-828ddfef6538	TCGA-FI-A2EW-01A-11D-A17C-01		TCGA-FI-A2EW-01A-11D-A17C-01	TCGA-FI-A2EW-01	TCGA-FI-A2EW-01	TCGA-FI-A2EW-01A-11D-A17F-05		e3abb7cf-945d-496f-8bf0-828ddfef6538
TCGA-FI-A2EX-01	MSS	0	TCGA-FI-A2EX-01	284	0	days	High	C6-UCEC	UCEC non-CIMP c3	cluster 3	UCEC-like c5	UCEC-like c11	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-FI-A2EX	213	1	days	284	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO	NO	Progressive Disease	58	0	0	TCGA-FI-A2EX-F31519	TCGA-FI-A2EX	TCGA-FI-A2EX-01A		Stage IIIA	NO		-21489	2201		0	284			213	NO		Scheduled Follow-up Submission	2012-5-4	FEMALE	154	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	110	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3		Metastatic			YES	true	No	TCGA-FI-A2EX.68355069-2D77-4C5C-9AA9-E93A0C3CFD94.pdf	A2EX	13	positive	WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	6	0	28	Endometrial	A	LIVING	89	2005			TCGA-FI-A2EX-01		TCGA-FI-A2EX-01A-21-A18Q-20	10FFCFD0-5CD9-4530-AA2D-EB697F20CCA4				TCGA-FI-A2EX-01A-11D-A17D-09	TCGA-FI-A2EX-01A-11D-A17D-09	TCGA-FI-A2EX-01A-11D-A17D-09			TCGA-FI-A2EX-01	06745c8c-5e2b-4131-93a5-9023c32665ac	TCGA-FI-A2EX-01A-11D-A17C-01		TCGA-FI-A2EX-01A-11D-A17C-01	TCGA-FI-A2EX-01	TCGA-FI-A2EX-01	TCGA-FI-A2EX-01A-11D-A17F-05		06745c8c-5e2b-4131-93a5-9023c32665ac
TCGA-FI-A2EY-01	MSI-L	1	TCGA-FI-A2EY-01	880	1	days	Squamous		OV-like c1		squamous c3		miRNA cluster 14			TCGA-FI-A2EY	577	1	days	880	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	NO	NO	YES	Complete Response	63	0	0	TCGA-FI-A2EY-F31521	TCGA-FI-A2EY	TCGA-FI-A2EY-01A		Stage IIIA	NO	670	-23042	1866	880	0				577	NO		Scheduled Follow-up Submission	2012-5-4	FEMALE	183	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Tumor resection	140	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	New Primary Tumor			YES	true	No	TCGA-FI-A2EY.D529A633-2FC9-4C28-BEA4-994BABD51A48.pdf	A2EY	93	negative	TUMOR FREE	0	0		3	Complete Remission/Response	Never Used		NO	Surgical Resection		R0	R0	Primary Tumor	01	open	1988	YES	NO	YES	FI	0	0	0	0	Endometrial	A	DECEASED	96	2006	c23bc644-ff87-4c84-a156-686903524aaa		TCGA-FI-A2EY-01	c23bc644-ff87-4c84-a156-686903524aaa	TCGA-FI-A2EY-01A-21-A23Z-20	A57C3886-0CF2-40C1-9D4D-2F74B5D4F6F1			c23bc644-ff87-4c84-a156-686903524aaa				c23bc644-ff87-4c84-a156-686903524aaa		TCGA-FI-A2EY-01		TCGA-FI-A2EY-01A-12D-A18N-01		TCGA-FI-A2EY-01A-12D-A18N-01	TCGA-FI-A2EY-01	TCGA-FI-A2EY-01	TCGA-FI-A2EY-01A-12D-A18O-05		
TCGA-FI-A2F4-01	MSI-H	0	TCGA-FI-A2F4-01	2230	0	days	Iq		UCEC CIMP c18	cluster 1		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-FI-A2F4	2230	0	days	2230	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-FI-A2F4-F71670	TCGA-FI-A2F4	TCGA-FI-A2F4-01A		Stage IC	NO		-23621	860		0	2230				YES		Scheduled Follow-up Submission	2015-3-27	FEMALE	165	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	60	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	Yes	TCGA-FI-A2F4.B57570A5-2AE1-4D8B-9284-AB5769DDFDA6.pdf	A2F4	59		TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	1988	NO	NO	YES	FI	0	4	0	28	Endometrial	A	LIVING	74	2009			TCGA-FI-A2F4-01												TCGA-FI-A2F4-01	14198ecd-3508-4ece-8fea-8141d3e4b1e7	TCGA-FI-A2F4-01A-11D-A17C-01		TCGA-FI-A2F4-01A-11D-A17C-01	TCGA-FI-A2F4-01	TCGA-FI-A2F4-01	TCGA-FI-A2F4-01A-11D-A17F-05		14198ecd-3508-4ece-8fea-8141d3e4b1e7
TCGA-FI-A2F8-01	MSS	0	TCGA-FI-A2F8-01	933	0	days	Squamous	C6-UCEC	UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3	mutation cluster 5	TCGA-FI-A2F8	933	0	days	933	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-FI-A2F8-F31739	TCGA-FI-A2F8	TCGA-FI-A2F8-01A	Former User	Stage II	NO		-23649	679		0	933				NO		Scheduled Follow-up Submission	2012-5-8	FEMALE	173	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	70	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-FI-A2F8.9445945A-A7AC-4C36-889B-68A50644D556.pdf	A2F8	26	positive	WITH TUMOR	0	0		2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	YES	NO	YES	FI	0	6	0	24	Endometrial	A	LIVING	99	2009			TCGA-FI-A2F8-01							TCGA-FI-A2F8-01A-12D-A17D-09	TCGA-FI-A2F8-01A-12D-A17D-09	TCGA-FI-A2F8-01A-12D-A17D-09			TCGA-FI-A2F8-01	1b38dbc6-5830-4514-9317-9dcb23e36b98	TCGA-FI-A2F8-01A-12D-A17C-01		TCGA-FI-A2F8-01A-12D-A17C-01	TCGA-FI-A2F8-01	TCGA-FI-A2F8-01	TCGA-FI-A2F8-01A-12D-A17F-05		1b38dbc6-5830-4514-9317-9dcb23e36b98
TCGA-FI-A2F9-01	MSS	0	TCGA-FI-A2F9-01	1803	0	days	Kirc+		UCEC Serous c4	cluster 3		UCEC-like c11	miRNA c1uster 10	cluster 3		TCGA-FI-A2F9	1803	0	days	1803	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	79	0	0	TCGA-FI-A2F9-F71672	TCGA-FI-A2F9	TCGA-FI-A2F9-01A	Never Used	Stage IA	NO		-28886	709		0	1803				NO		Scheduled Follow-up Submission	2015-3-27	FEMALE	175	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	60	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-FI-A2F9.5D03E085-0588-47A8-8B1C-E243D8127325.pdf	A2F9	44	negative	TUMOR FREE	0	0	NO	4+	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009	NO	NO	YES	FI	0	3	0	35	Endometrial	A	LIVING	99	2009			TCGA-FI-A2F9-01												TCGA-FI-A2F9-01	2aef2acc-a065-4196-a278-1c1ce689e689	TCGA-FI-A2F9-01A-11D-A17C-01		TCGA-FI-A2F9-01A-11D-A17C-01	TCGA-FI-A2F9-01	TCGA-FI-A2F9-01	TCGA-FI-A2F9-01A-11D-A17F-05		2aef2acc-a065-4196-a278-1c1ce689e689
TCGA-FI-A3PV-01	MSS	1	TCGA-FI-A3PV-01	1264	1	days	Squamous		UCEC Serous c4				miRNA c1uster 10			TCGA-FI-A3PV			days	1264	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					68	0	0	TCGA-FI-A3PV-F71674	TCGA-FI-A3PV			Stage IA			-24898		1264	0								2015-3-27	FEMALE	174	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade							No		A3PV	0	negative	WITH TUMOR	0	0										R0	Primary Tumor	01	open	2009		NO	YES	FI	0	6	0	10	Endometrial		DECEASED	105	2003	af1f390e-abd4-4ed2-bc65-0b1080b786a9		TCGA-FI-A3PV-01	af1f390e-abd4-4ed2-bc65-0b1080b786a9					af1f390e-abd4-4ed2-bc65-0b1080b786a9				af1f390e-abd4-4ed2-bc65-0b1080b786a9		TCGA-FI-A3PV-01		TCGA-FI-A3PV-01A-11D-A227-01		TCGA-FI-A3PV-01A-11D-A227-01	TCGA-FI-A3PV-01	TCGA-FI-A3PV-01	TCGA-FI-A3PV-01A-11D-A22B-05		
TCGA-FI-A3PX-01	MSS	0	TCGA-FI-A3PX-01	2384	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 14			TCGA-FI-A3PX	2384	0	days	2384	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57		2	TCGA-FI-A3PX-F71661	TCGA-FI-A3PX	TCGA-FI-A3PX-01A		Stage IIIC2			-21063	1280		0	2384							2015-3-27	FEMALE	170	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	130	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade					NO	true	No	TCGA-FI-A3PX.5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46.pdf	A3PX	92	negative	TUMOR FREE		4	NO		Complete Remission/Response			NO				R0	Primary Tumor	01	open	2009		NO	YES	FI	2	5	4	10	Endometrial	A	LIVING	90	2008	773a978c-a52f-470b-b659-4c06de8a7e5b		TCGA-FI-A3PX-01	773a978c-a52f-470b-b659-4c06de8a7e5b	TCGA-FI-A3PX-01A-21-A23Z-20	219D9644-1FAC-4682-A1DC-37448FA3823A			773a978c-a52f-470b-b659-4c06de8a7e5b				773a978c-a52f-470b-b659-4c06de8a7e5b		TCGA-FI-A3PX-01		TCGA-FI-A3PX-01A-11D-A227-01		TCGA-FI-A3PX-01A-11D-A227-01	TCGA-FI-A3PX-01	TCGA-FI-A3PX-01	TCGA-FI-A3PX-01A-11D-A22B-05		
TCGA-FL-A1YF-11			TCGA-FL-A1YF-11			days										TCGA-FL-A1YF			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium																																																																				Solid Tissue Normal	11																b80bd803-b042-474e-864e-b2c6ee4708e5			b80bd803-b042-474e-864e-b2c6ee4708e5					b80bd803-b042-474e-864e-b2c6ee4708e5				b80bd803-b042-474e-864e-b2c6ee4708e5		TCGA-FL-A1YF-11					TCGA-FL-A1YF-11		TCGA-FL-A1YF-11A-12D-A16G-05		
TCGA-FL-A1YG-11			TCGA-FL-A1YG-11			days										TCGA-FL-A1YG			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YG-11A																													170	NO									false																			Solid Tissue Normal	11												A				88802e34-7269-4b5e-b552-a969281ab241			88802e34-7269-4b5e-b552-a969281ab241					88802e34-7269-4b5e-b552-a969281ab241				88802e34-7269-4b5e-b552-a969281ab241		TCGA-FL-A1YG-11					TCGA-FL-A1YG-11		TCGA-FL-A1YG-11A-12D-A16G-05		
TCGA-FL-A1YH-11			TCGA-FL-A1YH-11			days										TCGA-FL-A1YH			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium																																																																				Solid Tissue Normal	11																ba70deb1-e8c2-4f74-9883-46e7095f677d			ba70deb1-e8c2-4f74-9883-46e7095f677d					ba70deb1-e8c2-4f74-9883-46e7095f677d				ba70deb1-e8c2-4f74-9883-46e7095f677d		TCGA-FL-A1YH-11					TCGA-FL-A1YH-11		TCGA-FL-A1YH-11A-11D-A16G-05		
TCGA-FL-A1YI-11			TCGA-FL-A1YI-11			days										TCGA-FL-A1YI			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YI-11A																													120	NO									false																			Solid Tissue Normal	11												A				0c5df2a7-417c-478d-9a7e-675a8777747c			0c5df2a7-417c-478d-9a7e-675a8777747c					0c5df2a7-417c-478d-9a7e-675a8777747c				0c5df2a7-417c-478d-9a7e-675a8777747c		TCGA-FL-A1YI-11					TCGA-FL-A1YI-11		TCGA-FL-A1YI-11A-11D-A16G-05		
TCGA-FL-A1YL-11			TCGA-FL-A1YL-11			days										TCGA-FL-A1YL			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YL-11A																													80	NO									false																			Solid Tissue Normal	11												A				4ad4e642-d5fc-459e-8553-bb1c9795c09d			4ad4e642-d5fc-459e-8553-bb1c9795c09d					4ad4e642-d5fc-459e-8553-bb1c9795c09d				4ad4e642-d5fc-459e-8553-bb1c9795c09d		TCGA-FL-A1YL-11					TCGA-FL-A1YL-11		TCGA-FL-A1YL-11A-11D-A16G-05		
TCGA-FL-A1YM-11			TCGA-FL-A1YM-11			days										TCGA-FL-A1YM			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YM-11A																													80	NO									false																			Solid Tissue Normal	11												A																		TCGA-FL-A1YM-11	3499b1ce-1d6d-423d-8509-77e3f6818b0c				TCGA-FL-A1YM-11		TCGA-FL-A1YM-11A-12D-A17F-05		3499b1ce-1d6d-423d-8509-77e3f6818b0c
TCGA-FL-A1YN-11			TCGA-FL-A1YN-11			days										TCGA-FL-A1YN			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YN-11A																													60	NO									false																			Solid Tissue Normal	11												A				331785a5-59ba-441f-81dc-384d7f80905b			331785a5-59ba-441f-81dc-384d7f80905b					331785a5-59ba-441f-81dc-384d7f80905b				331785a5-59ba-441f-81dc-384d7f80905b		TCGA-FL-A1YN-11					TCGA-FL-A1YN-11		TCGA-FL-A1YN-11A-11D-A17F-05		
TCGA-FL-A1YQ-11			TCGA-FL-A1YQ-11			days										TCGA-FL-A1YQ			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YQ-11A																													130	NO									false																			Solid Tissue Normal	11												A				21a04fd6-500e-4d42-846b-b6b7783098fb			21a04fd6-500e-4d42-846b-b6b7783098fb					21a04fd6-500e-4d42-846b-b6b7783098fb				21a04fd6-500e-4d42-846b-b6b7783098fb		TCGA-FL-A1YQ-11					TCGA-FL-A1YQ-11		TCGA-FL-A1YQ-11A-11D-A17F-05		
TCGA-FL-A1YT-11			TCGA-FL-A1YT-11			days										TCGA-FL-A1YT			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YT-11A																													70	NO									false																			Solid Tissue Normal	11												A				2532b16b-1217-43df-aa69-cdbb5f9c3778			2532b16b-1217-43df-aa69-cdbb5f9c3778					2532b16b-1217-43df-aa69-cdbb5f9c3778				2532b16b-1217-43df-aa69-cdbb5f9c3778		TCGA-FL-A1YT-11					TCGA-FL-A1YT-11		TCGA-FL-A1YT-11A-12D-A17F-05		
TCGA-FL-A1YU-11			TCGA-FL-A1YU-11			days										TCGA-FL-A1YU			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium																																																																				Solid Tissue Normal	11																f0d6b561-bfd2-41b7-a43c-1006370eec8f			f0d6b561-bfd2-41b7-a43c-1006370eec8f					f0d6b561-bfd2-41b7-a43c-1006370eec8f				f0d6b561-bfd2-41b7-a43c-1006370eec8f		TCGA-FL-A1YU-11					TCGA-FL-A1YU-11		TCGA-FL-A1YU-11A-11D-A17F-05		
TCGA-FL-A1YV-11			TCGA-FL-A1YV-11			days										TCGA-FL-A1YV			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A1YV-11A																													110	NO									false																			Solid Tissue Normal	11												A				da44c9b1-d38b-4b75-887c-ec1646969758			da44c9b1-d38b-4b75-887c-ec1646969758					da44c9b1-d38b-4b75-887c-ec1646969758				da44c9b1-d38b-4b75-887c-ec1646969758									TCGA-FL-A1YV-11A-12D-A17F-05		
TCGA-FL-A3WE-11			TCGA-FL-A3WE-11			days										TCGA-FL-A3WE			days		days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium										TCGA-FL-A3WE-11A																													80	NO									true																			Solid Tissue Normal	11												A				6b961695-40e4-4c88-976a-8fb6c99b4f0f			6b961695-40e4-4c88-976a-8fb6c99b4f0f					6b961695-40e4-4c88-976a-8fb6c99b4f0f				6b961695-40e4-4c88-976a-8fb6c99b4f0f		TCGA-FL-A3WE-11					TCGA-FL-A3WE-11		TCGA-FL-A3WE-11A-11D-A22B-05		
TCGA-H5-A2HR-01	MSI-L	0	TCGA-H5-A2HR-01	39	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 12			TCGA-H5-A2HR			days	39	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	71			TCGA-H5-A2HR-F37038	TCGA-H5-A2HR	TCGA-H5-A2HR-01A		Stage IB			-25986	1627		0	39				NO			2012-11-21	FEMALE		Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	110	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						false	No	TCGA-H5-A2HR.3747A4AC-811E-49A1-8459-93807BB363C6.pdf	A2HR	18	negative	TUMOR FREE		0		4+								R0	Primary Tumor	01	open	1988		NO	YES	H5		0	0	19	Endometrial	A	LIVING	95	2006	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6		TCGA-H5-A2HR-01	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6	TCGA-H5-A2HR-01A-21-A18R-20	FF5E27B1-C378-4BB7-9F66-BEF3E837F372			9ed0c69e-a7e6-4c99-8c93-541d7bde4be6				9ed0c69e-a7e6-4c99-8c93-541d7bde4be6		TCGA-H5-A2HR-01		TCGA-H5-A2HR-01A-11D-A17U-01		TCGA-H5-A2HR-01A-11D-A17U-01	TCGA-H5-A2HR-01	TCGA-H5-A2HR-01	TCGA-H5-A2HR-01A-11D-A17Z-05		
TCGA-JU-AAVI-01	MSS	1	TCGA-JU-AAVI-01	540	1	days										TCGA-JU-AAVI	505	1	days	540	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	61			TCGA-JU-AAVI-F69309	TCGA-JU-AAVI			Stage IIIC1	NO		-22289		540	0	236			505	NO			2015-1-20	FEMALE	150	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Incisional Biopsy			NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Distant Metastasis	Porta Hepatis	NO	YES		No		AAVI	93	negative	WITH TUMOR			YES	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	1988		YES	NO	JU	0	2	2	16	Endometrial		DECEASED	121	2013	e860c29e-5d8d-4aee-b631-f55664403bdc		TCGA-JU-AAVI-01	e860c29e-5d8d-4aee-b631-f55664403bdc					e860c29e-5d8d-4aee-b631-f55664403bdc				e860c29e-5d8d-4aee-b631-f55664403bdc		TCGA-JU-AAVI-01		TCGA-JU-AAVI-01A-11D-A402-01		TCGA-JU-AAVI-01A-11D-A402-01	TCGA-JU-AAVI-01	TCGA-JU-AAVI-01	TCGA-JU-AAVI-01A-11D-A409-05		
TCGA-K6-A3WQ-01	MSS	1	TCGA-K6-A3WQ-01	427	1	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 12			TCGA-K6-A3WQ	351	1	days	427	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES			Progressive Disease	60			TCGA-K6-A3WQ-F59157	TCGA-K6-A3WQ	TCGA-K6-A3WQ-01A		Stage IVB			-22092	63	427	0	400			351				2014-5-1	FEMALE	171	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	440	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Locoregional Recurrence	uterine	NO	YES	true	No	TCGA-K6-A3WQ.16F848AA-C14C-45F7-A756-414615853761.pdf	A3WQ	95	positive	WITH TUMOR	1	1	YES					YES					Primary Tumor	01	Minimally Invasive	2009		YES	NO	K6		0	1	2	Endometrial	A	DECEASED	99	2012	8fac215c-7172-42ed-af07-00b27c05d3a6		TCGA-K6-A3WQ-01	8fac215c-7172-42ed-af07-00b27c05d3a6	TCGA-K6-A3WQ-01A-21-A240-20	2F07DA77-7FFB-44F5-A741-FEFC6577AEDE			8fac215c-7172-42ed-af07-00b27c05d3a6				8fac215c-7172-42ed-af07-00b27c05d3a6		TCGA-K6-A3WQ-01		TCGA-K6-A3WQ-01A-11D-A227-01		TCGA-K6-A3WQ-01A-11D-A227-01	TCGA-K6-A3WQ-01	TCGA-K6-A3WQ-01	TCGA-K6-A3WQ-01A-11D-A22B-05		
TCGA-KJ-A3U4-01	MSS	0	TCGA-KJ-A3U4-01	1095	0	days	Squamous		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-KJ-A3U4	306	1	days	1095	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium	YES	NO		Progressive Disease	55		0	TCGA-KJ-A3U4-F71041	TCGA-KJ-A3U4	TCGA-KJ-A3U4-01A	Never Used	Stage IA	NO		-20392	56		0	1095		306	306	NO			2015-3-15	FEMALE	165	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Tumor resection	420	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1	Other, specify	Locoregional Recurrence	abdominal	YES	YES	true	Yes	TCGA-KJ-A3U4.F0B04416-21FE-4DBC-84BB-7188131399B6.pdf	A3U4	21		TUMOR FREE		0	YES	2	Progressive Disease			NO	Surgical Resection		R0	R0	Primary Tumor	01	open	2009		YES	NO	KJ	0	1	0	11	Endometrial	A	LIVING	96	2012	ad229cea-5cac-422d-a773-370ed37152e9		TCGA-KJ-A3U4-01	ad229cea-5cac-422d-a773-370ed37152e9	TCGA-KJ-A3U4-01A-21-A23Z-20	99182DDF-D675-4FD2-9EB4-FE8D00804C93			ad229cea-5cac-422d-a773-370ed37152e9				ad229cea-5cac-422d-a773-370ed37152e9				TCGA-KJ-A3U4-01A-11D-A227-01		TCGA-KJ-A3U4-01A-11D-A227-01		TCGA-KJ-A3U4-01	TCGA-KJ-A3U4-01A-11D-A22B-05		
TCGA-KP-A3VZ-01	MSS	0	TCGA-KP-A3VZ-01	722	0	days	High		OV-like c1		UCEC-like c5		miRNA cluster 13			TCGA-KP-A3VZ			days	722	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					69				TCGA-KP-A3VZ	TCGA-KP-A3VZ-01A		Stage IV			-25366	633		0	722							2012-7-16	FEMALE	163	Serous endometrial adenocarcinoma	No			C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	200	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	High Grade						true	Yes	TCGA-KP-A3VZ.FF834E31-78F7-4A56-8EC0-E026BE940FD4.pdf	A3VZ	75	positive	WITH TUMOR	0	0										RX	Primary Tumor	01	open	2009		NO	YES	KP		0	0	7	Endometrial	A	LIVING	55	2010	0f347f95-e4bc-480e-ab1a-84c9df4018c9		TCGA-KP-A3VZ-01	0f347f95-e4bc-480e-ab1a-84c9df4018c9	TCGA-KP-A3VZ-01A-21-A240-20	F48CD35C-BA90-4686-97F7-DCB03EF55CC2			0f347f95-e4bc-480e-ab1a-84c9df4018c9				0f347f95-e4bc-480e-ab1a-84c9df4018c9		TCGA-KP-A3VZ-01		TCGA-KP-A3VZ-01A-11D-A227-01		TCGA-KP-A3VZ-01A-11D-A227-01	TCGA-KP-A3VZ-01	TCGA-KP-A3VZ-01	TCGA-KP-A3VZ-01A-11D-A22B-05		
TCGA-KP-A3W0-01	MSS	0	TCGA-KP-A3W0-01	404	0	days	BRCA-LUAD+		OV-like c1		UCEC-like c5		miRNA cluster 5			TCGA-KP-A3W0	404	0	days	404	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					72				TCGA-KP-A3W0	TCGA-KP-A3W0-01A	Never Used	Stage IB	NO		-26378	351		0	404				NO			2012-7-19	FEMALE	162	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	90	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-KP-A3W0.8623B627-C3E3-469B-A640-2F8BCFC0B711.pdf	A3W0	75	positive	TUMOR FREE			YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0		0	Endometrial	A	LIVING	94	2011	0ed2207e-47d3-47aa-804f-abffb6f42e64		TCGA-KP-A3W0-01	0ed2207e-47d3-47aa-804f-abffb6f42e64	TCGA-KP-A3W0-01A-11-A240-20	516DD408-6008-4824-852D-77384BAD6142			0ed2207e-47d3-47aa-804f-abffb6f42e64				0ed2207e-47d3-47aa-804f-abffb6f42e64		TCGA-KP-A3W0-01		TCGA-KP-A3W0-01A-21D-A227-01		TCGA-KP-A3W0-01A-21D-A227-01	TCGA-KP-A3W0-01	TCGA-KP-A3W0-01	TCGA-KP-A3W0-01A-21D-A22B-05		
TCGA-KP-A3W1-01	MSS	0	TCGA-KP-A3W1-01	288	0	days	High		UCEC non-CIMP c3		BRCA basal-like c6		miRNA cluster 14			TCGA-KP-A3W1	288	0	days	288	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					76				TCGA-KP-A3W1	TCGA-KP-A3W1-01A	Never Used	Stage IA	NO		-27902	198		0	288				NO			2012-7-19	FEMALE	170	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Dilation and curettage procedure	710	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-KP-A3W1.58145248-B111-463A-A1CC-32DA993F0B26.pdf	A3W1	25	negative	TUMOR FREE	0	0	YES	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0	0	5	Endometrial	A	LIVING	66	2011	b1ee7148-ddae-404a-b796-004539c02aa7		TCGA-KP-A3W1-01	b1ee7148-ddae-404a-b796-004539c02aa7	TCGA-KP-A3W1-01A-21-A240-20	23F4AE6E-5C55-4107-8B98-CE129078D051			b1ee7148-ddae-404a-b796-004539c02aa7				b1ee7148-ddae-404a-b796-004539c02aa7		TCGA-KP-A3W1-01		TCGA-KP-A3W1-01A-11D-A227-01		TCGA-KP-A3W1-01A-11D-A227-01	TCGA-KP-A3W1-01	TCGA-KP-A3W1-01	TCGA-KP-A3W1-01A-11D-A22B-05		
TCGA-KP-A3W3-01	MSS	0	TCGA-KP-A3W3-01	794	0	days	High		UCEC Serous c4		UCEC-like c5		miRNA cluster 7			TCGA-KP-A3W3			days	794	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					72				TCGA-KP-A3W3	TCGA-KP-A3W3-01A		Stage IB	NO		-26310	739		0	794				NO			2012-7-19	FEMALE	164	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	680	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	No	TCGA-KP-A3W3.9D8F170A-A4B1-463A-B92C-357870762EAD.pdf	A3W3	75	positive	WITH TUMOR			YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	KP		0		0	Endometrial	A	LIVING	126	2010	b2d5d73b-6669-438a-b6fd-0e29b7bce645		TCGA-KP-A3W3-01	b2d5d73b-6669-438a-b6fd-0e29b7bce645	TCGA-KP-A3W3-01A-22-A240-20	D0D776F7-12A4-4219-A969-DB67B1908683			b2d5d73b-6669-438a-b6fd-0e29b7bce645				b2d5d73b-6669-438a-b6fd-0e29b7bce645		TCGA-KP-A3W3-01		TCGA-KP-A3W3-01A-11D-A227-01		TCGA-KP-A3W3-01A-11D-A227-01	TCGA-KP-A3W3-01	TCGA-KP-A3W3-01	TCGA-KP-A3W3-01A-11D-A22B-05		
TCGA-KP-A3W4-01	MSS	1	TCGA-KP-A3W4-01	554	1	days	Kirc+		UCEC Serous c4		UCEC-like c5		miRNA cluster 4			TCGA-KP-A3W4			days	554	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					63				TCGA-KP-A3W4	TCGA-KP-A3W4-01A	Former User	Stage IIIA	NO		-23200	688	554	0					NO			2012-7-19	FEMALE	151	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	540	NO		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					YES	true	No	TCGA-KP-A3W4.5B8C1B60-7046-4A3A-9D65-ECCB91BF9847.pdf	A3W4	75	positive	WITH TUMOR	0	0	YES	3	Partial Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	KP		0	0	19	Endometrial	A	DECEASED	61	2010	8488db37-440c-407d-a184-72ee19632c9f		TCGA-KP-A3W4-01	8488db37-440c-407d-a184-72ee19632c9f	TCGA-KP-A3W4-01A-21-A240-20	EBA5622C-234D-4AA9-B586-10F48DC05A17			8488db37-440c-407d-a184-72ee19632c9f				8488db37-440c-407d-a184-72ee19632c9f		TCGA-KP-A3W4-01		TCGA-KP-A3W4-01A-11D-A227-01		TCGA-KP-A3W4-01A-11D-A227-01	TCGA-KP-A3W4-01	TCGA-KP-A3W4-01	TCGA-KP-A3W4-01A-11D-A22B-05		
TCGA-PG-A5BC-01	MSS	0	TCGA-PG-A5BC-01	707	0	days										TCGA-PG-A5BC	707	0	days	707	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	72			TCGA-PG-A5BC-F59222	TCGA-PG-A5BC	TCGA-PG-A5BC-01A		Stage II	NO		-26436	205		0	707				YES			2014-5-6	FEMALE	163	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-PG-A5BC.040F4583-2683-42A8-B185-56A08874F3A0.pdf	A5BC			TUMOR FREE			NO	4+	Complete Remission/Response	Never Used		NO					Primary Tumor	01		2009		NO	YES	PG					Endometrial	A	LIVING	87	2012	47e8bbd2-fd10-4dc8-882e-cb88ca27338d		TCGA-PG-A5BC-01	47e8bbd2-fd10-4dc8-882e-cb88ca27338d		19F3BEE7-5B36-4114-A3B4-47A3F1BC941E			47e8bbd2-fd10-4dc8-882e-cb88ca27338d				47e8bbd2-fd10-4dc8-882e-cb88ca27338d		TCGA-PG-A5BC-01		TCGA-PG-A5BC-01A-12D-A27O-01		TCGA-PG-A5BC-01A-12D-A27O-01	TCGA-PG-A5BC-01	TCGA-PG-A5BC-01	TCGA-PG-A5BC-01A-12D-A27Y-05		
TCGA-PG-A6IB-01	MSI-H	0	TCGA-PG-A6IB-01	648	0	days										TCGA-PG-A6IB	648	0	days	648	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	68			TCGA-PG-A6IB-F66521	TCGA-PG-A6IB	TCGA-PG-A6IB-01A	Never Used	Stage IA	NO		-24969	160		0	648				NO			2014-10-30	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-PG-A6IB.C975AE5D-7370-4D1D-81AE-D3ABE5364055.pdf	A6IB	38	negative	TUMOR FREE				2	Complete Remission/Response	Never Used						R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2012	55b5dd8f-9e80-4084-9cb2-c04ccf558802		TCGA-PG-A6IB-01	55b5dd8f-9e80-4084-9cb2-c04ccf558802		91F3B808-ED4A-4631-8FFC-37AB68EBEF9B			55b5dd8f-9e80-4084-9cb2-c04ccf558802				55b5dd8f-9e80-4084-9cb2-c04ccf558802		TCGA-PG-A6IB-01		TCGA-PG-A6IB-01A-21D-A31T-01		TCGA-PG-A6IB-01A-21D-A31T-01	TCGA-PG-A6IB-01	TCGA-PG-A6IB-01	TCGA-PG-A6IB-01A-21D-A31V-05		
TCGA-PG-A7D5-01	MSS	0	TCGA-PG-A7D5-01	1177	0	days										TCGA-PG-A7D5	1177	0	days	1177	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	62			TCGA-PG-A7D5-F71179	TCGA-PG-A7D5	TCGA-PG-A7D5-01A	Former User	Stage IA	NO		-23006	618		0	1177				YES			2015-3-20	FEMALE	158	Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8441/3	C54.1	YES		Office Endometrial Biopsy	100	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-PG-A7D5.2E996CFE-9F6E-432F-9B09-6FBC2A920B24.pdf	A7D5	47	negative	TUMOR FREE			YES	4+	Stable Disease	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING	79	2011	460f0df0-00fb-43bf-9143-782a45ca490c		TCGA-PG-A7D5-01	460f0df0-00fb-43bf-9143-782a45ca490c		3D9099E7-D773-46F2-BEB3-B0A53B6FEB5B			460f0df0-00fb-43bf-9143-782a45ca490c				460f0df0-00fb-43bf-9143-782a45ca490c		TCGA-PG-A7D5-01		TCGA-PG-A7D5-01A-11D-A34P-01		TCGA-PG-A7D5-01A-11D-A34P-01	TCGA-PG-A7D5-01	TCGA-PG-A7D5-01	TCGA-PG-A7D5-01A-11D-A34S-05		
TCGA-PG-A914-01	MSS	0	TCGA-PG-A914-01	687	0	days										TCGA-PG-A914	687	0	days	687	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	73			TCGA-PG-A914-F71183	TCGA-PG-A914	TCGA-PG-A914-01A	Never Used	Stage IA	NO		-26992	263		0	687				NO			2015-3-20	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8461/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	260	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-PG-A914.B073614D-A6E3-4A83-96C4-1F189F8D16B4.pdf	A914	13	negative	TUMOR FREE			NO	4+	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2013	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0		TCGA-PG-A914-01	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0		95D3256E-1073-4BD1-8097-937B3CA2CDF7			6e5ab8c9-03de-4a9d-ac92-37f28170c0a0				6e5ab8c9-03de-4a9d-ac92-37f28170c0a0		TCGA-PG-A914-01		TCGA-PG-A914-01A-11D-A37M-01		TCGA-PG-A914-01A-11D-A37M-01	TCGA-PG-A914-01	TCGA-PG-A914-01	TCGA-PG-A914-01A-11D-A37Q-05		
TCGA-PG-A915-01	MSS	0	TCGA-PG-A915-01	249	0	days										TCGA-PG-A915	249	0	days	249	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					60			TCGA-PG-A915-F67387	TCGA-PG-A915	TCGA-PG-A915-01A	Never Used	Stage IA	NO		-22119	238		0	249				NO			2015-3-20	FEMALE		Serous endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.1	8461/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	410	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	true	No	TCGA-PG-A915.F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C.pdf	A915		negative	TUMOR FREE			NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2013	c590ff56-1d2d-40ea-9fba-0768d66ec12c		TCGA-PG-A915-01	c590ff56-1d2d-40ea-9fba-0768d66ec12c		7629E5EF-DE9B-46C7-93BC-03D42328EC4A			c590ff56-1d2d-40ea-9fba-0768d66ec12c				c590ff56-1d2d-40ea-9fba-0768d66ec12c		TCGA-PG-A915-01		TCGA-PG-A915-01A-11D-A37M-01		TCGA-PG-A915-01A-11D-A37M-01	TCGA-PG-A915-01	TCGA-PG-A915-01	TCGA-PG-A915-01A-11D-A37Q-05		
TCGA-PG-A916-01	MSS	0	TCGA-PG-A916-01	522	0	days										TCGA-PG-A916	522	0	days	522	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	70			TCGA-PG-A916-F71185	TCGA-PG-A916	TCGA-PG-A916-01A	Former User	Stage I	NO		-25617	224		0	522				NO			2015-3-20	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	220	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-PG-A916.3E66FA38-0D87-47CA-A72D-63C0619A2182.pdf	A916		negative	TUMOR FREE			NO	1	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2013	a9430dc8-38cf-4ef1-8442-e20582f6d893		TCGA-PG-A916-01	a9430dc8-38cf-4ef1-8442-e20582f6d893		577759B3-B76A-445B-84C7-DCA24C120A56			a9430dc8-38cf-4ef1-8442-e20582f6d893				a9430dc8-38cf-4ef1-8442-e20582f6d893		TCGA-PG-A916-01		TCGA-PG-A916-01A-11D-A37M-01		TCGA-PG-A916-01A-11D-A37M-01	TCGA-PG-A916-01	TCGA-PG-A916-01	TCGA-PG-A916-01A-11D-A37Q-05		
TCGA-PG-A917-01	MSI-H	0	TCGA-PG-A917-01	212	0	days										TCGA-PG-A917	212	0	days	212	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	74			TCGA-PG-A917-F67180	TCGA-PG-A917	TCGA-PG-A917-01A	Former User	Stage IA	NO		-27104	583		0	212				NO			2014-10-31	FEMALE		Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Cytology (e.g. Peritoneal or pleural fluid)	390	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	true	No	TCGA-PG-A917.9836008F-81F7-4029-9A28-10AB6021DFEA.pdf	A917		positive	TUMOR FREE			NO	2	Complete Remission/Response	Never Used		NO				R0	Primary Tumor	01	open	2009		NO	YES	PG		0		0	Endometrial	A	LIVING		2012	2dc0d41b-72fa-4514-889f-3c46507fd5e8		TCGA-PG-A917-01	2dc0d41b-72fa-4514-889f-3c46507fd5e8					2dc0d41b-72fa-4514-889f-3c46507fd5e8				2dc0d41b-72fa-4514-889f-3c46507fd5e8		TCGA-PG-A917-01		TCGA-PG-A917-01A-31D-A37M-01		TCGA-PG-A917-01A-31D-A37M-01	TCGA-PG-A917-01	TCGA-PG-A917-01	TCGA-PG-A917-01A-31D-A37Q-05		
TCGA-QF-A5YS-01	MSS	0	TCGA-QF-A5YS-01	689	0	days										TCGA-QF-A5YS	689	0	days	689	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57		0	TCGA-QF-A5YS-F58613	TCGA-QF-A5YS	TCGA-QF-A5YS-01A	Never Used	Stage II	NO		-20841	158		0	689				NO			2014-4-16	FEMALE	162	Mixed serous and endometrioid	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	120	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-QF-A5YS.2608B03E-0D29-49EF-BC3D-A26D5017C265.pdf	A5YS	22		TUMOR FREE		0	YES	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	QF	0	5	0	2	Endometrial	A	LIVING	79	2012	646422f2-97e3-43e4-bb4f-260277cff6f4		TCGA-QF-A5YS-01	646422f2-97e3-43e4-bb4f-260277cff6f4		AD17002A-950C-42A0-8590-3A491D5621A1			646422f2-97e3-43e4-bb4f-260277cff6f4				646422f2-97e3-43e4-bb4f-260277cff6f4		TCGA-QF-A5YS-01		TCGA-QF-A5YS-01A-11D-A31T-01		TCGA-QF-A5YS-01A-11D-A31T-01	TCGA-QF-A5YS-01	TCGA-QF-A5YS-01	TCGA-QF-A5YS-01A-11D-A31V-05		
TCGA-QF-A5YT-01	MSS	0	TCGA-QF-A5YT-01	1215	0	days										TCGA-QF-A5YT	1215	0	days	1215	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	57			TCGA-QF-A5YT-F58612	TCGA-QF-A5YT	TCGA-QF-A5YT-01A	Never Used	Stage II	NO		-20981	804		0	1215				NO			2014-4-16	FEMALE	170	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	NO	C54.0	8380/3	C54.0	YES		Office Endometrial Biopsy	40	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-QF-A5YT.1CCA2D47-BA5D-46A9-89F9-681C58EFC10D.pdf	A5YT	50		TUMOR FREE			NO	0	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		NO	YES	QF		0		0	Endometrial	A	LIVING	146	2010	86ae75e5-6460-45a3-89f0-aaeba2462268		TCGA-QF-A5YT-01	86ae75e5-6460-45a3-89f0-aaeba2462268					86ae75e5-6460-45a3-89f0-aaeba2462268				86ae75e5-6460-45a3-89f0-aaeba2462268		TCGA-QF-A5YT-01		TCGA-QF-A5YT-01A-11D-A31T-01		TCGA-QF-A5YT-01A-11D-A31T-01	TCGA-QF-A5YT-01	TCGA-QF-A5YT-01	TCGA-QF-A5YT-01A-11D-A31V-05		
TCGA-QS-A5YQ-01	MSS	0	TCGA-QS-A5YQ-01	759	0	days										TCGA-QS-A5YQ	759	0	days	759	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	55			TCGA-QS-A5YQ-F59570	TCGA-QS-A5YQ	TCGA-QS-A5YQ-01A		Stage IIIA	NO		-20425	43		0	759				NO			2014-5-15	FEMALE	160	Endometrioid endometrial adenocarcinoma	No		NO	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	370	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1					NO	false	No	TCGA-QS-A5YQ.D1631D6F-F055-4D35-A6DD-FE7A251BD4C2.pdf	A5YQ	10		TUMOR FREE	0	0	YES	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0	0	7	Endometrial	A	LIVING	83	2013	618b52e3-9797-4c61-a0dd-1ffa8ea6d321		TCGA-QS-A5YQ-01	618b52e3-9797-4c61-a0dd-1ffa8ea6d321		E9379320-2726-431E-B512-78858CEA26C3			618b52e3-9797-4c61-a0dd-1ffa8ea6d321				618b52e3-9797-4c61-a0dd-1ffa8ea6d321		TCGA-QS-A5YQ-01		TCGA-QS-A5YQ-01A-11D-A31T-01		TCGA-QS-A5YQ-01A-11D-A31T-01	TCGA-QS-A5YQ-01	TCGA-QS-A5YQ-01	TCGA-QS-A5YQ-01A-11D-A31V-05		
TCGA-QS-A5YR-01	MSI-H	0	TCGA-QS-A5YR-01	719	0	days										TCGA-QS-A5YR	719	0	days	719	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Stable Disease	61			TCGA-QS-A5YR-F58590	TCGA-QS-A5YR	TCGA-QS-A5YR-01A	Never Used	Stage IIIB	NO		-22372	118		0	719				YES			2014-4-15	FEMALE	168	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES		Dilation and curettage procedure	280	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-QS-A5YR.D9417AEE-FD30-42FA-986E-26C98E29C428.pdf	A5YR	13		WITH TUMOR	0	0	NO	4+	Stable Disease	Never Used		NO				RX	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0	0	5	Endometrial	A	LIVING	100	2012	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63		TCGA-QS-A5YR-01	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63		E55BD3ED-96B6-4277-A869-A47B08840653			0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63				0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63		TCGA-QS-A5YR-01		TCGA-QS-A5YR-01A-31D-A31T-01		TCGA-QS-A5YR-01A-31D-A31T-01	TCGA-QS-A5YR-01	TCGA-QS-A5YR-01	TCGA-QS-A5YR-01A-31D-A31V-05		
TCGA-QS-A744-01	MSS	0	TCGA-QS-A744-01	451	0	days										TCGA-QS-A744	451	0	days	451	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					86			TCGA-QS-A744-F64971	TCGA-QS-A744	TCGA-QS-A744-01A		Stage IIIB	NO		-31520	44		0	451				NO			2014-9-16	FEMALE	163	Endometrioid endometrial adenocarcinoma	No		YES	C54.0	8380/3	C54.0	YES		Office Endometrial Biopsy	310	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-QS-A744.F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F.pdf	A744	86		TUMOR FREE			YES	4+		Never Used		NO				R0	Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0		0	Endometrial	A	LIVING	76	2013	2eede096-06aa-4026-9c23-2a2d1d9015c1		TCGA-QS-A744-01	2eede096-06aa-4026-9c23-2a2d1d9015c1		59780BBC-3B71-437F-9C0F-2FD11DA2AA92			2eede096-06aa-4026-9c23-2a2d1d9015c1				2eede096-06aa-4026-9c23-2a2d1d9015c1		TCGA-QS-A744-01		TCGA-QS-A744-01A-11D-A34P-01		TCGA-QS-A744-01A-11D-A34P-01	TCGA-QS-A744-01	TCGA-QS-A744-01	TCGA-QS-A744-01A-11D-A34S-05		
TCGA-QS-A8F1-01	MSS	1	TCGA-QS-A8F1-01	135	1	days										TCGA-QS-A8F1	135	0	days	135	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Progressive Disease	85			TCGA-QS-A8F1-F66552	TCGA-QS-A8F1	TCGA-QS-A8F1-01A	Never Used	Stage IIIA	NO		-31386	29	135	0	125				NO			2014-10-20	FEMALE	168	Serous endometrial adenocarcinoma	No		NO	C54.3	8441/3	C54.3	YES		Tumor resection	250	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3					NO	false	No	TCGA-QS-A8F1.563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81.pdf	A8F1	50	negative	WITH TUMOR			YES	0	Progressive Disease	Never Used		NO					Primary Tumor	01	Minimally Invasive	2009		YES	NO	QS		0		0	Other  Specify	A	DECEASED	75	2013	d05ea5d7-8d21-4fd6-9199-fdc606a9843c		TCGA-QS-A8F1-01	d05ea5d7-8d21-4fd6-9199-fdc606a9843c		F4063512-BBF4-4CB1-B21E-E63FC0753FD0			d05ea5d7-8d21-4fd6-9199-fdc606a9843c				d05ea5d7-8d21-4fd6-9199-fdc606a9843c		TCGA-QS-A8F1-01		TCGA-QS-A8F1-01A-21D-A37M-01		TCGA-QS-A8F1-01A-21D-A37M-01	TCGA-QS-A8F1-01	TCGA-QS-A8F1-01	TCGA-QS-A8F1-01A-21D-A37Q-05		
TCGA-SJ-A6ZI-01	MSI-H	0	TCGA-SJ-A6ZI-01	631	0	days										TCGA-SJ-A6ZI	631	0	days	631	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	64	0	0	TCGA-SJ-A6ZI-F70447	TCGA-SJ-A6ZI	TCGA-SJ-A6ZI-01A	Never Used	Stage IB	NO		-23653	88		0	631				NO			2015-2-26	FEMALE	66	Endometrioid endometrial adenocarcinoma	No	No, I have never taken menopausal hormone therapy.	YES	C54.1	8380/3	C54.1	YES	Radical hysterectomy, bilateral salpingo-oophorectomy	Other method, specify:	880	NO	NO		G1					NO	false	No	TCGA-SJ-A6ZI.2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8.pdf	A6ZI	75	negative	TUMOR FREE	0	0	NO	2	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	SJ	0	9	0	18	Endometrial	A	LIVING	93	2013	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6		TCGA-SJ-A6ZI-01	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6		43EBE86A-68BA-46A4-A4B9-A6AD5E615BFE			0d5a9a1e-e473-4b9a-bc27-60147dca9fe6				0d5a9a1e-e473-4b9a-bc27-60147dca9fe6		TCGA-SJ-A6ZI-01		TCGA-SJ-A6ZI-01A-12D-A34P-01		TCGA-SJ-A6ZI-01A-12D-A34P-01	TCGA-SJ-A6ZI-01	TCGA-SJ-A6ZI-01	TCGA-SJ-A6ZI-01A-12D-A34S-05		
TCGA-SJ-A6ZJ-01	MSS	0	TCGA-SJ-A6ZJ-01	556	0	days										TCGA-SJ-A6ZJ	556	0	days	556	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium				Complete Response	61			TCGA-SJ-A6ZJ-F67768	TCGA-SJ-A6ZJ	TCGA-SJ-A6ZJ-01A	Former User	Stage IB	NO		-22597	216		0	556				NO			2014-11-11	FEMALE	168	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Office Endometrial Biopsy	580	NO	NO	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2					NO	false	No	TCGA-SJ-A6ZJ.B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5.pdf	A6ZJ	62.5	negative	TUMOR FREE	0	0	NO	1	Complete Remission/Response	Never Used		YES				R0	Primary Tumor	01	open	2009		YES	NO	SJ			0	28	Endometrial	A	LIVING	132	2012	d3473471-b625-4f56-8300-590324d48002		TCGA-SJ-A6ZJ-01	d3473471-b625-4f56-8300-590324d48002		272FE29A-16A0-4E92-8B02-84FCC35D8BF4			d3473471-b625-4f56-8300-590324d48002				d3473471-b625-4f56-8300-590324d48002		TCGA-SJ-A6ZJ-01		TCGA-SJ-A6ZJ-01A-12D-A34P-01		TCGA-SJ-A6ZJ-01A-12D-A34P-01	TCGA-SJ-A6ZJ-01	TCGA-SJ-A6ZJ-01	TCGA-SJ-A6ZJ-01A-12D-A34S-05		
TCGA-SL-A6J9-01	MSS	0	TCGA-SL-A6J9-01	2	0	days										TCGA-SL-A6J9			days	2	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					73	0	0	TCGA-SL-A6J9-F68332	TCGA-SL-A6J9	TCGA-SL-A6J9-01A		Stage IB	NO		-26701	86		0	2				NO			2014-11-14	FEMALE	167	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Tumor resection	280	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-SL-A6J9.DFD43EFD-E91F-487F-A737-93C57C065A49.pdf	A6J9	50	negative		0	0		2								RX	Primary Tumor	01	open	2009		NO	YES	SL	0	2	0	9	Endometrial	A	LIVING	88	2013	55477806-1928-4281-8ee4-69da5b60c6a8		TCGA-SL-A6J9-01	55477806-1928-4281-8ee4-69da5b60c6a8		D703CF4D-5D96-4B15-8944-2EDD5BECA5A0			55477806-1928-4281-8ee4-69da5b60c6a8				55477806-1928-4281-8ee4-69da5b60c6a8		TCGA-SL-A6J9-01		TCGA-SL-A6J9-01A-11D-A31T-01		TCGA-SL-A6J9-01A-11D-A31T-01	TCGA-SL-A6J9-01	TCGA-SL-A6J9-01	TCGA-SL-A6J9-01A-11D-A31V-05		
TCGA-SL-A6JA-01	MSI-H	0	TCGA-SL-A6JA-01	7	0	days										TCGA-SL-A6JA			days	7	days	TCGA Endometrioid Cancer (UCEC)	uterine corpus endometrioid carcinoma	Endometrium					77	0	0	TCGA-SL-A6JA-F68333	TCGA-SL-A6JA	TCGA-SL-A6JA-01A		Stage IB	NO		-28401	45		0	7				NO			2014-11-14	FEMALE	167	Endometrioid endometrial adenocarcinoma	No		YES	C54.1	8380/3	C54.1	YES		Tumor resection	200	NO	YES	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3						true	No	TCGA-SL-A6JA.60CDA761-5DF1-4580-AD84-1CE9A15F31F8.pdf	A6JA	50		TUMOR FREE	0	0	NO	4+	Complete Remission/Response			NO					Primary Tumor	01	open	2009		NO	YES	SL	0	1	0	11	Endometrial	A	LIVING	129	2013	1be5c0c6-8645-4894-8573-05ece1839689		TCGA-SL-A6JA-01	1be5c0c6-8645-4894-8573-05ece1839689		8D9E4270-BBA4-483C-82D0-88CD5FF6DA4C			1be5c0c6-8645-4894-8573-05ece1839689				1be5c0c6-8645-4894-8573-05ece1839689		TCGA-SL-A6JA-01		TCGA-SL-A6JA-01A-11D-A31T-01		TCGA-SL-A6JA-01A-11D-A31T-01	TCGA-SL-A6JA-01	TCGA-SL-A6JA-01	TCGA-SL-A6JA-01A-11D-A31V-05		
